0001477932-21-008406.txt : 20211115 0001477932-21-008406.hdr.sgml : 20211115 20211115165400 ACCESSION NUMBER: 0001477932-21-008406 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 72 CONFORMED PERIOD OF REPORT: 20210930 FILED AS OF DATE: 20211115 DATE AS OF CHANGE: 20211115 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SOBR Safe, Inc. CENTRAL INDEX KEY: 0001425627 STANDARD INDUSTRIAL CLASSIFICATION: PERIODICALS: PUBLISHING OR PUBLISHING AND PRINTING [2721] IRS NUMBER: 260731818 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-53316 FILM NUMBER: 211411928 BUSINESS ADDRESS: STREET 1: 885 ARAPAHOE ROAD CITY: BOULDER STATE: CO ZIP: 80302 BUSINESS PHONE: 303-443-4430 MAIL ADDRESS: STREET 1: 885 ARAPAHOE ROAD CITY: BOULDER STATE: CO ZIP: 80302 FORMER COMPANY: FORMER CONFORMED NAME: TransBiotec, Inc. DATE OF NAME CHANGE: 20120302 FORMER COMPANY: FORMER CONFORMED NAME: IMAGINE MEDIA LTD DATE OF NAME CHANGE: 20080130 10-Q 1 sobr_10q.htm FORM 10-Q sobr_10q.htm

  

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 

Form 10-Q

 

(Mark One)

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

 

For the quarterly period ended September 30, 2021

 

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _______________ to _______________.

 

Commission file number:  000-53316

 

SOBR Safe, Inc.

(Exact name of registrant as specified in its charter)

 

 Delaware

 

26-0731818 

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

 

 

885 Arapahoe Avenue

Boulder, CO

 

 

80302

(Address of principal executive offices)

 

(Zip Code)

 

(844) 762-7723

Registrant’s telephone number, including area code

 

________________________________________ 

(Former name, address, if changed since last report)

 

___________________________________

(Former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading Symbol(s)

 

Name of each exchange on which registered

None 

 

None 

 

 None

 

Securities registered pursuant to Section 12(g) of the Act:

 

Common Stock, $0.00001 par value

(Title of class)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒    No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒    No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.  See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

 

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes     No ☒.

 

Applicable only to issuers involved in bankruptcy proceedings during the preceding five years:

 

Indicate by check mark whether the registrant filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court.   Yes ☐    No ☐

 

Applicable only to corporate issuers:

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date. As of November 12, 2021, there were 25,981,203 shares of common stock, $0.00001 par value, issued and outstanding.

 

  

SOBR SAFE, INC.

 

TABLE OF CONTENTS

 

PART I – FINANCIAL INFORMATION

 

 

 

 

 

 

 

 

ITEM 1

Condensed Consolidated Financial Statements

 

4

 

 

 

 

 

 

ITEM 2

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

29

 

 

 

 

 

 

ITEM 3

Quantitative and Qualitative Disclosures About Market Risk

 

 38

 

 

 

 

 

 

ITEM 4

Controls and Procedures

 

 39

 

 

 

 

 

 

PART II – OTHER INFORMATION

 

 

 

 

 

 

 

 

ITEM 1

Legal Proceedings

 

 40

 

 

 

 

 

 

ITEM 1A

Risk Factors

 

 40

 

 

 

 

 

 

ITEM 2

Unregistered Sales of Equity Securities and Use of Proceeds

 

 40

 

 

 

 

 

 

ITEM 3

Defaults Upon Senior Securities

 

 41

 

 

 

 

 

 

ITEM 4

Mine Safety Disclosures

 

 41

 

 

 

 

 

 

ITEM 5

Other Information

 

 41

 

 

 

 

 

 

ITEM 6

Exhibits

 

42

 

 

2

Table of Contents

  

PART I – FINANCIAL INFORMATION

 

Forward-Looking Statement Disclaimer

 

This Quarterly Report includes forward-looking statements within the meaning of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These statements are based on management’s beliefs and assumptions, and on information currently available to management. Forward-looking statements include the information concerning our possible or assumed future results of operations set forth under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Forward-looking statements also include statements in which words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “estimate,” “consider,” or similar expressions are used.

 

Forward-looking statements are not guarantees of future performance. They involve risks, uncertainties, and assumptions. Our future results and shareholder values may differ materially from those expressed in these forward-looking statements. Readers are cautioned not to put undue reliance on any forward-looking statements.

 

Reverse Stock Split

 

At the open of market on June 8, 2020, our 1-for-33.26 reverse split of our common stock went effective with OTC Markets. As a result, all common stock share amounts, as well as share amounts and exercise and conversion prices in derivative security instruments have been adjusted to reflect the reverse stock split.

 

3

Table of Contents

 

ITEM 1 Condensed Consolidated Financial Statements

 

The condensed consolidated balance sheets as of September 30, 2021 and December 31, 2020, the condensed consolidated statements of operations for the three and nine months ended September 30, 2021 and 2020, the condensed consolidated statements of changes in stockholders’ equity (deficit) for the three and nine months ended September 30, 2021 and 2020, and the condensed consolidated statements of cash flows for the nine months ended September 30, 2021 and 2020, follow. The unaudited condensed consolidated financial statements reflect all adjustments which are, in the opinion of management, necessary to a fair statement of the results for the interim periods presented.  All such adjustments are of a normal and recurring nature.

   

SOBR Safe, Inc.

CONDENSED CONSOLIDATED BALANCE SHEETS

 

 

 

September 30,

2021

 

 

December 31,

2020

 

 

 

(Unaudited)

 

 

(Audited)

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

Cash

 

$2,185,233

 

 

$232,842

 

Prepaid expenses

 

 

24,899

 

 

 

115,230

 

Total current assets

 

 

2,210,132

 

 

 

348,072

 

 

 

 

 

 

 

 

 

 

SOBR Safe Intellectual Technology, net of accumulated amortization of $513,952 and $224,854 at September 30, 2021 and December 31, 2020, respectively

 

 

3,340,723

 

 

 

3,629,821

 

 

 

 

 

 

 

 

 

 

Other assets

 

 

15,826

 

 

 

8,680

 

Total Assets

 

$5,566,681

 

 

$3,986,573

 

 

 

 

 

 

 

 

 

 

LIABILITIES & STOCKHOLDERS' EQUITY

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

 

 

Accounts payable

 

$706,142

 

 

$101,308

 

Accrued expenses

 

 

306,071

 

 

 

313,032

 

Accrued interest payable

 

 

193,177

 

 

 

134,444

 

Related party payables

 

 

29,404

 

 

 

28,624

 

Common stock subscriptions payable

 

 

228,046

 

 

 

253,688

 

Derivative liability

 

 

980,000

 

 

 

-

 

Convertible debenture payable

 

 

 

 

 

 

 

 

* Includes unamortized debt discount related to detached warrants and convertible debenture of $2,608,900 and none at September 30, 2021 and December 31, 2020, respectively

 

 

439,881*

 

 

-

 

Current portion notes payable - related parties

 

 

11,810

 

 

 

11,810

 

Current portion notes payable - non-related parties

 

 

104,183

 

 

 

79,183

 

Total current liabilities

 

 

2,998,714

 

 

 

922,089

 

 

 

 

 

 

 

 

 

 

Notes payable -related parties-less current portion

 

 

 

 

 

 

 

 

* Includes unamortized debt discount and beneficial conversion feature related to detached warrants and convertible notes of $771,576 and none at September 30, 2021 and December 31, 2020, respectively

 

 

228,424*

 

 

-

 

Notes payable -non-related parties-less current portion

 

 

 

 

 

 

 

 

* Includes unamortized debt discount and beneficial conversion feature related to detached warrants and convertible notes of $774,850 and none at September 30, 2021 and December 31, 2020, respectively

 

 

230,150*

 

 

25,000

 

 

 

 

 

 

 

 

 

 

Total Liabilities

 

 

3,457,288

 

 

 

947,089

 

Stockholders' Equity

 

 

 

 

 

 

 

 

Preferred stock, $0.00001 par value; 19,300,000 shares authorized, no shares issued or outstanding as of September 30, 2021 and December 31, 2020

 

 

-

 

 

 

-

 

Series A Convertible Preferred stock, $0.00001 par value; 3,000,000 shares authorized, no shares issued or outstanding as of September 30, 2021 and December 31, 2020

 

 

-

 

 

 

-

 

Series A-1 Convertible Preferred stock, $0.00001 par value; 2,700,000 shares authorized, no shares issued or outstanding as of September 30, 2021 and December 31, 2020

 

 

-

 

 

 

-

 

Common stock, $0.00001 par value; 100,000,000 shares authorized; 25,981,203 and 25,922,034 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively

 

 

260

 

 

 

260

 

Additional paid-in capital

 

 

56,330,450

 

 

 

52,693,974

 

Accumulated deficit

 

 

(54,167,685)

 

 

(49,601,220)

Total SOBR Safe, Inc. stockholders' equity

 

 

2,163,025

 

 

 

3,093,014

 

Noncontrolling interest

 

 

(53,632)

 

 

(53,530)

 

 

 

 

 

 

 

 

 

Total Stockholders' Equity

 

 

2,109,393

 

 

 

3,039,484

 

 

 

 

 

 

 

 

 

 

Total Liabilities and Stockholders' Equity

 

$5,566,681

 

 

$3,986,573

 

 

 

 

 

 

 

 

 

 

The accompanying notes are an integral part of the condensed consolidated financial statements.  

 

4

Table of Contents

  

SOBR SAFE, Inc.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)

 

 

 

For The Three Months Ended

 

 

For The Nine Months Ended

 

 

 

September 30,

 

 

September 30,

 

 

September 30,

 

 

September 30,

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

 

 

 

 

 

 

 

 

 

Revenues

 

$-

 

 

$-

 

 

$-

 

 

$-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

General and administrative

 

 

316,329

 

 

 

191,589

 

 

 

875,378

 

 

 

400,127

 

Stock-based compensation expense

 

 

147,163

 

 

 

-

 

 

 

334,228

 

 

 

41,302

 

Management salaries and consulting fees

 

 

632,964

 

 

 

352,266

 

 

 

1,682,557

 

 

 

1,103,828

 

Research and development

 

 

566,655

 

 

 

152,123

 

 

 

1,052,650

 

 

 

309,403

 

Asset impairment adjustment

 

 

-

 

 

 

-

 

 

 

-

 

 

 

25,320,555

 

Total operating expenses

 

 

1,663,111

 

 

 

695,978

 

 

 

3,944,813

 

 

 

27,175,215

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss from operations

 

 

(1,663,111)

 

 

(695,978)

 

 

(3,944,813)

 

 

(27,175,215)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other income (expense):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss on extinguishment of debt, net

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(269,144)

Gain on fair value adjustment - derivatives

 

 

-

 

 

 

-

 

 

 

-

 

 

 

60,650

 

Interest expense

 

 

(227,475)

 

 

(41,622)

 

 

(399,381)

 

 

(107,253)

Amortization of interest - conversion features

 

 

(130,830)

 

 

-

 

 

 

(222,373)

 

 

(1,407,675)

Total other expense, net

 

 

(358,305)

 

 

(41,622)

 

 

(621,754)

 

 

(1,723,422)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss before provision for income taxes

 

 

(2,021,416)

 

 

(737,600)

 

 

(4,566,567)

 

 

(28,898,637)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Provision for income taxes

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

 

(2,021,416)

 

 

(737,600)

 

 

(4,566,567)

 

 

(28,898,637)

Net (income) loss attributable to noncontrolling interest

 

 

4

 

 

 

(98)

 

 

102

 

 

 

(48)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss attributable to SOBR Safe, Inc.

 

 

(2,021,412)

 

 

(737,698)

 

 

(4,566,465)

 

 

(28,898,685)

Accrued dividends on convertible preferred stock

 

 

-

 

 

 

(161,880)

 

 

-

 

 

 

(161,880)

Net loss attributable to common stockholders

 

$(2,021,412)

 

$(899,578)

 

$(4,566,465)

 

$(29,060,565)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted loss per common share

 

$(0.08)

 

$(0.04)

 

$(0.18)

 

$(2.23)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of common shares outstanding

 

 

25,981,203

 

 

 

20,046,424

 

 

 

25,974,042

 

 

 

13,030,845

 

  

The accompanying notes are an integral part of the condensed consolidated financial statements.

 

5

Table of Contents

 

SOBR SAFE, Inc.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT)

(UNAUDITED)

 

 

 

Common Stock

 

 

Preferred Stock

 

 

 

 

 

 

 

 

Stockholders'

Equity

 

 

 

 

 

Total

 

 

 

 

 

 

Amount

 

 

 

 

 

Amount

 

 

Additional

 

 

 

 

 

(Deficit)

 

 

 

 

 

Stockholders'

 

 

 

Shares

 

 

($0.00001 Par)

 

 

Shares

 

 

($0.00001 Par)

 

 

Paid-in

Capital

 

 

Accumulated

Deficit

 

 

SOBR Safe, Inc.

 

 

Noncontrolling

Interest

 

 

Equity (Deficit)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balances at January 1, 2020

 

 

6,452,993

 

 

$65

 

 

 

-

 

 

$-

 

 

$15,971,392

 

 

$(19,511,168)

 

$(3,539,711)

 

$(53,410)

 

$(3,593,121)

Common stock issued for compensation

 

 

601

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

20,800

 

 

 

-

 

 

 

20,800

 

 

 

-

 

 

 

20,800

 

Common stock issued due to stock warrants exercise

 

 

454,097

 

 

 

4

 

 

 

-

 

 

 

-

 

 

 

65,724

 

 

 

-

 

 

 

65,728

 

 

 

-

 

 

 

65,728

 

Common stock issued to settle related party payables

 

 

214,883

 

 

 

2

 

 

 

-

 

 

 

-

 

 

 

493,072

 

 

 

-

 

 

 

493,074

 

 

 

-

 

 

 

493,074

 

Common stock issued to settle accounts payable and accrued expenses

 

 

38,323

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

92,385

 

 

 

-

 

 

 

92,385

 

 

 

-

 

 

 

92,385

 

Common stock issued to settle related party debt

 

 

648,739

 

 

 

6

 

 

 

-

 

 

 

-

 

 

 

826,958

 

 

 

-

 

 

 

826,964

 

 

 

-

 

 

 

826,964

 

Common stock issued to settle non-related party debt

 

 

70,448

 

 

 

1

 

 

 

-

 

 

 

-

 

 

 

166,525

 

 

 

-

 

 

 

166,526

 

 

 

-

 

 

 

166,526

 

Paid-in capital - fair value of stock options vested

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

39,450

 

 

 

-

 

 

 

39,450

 

 

 

-

 

 

 

39,450

 

Paid-in capital - gain on related party debt conversion

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

124,291

 

 

 

-

 

 

 

124,291

 

 

 

-

 

 

 

124,291

 

Paid-in capital - gain on related party payables conversion

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

221,557

 

 

 

-

 

 

 

221,557

 

 

 

-

 

 

 

221,557

 

Paid-in capital - loss on debt extinguishment

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

116,893

 

 

 

-

 

 

 

116,893

 

 

 

-

 

 

 

116,893

 

Paid-in capital - beneficial conversion feature

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

174

 

 

 

-

 

 

 

174

 

 

 

-

 

 

 

174

 

Net loss for the period

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(450,023)

 

 

(450,023)

 

 

149

 

 

 

(449,874)

Balances at March 31, 2020

 

 

7,880,084

 

 

$78

 

 

 

-

 

 

$-

 

 

$18,139,221

 

 

$(19,961,191)

 

$(1,821,892)

 

$(53,261)

 

$(1,875,153)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common stock issued to settle accounts payable and accrued expenses

 

 

121,072

 

 

 

2

 

 

 

-

 

 

 

-

 

 

 

173,290

 

 

 

-

 

 

 

173,292

 

 

 

-

 

 

 

173,292

 

Common stock issued to settle related party payables

 

 

45,268

 

 

 

1

 

 

 

-

 

 

 

-

 

 

 

86,739

 

 

 

-

 

 

 

86,740

 

 

 

-

 

 

 

86,740

 

Common stock issued for asset purchase

 

 

12,000,000

 

 

 

120

 

 

 

-

 

 

 

-

 

 

 

27,119,880

 

 

 

-

 

 

 

27,120,000

 

 

 

-

 

 

 

27,120,000

 

Paid-in capital - beneficial conversion feature

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,407,501

 

 

 

-

 

 

 

1,407,501

 

 

 

-

 

 

 

1,407,501

 

Paid-in capital - fair value of stock warrants granted

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

695,454

 

 

 

-

 

 

 

695,454

 

 

 

-

 

 

 

695,454

 

Paid-in capital - gain on related party payables conversion

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

50,741

 

 

 

-

 

 

 

50,741

 

 

 

-

 

 

 

50,741

 

Paid-in capital - loss on extinguishment of convertible notes

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

273,462

 

 

 

-

 

 

 

273,462

 

 

 

-

 

 

 

273,462

 

Paid-in capital - fair value of stock options vested

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

257,482

 

 

 

-

 

 

 

257,482

 

 

 

-

 

 

 

257,482

 

Net loss for the period

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(27,710,964)

 

 

(27,710,964)

 

 

(199)

 

 

(27,711,163)

Balances at June 30, 2020

 

 

20,046,424

 

 

$201

 

 

 

-

 

 

$-

 

 

$48,203,770

 

 

$(47,672,155)

 

$531,816

 

 

$(53,460)

 

$478,356

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Paid-in capital - fair value of stock options vested

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

46,617

 

 

 

-

 

 

 

46,617

 

 

 

-

 

 

 

46,617

 

Dividends payable-Series A-1 convertible preferred stock

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(161,880)

 

 

(161,880)

 

 

-

 

 

 

(161,880)

Net loss for the period

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(737,698)

 

 

(737,698)

 

 

98

 

 

 

(737,600)

Balances at September  30, 2020

 

 

20,046,424

 

 

$201

 

 

 

-

 

 

$-

 

 

$48,250,387

 

 

$(48,571,733)

 

$(321,145)

 

$(53,362)

 

$(374,507)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balances at January 1, 2021

 

 

25,922,034

 

 

$260

 

 

 

-

 

 

$-

 

 

$52,693,974

 

 

$(49,601,220)

 

$3,093,014

 

 

$(53,530)

 

$3,039,484

 

Common stock issued to settle dividends - Series A-1 Convertible Preferred stock

 

 

43,169

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

107,880

 

 

 

-

 

 

 

107,880

 

 

 

-

 

 

 

107,880

 

Paid-in capital - fair value of stock options and RSU vested

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

105,013

 

 

 

-

 

 

 

105,013

 

 

 

-

 

 

 

105,013

 

Paid-in capital - relative fair value of stock warrants granted

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

619,381

 

 

 

-

 

 

 

619,381

 

 

 

-

 

 

 

619,381

 

Paid-in capital - beneficial conversion feature

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

480,619

 

 

 

-

 

 

 

480,619

 

 

 

-

 

 

 

480,619

 

Net loss for the period

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(1,002,340)

 

 

(1,002,340)

 

 

(94)

 

 

(1,002,434)

Balances at March 31, 2021

 

 

25,965,203

 

 

$260

 

 

 

-

 

 

$-

 

 

 

54,006,867

 

 

$(50,603,560)

 

$3,403,567

 

 

$(53,624)

 

$3,349,943

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common stock issued for facility lease

 

 

16,000

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

49,600

 

 

 

-

 

 

 

49,600

 

 

 

-

 

 

 

49,600

 

Paid-in capital - fair value of stock options and RSU vested

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

138,010

 

 

 

-

 

 

 

138,010

 

 

 

-

 

 

 

138,010

 

Paid-in capital - relative fair value of stock warrants granted

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

473,327

 

 

 

-

 

 

 

473,327

 

 

 

-

 

 

 

473,327

 

Paid-in capital - beneficial conversion feature

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

428,595

 

 

 

-

 

 

 

428,595

 

 

 

-

 

 

 

428,595

 

Net loss for the period

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(1,542,713)

 

 

(1,542,713)

 

 

(4)

 

 

(1,542,717)

Balances at June 30, 2021

 

 

25,981,203

 

 

$260

 

 

 

-

 

 

$-

 

 

 

55,096,399

 

 

$(52,146,273)

 

$2,950,386

 

 

$(53,628)

 

$2,896,758

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Paid-in capital - fair value of stock options and RSU vested

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

387,003

 

 

 

-

 

 

 

387,003

 

 

 

-

 

 

 

387,003

 

Paid-in capital - relative fair value of stock warrants granted

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

847,048

 

 

 

-

 

 

 

847,048

 

 

 

-

 

 

 

847,048

 

Net loss for the period

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(2,021,412)

 

 

(2,021,412)

 

$(4)

 

 

(2,021,416)

Balances at September 30, 2021

 

 

25,981,203

 

 

$260

 

 

 

-

 

 

$-

 

 

 

56,330,450

 

 

$(54,167,685)

 

$2,163,025

 

 

$(53,632)

 

$2,109,393

 

 

The accompanying notes are an integral part of the condensed consolidated financial statements.

 

6

Table of Contents

 

SOBR SAFE, Inc.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

 

 

 

 

 

 

 

 

 

For The Nine Months Ended

 

 

 

September 30,

 

 

 

2021

 

 

2020

 

 

 

 

 

 

 

 

Operating Activities:

 

 

 

 

 

 

Net loss

 

$(4,566,567)

 

$(28,898,637)

 

 

 

 

 

 

 

 

 

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

289,098

 

 

 

133,571

 

Loss on debt extinguishment, net

 

 

-

 

 

 

269,144

 

Change in fair value of derivative liability

 

 

-

 

 

 

(60,650)

Amortization of interest - conversion features

 

 

222,373

 

 

 

1,407,675

 

Amortization of interest

 

 

275,052

 

 

 

8,656

 

Stock options expense

 

 

399,259

 

 

 

343,549

 

Stock-based compensation expense

 

 

334,228

 

 

 

41,302

 

Asset impairment adjustment

 

 

-

 

 

 

25,320,555

 

Changes in assets and liabilities:

 

 

 

 

 

 

 

 

Prepaid expenses

 

 

(19,361)

 

 

994

 

Other assets

 

 

(7,146)

 

 

(8,680)

Accounts payable

 

 

604,834

 

 

 

140,906

 

Accrued expenses

 

 

(6,961)

 

 

(83,495)

Accrued interest payable

 

 

58,733

 

 

 

(6,697)

Related party payables

 

 

780

 

 

 

(51,976)

Common stock subscriptions payable

 

 

138,069

 

 

 

-

 

 

 

 

 

 

 

 

 

 

Net cash used in operating activities

 

 

(2,277,609)

 

 

(1,443,783)

 

 

 

 

 

 

 

 

 

Financing Activities:

 

 

 

 

 

 

 

 

Proceeds from notes payable - related parties

 

 

1,030,000

 

 

 

-

 

Repayments of notes payable - related parties

 

 

(30,000)

 

 

-

 

Proceeds from notes payable - non-related parties

 

 

1,005,000

 

 

 

41,665

 

Proceeds from convertible debenture payable

 

 

2,500,000

 

 

 

-

 

Debt issuance costs

 

 

(275,000)

 

 

-

 

Proceeds from offering of preferred stock - related parties

 

 

-

 

 

 

1,700,000

 

Net cash provided by financing activities

 

 

4,230,000

 

 

 

1,741,665

 

 

 

 

 

 

 

 

 

 

Net Change In Cash

 

 

1,952,391

 

 

 

297,882

 

 

 

 

 

 

 

 

 

 

Cash At The Beginning Of The Period

 

 

232,842

 

 

 

681,759

 

 

 

 

 

 

 

 

 

 

Cash At The End Of The Period

 

$2,185,233

 

 

$979,641

 

 

 

 

 

 

 

 

 

 

Schedule Of Non-Cash Investing And Financing Activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Issuance of common shares for rent

 

$49,600

 

 

$-

 

 

 

 

 

 

 

 

 

 

Issuance of common stock for prior year accrued dividends

 

$107,880

 

 

$-

 

 

 

 

 

 

 

 

 

 

Intrinsic value-beneficial conversion feature

 

$909,214

 

 

$1,407,501

 

 

 

 

 

 

 

 

 

 

Relative fair value of stock warrants granted

 

$1,939,756

 

 

$-

 

 

 

 

 

 

 

 

 

 

Convertible debenture payable discount

 

$823,781

 

 

$-

 

 

 

 

 

 

 

 

 

 

Fair value of embedded conversion feature

 

$980,000

 

 

$-

 

 

 

 

 

 

 

 

 

 

Gain on related party payables converted to capital

 

$-

 

 

$272,299

 

 

 

 

 

 

 

 

 

 

Accounts payable and accrued expenses converted to capital

 

$-

 

 

$265,677

 

 

 

 

 

 

 

 

 

 

Related party payables converted to capital

 

$-

 

 

$579,814

 

 

 

 

 

 

 

 

 

 

Related party debt converted to capital after exercise of cashless stock warrants

 

$-

 

 

$65,728

 

 

 

 

 

 

 

 

 

 

Related party debt converted to capital

 

$-

 

 

$826,964

 

 

 

 

 

 

 

 

 

 

Non-related party debt converted to capital

 

$-

 

 

$166,526

 

 

 

 

 

 

 

 

 

 

Gain on related party debt converted to capital

 

$-

 

 

$124,291

 

 

 

 

 

 

 

 

 

 

Shares issued for cash received in prior years

 

$-

 

 

$20,800

 

 

 

 

 

 

 

 

 

 

Issuance of common stock, stock warrants and convertible note for asset purchase

 

$-

 

 

$29,222,955

 

 

 

 

 

 

 

 

 

 

Preferred stock dividend accrued

 

$-

 

 

$161,880

 

 

 

 

 

 

 

 

 

 

Supplemental Disclosure:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash paid for interest

 

$67,618

 

 

$765

 

 

 

 

 

 

 

 

 

 

Cash paid for income taxes

 

$-

 

 

$-

 

 

 

 

 

 

 

 

 

 

The accompanying notes are an integral part of the condensed consolidated financial statements.

  

7

Table of Contents

   

SOBR SAFE, Inc.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2021

 

NOTE 1. ORGANIZATION, OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

SOBR Safe, Inc. (“SOBR Safe”), formerly TransBiotec, Inc., was incorporated as Imagine Media LTD. in August 2007 in the State of Delaware. A corporation also named TransBiotec, Inc. (“TransBiotec – CA”) was formed in the state of California July 4, 2004. Effective September 19, 2011, TransBiotec was acquired by TransBiotec - CA in a transaction classified as a reverse acquisition as the shareholders of TransBiotec - CA retained the majority of the outstanding common stock of TransBiotec after the share exchange. The consolidated financial statements represent the activity of TransBiotec - CA from July 4, 2004 forward, and the consolidated activity of SOBR Safe and TransBiotec - CA from September 19, 2011 forward. SOBR Safe and TransBiotec - CA are hereinafter referred to collectively as the “Company” or “We”. The Company has developed and plans to market and sell a non-invasive alcohol sensing system which includes an ignition interlock. The Company has not generated any revenues from its operations.

 

On March 23, 2020, the Company filed a Definitive 14C providing notice that the Board of Directors has recommended, and that holders of a majority of the voting power of the Company’s outstanding stock voted, to approve the following.

 

 

1.

To remove and re-elect four (4) directors to serve until the next Annual Meeting of Shareholders and thereafter until their successors are elected and qualified; and

 

 

 

 

2.

To approve an amendment to the Company’s Certificate of Incorporation to: (a) change the Company’s name to SOBR SAFE, Inc., (b) decrease the Company’s authorized common stock from 800,000,000 shares, par value $0.00001 to 100,000,000 shares, par value $0.00001, and (c) effect a reverse stock split of the Company’s outstanding common stock at a ratio between 1-for-32 and 1-for-35 (with the exact ratio to be determined by the directors in their sole discretion without further approval by the shareholders).

 

The above actions taken by the Company’s stockholders became effective on or about May 21, 2020. The effective dates of the above actions were June 5, 2020 and April 20, 2020, respectively, and the actual reverse stock split ratio was 1-for-33.26. All share and per share amounts have been adjusted in these consolidated financial statements to reflect the effect of the reverse stock split. 

 

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”) as promulgated in the United States of America and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and related notes for the year ended December 31, 2020, included in the Company’s Annual Report on Form 10-K filed with the SEC on March 31, 2021.

 

In management’s opinion, the unaudited condensed consolidated financial statements reflect all adjustments (including reclassifications and normal recurring adjustments) necessary to present fairly the financial position as of September 30, 2021 and December 31, 2020, and results of operations and cash flows for the three and nine month periods ended September 30, 2021 and 2020.

 

Principles of Consolidation

The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its majority owned subsidiary, TransBiotec-CA. We have eliminated all intercompany transactions and balances between entities consolidated in these unaudited condensed financial statements.

 

8

Table of Contents

 

Use of Estimates

The preparation of unaudited condensed consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Specifically, such estimates were made by the Company for the recoverability and useful lives of long-lived assets, the intellectual technology, the valuation of the derivative liabilities, beneficial conversion feature expenses, stock-based compensation and the valuation allowance related to deferred tax assets. Actual results could differ from those estimates.

 

Financial Instruments 

Pursuant to  Accounting Standards Codification (“ASC”) Topic 820, Fair Value Measurements and Disclosures, and ASC 825, Financial Instruments, an entity is required to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 and 825 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 and 825 prioritizes the inputs into three levels that may be used to measure fair value:

 

Level 1

Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.

 

Level 2

Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets: quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.

 

Level 3

Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.

 

The Company’s financial instruments consist primarily of cash, accounts payable, accrued expenses, accrued interest payable,  related party payables, notes payable, convertible debentures, and other liabilities. Pursuant to ASC 820 and 825, the fair value of our derivative liabilities is determined based on “Level 3” inputs. We believe that the recorded values of all of our other financial instruments approximate their current fair values because of their nature and respective maturity dates or durations.

 

The following table presents assets and liabilities that are measured and recognized at fair value as of September 30, 2021 and December 31, 2020:

 

September 30, 2021

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

Derivative liability

 

$-

 

 

$-

 

 

$980,000

 

 

 

$-

 

 

$-

 

 

$980,000

 

 

December 31, 2020

   

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

Derivative liability

 

$-

 

 

$-

 

 

$-

 

 

 

$-

 

 

$-

 

 

$-

 

 

9

Table of Contents

 

Cash

The Company considers all highly liquid investments with an original maturity of three months or less as cash equivalents. The Company does not have any cash equivalents as of September 30, 2021 and December 31, 2020. 

 

Prepaid Expenses

Amounts incurred in advance of contractual performance or coverage periods are recorded as prepaid assets and recognized as expense in the period service or coverage is provided.  

 

Beneficial Conversion Features

From time to time, the Company may issue convertible notes that may contain a beneficial conversion feature. A beneficial conversion feature exists on the date a convertible note is issued when the fair value of the underlying common stock to which the note is convertible into is in excess of the remaining unallocated proceeds of the note after first considering the allocation of a portion of the note proceeds to the fair value of the warrants, if related warrants have been granted. The intrinsic value of the beneficial conversion feature is recorded as a debt discount with a corresponding amount to additional paid-in capital. The debt discount is amortized to interest expense over the life of the note using the effective interest method.

 

 Derivative Instruments

The Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instruments are initially recorded at their fair values and are then re-valued at each reporting date, with changes in the fair value reported in the unaudited condensed consolidated statements of operations under other income (expense). The accounting treatment of derivative financial instruments requires that the Company record the embedded conversion option at its fair value as of the inception date of the agreement and at fair value as of each subsequent balance sheet date. Any change in fair value is recorded as non-operating, non-cash income or expense for each reporting period at each balance sheet date. If the classification changes as a result of events during the period, the contract is reclassified as of the date of the event that caused the reclassification. As a result of entering into warrant agreements, for which such instruments contained a variable conversion feature with no floor, the Company has adopted a sequencing policy in accordance with ASC 815-40-35-12 whereby all future instruments may be classified as a derivative liability with the exception of instruments related to share-based compensation issued to employees or directors. For stock-based derivative financial instruments, the Company uses a Monte Carlo Simulation model to value the derivative instruments at inception and on subsequent valuation dates.

 

The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date. 

 

10

Table of Contents

 

Debt Issuance Costs

Debt issuance costs incurred in connection with the issuance of debt are capitalized and amortized to interest expense over the term of the debt using the effective interest method. The unamortized amount is presented as a reduction of debt on the balance sheet.

 

Preferred Stock

We apply the guidance enumerated in ASC 480 “Distinguishing Liabilities from Equity” when determining the classification and measurement of preferred stock. Preferred shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. We classify conditionally redeemable preferred shares (if any), which includes preferred shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control, as temporary equity. At all other times, we classified our preferred shares in stockholders’ equity.

 

Minority Interest (Noncontrolling Interest)

A subsidiary of the Company has minority members representing ownership interests of 1.38% at September 30, 2021 and December 31, 2020. The Company accounts for these minority, or noncontrolling interests, pursuant to ASC 810-10-65 whereby gains and losses in a subsidiary with a noncontrolling interest are allocated to the noncontrolling interest based on the ownership percentage of the noncontrolling interest, even if that allocation results in a deficit noncontrolling interest balance.

 

Stock-based Compensation

The Company follows the guidance of the accounting provisions of ASC 718 “Share-based Compensation”, which requires the use of the fair-value based method to determine compensation for all arrangements under which employees and others receive shares of stock or equity instruments (warrants and options). The fair value of each option award is estimated on the date of grant using the Black-Scholes options pricing model that uses assumptions for expected volatility, expected dividends, expected term, and the risk-free interest rate. The Company has not paid common stock dividends historically and does not expect to pay them in the future. Expected volatilities are based on weighted averages of the historical volatility of the Company’s common stock estimated over the expected term of the options. The expected term of options granted is derived using the “simplified method” which computes expected term as the average of the sum of the vesting term plus the contract term as historically the Company had limited activity surrounding its options. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the period of the expected term.

 

Research and Development

The Company accounts for its research and development costs pursuant to ASC 730, whereby it requires the Company to disclose the amounts of costs for company and customer-sponsored research and development activities, if material. Research and development costs are expensed as incurred. The Company incurred research and development costs as it acquired new knowledge to bring about significant improvements in the functionality and design of its SOBR product. Research and development costs were $1,026,679 and $309,403 during the nine month periods ended September 30, 2021 and 2020, respectively.

 

Advertising and Marketing Costs

Advertising and marketing costs are charged to operations as incurred.  Advertising and marketing costs were $70,692 and $70,198 during the nine month periods ended September 30, 2021 and 2020, respectively, and are included in general and administrative expenses in the consolidated statements of operations.    

 

Depreciation

Depreciation is computed on a straight-line basis over the assets estimated useful lives of three years. There was no depreciation for the three and nine months ended September 30, 2021. Depreciation for the three and nine months ended September 30, 2020 was $3,978 and $5,083, respectively .

 

Income Tax

The Company accounts for income taxes pursuant to ASC 740. Under ASC 740 deferred taxes are provided on a liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss carry forwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. The Company has not recorded any deferred tax assets or liabilities at September 30, 2021 and December 31, 2020 as these have been offset by a 100% valuation allowance.

 

11

Table of Contents

 

Net Loss Per Share

Basic net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period.  Diluted  loss per share gives the effect to all dilutive potential common shares outstanding during the period,  including stock options, warrants and convertible instruments.  Diluted net loss per share excludes all potentially issuable shares if their effect is anti-dilutive.  Because the effect of the Company’s dilutive securities is anti-dilutive, diluted net loss per share is the same as basic loss per share for the periods presented.

 

Concentration of Credit Risk

Certain financial instruments potentially subject the Company to concentrations of credit risk. Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash deposits. Cash held in operating accounts may exceed the Federal Deposit Insurance Corporation (“FDIC”) insurance limits. Accounts at each institution are insured by the FDIC up to $250,000. While the Company monitors cash balances in our operating accounts on a regular basis and adjust the balances as appropriate, these balances could be impacted if the underlying financial institutions fail. To date, the Company has experienced no loss or lack of access to our cash; however, the Company can provide no assurances that access to our cash will not be impacted by adverse conditions in the financial markets. At September 30, 2021 and December 31, 2020, the Company had $1,934,969 and none, respectively in excess of the FDIC insured limits.

 

Related Parties

Related parties are any entities or individuals that, through employment, ownership, or other means, possess the ability to direct or cause the direction of the management and policies of the Company.

 

New Pronouncements 

In December 2019, the FASB issued ASU No. 2019-12, Simplifying the Accounting for Income Taxes (“ASU 2019-12”), which simplifies the accounting for income taxes, eliminates certain exceptions within ASC 740, Income Taxes, and clarifies certain aspects of the current guidance to promote consistency among reporting entities. ASU 2019-12 is effective for fiscal years beginning after December 15, 2021. Most amendments within the standard are required to be applied on a prospective basis, while certain amendments must be applied on a retrospective or modified retrospective basis. The Company is evaluating the effects, if any, of the adoption of ASU 2019-12 guidance on the Company's financial position, results of operations and cash flows.

 

In August 2020, the FASB issued ASU No. 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, which address issues identified as a result of the complexity associated with applying generally accepted accounting principles for certain financial instruments with characteristics of liabilities and equity.  This amendment is effective for public business entities that meet the definition of a SEC filer, excluding entities eligible to be smaller reporting companies as defined by the SEC, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company is evaluating the effects, if any, of the adoption of ASU 2020-06 guidance on the Company's financial position, results of operations and cash flows.

 

In October 2020, the FASB issued ASU No. 2020-08, Codification Improvements to Subtopic 310-20, Receivables-Nonrefundable Fees and Other Costs, amendments the guidance in ASU No. 2017-08, (Subtopic 310-20): Premium Amortization on Purchased Callable Debt Securities, which addresses multiple call dates of a callable debt security.  This amendment is effective for public business entities, for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. Early application is not permitted.  The Company evaluated the adoption of ASU 2020-08 guidance and determined no effects on the Company's financial position, results of operations and cash flows.

   

12

Table of Contents

  

In May 2021, the FASB issued ASU No. 2021-04, Earnings Per Share (Topic 260), Debt-Modifications and Extinguishments (Subtopic 470-50), Compensation-Stock Compensation (Topic 718), and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtpoic 815-40), which addresses issuer’s accounting for certain modifications or exchanges of freestanding equity-classified written call options.  This amendment is effective for all entities, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted.  The Company is evaluating the effects, if any, of the adoption of ASU 2021-04 guidance on the Company's financial position, results of operations and cash flows.

 

Correction of Error

While preparing financial statements for periods in 2021, the Company discovered an error in the statement of operations for the year ended December 31, 2020.  The error related to the presentation of the loss on disposal of property and equipment and asset impairment adjustment in accordance with ASC 360-10-45.

 

Loss on disposal of property and equipment and asset impairment adjustment of  $39,434 and $25,320,555, respectively, were presented as other income/expense-net, instead of as operating expenses.  As a result, loss from operations for the year ended December 31, 2020, was understated by $25,359,989 and other income/expenses-net was overstated by the same amount.  The errors had no affect on the net loss or net loss per share for the year ended December 31, 2020.

 

As a result of this correction, the statement of operations for the three and nine month periods ended September 30, 2020 in the accompanying financial statements has been retroactively restated.

 

NOTE 2. GOING CONCERN

 

The Company has incurred recurring losses from operations and has limited cash liquidity and capital resources. Future capital requirements will depend on many factors, including the Company’s ability to develop products, cash flow from operations, and competing market developments. The Company will need additional capital in the near future. Sources of debt financing may result in high interest expense. Any financing, if available, may be on unfavorable terms. If adequate funds are not obtained, we will be required to reduce or curtail operations.

 

As of September 30, 2021, the Company has an accumulated deficit of approximately $54,200,000. During the nine months ended September 30, 2021, the Company also experienced negative cash flows from operating activities of approximately $2,300,000. It appears these principal conditions or events, considered in the aggregate, indicate it is probable that the Company will be unable to meet its obligations as they become due within one year after the date the financial statements are issued. As such, there is substantial doubt about the entity’s ability to continue as a going concern.

 

The Company has identified factors that mitigate the probable conditions that have raised substantial doubt about the entity’s ability to continue as a going concern.  On January 15, 2021, the Company initiated a Private Offering (the “Offering”) of up to 40 Units ($2,000,000) with each Unit consisting of one $50,000 principal amount secured convertible debenture, convertible at $3 per share, and a Warrant to purchase 25,000 shares of the Company’s common stock at $3 per share. The Secured Debentures carry interest at 12% and mature 24 months after issuance. The Warrants are exercisable six months after issuance and expire 24 months after issuance .  The Offering closed on May 31, 2021 and raised $2,005,000, see Note 8. On September 28, 2021 the Company closed the sale of a convertible debenture and issued warrants that raised $2,225,000 of net proceeds after debt issuance costs.  The debenture is for a face amount $3,048,781 with an OID of 18% and due March 27, 2022, if not converted, see Note 7.

 

We will need additional funds beyond the money raised in this Offering.  As a result, we are planning on additional financings in the future.

 

13

Table of Contents

 

On January 30, 2020, the World Health Organization (“WHO”) announced a global health emergency because of a new strain of coronavirus originating in Wuhan, China (the “COVID-19 outbreak”) and the risks to the international community as the virus spreads globally beyond its point of origin. In March 2020, the WHO classified the COVID-19 outbreak as a pandemic, based on the rapid increase in exposure globally. The full impact of the COVID-19 outbreak continues to evolve as of the date of this report. Management is actively monitoring the global situation on its financial condition, liquidity, operations, suppliers, industry, and workforce. Given the daily evolution of the COVID-19 outbreak and the global responses to curb its spread, the Company is not able to estimate the effects of the COVID-19 outbreak on its results of operations, financial condition, or liquidity for fiscal year 2021. However, if the pandemic continues, it may have an adverse effect on the Company’s results of future operations, financial position, and liquidity in fiscal year 2021.

 

Management believes actions presently being taken to obtain additional funding provide the opportunity for the Company to continue as a going concern; however, these plans are contingent upon actions to be performed by the Company and these conditions have not been met on or before September 30, 2021. Additionally, the COVID-19 outbreak could have a continued material adverse impact on economic and market conditions and trigger a period of global economic slowdown, which would impair the Company’s ability to raise needed funds to continue as a going concern. As such, substantial doubt about the entity’s ability to continue as a going concern was not alleviated as of September 30, 2021.

 

NOTE 3. ASSET PURCHASE

 

On June 5, 2020, the Company completed a transaction (the “Transaction”) with IDTEC subject to the terms and conditions of the APA and that was accounted for as an asset purchase. Pursuant to the APA, IDTEC provided personnel, experience, and access to funding to assist with the development of the SOBR device, as well as sold to us certain robotics assets, which our management believes are synergistic with our current assets, in exchange for 12,000,000 shares of our common stock after giving effect to the reverse stock split effected in connection with closing the Transaction.

 

As a result of closing the Transaction, the Company issued a convertible promissory note for all the funds spent or advanced by IDTEC prior to closing. This note totaled $1,485,189(the “APA Note”), with simple interest at 10% per annum, due upon demand, and may be convertible into shares of common stock at $0.50 per share (after giving effect to the reverse stock split and subject to anti-dilution protection against any future securities we may issue at an effective price of less than $0.50 per share) at the discretion of the holder. The repayment of APA Note is secured by a first priority security lien or security interest in the patents, trademarks, tradenames, and other intellectual property of the Company.

 

At closing, some of the closing conditions under the APA were either waived and/or modified by the parties. In order to document those modifications and waivers, we entered into a Waiver Under Asset Purchase Agreement and Post-Closing Covenant Agreement with IDTEC. One of the closing conditions that was the subject of the Waiver Under Asset Purchase Agreement and Post-Closing Covenant Agreement was the requirement that the Company have under $125,000 in permitted liabilities (not including aged liabilities) after closing of the Transaction. At closing we had approximately $158,000 in non-permitted liabilities under the APA. As a result, the Company issued a Warrant to Purchase Common Stock to IDTEC (the “Warrant”), under which IDTEC will purchase up to 320,000 shares of our common stock (post-split) at an exercise price of $0.50 per share, if either (i) we are forced to pay a non-permitted liability, then we may force IDTEC to exercise the Warrant and pay the exercise price to pay the non-permitted liability, but only in an amount sufficient to pay the non-permitted liability, or (ii) if IDTEC otherwise elects to exercise the Warrant and acquire some or all of the shares underlying the Warrant. The Warrant expires five years after the date of issuance.

 

The Transaction recorded as an asset purchase was valued at $29,222,955, which consists of the market price as of June 5, 2020 of the Company’s 12,000,000 shares of common stock issued totaling $27,120,000, the funds spent by IDTEC and affiliates prior to closing of $1,407,051 and the fair value of the Warrant issued of $695,454.  In determining the fair value of the intangible assets, the Company considered, among other factors, the best use of acquired assets such as the analysis of historical financial performance of the products and estimates of future performance of the products and intellectual properties acquired. The  allocation to identifiable intangible assets required extensive use of financial information and management's best estimate of fair value.  

 

14

Table of Contents

 

The following summarizes the transaction closing with IDTEC on June 5, 2020:

 

Property and equipment

 

$47,725

 

Intangible assets

 

 

29,175,230

 

Total assets

 

$29,222,955

 

 

 

 

 

 

Net purchase (fair value of stock issued, warrants and notes payable) 

 

$29,222,955

 

 

Subsequent to the Transaction closing, the Company evaluated the fair value of theassets acquired based on market estimates for property and equipment and discounted net cash flow for the SOBR Safe intellectual technology. The present value of the discounted cash flow utilized a 75% discount, which included a 25% risk return premium, over an estimated five-year net revenue stream expected to be derived from the technology acquired. Based on the assessment of fair value, the Company recognized an asset impairment loss of $25,320,555 resulting from the APA during the year ended December 31, 2020. The impairment was due to the increase of the Company's stock price value. The stock price of the Company at closing of the Transaction was significantly higher than expected from the stock price of the Company when the Company signed the APA. The number of shares to be given to IDTEC as consideration for the Transaction would not get updated for any stock price changes.

 

NOTE 4. PREPAID EXPENSES

 

Prepaid expenses consist of the following:

 

 

 

September 30,

 

 

December 31,

 

 

 

2021

 

 

2020

 

Consulting service

 

$-

 

 

$111,860

 

Rent

 

 

20,667

 

 

 

-

 

Insurance

 

 

4,232

 

 

 

3,370

 

Prepaid expenses

 

$24,899

 

 

$115,230

 

 

On February 26, 2021, the Company entered into a new lease agreement for its office facility for a 12-month term beginning March 1, 2021.  In addition to monthly base rent of $6,000, the agreement requires the issuance on 16,000 shares of its common stock valued at $49,600, all of which has been issued as of September 30, 2021. 

 

NOTE 5. INTANGIBLE ASSETS

 

Intangible assets consist of the following at September 30, 2021:

 

 

 

Gross Carrying

Amount

 

 

Accumulated

Amortization

 

 

Net Intangible

Asset

 

 

Amortization

Period (in years)

 

SOBR Safe Intellectual Technology

 

$3,854,675

 

 

$513,952

 

 

$3,340,723

 

 

 

10

 

                                                                           

Amortization expense for the nine-month period ended September 30, 2021 and 2020 was $298,098 and $128,488, respectively, and is included in general and administrative expenses in the consolidated statements of operations.

 

15

Table of Contents

 

Estimated future amortization expense for device technology intangible assets is as follows:

 

2022

 

 

 2023

 

 

  2024

 

 

2025

 

 

   2026

 

 

 Thereafter

 

$

385,467

 

 

$385,467

 

 

$385,467

 

 

$385,467

 

 

$385,467

 

 

$1,413,388

 

 

NOTE 6. RELATED PARTY TRANSACTIONS

 

On July 1, 2015, the Company amended a December 3, 2014, note payable agreement with Lanphere Law Group, a related party and  shareholder, which forgave $108,000 of a note payable’s principal balance. This debt forgiveness decreased the original principal balance on the note of $214,334 to a new principal balance of $106,335, and a related party gain of $108,000 was recorded to additional paid-in capital. This amendment also extended the note payable’s due date toDecember 2, 2015. The note was converted to common stock during the three months ended March 31, 2020.

 

On March 8, 2017, Lanphere Law Group irrevocably elected to exercise warrants in order to acquire 969,601 shares of the Company’s common stock in exchange for an aggregate exercise price of $112,871, which was used for the deduction of $74,672 of principal and $38,199 of accrued interest related to the December 3, 2014, note payable agreement with Lanphere Law Group. The forgiveness of the note payable principal of $74,672 was recorded to equity and the $38,199 of related accrued interest was also recorded to equity. The principal balance of the note after the debt deduction was $31,662. On January 3, 2020, the note payable principal balance of $31,662 was converted to 9,520 common shares at a per share price of $3.326

 

On January 3, 2020, the Company entered into a Debt Conversion and Common Stock Purchase Plan with Michael Lanphere, a beneficial owner of the Company, under which he agreed to exercise warrants and the Company agreed to issue 454,097 shares of its common stock in exchange for a reduction in the amounts owed to Mr. Lanphere under two promissory notes. Mr. Lanphere’s option to acquire the shares was under the terms of certain Loan Agreement with Promissory Note and Stock Fees agreements entered into with the Company and Mr. Lanphere on April 17, 2019 and July 17, 2019. The amount of the debt reduction, and therefore the purchase price of the shares, was approximately $66,000 which was used for the deduction of related party notes payable principal of  approximately $66,000. 180,397 common shares were issued on January 3, 2020, at an effective conversion price of $0.133 and 273,700 common shares were issued on January 3, 2020 at an effective conversion price of $0.153. After this exercise, Lanphere Law Group owns no warrants for shares of our common stock.

 

On January 3, 2020, the Company entered into another Debt Conversion and Common Stock Purchase Plan with Michael Lanphere, under which the Company agreed to issue 63,225 shares of its common stock in exchange for a reduction in the amounts owed to Mr. Lanphere under numerous other remaining promissory notes. The amount of the debt reduction, and therefore the purchase price of the shares, was $210,285 which was used for the deduction of related party notes payable principal of $169,606 and accrued interest of $40,679. Based on the fair value of the shares issued, the Company recognized a related party gain of approximately $52,000 and accounted for it as additional paid-in capital. The common shares were issued on January 3, 2020 at an effective conversion price of $3.326 per share.

 

On January 3, 2020, the Company entered into a Debt Conversion and Common Stock Purchase Plan with Vernon Justus, a shareholder, under which the Company agreed to issue 84,963 shares of its common stock in exchange for a reduction in the amounts owed to Mr. Justus under a promissory note. The amount of the debt reduction, and therefore the purchase price of the shares, was $282,588 which was used for the deduction of a related party note payable principal of $180,001 and accrued interest of $102,587. Based on the fair value of the shares issued, the Company recognized a related party gain of approximately $70,000 and accounted for it as additional paid-in capital. The common shares were issued on January 3, 2020 at an effective conversion price of $3.326 per share.

 

On January 16, 2020, the Company entered into a Accounts Payable Conversion and Common Stock Purchase Plan with Michael Lanphere, under which the Company agreed to issue 214,883 shares of its common stock in exchange for a reduction in the amounts owed to Mr. Lanphere for unpaid legal bills. The amount of the debt reduction, and therefore the purchase price of the shares, was $714,700 which was used for the deduction of related party payables of $714,700. Based on the fair value of the shares issued, the Company recognized a related party gain of approximately $222,000 and accounted for it as additional paid-in capital. The common shares were issued on January 16, 2020 at an effective conversion price of $3.326 per share.

 

16

Table of Contents

 

On January 30, 2020, the Company entered into a Debt Conversion and Common Stock Purchase Plan with Devadatt Mishal, one of the Company’s former directors and current shareholder, under which the Company agreed to issue 499,965 shares of its common stock in exchange for a reduction in the amounts owed to Mr. Mishal under numerous promissory notes. The amount of the debt reduction, and therefore the purchase price of the shares, was $456,641 which was used for the deduction of related party notes payable principal of $270,300 and accrued interest of $186,341. The Company also recorded a loss on related party debt extinguishment of approximately $144,000. The common shares were issued on January 30, 2020 at an effective conversion price of $0.91465 per share.

 

On March 23, 2020, the Company entered into a Debt Conversion and Common Stock Purchase Plan with Prakash Gadgil, one of the Company’s former directors and current shareholder, under which the Company agreed to issue 586 shares of its common stock in exchange for a reduction in the amounts owed to Mr. Gadgil under a promissory note. The amount of the debt reduction, and therefore the purchase price of the shares, was $1,950 which was used for the deduction of a related party note payable principal of $1,950. Based on the fair value of the shares issued, the Company recognized a related party gain of approximately $1,000 and accounted for it as additional paid-in capital. The common shares were issued on March 23, 2020 at an effective conversion price of $3.326 per share.

 

On April 6, 2020, the Company agreed with Nick Noceti, the Company’s former Chief Financial Officer, to issue 38,437 shares of its common stock in exchange for amounts due for accounting fees. The amount of the debt reduction, and therefore the purchase price of the shares, was $127,840 which was used for the deduction of a related party accounts payable of $127,480. Based on the fair value of the shares issued, the Company recognized a related party gain of approximately $49,000 and accounted for it as additional paid-in capital. The common shares were issued on April 4, 2020 at an effective conversion price of $3.326 per share.

 

On April 7, 2020, the Company agreed with Charles Bennington, one of the Company’s former directors, to issue 6,831 shares of its common stock in exchange for amounts due for Board of Director fees. The amount of the debt reduction, and therefore the purchase price of the shares, was $9,656 which was used for the deduction of a related party accounts payable of $9,656. Based on the fair value of the shares issued, the Company recognized a related party gain of approximately $2,000 and accounted for it as additional paid-in capital. The common shares were issued on April 7, 2020 at an effective conversion price of $1.41 per share.

 

On February 12, 2021, the Company entered into a note payable agreement with David Gandini, an officer and shareholder, under which Mr. Gandini advanced the Company $30,000 for working capital purposes.  The  unsecured note carried interest at 0% and was paid in April 2021.

 

On March 30, 2021, the Company received notification from IDTEC that it was exercising a portion of the 320,000 warrants issued resulting from the Waiver Under Asset Purchase Agreement and Post-Closing Covenant Agreement with IDTEC.  The warrant exercise price is $0.50 per share.  With the proceeds of the exercise we paid $88,469 during the six-month period ended June 30, 2021 to settle an outstanding judgement (see Note 14) against the Company which was considered as a non-permitted liability under the Post-Closing Covenant Agreement.  We will issue 176,938 shares of our common stock for the $88,469 we received from IDTEC to pay the settlement.  As the shares had not been issued by June 30, 2021, the amount received from IDTEC is included in the common stock subscriptions payable balance at June 30, 2021.

 

On March 3 and 31, 2021, the Company issued convertible notes payable (see Note 8) totaling $450,000 to existing shareholders holding a direct or indirect interest in the Company and $100,000 to a Company’s director and another director’s family member. The principal amount of the secured convertible debentures are convertible at $3 per share, and include warrants to purchase in total 275,000 shares of the Company’s common stock at $3 per share.

 

On May 31, 2021, the Company issued convertible notes payable (see Note 8) totaling $400,000 to existing shareholders holding a direct or indirect interest in the Company and $50,000 to a Company’s officer. The principal amount of the secured convertible debentures are convertible at $3 per share, and include warrants to purchase in total 225,000 shares of the Company’s common stock at $3 per share.

 

17

Table of Contents

 

NOTE 7. CONVERTIBLE DEBENTURE PAYABLE

 

Convertible debenture payable consists of the following:

 

 

 

September 30,

2021

 

 

December 31,

2020

 

Convertible Debenture Payable with Detached Free-standing Warrant

 

$3,048,781

 

 

$-

 

Unamortized Debt Discount

 

 

(2,608,900)

 

 

-

 

 

 

 

 

 

 

 

 

 

Net Convertible Debenture Payable

 

$439,881

 

 

$-

 

 

On September 28, 2021, (the “Closing Date”) the Company completed a financing transaction under a Securities Purchase Agreement (the “SPA”) and corresponding 18% Original Issue Discount Convertible Debenture (the “Debenture”), Common Stock Purchase Warrant (the “Warrant”) and Registration Rights Agreement (“RRA”). Under the terms of the SPA, the Company received $2,500,000 from the Purchaser and in exchange issued the Debenture in the principal amount of $3,048,781 and Warrants to purchase up to 1,219,512 shares of the Company’s common stock. The Debenture is convertible voluntarily by the Purchaser at any time into shares of our common stock, at the lesser of $2.50, representing 100% of the closing price of our common stock on the trading day immediately prior to the Closing Date, or 75% of the average VWAP of our common stock during the 5 trading day period immediately prior to the conversion date (the “Conversion Price”), or automatically upon the occurrence of a single public offering of our common stock which results in the listing of our common stock on a national securities exchange as defined in the Exchange Act (the “Qualified Offering”) into shares of our common stock at the lesser of the Conversion Price, or 75% of the offering price of the securities offered in the Qualified Offering. The Debenture matures on March 27, 2022, does not accrue interest unless there is an event of default under the terms of the Debenture. The Warrant is exercisable at any time through September 28, 2026 into shares of our common stock at an exercise price of $2.00 per share, unless an event of default occurs, at which time the exercise price will adjust to $1.00 per share. The Warrant contains a cashless exercise provision but only in the event the Company fails to have an effective registration statement registering the common shares underlying the Warrant at any time beginning six months from the Closing Date.  The RRA requires the Company to register for resale and maintain effectiveness of such Registration Statement for such all of the registrable securities under the terms of the Debenture and Warrant, within defined time frames. Should the Company fail to meet the RRA requirements, until the date causing such event of noncompliance is cured, the Company shall pay to the Purchaser as partial liquidated damages equal to the product of 2% of the principal amount not to exceed 24% of the aggregate principal. If the Company fails to pay of the liquidated damages within seven days after the date payable, the Company will pay interest at 18% until such amounts are paid in full. The Company evaluated the Debenture for derivative embedded and beneficial conversion features and determined that its embedded conversion feature carried a debt discount. The total conversion feature debt discount of $980,000 is amortized over the life of the convertible debenture. The debt discount amortization expense recorded as amortization of interest in the consolidated statements of operations was $16,245 for the nine-month period ended September 30, 2021.  As of September 30, 2021, the debenture carries outstanding warrants of 1,219,512. The relative fair market value of the related stock warrants granted during the nine month period ended September 30, 2021 and 2020 was $847,048 and none, respectively.  The unamortized discount at September 30, 2021 and December 31, 2020 was $833,008 and none, respectively. Stock warrants amortization expense recorded as interest expense was $14,039 for the nine month period ended September 30, 2021. The Company incurred $548,781 of Original Issue Discount and $275,000 of debt issuance costs related to the Debenture which is being amortized to interest expense over the term of the debt using the effective interest method. Interest expense related to the Original Issue Discount and debt issuance costs was $11,645 for the nine month period ended September 30, 2021. The unamortized discount and issuance costs at September 30, 2021 and December 31, 2020 was $812,134 and none, respectively. 

 

18

Table of Contents

 

NOTE 8. NOTES PAYABLE

 

RELATED PARTIES

 

Related party notes payable consist of the following:

 

 

 

    September 30,

        2021

 

 

December 31,

2020

 

Convertible Notes Payable with Detached Free-standing Warrants

 

$1,000,000

 

 

$-

 

Conventional Non-Convertible Notes Payable

 

 

11,810

 

 

 

11,810

 

Unamortized Debt Discount

 

 

(771,576)

 

 

-

 

Net Related Party Notes Payable

 

$240,234

 

 

$11,810

 

Current Portion

 

 

(11,810)

 

 

(11,810)

Net Long-Term Portion

 

$228,424

 

 

$-

 

 

Total interest expense for related party notes was $55,151 and $79,596 for the nine month period ended September 30, 2021 and 2020, respectively.

 

Related Party Convertible Notes Payable with Warrants

 

The Company has thirteen convertible notes payable to related parties, each with detached free-standing warrants to purchase the Company’s common stock at $3 per share, that have a total principal balance of $1,000,000 as of September 30, 2021. The notes, secured by the Company’s patents and patents applications, include interest at 12%, are convertible at $3 per share of the Company’s common stock and are due 24 months after issuance. The note holders may elect to have the interest paid in cash monthly or have the interest accrue and be payable on the maturity date. Interest elected to be accrued will be paid in cash or may be converted into shares of our common stock under the same terms as the principal amount on the maturity date. The notes contain both voluntary and automatic conversion features. The notes will be convertible at any time, by the holders, beginning on the date of issuance. However, the holders may not convert any outstanding amounts due under the note if at the time of such conversion the amount of common stock issued for the conversion, when added to other shares of Company common stock owned by the holders or which can be acquired by holders upon exercise or conversion of any other instrument, would cause the holder to own more than 4.9% of the Company’s outstanding common stock.  Beginning on the issuance date, the outstanding principal amount of the note, and any accrued interest, will automatically convert into shares of the Company’s common stock if the Company’s common stock closes at or above $6 per share for five (5) consecutive trading days while listed on NASDAQ. The Company evaluated the convertible notes payable for derivative embedded and beneficial conversion features. The Company determined that there were beneficial conversion features to record. The total beneficial conversion feature debt discount of $448,999 is amortized over the life of the convertible notes payable. The debt discount amortization expense recorded as amortization of interest – beneficial conversion feature in the consolidated statements of operations was $101,070for the nine-month period ended September 30, 2021. As of September 30, 2021, these notes carry outstanding warrants of 500,000. The relative fair market value of the related stock warrants granted during the nine-month period ended September 30, 2021 and 2020 was $551,001 and none, respectively.  The unamortized discount at September 30, 2021 and December 31, 2020 is $423,647 and none, respectively. Stock warrants amortization expense recorded as interest expense was $127,354 for the nine-month period ended September 30, 2021.

 

19

Table of Contents

 

Related Party Convertible Notes Payable

 

On June 5, 2020 the Company issued the convertible APA Note to a related party with a principal balance of  $1,485,189, which included the $70,000 balance of three convertible notes payable to related parties and related accrued interest of $7,689 outstanding at December 31, 2019.  The note includes simple interest at 10% per annum, due upon demand, and may be convertible into shares of common stock at $0.50 per share (after giving effect to the reverse stock split and subject to anti-dilution protection against any future securities we may issue at an effective price of less than $0.50 per share) at the discretion of the holder.  The Company evaluated the convertible note payable for derivative embedded and beneficial  conversion features. The Company determined that there was a  beneficial conversion feature to record. During the year ended December 31, 2020, beneficial conversion feature amortization expense related to this related party convertible note payable of $1,407,675 was accounted for as amortization of interest - beneficial conversion feature expense in the consolidated statements of operations. On November 15, 2020, the related party holder elected to convert the note principal and accrued interest balance of $1,551,514 into 3,103,028 of shares of common stock.

 

Related Party Non-convertible Notes Payable

 

The Company has one non-convertible note payable to a related party that has a principal balance of  $11,810 as of September 30, 2021 and December 31, 2020. The note carries an interest rate at 0%.  The note payable had a due date of December 31, 2012 and is currently in default.    

 

NON-RELATED PARTIES 

 

Non-related party notes payable consist of the following:

 

 

 

September 30,

2021

 

 

December 31,

2020

 

Convertible Notes Payable with Detached Free-standing Warrants

 

$1,005,000

 

 

$-

 

Convertible Notes Payable

 

 

56,683

 

 

 

56,683

 

Conventional Non-Convertible Notes Payable

 

 

42,500

 

 

 

42,500

 

Notes Payable with Detached Free-standing Warrants

 

 

5,000

 

 

 

5,000

 

Unamortized Debt Discount

 

 

(774,850)

 

 

-

 

Net Non-Related Party Notes Payable

 

$334,333

 

 

$104,183

 

Current Portion

 

 

(104,183)

 

 

(79,183)

Net Long-Term Portion

 

$230,150

 

 

$25,000

 

 

Total interest expense for non-related party notes was $65,130 and $14,036 for the nine-month periods ended September 30, 2021 and 2020, respectively.

 

Convertible Notes Payable with Warrants

 

The Company has sixteen convertible notes payable to non-related parties, each with detached free-standing warrants to purchase the Company’s common stock at $3 per share, that have a total principal balance of $1,005,000 as of September 30, 2021. The notes, secured by the Company’s patents and patents applications, include interest at 12%, are convertible at $3 per share of the Company’s common stock and are due 24 months after issuance.  The note holders may elect to have the interest paid in cash monthly or have the interest accrue and be payable on the maturity date.  Interest elected to be accrued will be paid in cash or may be converted into shares of our common stock under the same terms as the principal amount on the maturity date.  The notes contain both voluntary and automatic conversion features. The notes will be convertible at any time, by the holders, beginning on the date of issuance. However, the holders may not convert any outstanding amounts due under the note if at the time of such conversion the amount of common stock issued for the conversion, when added to other shares of Company common stock owned by the holders or which can be acquired by holders upon exercise or conversion of any other instrument, would cause the holder to own more than 4.9% of the Company’s outstanding common stock.  Beginning on the issuance date, the outstanding principal amount of the note, and any accrued interest, will automatically convert into shares of the Company’s common stock if the Company’s common stock closes at or above $6 per share for five (5) consecutive trading days while listed on NASDAQ. The Company evaluated the convertible notes payable for derivative embedded and beneficial conversion features. The Company determined that there were beneficial conversion features to record. The total beneficial conversion feature debt discount of $460,215 is amortized over the life of the convertible notes payable.  The debt discount recorded as amortization of interest – beneficial conversion feature in the consolidated statements of operations was $105,060 for the nine-month period ended September 30, 2021.  As of September 30, 2021, these notes carry outstanding warrants of 502,500. The relative fair market value of the related stock warrants granted during the nine-month period ended September 30, 2021 and 2020 was $541,707 and none, respectively.  The unamortized discount at September 30, 2021 and December 31, 2020 was $419,695 and none, respectively. Stock warrants amortization expense recorded as interest expense was $122,012 for the nine-month period ended September 30, 2021.

 

20

Table of Contents

 

Convertible Notes Payable

 

The Company has three convertible notes payable to non-related parties that have a principal balance of $56,683 as of September 30, 2021 and December 31, 2020. These notes carry interest rates ranging from 5% - 12% and have due dates ranging from February 2013 to March 2022. Two of the three notes are currently in default. These notes carry conversion prices ranging from $1.99- $10.7619 per share. The Company evaluated these convertible notes payable for derivative embedded and beneficial conversion features. The Company determined that there were beneficial conversion features to record. The conversion features were either fully amortized upon grant or over the life of the convertible notes payable. The conversion features were fully amortized prior to 2020.

 

During the three months ended March 31, 2020, the Company entered into Debt Conversion and Common Stock Purchase Plans with six non-related parties, under which the Company agreed to issue 50,135 shares of its common stock in exchange for a reduction of eleven convertible notes payable to non-related parties. The amount of the debt reduction, and therefore the purchase price of the shares, was $166,750 which was used for the deduction of non-related party convertible notes payable principal of $83,953 and accrued interest of $82,797. The Company recorded a non-related party gain on loan extinguishment  of approximately $103,000.

 

During the three months ended March 31, 2020, the Company entered into a non-related party convertible note payable agreement to convert a high interest rate convertible non-related party note payable with a principal balance of $25,000 and accrued interest due of $22,500 to a non-related party convertible note payable of $47,500 that accrues interest at 5%. The note conversion rate is $2 per common share. The Company recorded a loss on non-related party debt extinguishment of $11,697.

 

During 2020, the holder of a $25,000 convertible promissory note with interest at 30% and accrued interest of $61,875 replaced the carrying amount of the note and its conversion features with a new non-convertible note totaling $25,000 that bears interest at 5%. The Company recorded a gain on non-related party debt extinguishment of $61,875.

 

Non-convertible Notes Payable

 

The Company has three non-convertible notes payable to non-related parties that have a principal balance of $42,500 as of September 30, 2021, and December 31, 2020. These notes carry interest rates ranging from  5% - 10% and have due dates ranging from 12/25/2013 - 6/06/2022. Two of the three notes are currently in default. 

 

During 2020, the Company entered into a Debt Conversion and Common Stock Purchase Plan with a non-related party, under which the Company agreed to issue 20,313 shares of its common stock in exchange for a reduction of a non-convertible non-related party note payable. The amount of the debt reduction, and therefore the purchase price of the shares, was $67,561 which was used for the deduction of non-related party non-convertible notes payable principal of $3,938 and accrued interest of $63,623. The Company recorded a non-related party gain on loan extinguishment  of approximately $14,000.

 

On May 12, 2020, the Company received proceeds of $41,665 from a commercial bank under the SBA Payroll Protection Loan Program. The loan requires interest at 1% and 18 monthly payments of principal and interest beginning December 5, 2020. Provisions of the SBA Payroll Protection Loan Program allow for portions or all the loan balance to be forgiven should certain criteria be met.  On December 7, 2020 the Company was notified that the principal balance and accrued interest of $242 was forgiven, and thus the Company  recorded a gain on loan extinguishment of approximately $42,000.

 

Notes Payable with Warrants

 

The Company has one note payable with detached free-standing warrants to a non-related party that has a principal balance of $5,000 as of  September 30, 2021 and December 31, 2020. This note carries an interest rate of 10% and had a due date of 9/11/2014. This note is currently in default. The detached free-standing warrants for this note payable were not exercised by the note holder and expired on May 16, 2019.

 

21

Table of Contents

 

NOTE 9. DERIVATIVE LIABILITY

 

In September 2021, the Company completed a financing transition and received $2,500,000 from the Purchaser and in exchange issued an 18% Original Issue Discount Convertible Debenture in the principal amount of $3,048,781. The debenture includes voluntary and automatic conversion features at a variable conversion prices convertible into the Company’s common shares at an undetermined future date. The Company analyzed the conversion features of the debenture agreement for derivative accounting consideration under ASU 2017-11 (ASC 815-15, Derivatives and Hedging), and determined the embedded conversion features should be classified as a derivative because the exercise price of the convertible note is subject to a variable conversion rate and should therefore be accounted for at fair value under ASC 820, Fair Value Measurements and Disclosures, and ASC 825, Financial Instruments. In accordance with ASC 815-15, the Company bifurcated the conversion feature of the debenture and recorded a derivative liability.

 

The embedded derivative for the debenture is carried on the Company’s balance sheet at fair value. The derivative liability is marked to market each measurement period and any unrealized change in fair value is recorded as a component of the consolidated statement of operations and the associated fair value carrying amount on the balance sheet was adjusted by the change. The Company fair valued the embedded derivative using a Monte Carlo simulation model based on the following assumptions: (1) expected volatility of 120%, (2) risk-free interest rate of 0.05%, and (3) expected life from 4 to 6 months. On September 28, 2021, the Closing Date of the transaction, the fair value of the embedded derivative was $980,000 and is amortized to interest expense over the term of the Debenture. Utilizing level 3 inputs, the Company did not record a fair market value gain or loss for the nine months ended September 30, 2021. The fair value of the embedded derivative recorded on the balance sheet as a liability was $980,000 at September 30, 2021.

 

NOTE 10. STOCK SUBSCRIPTIONS PAYABLE

 

The Company has common stock subscriptions payable due to related parties of $91,613 payable with 193,856 of its common shares at September 30, 2021.  The Company has common stock subscriptions payable due to related parties of $111,024 payable with 60,087 of its common shares at December 31, 2020.

 

The Company has common stock subscriptions payable due to non-related parties of $136,433 payable with 87,500 of its common shares at September 30, 2021 and December 31, 2020.

 

NOTE 11. COMMON STOCK

 

The Company’s common stock transactions for the nine months ended September 30, 2020, consist of the following:

 

The Company issued 601 shares of its common stock for compensation for services rendered.

 

The Company issued 454,097 shares of its common stock for the conversion of $65,728 of related parties’ debt from $0.1530 to $0.13304 per share pursuant to terms of the convertible promissory notes. 454,097 stock warrants were settled along with the related party debt.

 

The Company issued 214,883 shares of its common stock for the settlement of related party payables of $714,700.  A related party gain of approximately $222,000 was recorded as additional paid-in capital from the stock issuance.

 

The Company issued 38,323 shares of its common stock for the settlement of  accounts payables and accrued expenses of approximately $127,000.  The Company recorded a net gain of approximately $27,000 from the stock issuance.

 

The Company issued 648,739 shares of its common stock to related parties for the conversion of $622,004 of debt from $0.9146 to $3.326 per share.  The Company recorded $143,660 of loss on debt extinguishment  and a related party gain of $124,291 as additional paid in-capital as a result of the stock issuance.

 

22

Table of Contents

  

The Company issued 70,448 shares of its common stock to non-related parties for the conversion of $65,391 of debt  at $3.326 per share.  The Company recorded $41,665 of loss resulting from the stock issuance. 

 

The Company agreed to convert 121,072 shares of its common stock at values between $0.5821 to $1.039 per share to non-related parties in exchange for their agreement to settle payable balances of $91,464 owed to them. The conversion was in full satisfaction of all outstanding amounts owed. The Company recorded a non-related party loss of $81,867 as other expense in the consolidated statements of operations.

 

The Company issued 45,268 shares of its common stock to related parties in exchange for their agreement to settle  related party accounts payable of $137,496 owed to them. The shares were issued at a value of $86,739 and recorded a related party gain of $50,741 to additional paid-in-capital.

 

The Company issued 12,000,000 shares of its common stock valued at $2.26 as result of the Transaction with IDTEC (see Note 3).

 

The Company’s common stock transactions for the nine months ended September 30, 2021, consist of the following:

 

The Company issued 43,169 shares of its common stock to SOBR Safe, LLC, an entity controlled by a beneficial owner of the Company, in full satisfaction of $107,880 of accrued dividends resulting from the December 2020 conversion of the Series A-1 Convertible Preferred Stock into common shares, see Note 11.

 

The Company issued 16,000 shares of its common stock valued at $49,600 to its landlord under the terms of a lease agreement expiring in February 2022.  The amount has been recorded as prepaid expense and amortized monthly over the lease term as general and administrative expense in the consolidated statement of operations.  

 

NOTE 12. PREFERRED STOCK

 

On November 20, 2015, the Company’s Board of Directors authorized a class of stock designated as preferred stock with a par value of $0.00001 per share comprising 25,000,000 shares, 3,000,000 shares of which were classified as Series A Convertible Preferred Stock. In each calendar year, the holders of the Series A Convertible Preferred Stock are entitled to receive, when, as and if, declared by the Board of Directors, out of any funds and assets of the Company legally available, non-cumulative dividends, in an amount equal to any dividends or other Distribution on the common stock in such calendar year (other than a Common Stock Dividend). No dividends (other than a Common Stock Dividend) shall be paid and no distribution shall be made with respect to the common stock unless dividends shall have been paid or declared and set apart for payment to the holders of the Series A Convertible Preferred Stock simultaneously. Dividends on the Series A Convertible Preferred Stock shall not be mandatory or cumulative, and no rights or interest shall accrue to the holders of the Series A Convertible Preferred Stock by reason of the fact that the Company shall fail to declare or pay dividends on the Series A Convertible Preferred Stock, except for such rights or interest that may arise as a result of the Company paying a dividend or making a distribution on the common stock in violation of the terms. The holders of each share of Series A Convertible Preferred Stock then outstanding shall be entitled to be paid, out of the Available Funds and Assets, and prior and in preference to any payment or Distribution (or any setting part of any payment or Distribution) of any Available Funds and Assets on any shares of common stock, and equal in preference to any payment or Distribution (or any setting part of any payment or Distribution)  of any Available Funds and Assets on any shares of any other series of preferred stock that have liquidation preference, an amount per share equal to the Original Issue Price of the Series A Convertible Preferred Stock plus all declared but unpaid dividends on the Series A Convertible Preferred Stock. A reorganization, or any other consolidation or merger of the Company with or into any other corporation, or any other sale of all or substantially all of the assets of the Company, shall not be deemed a liquidation, dissolution, or winding up of the Company. Shares of the Series A Convertible Preferred Stock are convertible at a 35% discount rate to the average closing price per share of the Company’s common stock (either as listed on a national exchange or as quoted over-the-market) for the last 15 trading days immediately prior to conversion. However, no conversions of the Series A Convertible Preferred Stock to shares of common stock can occur unless the average closing price per share of the Company’s common stock (either as listed on a national exchange or as quoted over-the-market) for the last  15 trading days immediately prior to conversion is at least $1.67. The shares of Series A Convertible Preferred Stock vote on a one for one basis. The right of conversion is limited by the fact the holder of the Series A Convertible Preferred Stock may not convert if such conversion would cause the holder to beneficially own more than 4.9% of the Company’s common stock after giving effect to such conversion. 

 

23

Table of Contents

 

On December 9, 2019, the Company’s Board of Directors created a class of preferred stock designated as 8% Series A-1 Convertible Preferred Stock comprising of 2,000,000 shares. During 2020, the authorized shares were increased to 2,700,000 shares.  The rights and preferences of the 8% Series A-1 Convertible Preferred Stock are as follows: (a) dividend rights of 8% per annum based on the original issuance price of $1 per share, (b) liquidation preference over the Company’s common stock, (c) conversion rights into shares of the Company’s common stock at $1 per share (not to be affected by any reverse stock split in connection with the Asset Purchase Agreement with IDTEC), (d) redemption rights such that we have the right, upon 30 days written notice, at any time after one year from the date of issuance, to redeem all or part of the Series A-1 Convertible Preferred Stock for 150% of the original issuance price, (e) no call rights by the Company, and (f) each share of Series A-1 Convertible Preferred Stock will vote on an “as converted” basis.

 

On December 12, 2019, the Company entered into a Series A-1 Preferred Stock Purchase Agreement (the “SPA”) with SOBR SAFE, LLC (“SOBR SAFE”), a Delaware limited liability company and an entity controlled by a beneficial owner of the Company, under which SOBR SAFE agreed to acquire 1,000,000 shares of our Series A-1 Convertible Preferred Stock  in exchange for $1,000,000 (the “Purchase Price”). The Company received the Purchase Price on December 12, 2019.

 

On May 7, 2020, the Company amended a Convertible Preferred Stock Investment Agreement  granting the exclusive right to SOBR SAFE to purchase up to 2,700,000 shares of Series A-1 Convertible Preferred Stock.   

 

On July 2, 2020, the Company executed Amendment No. 2 to the Stock Investment Agreement which provides that the full amount of each dividend due on a dividend payment date, even if not declared, shall be paid to any holder regardless of the date on which the holder acquired the stock. 

 

The Series A-1 Convertible Preferred Stock earns cumulative dividends at a rate of 8% per annum, payable in cash or common stock at the option of the Company on June 30 and December 31 of each year. If paid in common stock, the common stock will be valued at the average of the closing price for the five business days prior to the dividend payment date. The preferred shareholders will participate in any common stock dividends on an as converted basis. Although no dividends were declared as of September 30, 2020, the Company has accrued dividends payable of $161,880 related to the 8% Series A-1 Convertible Preferred Stock as of September 30, 2020.  On December 7, 2020, we sent a Notice of Automatic Conversion and Calculation of Dividend Shares to SOBR SAFE notifying them that under the terms governing the shares of Series A-1 Convertible Preferred Stock the 2,700,000 shares of Series A-1 Convertible Preferred Stock owned by SOBR SAFE automatically converted into 2,700,000 shares of our common stock.  In addition, as a result of the conversion of the Series A-1 Convertible Preferred Stock we owed SOBR SAFE accrued dividends totaling $107,880, which we could pay in cash or in shares of our common stock based on the price of common stock on the applicable dividend dates.  Our management and Board of Directors elected to pay SOBR SAFE the accrued dividends in shares of our common stock.

 

24

Table of Contents

 

NOTE 13 STOCK WARRANTS AND STOCK OPTIONS

 

Stock Warrants

 

The Company accounts for employee stock options and stock warrants under ASC 718 and ASC 505, whereby option costs are recorded based on the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable, utilizing the Black-Scholes pricing model. Unless otherwise provided for, the Company covers option exercises by issuing new shares. 

 

On August 8, 2019, the Company entered into an 8% Series A-1 Convertible Preferred Stock Investment agreement with First Capital Ventures, LLC (“FCV”), an entity controlled by a beneficial owner of the Company. FCV set up a special purpose vehicle (“SPV”) or SOBR SAFE, LLC, an entity controlled by a beneficial owner of the Company,  that purchased 1,000,000 of the 8% Series A-1 Convertible Preferred Shares at $1 per share on December 12, 2019. Upon purchase, the Company issued the SPV through FCV a three-year warrant to purchase 144,317 shares of the Company’s common stock at an exercise price of $1.039375 per share. The number of warrants outstanding to the SPV through FCV at September 30, 2021 and December 31, 2020 are 144,317

 

On May 4, 2020, the Company entered into an agreement with a vendor to provide investor relations services.  Under the terms of the agreement, we issued warrants to purchase up to 120,000 shares of our common stock at an exercise price of $2.00 per share. The warrants expire five years after the date of issuance. Approximately $220,000 of expense was recognized for the warrants issued for the services provide by the vendor.

 

On June 5, 2020, at closing of the Transaction, the Company entered into a Waiver Under Asset Purchase Agreement and Post-Closing Covenant Agreement under which we issued warrants to IDTEC to purchase up to 320,000 shares of our common stock (post-split) at an exercise price of $0.50 per share. The warrants expire five years after the date of issuance.

 

During March, April and May 2021, the Company issued through the Offering convertible notes payable with warrants, see Note 8, to purchase up to 1,002,500 shares of our common stock at an exercise price of $3 per share. The warrants expire two years after the date of issuance.

 

On September 28, 2021, the Closing Date,  the Company issued through the sale of the Debenture warrants, see Note 7, to purchase up to 1,219,512 shares of our common stock at an exercise price of $2 per share. The warrants expire five years after the date of issuance.

 

The total outstanding balance of all stock warrants in the Company is 2,629,391 and 584,317 at September 30, 2021 and December 31 2020, respectively. There were 2,222,012 detached free-standing stock warrants granted during the nine month period ended September 30, 2021, and 320,000  detached free-standing stock warrants granted during the nine month period ended September 30, 2020. The fair value of these non-employee stock warrants granted during the nine-month periods ended September 30, 2021 and 2020 totaled $1,939,756 and $695,454, respectively, and were determined using the Black-Scholes option pricing model based on the following assumptions:

 

 

 

September 30,

2021

 

 

  September 30,

2020 

 

Exercise Price 

 

$

3.00-2.00

 

 

$0.50

 

Dividend Yield 

 

 

0%

 

 

0%

Volatility 

 

158-120

 

 

153%

Risk-free Interest Rate 

 

0.14%-0.98

 

 

0.29%

Life of Warrants

 

2-5 Years

 

 

   5 Years

 

 

25

Table of Contents

 

The following table summarizes the changes in the Company’s outstanding warrants during the nine-month period ended September 30, 2021 and 2020, and as of September 30, 2021 and 2020:

 

 

 

Warrants

Outstanding

Number of

Shares

 

 

Exercise Price Per

Share

 

 

Weighted Average Remaining Contractual Life

 

Weighted Average

Exercise Price Per Share

 

 

Aggregate Intrinsic Value

 

Balance at December 31, 2019

 

 

598,414

 

 

$

0.133041.039375

 

 

3.97 Years

 

$0.3607

 

 

$1,276,870

 

Warrants Granted

 

 

320,000

 

 

$0.50

 

 

4.68Years

 

$0.50

 

 

$761,000

 

Warrants Exercised

 

 

(454,097)

 

$

0.13304 - 0.15299

 

 

 

 

$0.1451

 

 

 

 

 

Warrants Expired

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at September 30, 2020

 

 

464,317

 

 

$

0.50- 1.039375

 

 

3.91 Years

 

$0.66765

 

 

$1,027,234

 

 

 

 

Warrants

Outstanding

Number of

Shares

 

 

Exercise Price Per

Share

 

 

Weighted Average Remaining Contractual Life

 

Weighted Average

Exercise Price Per Share

 

 

Aggregate Intrinsic Value

 

Balance at December 31, 2020

 

 

584,317

 

 

$

0.502.00

 

 

3.80 Years

 

$0.9413

 

 

$1,173,737

 

Warrants Granted

 

 

2,222,012

 

 

$

3.00-2.00

 

 

3.40 Years

 

$2.45

 

 

$108,506

 

Warrants Exercised

 

 

(176,938)

 

$0.50

 

 

 

 

$0.50

 

 

 

 

 

Warrants Expired

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at September 30, 2021

 

 

2,629,391

 

 

$

0.503.00

 

 

3.30 Years

 

$2.25

 

 

$665,424

 

 

Stock Options

 

On October 24, 2019, the Company’s 2019 Equity Incentive Plan went effective. The plan was approved by the Company’s Board of Directors and the holders of a majority of the Company’s voting stock on September 9, 2019. The plan’s number of authorized shares is 3,848,467. As of September 30, 2021 and December 31, 2020, the Company has granted stock options to acquire 2,921,861 and 2,521,921 shares of common stock under the plan, respectively. As of September 30, 2021, the plan has 1,893,347 vested shares and 1,028,514 non-vested shares. As of December 31, 2020, the plan had 1,202,724 vested shares and 1,319,197 non-vested shares. As of September 30, 2021 and December 31, 2020 the plan has options available to be issued of 926,606 and 1,326,546, respectively.  The stock options are held by our officers, directors, employees, and certain key consultants. 

 

In total for the nine months ended September 30, 2021 and 2020, the Company recorded $630,027 and $343,549, respectively, of share-based compensation expense related to stock options and restricted stock units. The unrecognized compensation expense as of September 30, 2021, was approximately $813,000 for non-vested share-based awards to be recognized over periods of approximately one to three years.

 

26

Table of Contents

 

In applying the Black-Scholes options pricing model, assumptions used to compute the fair value of the stock options granted during the nine-month period ended September 30, 2021 and 2020 were as follows:

 

 

 

September 30,

2021

 

 

September 30,

2020

 

Exercise Price

 

$

2.50 - $3.58

 

 

$

0.26-$3.30

 

Dividend Yield

 

 

0%

 

 

0%

Expected Volatility

 

44% - 185

 

153%-171

Risk-free Interest Rate

 

0.16% - 1.69

 

0.19%-0.43

Expected Life

 

1.3 - 7 years

 

 

2.2-5 years

 

  

The following table summarizes the changes in the Company’s outstanding stock options during the nine-month period ended September 30, 2021 and 2020, and as of September 30, 2021 and 2020:

 

 

 

Options

Outstanding

Number of

Shares

 

 

Exercise Price Per

Share

 

 

Weighted Average Remaining Contractual Life

 

Weighted Average

Exercise Price Per Share

 

 

Aggregate

Intrinsic Value

 

Balance at December 31, 2019

 

 

2,381,239

 

 

$

0.2634-1.039

 

 

8.86 Years

 

$0.2948

 

 

$5,238,080

 

Options Granted

 

 

160,000

 

 

$

0.26341-3.30

 

 

4.10 Years

 

$1.9454

 

 

$149,532

 

Options Exercised

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options Cancelled

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

Options Expired

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at September 30, 2020

 

 

2,541,239

 

 

$

0.26343.30

 

 

7.86 Years

 

$0.3987

 

 

$6,305,579

 

 

 

 

Options

Outstanding

Number of

Shares

 

 

Exercise Price Per

Share

 

 

Weighted Average Remaining Contractual Life

 

Weighted Average

Exercise Price Per Share

 

 

Aggregate Intrinsic Value

 

Balance at December 31, 2020

 

 

2,572,227

 

 

$

0.26343.300

 

 

7.45 Years

 

$0.4999

 

 

$6,302,277

 

Options Granted

 

 

610,526

 

 

$

2.503.575

 

 

2.58 Years

 

$3.1783

 

 

$(414,147)

Options Exercised

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options Cancelled

 

 

(210,587)

 

$

0.2634-3.29

 

 

 

 

$2.969

 

 

 

 

 

Options Expired

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at September 30, 2021

 

 

2,972,166

 

 

$

0.26343.575

 

 

6.15 Years

 

$0.8751

 

 

$4,829,417

 

 

Exercisable at December 31, 2020

 

 

1,253,030

 

 

0.26343.300

 

 

7.4 Years

 

$0.3165

 

 

$3,299,765

 

Exercisable at September 30, 2021

 

 

1,943,652

 

 

$

0.26343.575

 

 

6.3 Years

 

$0.6527

 

 

$3,590,430

 

 

Executive Stock Options

 

The Company has 1,553,152 and 981,771 outstanding executive stock options exercisable at $0.2634 to $3.38 per share as of  September 30, 2021, and December 31, 2020, respectively.

 

27

Table of Contents

 

NOTE 14. COMMITMENTS AND CONTINGENCIES

 

Operating Leases

On October 15, 2019, the Company entered into a short-term lease agreement that is between $2,800 - $2,900per month and ended on October 31, 2020. The lease has been renewed for another twelve months under the same general terms and conditions.  The lease was subsequently canceled to accommodate additional space, and a new lease was executed February 26, 2021, effective for a 12-month term beginning March 1, 2021.  The lease requires monthly base rent payments of $6,000 and the issuance of 16,000 shares of the Company’s common stock.  The value of the common stock of $49,600 is amortized to rent expense on a monthly basis over the lease term.  The Company also leases an office space for approximately $3,500 per month on a short-term (month to month) basis through a related party that terminates at any time.  Rent expense under office leases, including CAM charges, was $106,997 and $47,711 for the nine-month period ended September 30, 2021 and 2020, respectively.

 

Legal Proceedings

On December 6, 2006, Orange County Valet and Security Patrol, Inc. filed a lawsuit against us in Orange County California State Superior Court for Breach of Contract in the amount of $11,164. A default judgment was taken against us in this matter. In mid-2013 we learned the Plaintiff’s perfected the judgment against us, but we have not heard from the Plaintiffs as of the date of this report.  As of September 30, 2021, and December 31, 2020, the Company has accrued $11,164 plus accrued interest of approximately $18,000.  In the event we pay any money related to this lawsuit, IDTEC agreed, in connection with us closing the asset purchase transaction with IDTEC, to pay the amount for us in exchange for shares of our common stock.

 

We had one outstanding judgment against us involving a past employee of the Company. The matter was under the purview of the State of California, Franchise Tax Board, Industrial Health and Safety Collections. We owed  $28,786 plus accrued interest of approximately $53,000, which had been accrued as of December 31, 2020, to our ex-employee for unpaid wages under these Orders.  On March 8, 2021 we received an Acknowledgement of Satisfaction of Judgement-Full by the California Court that the judgement has been settled with a payment of approximately $85,000 including accrued interest through settlement date and legal fees of approximately $3,000.  IDTEC agreed, in connection with us closing the asset purchase transaction with IDTEC, to pay the amounts for us in exchange for shares of our common stock. 

 

NOTE 15. SUBSEQUENT EVENTS

 

The Company has evaluated subsequent events for recognition and disclosure through November 15, 2021, which is the date the condensed consolidated financial statements were available to be issued, and has determined that there are no other material subsequent events that require recognition or disclosure in the accompanying condensed consolidated financial statements.

 

28

Table of Contents

 

ITEM 2 Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

Disclaimer Regarding Forward Looking Statements

 

Our Management’s Discussion and Analysis or Plan of Operations contains not only statements that are historical facts, but also statements that are forward-looking. Forward-looking statements are, by their very nature, uncertain and risky. These risks and uncertainties include international, national and local general economic and market conditions; demographic changes; our ability to sustain, manage, or forecast growth; our ability to successfully make and integrate acquisitions; raw material costs and availability; new product development and introduction; existing government regulations and changes in, or the failure to comply with, government regulations; adverse publicity; competition; the loss of significant customers or suppliers; fluctuations and difficulty in forecasting operating results; changes in business strategy or development plans; business disruptions; the ability to attract and retain qualified personnel; the ability to protect technology; and other risks that might be detailed from time to time in our filings with the Securities and Exchange Commission (“SEC”).

 

Although the forward-looking statements in this Quarterly Report reflect the good faith judgment of our management, such statements can only be based on facts and factors currently known by them. Consequently, and because forward-looking statements are inherently subject to risks and uncertainties, the actual results and outcomes may differ materially from the results and outcomes discussed in the forward-looking statements. You are urged to carefully review and consider the various disclosures made by us in this report and in our other reports as we attempt to advise interested parties of the risks and factors that may affect our business, financial condition, and results of operations and prospects.

 

Reverse Stock Split

 

At the open of market on June 8, 2020, our 1-for-33.26 reverse split of our common stock went effective with OTC Markets. As a result, all common stock share amounts, as well as share amounts and exercise and conversion prices in derivative security instruments have been adjusted to reflect the reverse stock split.

 

Overview

 

We intend to create substance-free environments by integrating and commercializing critical substance detection technologies. These technologies will be integrated within our robust and scalable data platform producing statistical analytics and predictive user data. Our mission is to save lives, accelerate intervention, increase productivity, create significant economic benefit and positively impact behavior. To that end, we developed the scalable, patented SOBRSafe™ software platform for non-invasive alcohol detection and identity verification, a solution that has anticipated applications in school buses, commercial vehicle fleets and facility access control, as well as addiction treatment and managed care.

 

Currently, our plan is to deploy our SOBRSafe™ technology in two initial devices: the SOBRtab™ wearable band and the SOBRCheck™ system. SOBRtab™ is a transdermal, alcohol-detecting wearable band containing our SOBRSafe™ technology for ongoing, real-time alcohol monitoring, with predictive heart rate monitoring. SOBRCheck™ is our centralized access control product. When installed in manufacturing facilities, warehouses and more, SOBRCheck™ enables a rapid, hygienic finger scan, with real-time results delivered securely to the employer for any necessary corrective action. The SOBRSafe™ technology can also be deployed across numerous additional devices for various uses. Currently, additional devices for our SOBRSafe™ alcohol detection technology we are exploring include possible integrations with existing law enforcement technologies to enhance public safety. In addition, we are proactively evaluating other emerging detection technologies for alcohol, cannabis, opioids, human health and more.

 

29

Table of Contents

 

Statistical analytics and predictive user data is another potential valuable asset. We believe our device portfolio approach could yield this highly valuable information asset. The opportunity to collect millions of data points over time could enable the development of predictive analytics for perpetual safety improvement (and associated cost savings capture). And by demonstrating substance-free environments, employers could deliver a data-driven argument for lowering insurance premiums and we could potentially partner with insurance providers to mandate use of the SOBRSafe™ devices and/or technology.

 

In addition to focusing on the development, marketing and commercialization of the SOBRCheck™ and SOBRtab™ devices, we are also constantly reviewing synergistic technologies and businesses for potential partnerships, including licensing of the SOBRSafe™ technology.

 

On June 5, 2020, we closed the transaction (the “Transaction”) that was the subject of that certain Asset Purchase Agreement dated May 6, 2019 (and Amendment No. 1 dated March 9, 2020, together the “APA”) with IDTEC, LLC (“IDTEC”), under which IDTEC agreed to provide personnel, experience, and access to funding to assist with the development of our SOBR device, as well as to sell to us certain robotics assets, which our management believes are synergistic with our current assets, in exchange for 12,000,000 shares of our common stock after giving effect to the reverse stock split effected in connection with closing the transaction. The closing of the Transaction was subject to several conditions precedent, primarily: (i) we had to be current in our reporting requirements under the Securities Exchange Act of 1934, as amended, (ii) we had to complete a reverse stock split of our common stock such that approximately 8,000,000 shares were outstanding immediately prior to closing the transaction, (iii) we could only have outstanding convertible instruments as set forth in the APA, (iv) our authorized common stock had to be reduced to 100,000,000 shares, and (v) we could not have more than approximately $125,000 in current liabilities. Effective with the closing of the transaction all of the closing conditions had been met, modified or waived by IDTEC, and we issued the 12,000,000 shares to IDTEC in exchange for IDTEC providing access to personnel, experience, funding to assist with the development of our SOBR device, as well as the robotics assets. The description of the APA set forth in this report is qualified in its entirety by reference to the full text of that document and the amendment, which are attached hereto as Exhibits 10.1 and 10.12, respectively.

 

In advance of closing the Transaction, IDTEC and a few other affiliated parties (i) loaned funds directly to us, (ii) spent funds for the general costs related to the transaction, and/or (iii) spent funds to further develop and enhance the current SOBR product. As a result of closing the transaction, all the funds spent by IDTEC for any reason related to the transaction were turned into a convertible promissory note. The note totaled approximately $1,500,000 at closing, carry a simple interest rate of 10% per annum, are due upon demand, and may be convertible into shares of our common stock at $0.50 per share (after giving effect to the reverse stock split and subject to anti-dilution protection against any future securities we may issue at an effective price of less than $0.50 per share) at the discretion of the holder. The promissory note is due on demand of the holder. The repayment of this promissory note is secured by a first priority security lien or security interest in our patents, trademarks, tradenames and other intellectual property described in Exhibit A of the promissory note. The convertible promissory notes we issued are in the form attached hereto as Exhibit 10.13.

 

As noted above, in connection with the closing of the Transaction, both companies had certain closing conditions under the APA that had to be met. At closing, some of the closing conditions under the APA were either waived and/or modified by the parties. In order to document those modifications and waivers, we entered into a Waiver Under Asset Purchase Agreement and Post-Closing Covenant Agreement with IDTEC. The description of the Waiver Under Asset Purchase Agreement and Post-Closing Covenant Agreement set forth in this report is qualified in its entirety by reference to the full text of that document, which is attached hereto as Exhibit 10.14.

 

One of the closing conditions that was the subject of the Waiver Under Asset Purchase Agreement and Post-Closing Covenant Agreement was the requirement that we have under $125,000 in permitted liabilities (not including aged liabilities) after closing of the Transaction. At closing we had approximately $158,000 in non-permitted liabilities under the APA. As a result, we issued a Warrant to Purchase Common Stock to IDTEC (the “Warrant”), under which IDTEC will purchase up to 320,000 shares of our common stock (post-split) at an exercise price of $0.50 per share, if either (i) we are forced to pay a non-permitted liability, then we may force IDTEC to exercise the Warrant and pay the exercise price to pay the non-permitted liability, but only in an amount sufficient to pay the non-permitted liability (which are listed on Exhibit A of the Warrant), or (ii) if IDTEC otherwise elects to exercise the Warrant and acquire some or all of the shares underlying the Warrant. The Warrant expires five years after the date of issuance. The description of the Warrant set forth in this report is qualified in its entirety by reference to the full text of that document, which is attached hereto as Exhibit 10.15.

 

30

Table of Contents

 

Corporate Overview

 

We were incorporated under the name Imagine Media, Ltd. in August 2007 to publish and distribute Image Magazine, a monthly guide and entertainment source for the Denver, Colorado area. We generated only limited revenue and essentially abandoned the business plan in January 2009. On September 19, 2011, we, Imagine Media, Ltd., a Delaware corporation, acquired approximately 52% of the outstanding shares of TransBiotec, Inc. (the “Company” or “TBT”), a California corporation, from TBT’s directors in exchange for 373,315 shares of our common stock.

 

On January 17, 2012, our Board of Directors amended our Certificate of Incorporation changing our name from Imagine Media, Ltd. to TransBiotec, Inc.

 

On January 31, 2012, we acquired approximately 45% of the remaining outstanding shares of TBT in exchange for 329,936 shares of our common stock.

 

With the acquisitions in September 2011 and January 2012 of TBT common stock, we own approximately 99% of the outstanding shares of TBT.

 

As a result of the acquisitions, TBT’s business is our business, and, unless otherwise indicated, any references to “we” or “us” include the business and operations of TBT.

 

On March 9, 2020, in connection with our transaction with IDTEC, LLC (as detailed herein) our Board of Directors approved the amendment to our Certificate of Incorporation on March 9, 2020 and stockholders holding 52.24% of our then outstanding voting stock approved the amendment to our Articles of Incorporation. The Certificate of Amendment to our Certificate of Incorporation was for the purpose of, among other things, (i) changing our name from “TransBiotec, Inc.” to “SOBR Safe, Inc.”, (ii) effecting a 1-for-33.26 reverse stock split of our common stock, and (iii) decreasing our authorized common stock from 800,000,000 shares to 100,000,000 shares, and became effective with the State of Delaware on April 24, 2020.

 

As a result of the reverse stock split effected by our Certificate of Amendment to our Certificate of Incorporation, every 33.26 shares of our outstanding common stock prior to the effect of that amendment were combined and reclassified into one share of our common stock, and the number of outstanding shares of our common stock at the time was reduced from 266,097,657 (pre-split) to approximately 8,000,000 (post-split). No fractional shares were issued in connection with the reverse stock split, and any of our stockholders that would have been entitled to receive a fractional share as a result of the reverse stock split will instead receive one additional share of our common stock in lieu of the fractional share. The reverse stock split will not in itself affect any stockholder’s ownership percentage of our common stock, except to the extent that any fractional share is rounded up to the nearest whole share.

 

At the open of trading on June 8, 2020, our new name and reverse stock split went effective with OTC Markets, and we began trading on the “OTC Pink Current Information” tier of OTC Markets on a post reverse stock split basis. Our ticker symbol for the quotation of our common stock is now “SOBR”. On November 16, 2020, we began trading on the “OTCQB” tier of OTC Markets.

 

Our corporate offices are located at 885 Arapahoe Avenue, Boulder, CO 80302, telephone number (844) 762-7723.

 

The following discussion:

 

 

o

summarizes our plan of operation; and

 

o

analyzes our financial condition and the results of our operations for the three and nine months ended September 30, 2021.

 

This discussion and analysis should be read in conjunction with our financial statements included as part of this Quarterly Report on Form 10-Q, as well as our financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2020.

 

31

Table of Contents

 

Results of Operations for Three Months Ended September 30, 2021 Compared to Three Months Ended September 30, 2020

 

Summary of Results of Operations

 

 

 

Three Months Ended

September 30,

 

 

 

2021

 

 

2020

 

Revenue

 

$-

 

 

$-

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

General and administrative

 

 

316,329

 

 

 

191,589

 

Stock-based compensation expense

 

 

147,163

 

 

 

-

 

Management salaries and consulting fees

 

 

632,964

 

 

 

352,266

 

Research and development

 

 

566,655

 

 

 

152,123

 

Asset impairment adjustment

 

 

-

 

 

 

-

 

Total operating expenses

 

 

1,663,111

 

 

 

695,978

 

 

 

 

 

 

 

 

 

 

Operating loss

 

 

(1,663,111)

 

 

(695,978)

 

 

 

 

 

 

 

 

 

Other income (expense):

 

 

 

 

 

 

 

 

Loss on extinguishment of debt, net

 

 

-

 

 

 

-

 

Gain on fair value adjustment – derivatives

 

 

-

 

 

 

-

 

Interest expense

 

 

(227,475)

 

 

(41,622)

Amortization of interest – conversion features

 

 

(130,830)

 

 

-

 

Total other expense, net

 

 

(358,305)

 

 

(41,622)

 

 

 

 

 

 

 

 

 

Net loss

 

$(2,021,416)

 

$(737,600)

 

Operating Loss; Net Loss

 

Our net loss increased by $1,283,816 from $737,600 to $2,021,416, from the three-month period ended September 30, 2020 compared to the three-month period ended September 30, 2021. Our operating loss increased by $967,133, from $695,978 to $1,663,111 for the same periods. The change in our net loss and operating loss for the three months ended September 30, 2021, compared to the prior year period, is primarily a result of increases in our general and administrative expense, stock-based compensation expense, and research and development expense. The changes are detailed below.

 

Revenue

 

We have not had any revenues since our inception. Since September 2011, we have been involved in the development of our patented SOBR® Safe™ system, including, but not limited to, the developing, testing and marketing of SOBR®Check™, our unique alcohol sensor technology. Although we have not had any sales to date, we are planning to be ready to commercialize the SOBR®Check™ device in the fourth quarter of 2021 or first quarter of 2022.

 

General and Administrative Expenses

 

General and administrative expenses increased by $124,740, from $191,589 for the three month period ended September 30, 2020 to $316,329 for the three month period ended September 30, 2021, primarily due to increases in facilities rents, marketing and promotion, accounting and other professional fees.

 

32

Table of Contents

 

Stock-Based Compensation Expense

 

We had stock-based compensation expense of $147,163 for the three months ended September 30, 2021, compared to $0 for the three months ended September 30, 2020. The stock-based compensation expense in 2021 was related to the issuance of our common stock as compensation to certain consultants and employees.

 

Management Salaries and Consulting Fees

 

Management salaries and consulting fees increased by $280,698, to $632,964 for the three months ended September 30, 2021, compared to $352,266 for the three months ended September 30, 2020. The management salaries and consulting fees in both years were related to salaries, fees and incentive based stock options to our management and consultants.

 

Research and Development

 

Research and development increased by $403,532, to $555,655 for the three months ended September 30, 2021, compared to $152,123 for the three months ended September 30, 2020. The increase in research and development was due to the ramp up of expenses to develop our SOBR® Safe™ system, including, but not limited to, the developing and testing of SOBRCheck, our unique alcohol sensor technology, as we prepare to commercialize the device in the near future.

 

Interest Expense

 

Interest expense increased by $185,853, from $41,622 for the three-month period ended September 30, 2020 to $227,475 for the three-month period ended September 30, 2021. For both periods these amounts are largely due to the interest on outstanding debt. The increase between the two periods is largely related to the fact that we had significantly more outstanding debt during the three months ended September 30, 2021 compared to the same period in 2020.

 

Amortization of Interest – Conversion Features

 

During the three months ended September 30, 2021, we had amortization of interest – conversion features expense of $130,830 compared to $0 during the three months ended September 30, 2020. The expenses for the period in 2021 was related to the amortized discount on convertible notes payable.

 

33

Table of Contents

 

Results of Operations for Nine Months Ended September 30, 2021 Compared to Nine Months Ended September 30, 2020

 

Summary of Results of Operations

 

 

 

Nine Months Ended

September 30,

 

 

 

2021

 

 

2020

 

Revenue

 

$-

 

 

$-

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

General and administrative

 

 

875,378

 

 

 

400,127

 

Stock-based compensation expense

 

 

334,228

 

 

 

41,302

 

Management salaries and consulting fees

 

 

1,682,557

 

 

 

1,103,828

 

Research and development

 

 

1,052,650

 

 

 

309,403

 

Asset impairment adjustment

 

 

-

 

 

 

25,320,555

 

Total operating expenses

 

 

3,944,813

 

 

 

27,175,215

 

 

 

 

 

 

 

 

 

 

Operating loss

 

 

(3,944,813)

 

 

(27,175,215)

 

 

 

 

 

 

 

 

 

Other income (expense):

 

 

 

 

 

 

 

 

Loss on extinguishment of debt, net

 

 

-

 

 

 

(269,144)

Gain on fair value adjustment – derivatives

 

 

-

 

 

 

60,650

 

Interest expense

 

 

(399,381)

 

 

(107,253)

Amortization of interest – conversion features

 

 

(222,373)

 

 

(1,407,675)

Total other expense, net

 

 

(621,754)

 

 

(1,723,422)

 

 

 

 

 

 

 

 

 

Net loss

 

$(4,566,567)

 

$(28,898,637)

 

The asset impairment adjustment classified as an operating expense herein was previously reported as other expense, net. As a result, the operating loss previously reported for the nine-month period ended September 30, 2020 was understated by $25,320,555 and total other expenses, net was overstated by the same amount. The error had no effect on the net loss for the nine-month period ended September 30, 2020.

 

Operating Loss; Net Loss

 

Our net loss decreased by $24,332,070 from $28,898,637 to $4,566,567, from the nine-month period ended September 30, 2020 compared to the nine-month period ended September 30, 2021. Our operating loss decreased by $23,230,402, from $27,175,215 to $3,944,813 for the same periods. The change in our net loss and operating loss for the nine months ended September 30, 2021, compared to the prior year period, is primarily a result of an asset impairment expense related to the assets we acquired from IDTEC during the nine months ended September 30, 2020, partially offset by increases in general and administrative expenses, stock-based compensation expense, management salaries and consulting fees, and research in development, all of which are primarily related to our increased operations during the nine months ended September 30, 2021 compared to September 30, 2020. The changes are detailed below.

 

34

Table of Contents

 

Revenue

 

We have not had any revenues since our inception. Since September 2011, we have been involved in the development of our patented SOBR® Safe™ system, including, but not limited to, the developing, testing and marketing of SOBR®Check™, our unique alcohol sensor technology. Although we have not had any sales to date, we are planning to be ready to commercialize the SOBR®Check™ device in the fourth quarter of 2021 or first quarter of 2022.

 

General and Administrative Expenses

 

General and administrative expenses increased by $475,251, from $400,127 for the nine-month period ended September 30, 2020 to $875,378 for the nine-month period ended September 30, 2021, primarily due to increases in facilities rents, marketing and promotion, accounting and other professional fees.

 

Stock-Based Compensation Expense

 

We had stock-based compensation expense of $334,228 for the nine months ended September 30, 2021, compared to $41,302 for the nine months ended September 30, 2020. The stock-based compensation expense for both periods was related to the issuance of our common stock as compensation to certain consultants and employees.

 

Management Salaries and Consulting Fees

 

Management salaries and consulting fees increased by $578,729, to $1,682,557 for the nine months ended September 30, 2021, compared to $1,103,828 for the nine months ended September 30, 2020. The management salaries and consulting fees in both years were related to salaries, fees, and incentive based stock options to our management and consultants.

 

Research and Development

 

Research and development increased by $743,247, to $1,052,650 for the nine months ended September 30, 2021, compared to $309,403 for the nine months ended September 30, 2020. The increase in research and development was due to the ramp up of expenses to develop our SOBR® Safe™ system, including, but not limited to, the developing and testing of SOBRCheck, our unique alcohol sensor technology, as we prepare to commercialize the device in the near future.

 

Asset Impairment Adjustment

 

We had an asset impairment adjustment of $25,320,555 in the nine months ended September 30, 2020. We did not have an asset impairment adjustment in the nine months ended September 30, 2021. The asset impairment adjustment in 2020 was related to the value of the stock we issued to IDTEC that was attributed to the robotic assets we acquired from IDTEC versus the value of the assets. When we negotiated the transaction with IDTEC in early-to-mid-2019, the agreed to issue IDTEC 12,000,000 shares of our common stock (post-split) in exchange for the consideration they were transferring to us at the close of the transaction. At the time we negotiated the transaction and signed the Asset Purchase Agreement, our common stock was trading at a lower price than what it was trading at when we closed the transaction and issued the shares. As a result, during the nine months ended September 30, 2020, we impaired the value of the robotic assets we received in the transaction.

 

35

Table of Contents

 

Loss on Extinguishment of Debt, Net

 

Loss on extinguishment of debt, net was $0 for the nine months ended September 30, 2021, compared to $269,144 for the nine months ended September 30, 2020. This decrease was due to us converting several notes payable into shares of our common stock during the nine months ended September 30, 2020, but none during the nine months ended September 30, 2021.

 

Gain on Fair Value Adjustment – Derivatives

 

Gain on fair value adjustment – derivatives was $0 for the nine months ended September 30, 2021, compared to $60,650 for the nine months ended September 30, 2020. For the period in 2020 the amount is related to us having an outstanding financial instrument that contained an embedded derivative liability. The gain related to the instrument is tied to the price of our common stock.

 

Interest Expense

 

Interest expense increased by $292,128, from $107,253 for the nine-month period ended September 30, 2020 to $399,381 for the nine-month period ended September 30, 2021. For both periods these amounts are largely due to the interest on outstanding debt. The increase between the two periods is largely related to the fact that we had significantly more outstanding debt during the nine months ended September 30, 2021 compared to the same period in 2020.

 

Amortization of Interest – Conversion Features

 

During the nine months ended September 30, 2021, we had amortization of interest – conversion features expense of $222,373 compared to $1,407,675 during the nine months ended September 30, 2020. The expenses for both periods were related to the amortized discount on convertible notes payable.

 

36

Table of Contents

 

Liquidity and Capital Resources for Nine Months Ended September 30, 2021 Compared to Nine Months Ended September 30, 2020

 

Introduction

 

During the nine months ended September 30, 2021 and 2020, because of our operating losses, we did not generate positive operating cash flows. Our cash on hand as of September 30, 2021 is $2,185,233 and our monthly operating cash flow burn rate is approximately $200,000. As a result, we do not have short term cash needs, but need to raise additional funds to finance our long term business plans. Our cash needs are being satisfied through proceeds from the sales of our securities and loans from both related parties and third parties. We currently do not believe we will be able to satisfy our cash needs from our revenues for some time, and there is no guarantee we will be successful in the future satisfying these needs through the proceeds generated from the sales of our securities.

 

Our cash, current assets, total assets, current liabilities, and total liabilities as of September 30, 2021 and as of December 31, 2020, respectively, are as follows:

 

 

 

September 30,

2021

 

 

December 31,

2020

 

 

Change

 

 

 

 

 

 

 

 

 

 

 

Cash

 

$2,185,233

 

 

$232,842

 

 

$1,952,391

 

Total Current Assets

 

$2,210,132

 

 

$348,072

 

 

$1,862,060

 

Total Assets

 

$5,566,681

 

 

$3,986,573

 

 

$1,580,108

 

Total Current Liabilities

 

$2,998,714

 

 

$922,089

 

 

$2,076,625

 

Total Liabilities

 

$3,457,289

 

 

$947,089

 

 

$2,510,200

 

 

Our current assets and total assets increased as of September 30, 2021, as compared to December 31, 2020, primarily due to us having more cash on hand at September 30, 2021, as a result of debt issued during the nine months ended September 30, 2021.

 

Our current liabilities increased as of September 30, 2021, as compared to December 31, 2020. This increase was primarily due to increases in accounts payable, accrued interest payable, derivative liability and convertible debenture payable, partially offset by decreases in accrued expenses, and common stock subscriptions payable.

 

In order to repay our obligations in full or in part when due, we will be required to raise significant capital from other sources. There is no assurance, however, that we will be successful in these efforts.

 

Sources and Uses of Cash

 

Operations

 

We had net cash used in operating activities of $2,277,609 for the nine-month period ended September 30, 2021, as compared to net cash used for operating activities of $1,443,783 for the nine-month period ended September 30, 2020. For the period in 2021, the net cash used in operating activities consisted primarily of our net loss of $4,566,567, offset by depreciation and amortization of $289,098, amortization of interest – conversion features of $222,373, amortization of interest of $275,052, stock options expense of $399,259, and stock-based compensation expense of $334,228, and changes in our assets and liabilities of prepaid expenses of $(19,361), other assets of ($7,146), accounts payable of $604,834, accrued expenses of ($6,961), accrued interest payable of $58,733, related party payables of $780, and common stock subscriptions payable of $138,069. For the period in 2020, the net cash used in operating activities consisted primarily of our net loss of $28,898,637 and change in fair value of derivative liability of $60,650, offset by a loss on debt extinguishment, net of $269,144, depreciation and amortization of $133,571, amortization of interest – beneficial conversion feature of $1,407,675, stock warrants expense of $8,856, stock options expense of $343,549, stock-based compensation expense of $41,302, and asset impairment adjustment of $25,320,555, and changes in our assets and liabilities of prepaid expenses of $994, other assets of ($8,680), accounts payable of $140,906, accrued expenses of ($83,495), accrued interest payable of ($6,697), and related party payables of ($51,976).

 

37

Table of Contents

 

Investments

 

We had no cash provided by or used for investing activities during the nine-month period ended September 30, 2021 or September 30, 2020.

 

Financing

 

Our net cash provided by financing activities for the nine-month period ended September 30, 2021 was $4,230,000, compared to $1,741,665 for the nine-month period ended September 30, 2020. For the nine-month period ended September 30, 2021, our net cash from financing activities consisted of proceeds from notes payable – non-related parties of $1,005,000, proceeds from notes payable – related parties of $1,030,000, repayments of notes payable-related parties of ($30,000), proceeds from convertible debenture payable of $2,500,000 and debt issuance costs of ($275,000). For the nine-month period ended September 30, 2020, our net cash from financing activities consisted of proceeds from offering of preferred stock – related parties of $1,700,000, and proceeds from notes payable – non-related parties of $41,665.

 

On January 30, 2020, the World Health Organization (“WHO”) announced a global health emergency because of a new strain of coronavirus originating in Wuhan, China (the “COVID-19 outbreak”) and the risks to the international community as the virus spreads globally beyond its point of origin. In March 2020, the WHO classified the COVID-19 outbreak as a pandemic, based on the rapid increase in exposure globally. The full impact of the COVID-19 outbreak continues to evolve as of the date of this filing. Management is actively monitoring the global situation on our financial condition, liquidity, operations, suppliers, industry, and workforce. Given the daily evolution of the COVID-19 outbreak and the global responses to curb its spread, we are not able to estimate the effects of the COVID-19 outbreak on our results of operations, financial condition, or liquidity for fiscal year 2021. However, if the pandemic continues, it could have an adverse effect on our results of future operations, financial position, and liquidity in year 2021.

 

Off Balance Sheet Arrangements

 

We have no off balance sheet arrangements as of September 30, 2021 and December 31, 2020.

 

ITEM 3 Quantitative and Qualitative Disclosures About Market Risk

 

As a smaller reporting company, we are not required to provide the information required by this Item.

 

38

Table of Contents

 

ITEM 4 Controls and Procedures

 

(a) Evaluation of Disclosure and Controls Procedures

 

Disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) are designed to ensure that information required to be disclosed in reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms. Disclosure and control procedures are also designed to ensure that such information is accumulated and communicated to management, including the chief executive officer and chief financial officer, to allow timely decisions regarding required disclosures.

 

As of September 30, 2021, we carried out an evaluation, under the supervision and with the participation of management, including our chief executive officer (our Principal Executive Officer) and chief financial officer (our Principal Financial Officer), of the effectiveness of the design and operation of our disclosure controls and procedures. In designing and evaluating the disclosure controls and procedures, management recognizes that there are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding of the controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable assurance of achieving their desired control objectives. Additionally, in evaluating and implementing possible controls and procedures, management is required to apply its reasonable judgment. We also do not have an audit committee. Based on the evaluation described above, and as a result, in part, of not having an audit committee and having one individual serve as our chief executive officer and another individual serve as our chief financial officer, management has concluded that, as of the end of the period covered by this report, our disclosure controls and procedures were not effective to the same extent as reported in our Annual Report on Form 10-K for the year ended December 31, 2020.

 

As funds become available to us, we expect to implement additional measures to improve disclosure controls and procedures.

 

(b) Changes in Internal Controls over Financial Reporting

 

There was no change in our internal controls over financial reporting that occurred during the period covered by this report, which has materially affected, or is reasonably likely to materially affect, our internal controls over financial reporting.

 

(c) Officer’s Certifications

 

Appearing as an exhibit to this quarterly report on Form 10-Q are “Certifications” of our Chief Executive and Financial Officer. The Certifications are required pursuant to Sections 302 of the Sarbanes-Oxley Act of 2002 (the “Section 302 Certifications”). This section of the quarterly report on Form 10-Q contains information concerning the Controls Evaluation referred to in the Section 302 Certifications. This information should be read in conjunction with the Section 302 Certifications for a more complete understanding of the topics presented.

 

39

Table of Contents

 

PART II – OTHER INFORMATION

 

ITEM 1 Legal Proceedings

 

On December 6, 2006, Orange County Valet and Security Patrol, Inc. filed a lawsuit against us in Orange County California State Superior Court for Breach of Contract in the amount of $11,164. A default judgment was taken against us in this matter. In mid-2013 we learned the Plaintiff’s perfected the judgment against us, but we have not heard from the Plaintiffs as of November 2021. In the event we pay any money related to this lawsuit, IDTEC, LLC agreed, in connection with us closing the asset purchase transaction with IDTEC, to pay the amount for us in exchange for shares of our common stock.

 

We had one outstanding judgment against us involving a past employee of the Company. The matter was under the purview of the State of California, Franchise Tax Board, Industrial Health and Safety Collections. We owed approximately $28,786 plus accrued interest of approximately $53,000 to our ex-employee for unpaid wages under these Orders. On March 8, 2021, we received an Acknowledgement of Satisfaction of Judgement-Full by the California Court notifying us that the judgement has been settled with a payment of approximately $85,000 including the accrued interest owed through settlement date and legal fees of approximately $3,000. IDTEC, LLC agreed, in connection with us closing the asset purchase transaction with IDTEC, to pay the amount for us in exchange for shares of our common stock acquired through the exercise of a warrant held by IDTEC, LLC.

 

In the ordinary course of business, we are from time to time involved in various pending or threatened legal actions. The litigation process is inherently uncertain and it is possible that the resolution of such matters might have a material adverse effect upon our financial condition and/or results of operations. However, in the opinion of our management, other than as set forth herein, matters currently pending or threatened against us are not expected to have a material adverse effect on our financial position or results of operations.

 

ITEM 1A Risk Factors

 

As a smaller reporting company, we are not required to provide the information required by this Item.

 

ITEM 2 Unregistered Sales of Equity Securities and Use of Proceeds

 

During the three months ended September 30, 2021 we issued the following unregistered securities:

 

On September 28, 2021, we closed a financing transaction with a leading healthcare fund (the “Purchaser”). Under the terms of the financing, we received $2,500,000 from the Purchaser and in exchange issued the Purchaser an 18% Original Issue Discount Convertible Debenture in the principal amount of $3,048,780.50 (the “Debenture”) and a Common Stock Purchase Warrant to purchase up to 1,219,512 shares of our common stock (the “Warrant”). Additional terms of the Debenture and Warrant are set forth under Part II Item 5, herein. The issuance of these securities was exempt from registration pursuant to Section 4(a)(2) of the Securities Act of 1933. The investor is accredited, familiar with our operations, and there was no general solicitation or advertising.

 

40

Table of Contents

 

ITEM 3 Defaults Upon Senior Securities

 

On December 28, 2010, we borrowed $11,810 from a related party. The note payable carries an interest rate of 0% and matured on December 31, 2012. As of September 30, 2021 this note was in default.

 

On February 20, 2012, we borrowed $3,750 from a non-related party. The note payable carries an interest rate of 12% and matured on February 19, 2013. As of September 30, 2021 this note was in default.

 

On March 20, 2012, we borrowed $5,433 from a non-related party. The note payable carries an interest rate of 12% and matured on March 19, 2013. As of September 30, 2021 this note was in default.

 

On September 27, 2013, we borrowed $15,000 from a non-related party. The note payable carries an interest rate of 9% and matured on December 25, 2013. As of September 30, 2021 this note was in default.

 

On March 14, 2014, we borrowed $5,000 from a non-related party. The note payable carries an interest rate of 10% and matured on September 14, 2014. As of September 30, 2021 this note was in default.

 

On July 31, 2015, we borrowed $2,500 from a non-related party. The note payable carries an interest rate of 10% and matured on November 28, 2015. As of September 30, 2021 this note was in default.

 

ITEM 4 Mine Safety Disclosures

 

There have been no events which are required to be reported under this Item.

 

ITEM 5 Other Information

 

Financing Transaction

 

On September 28, 2021, we closed a financing transaction with a leading healthcare fund (the “Purchaser”). Under the terms of the financing, we received $2,500,000 from the Purchaser and in exchange issued the Purchaser an 18% Original Issue Discount Convertible Debenture in the principal amount of $3,048,780.50 (the “Debenture”) and a Common Stock Purchase Warrant to purchase up to 1,219,512 shares of our common stock (the “Warrant”).

 

The Debenture is convertible: (a) voluntarily by the Purchaser at any time into shares of our common stock at the lesser of (i) 100% of the closing price our common stock on the trading day immediate prior to the Closing Date under the Debenture, or (ii) 75% of the average VWAP of our common stock (representing a 25% discount) during the 5 trading day period immediately prior to the applicable conversion date (on an as adjusted basis giving effect to any splits, dividend and the like during such 5 Trading Day period) (the “Conversion Price”), or (b) automatically upon the occurrence of a Qualified Offering (as defined in the Debenture) into shares of our common stock at the lesser of: (i) the Conversion Price or (ii) 75% of the offering price of the securities offered in the Qualified Offering. The Debenture matures on March 27, 2022, does not accrue interest unless there is an event of default under the terms of the Debenture, and contains industry standard default and other provisions. The description of the Debenture set forth in this report is qualified in its entirety by reference to the full text of that document, which incorporated herein as Exhibit 10.17.

  

The Warrant is exercisable at any time in the next five (5) years into shares of our common at an exercise price of $2.00 per share, unless an event of default occurs, at which time the exercise price will adjust to $1.00 per share. The Warrant contains a cashless exercise provision but only in the event we fail to have an effective registration statement registering the shares underlying the Warrant at any time beginning six (6) months from the date of the Warrant. The description of the Warrant set forth in this report is qualified in its entirety by reference to the full text of that document, which is incorporated herein as Exhibit 10.18.

 

In connection with the financing transaction we entered into a Securities Purchase Agreement and Registration Rights Agreement with the Purchaser, both with standard industry terms. The descriptions of the Securities Purchase Agreement and Registration Rights Agreement set forth in this report are qualified in their entirety by reference to the full text of those documents, which are incorporated herein as Exhibit 10.19 and Exhibit 10.20, respectively.

 

41

Table of Contents

 

ITEM 6 Exhibits

 

Item No.

 

Description

 

 

 

3.1 (1)

 

Articles of Incorporation of Imagine Media, Ltd.

 

 

 

3.2 (2)

 

Articles of Amendment to Articles of Incorporation to TransBiotec, Inc.

 

 

 

3.3 (3)

 

Certificate of Amendment to Certificate of Incorporation filed with the State of Delaware on May 25, 2017

 

 

 

3.4 (6)

 

Amended and Restated Bylaws of SOBR Safe, Inc.

 

 

 

3.5 (10)

 

Certificate of Amendment to Certificate of Incorporation of TransBiotec, Inc. changing name to SOBR Safe, Inc., effecting 1-for-33.26 reverse stock split and decreasing authorized common stock to 100M shares

 

 

 

10.1 (4)

 

Asset Purchase Agreement dated May 6, 2019 between IDTEC, LLC and TransBiotec, Inc.

 

 

 

10.2 (5)

 

Common Stock Purchase Agreement with Charles Bennington dated August 23, 2019

 

 

 

10.3 (5)

 

Share Exchange Agreement with Michael Lanphere dated August 23, 2019

 

 

 

10.4 (5)

 

Share Exchange Agreement with Vernon Justus dated August 23, 2019

 

 

 

10.5 (5)

 

Debt Conversion and Common Stock Purchase Agreement with Michael Lanphere dated August 23, 2019

 

 

 

10.6 (5)

 

Debt Conversion and Common Stock Purchase Agreement with Devadatt Mishal dated August 23, 2019

 

 

 

10.7 (6)

 

TransBiotec, Inc. 2019 Equity Incentive Plan

 

 

 

10.8 (6)

 

Employment Agreement with Kevin Moore dated October 25, 2019

 

 

 

10.9 (8)

 

Amended Employment Agreement with Kevin Moore dated November 26, 2019

 

 

 

10.10 (6)

 

Employment Agreement with David Gandini dated October 25, 2019

 

 

 

10.11 (7)

 

Series A-1 Preferred Stock Purchase Agreement by and between TransBiotec, Inc. and SOBR SAFE, LLC dated December 12, 2019 (with Series A-1 Preferred Stock Certificate of Designation attached)

 

42

Table of Contents

 

10.12 (9)

 

Amendment No. 1 to Asset Purchase Agreement dated March 23, 2020 by and between IDTEC, LLC and TransBiotec, Inc.

 

 

 

10.13 (10)

 

Form of Convertible Promissory Note Issued to IDTEC, LLC at Close of Asset Purchase Transaction

 

 

 

10.14 (10)

 

Waiver Under Asset Purchase Agreement and Post-Closing Covenant Agreement dated June 5, 2020 by and between IDTEC, LLC and TransBiotec, Inc.

 

 

 

10.15 (10)

 

Warrant to Purchase Common Stock dated June 5, 2020 issued to IDTEC, LLC

 

 

 

10.16 (11)

 

Advisory Agreement with Steven Beabout dated October 9, 2020

 

 

 

10.17 (12)

 

18% Original Issue Discount Convertible Debenture issued by SOBR Safe, Inc. to a leading healthcare fund dated September 27, 2021

 

 

 

10.18 (12)

 

Warrant to Purchase Common Stock issued by SOBR Safe, Inc. to a leading healthcare fund dated September 27, 2021

 

 

 

10.19 (12)

 

Securities Purchase Agreement by and between SOBR Safe, Inc. and a leading healthcare fund dated September 27, 2021

 

 

 

10.20 (12)

 

Registration Rights Agreement by and between SOBR Safe, Inc. and a leading healthcare fund dated September 27, 2021

 

 

 

31.1*

 

Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer (filed herewith)

 

 

 

31.2*

 

Rule 13a-14(a)/15d-14(a) Certification of Chief Accounting Officer (filed herewith)

 

 

 

32.1*

 

Section 1350 Certification of Chief Executive Officer (filed herewith).

 

 

 

32.2*

 

Section 1350 Certification of Chief Accounting Officer (filed herewith).

 

 

 

101.INS **

 

Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).

 

 

 

101.SCH **

 

Inline XBRL Taxonomy Extension Schema Document

 

 

 

101.CAL **

 

Inline XBRL Taxonomy Extension Calculation Linkbase Document

 

 

 

101.DEF **

 

Inline XBRL Taxonomy Extension Definition Linkbase Document

 

 

 

101.LAB **

 

Inline XBRL Taxonomy Extension Label Linkbase Document

 

 

 

101.PRE **

 

Inline XBRL Taxonomy Extension Presentation Linkbase Document

 

 

 

104

 

Cover Page Interactive Data File (embedded within the Inline XBRL document)

________ 

* Filed herewith.

 

43

Table of Contents

 

** XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registrati0n statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.

 

(1)

Incorporated by reference from our Registration Statement on Form SB-2, filed with the Commission on January 31, 2008

 

 

(2)

Incorporated by reference from our Registration Statement on Form S-1, filed with the Commission on November 6, 2012

 

 

(3)

Incorporated by reference from our Annual Report on Form 10-K for the year ended December 31, 2017, filed with the Commission on February 6, 2019

 

 

(4)

Incorporated by reference from our Current Report on Form 8-K, filed with the Commission on May 14, 2019.

 

 

(5)

Incorporated by reference from our Current Report on Form 8-K, filed with the Commission on September 10, 2019.

 

 

(6)

Incorporated by reference from our Current Report on Form 8-K, filed with the Commission on November 19, 2019

 

 

(7)

Incorporated by reference from our Current Report on Form 8-K, filed with the Commission on December 23, 2019

 

 

(8)

Incorporated by reference from our Annual Report on Form 10-K, filed with the Commission on April 17, 2020

 

 

(9)

Incorporated by reference from our Quarterly Report on Form 10-Q for the period ended September 30, 2020, filed with the Commission on May 26, 2020

 

 

(10)

Incorporated by reference from our Current Report on Form 8-K filed with the Commission on June 11, 2020

 

 

(11)

Incorporated by reference from our Annual Report on Form 10-K for the period ended December 31, 2020, filed with the Commission on September 30, 2021

 

 

(12)

Incorporated by reference from our Current Report on Form 8-K filed with the Commission on October 1, 2021

 

44

Table of Contents

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

SOBR Safe, Inc.

 

 

 

 

 

Dated: November 15, 2021

By:

/s/ David Gandini

 

 

 

David Gandini

 

 

Its:

Chief Executive Officer and Principal Executive Officer

 

 

 
45

 

EX-31.1 2 sobr_ex311.htm CERTIFICATION sobr_ex311.htm

 

EXHIBIT 31.1

 

Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer

 

I, David Gandini, certify that:

 

1.

I have reviewed this Quarterly Report on Form 10-Q of SOBR Safe, Inc.;

 

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

 

4.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exhibit Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

 

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

 

 

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

 

 

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and

 

 

 

 

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

 

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and report financial information; and

 

 

 

 

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

  

 

 

 

Dated: November 15, 2021

By:

/s/ David Gandini

 

 

 

David Gandini

 

 

 

Chief Executive Officer and Principal Executive Officer

 

EX-31.2 3 sobr_ex312.htm CERTIFICATION sobr_ex312.htm

 

EXHIBIT 31.2

 

Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer
 

I, David Gandini, certify that:

 

1.

I have reviewed this Quarterly Report on Form 10-Q of SOBR Safe, Inc.;

 

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

 

4.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exhibit Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

 

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

 

 

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

 

 

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and

 

 

 

 

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

 

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

 

 

 

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

   

 

 

 

Dated: November 15, 2021

By:

/s/ David Gandini

 

 

David Gandini

 

 

 

Chief Financial Officer and Chief Accounting Officer

 

EX-32.1 4 sobr_ex321.htm CERTIFICATION sobr_ex321.htm

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO 18 USC, SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of SOBR Safe, Inc. (the “Company”) on Form 10-Q for the quarter ended September 30, 2021, as filed with the Securities and Exchange Commission on or about the date hereof (the “Report”), I, David Gandini, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:

 

 

(1)

The Report fully complies with the requirements of Sections 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

 

 

 

(2)

Information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated: November 15, 2021

 

 

 

 

 

/s/ David Gandini

 

 

By:

David Gandini

 

 

 

Chief Executive Officer and Principal Executive Officer

 

 

A signed original of this written statement required by Section 906 has been provided to SOBR Safe, Inc. and will be retained by SOBR Safe, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2 5 sobr_ex322.htm CERTIFICATION sobr_ex322.htm

EXHIBIT 32.2

 

CERTIFICATION PURSUANT TO 18 USC, SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of SOBR Safe, Inc. (the “Company”) on Form 10-Q for the quarter ended September 30, 2021, as filed with the Securities and Exchange Commission on or about the date hereof (the “Report”), I, David Gandini, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:

 

 

(1)

The Report fully complies with the requirements of Sections 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

 

 

 

(2)

Information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

 

 

Dated: November 15, 2021

By:

/s/ David Gandini

 

 

David Gandini

 

 

 

Chief Financial Officer and Chief Accounting Officer

 

 

A signed original of this written statement required by Section 906 has been provided to SOBR Safe, Inc. and will be retained by SOBR Safe, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

EX-101.SCH 6 imle-20210930.xsd XBRL TAXONOMY EXTENSION SCHEMA 000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 000007 - Disclosure - ORGANIZATION OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 000008 - Disclosure - GOING CONCERN link:presentationLink link:calculationLink link:definitionLink 000009 - Disclosure - ASSET PURCHASE link:presentationLink link:calculationLink link:definitionLink 000010 - Disclosure - PREPAID EXPENSES link:presentationLink link:calculationLink link:definitionLink 000011 - Disclosure - INTANGIBLE ASSETS link:presentationLink link:calculationLink link:definitionLink 000012 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 000013 - Disclosure - CONVERTIBLE DEBENTURE PAYABLE link:presentationLink link:calculationLink link:definitionLink 000014 - Disclosure - NOTES PAYABLE link:presentationLink link:calculationLink link:definitionLink 000015 - Disclosure - DERIVATIVE LIABILITY link:presentationLink link:calculationLink link:definitionLink 000016 - Disclosure - STOCK SUBSCRIPTIONS PAYABLE link:presentationLink link:calculationLink link:definitionLink 000017 - Disclosure - COMMON STOCK link:presentationLink link:calculationLink link:definitionLink 000018 - Disclosure - PREFERRED STOCK link:presentationLink link:calculationLink link:definitionLink 000019 - Disclosure - STOCK WARRANTS AND STOCK OPTIONS link:presentationLink link:calculationLink link:definitionLink 000020 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 000021 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 000022 - Disclosure - ORGANIZATION OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 000023 - Disclosure - ORGANIZATION OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 000024 - Disclosure - ASSET PURCHASE (Tables) link:presentationLink link:calculationLink link:definitionLink 000025 - Disclosure - PREPAID EXPENSES (Tables) link:presentationLink link:calculationLink link:definitionLink 000026 - Disclosure - INTANGIBLE ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 000027 - Disclosure - CONVERTIBLE DEBENTURE PAYABLE (Tables) link:presentationLink link:calculationLink link:definitionLink 000028 - Disclosure - NOTES PAYABLE (Tables) link:presentationLink link:calculationLink link:definitionLink 000029 - Disclosure - STOCK WARRANTS AND STOCK OPTIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 000030 - Disclosure - ORGANIZATION, OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) link:presentationLink link:calculationLink link:definitionLink 000031 - Disclosure - ORGANIZATION, OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000032 - Disclosure - GOING CONCERN (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000033 - Disclosure - ASSET PURCHASE (Details) link:presentationLink link:calculationLink link:definitionLink 000034 - Disclosure - ASSET PURCHASE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000035 - Disclosure - PREPAID EXPENSES (Details) link:presentationLink link:calculationLink link:definitionLink 000036 - Disclosure - PREPAID EXPENSES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000037 - Disclosure - INTANGIBLE ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 000038 - Disclosure - INTANGIBLE ASSETS (Details 1) link:presentationLink link:calculationLink link:definitionLink 000039 - Disclosure - INTANGIBLE ASSETS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000040 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000041 - Disclosure - CONVERTIBLE DEBENTURE PAYABLE (Details) link:presentationLink link:calculationLink link:definitionLink 000042 - Disclosure - CONVERTIBLE DEBENTURE PAYABLE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000043 - Disclosure - NOTES PAYABLE (Details) link:presentationLink link:calculationLink link:definitionLink 000044 - Disclosure - NOTES PAYABLE (Details 1) link:presentationLink link:calculationLink link:definitionLink 000045 - Disclosure - NOTES PAYABLE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000046 - Disclosure - DERIVATIVE LIABILITY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000047 - Disclosure - STOCK SUBSCRIPTIONS PAYABLE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000048 - Disclosure - COMMON STOCK (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000049 - Disclosure - PREFERRED STOCK (Details Narratve) link:presentationLink link:calculationLink link:definitionLink 000050 - Disclosure - STOCK WARRANTS AND STOCK OPTIONS (Details) link:presentationLink link:calculationLink link:definitionLink 000051 - Disclosure - STOCK WARRANTS AND STOCK OPTIONS (Details 1) link:presentationLink link:calculationLink link:definitionLink 000052 - Disclosure - STOCK WARRANTS AND STOCK OPTIONS (Details 2) link:presentationLink link:calculationLink link:definitionLink 000053 - Disclosure - STOCK WARRANTS AND STOCK OPTIONS (Details 3) link:presentationLink link:calculationLink link:definitionLink 000054 - Disclosure - STOCK WARRANTS AND STOCK OPTIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000055 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 7 imle-20210930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Entity Registrant Name Entity Central Index Key Document Type Amendment Flag Current Fiscal Year End Date Entity Small Business Entity Shell Company Entity Emerging Growth Company Entity Current Reporting Status Document Period End Date Entity Filer Category Document Fiscal Period Focus Document Fiscal Year Focus Entity Common Stock Shares Outstanding Document Quarterly Report Document Transition Report Entity Address Address Line 1 Entity Address City Or Town Entity Address State Or Province Entity Interactive Data Current Entity File Number Entity Incorporation State Country Code Entity Tax Identification Number Entity Address Postal Zip Code City Area Code Local Phone Number CONDENSED CONSOLIDATED BALANCE SHEETS Statement [Table] Statement [Line Items] Statement Class Of Stock Axis Series A Convertible Preferred Stock [Member] Series A-1 Convertible Preferred stock [Member] ASSETS Current assets Cash Prepaid expenses Total current assets [Assets, Current] SOBR Safe Intellectual Technology, net of accumulated amortization of $513,952 and $224,854 at September 30, 2021 and December 31, 2020, respectively Other assets Total Assets [Assets] LIABILITIES & STOCKHOLDERS' EQUITY Current liabilities Accounts payable Accrued expenses Accrued interest payable Related party payables Common stock subscriptions payable Derivative liability * Includes unamortized debt discount related to detached warrants and convertible debenture of $2,608,900 and none at September 30, 2021 and December 31, 2020, respectively Current portion notes payable - related parties Current portion notes payable - non-related parties Total current liabilities [Liabilities, Current] Notes payable -related parties-less current portion * Includes unamortized debt discount and beneficial conversion feature related to detached warrants and convertible notes of $771,576 and none at September 30, 2021 and December 31, 2020, respectively Notes payable -non-related parties-less current portion * Includes unamortized debt discount and beneficial conversion feature related to detached warrants and convertible notes of $774,850 and none at September 30, 2021 and December 31, 2020, respectively Total Liabilities [Liabilities] Stockholders' Equity Preferred stock, $0.00001 par value; 19,300,000 shares authorized, no shares issued or outstanding as of September 30, 2021 and December 31, 2020 Common stock, $0.00001 par value; 100,000,000 shares authorized; 25,981,203 and 25,922,034 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively Additional paid-in capital Accumulated deficit Total SOBR Safe, Inc. stockholders' equity Noncontrolling interest Total Stockholders' Equity Total Liabilities and Stockholders' Equity [Liabilities and Equity] SOBR Safe Intellectual Technology, net of accumulated amortization Current liabilities Notes payable -related parties-less current portion [Notes payable -related parties-less current portion] Notes payable -non-related parties-less current portion [Notes payable -non-related parties-less current portion] Discount beneficial features Stockholders' Deficit Common stock, shares par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Preferred stock, shares par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) Revenues Operating expenses: General and administrative Stock-based compensation expense Management salaries and consulting fees Research and development Asset impairment adjustment Total operating expenses [Operating Expenses] Loss from operations [Operating Income (Loss)] Other income (expense): Loss on extinguishment of debt, net Gain on fair value adjustment - derivatives Interest expense [Interest Expense] Amortization of interest - conversion features Total other expense, net [Other Noncash Income (Expense)] Loss before provision for income taxes [Income (Loss) from Continuing Operations before Income Taxes, Domestic] Provision for income taxes Net loss [Net Income (Loss) Attributable to Parent] Net (income) loss attributable to noncontrolling interest Net loss attributable to SOBR Safe, Inc. Accrued dividends on convertible preferred stock [Preferred Stock Dividends, Income Statement Impact] Net loss attributable to common stockholders Basic and diluted loss per common share Weighted average number of common shares outstanding CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (UNAUDITED) Equity Components [Axis] Common Stock [Member] Preferred Stock [Member] Additional Paid-in Capital [Member] Accumulated Deficit [Member] Stockholders Deficit SOBR Safe Inc [Member] Noncontrolling Interest Balance, shares [Shares, Issued] Balance, amount Common stock issued for compensation, shares Common stock issued for compensation, amount Common stock issued due to stock warrants exercise, shares Common stock issued due to stock warrants exercise, amount Common stock issued to settle related party payables, shares Common stock issued to settle related party payables, amount Common stock issued to settle accounts payable and accrued expenses, shares Common stock issued to settle accounts payable and accrued expenses, amount Common stock issued to settle related party debt, shares Common stock issued to settle related party debt, amount Common stock issued to settle non-related party debt, shares Common stock issued to settle non-related party debt, amount Paid-in capital - fair value of stock options vested Paid-in capital - gain on related party debt conversion Paid-in capital - gain on related party payables conversion Paid-in capital - loss on debt extinguishment Paid-in capital - beneficial conversion feature Net loss for the period Common stock issued for asset purchase, shares Common stock issued for asset purchase, amount Paid-in capital - fair value of stock warrants granted Paid-in capital - loss on extinguishment of convertible notes Dividends payable-Series A-1 convertible preferred stock Common stock issued to settle dividends - Series A-1 Convertible Preferred stock, shares Common stock issued to settle dividends - Series A-1 Convertible Preferred stock, amount Paid-in capital - fair value of stock options and RSU vested Paid-in capital - relative fair value of stock warrants granted Common stock issued for facility lease, shares Common stock issued for facility lease, amount Balance, shares Balance, amount CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) Operating Activities: Net loss Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and amortization Loss on debt extinguishment, net Change in fair value of derivative liability Amortization of interest - conversion feature Amortization of interest Stock options expense Stock-based compensation expense [Share-based Payment Arrangement, Expense, after Tax] Asset impairment adjustment [Asset impairment adjustment] Changes in assets and liabilities: Prepaid expenses [Increase (Decrease) in Prepaid Expense] Other assets [Increase (Decrease) in Other Noncurrent Assets] Accounts payable [Increase (Decrease) in Accounts Payable] Accrued expenses [Increase (Decrease) in Accrued Liabilities] Accrued interest payable [Increase (Decrease) in Interest Payable, Net] Related party payables [Increase (Decrease) in Due to Related Parties] Common stock subscriptions payable [Common stock subscriptions payable] Net cash used in operating activities [Net Cash Provided by (Used in) Operating Activities] Financing Activities: Proceeds from notes payable - related parties Repayments of notes payable - related parties Proceeds from notes payable - non-related parties Proceeds from convertible debenture payable Debt issuance costs [Proceeds from Issuance of Debt] Proceeds from offering of preferred stock - related parties Net cash provided by financing activities [Net Cash Provided by (Used in) Financing Activities] Net Change In Cash [Cash, Period Increase (Decrease)] Cash At The Beginning Of The Period [Cash and Cash Equivalents, at Carrying Value] Cash At The End Of The Period Schedule Of Non-Cash Investing And Financing Activities: Issuance of common shares for rent Issuance of common stock for prior year accrued dividends Intrinsic value-beneficial conversion feature Relative fair value of stock warrants granted Convertible debenture payable discount Fair value of embedded conversion feature Gain on related party payables converted to capital Accounts payable and accrued expenses converted to capital Related party payables converted to capital Related party debt converted to capital after exercise of cashless stock warrants Related party debt converted to capital Non-related party debt converted to capital Gain on related party debt converted to capital Shares issued for cash received in prior years Issuance of common stock, stock warrants and convertible note for asset purchase Preferred stock dividend accrued Supplemental Disclosure: Cash paid for interest Cash paid for income taxes ORGANIZATION OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES NOTE 1. ORGANIZATION, OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES GOING CONCERN NOTE 2. GOING CONCERN ASSET PURCHASE NOTE 3. ASSET PURCHASE PREPAID EXPENSES NOTE 4. PREPAID EXPENSES INTANGIBLE ASSETS NOTE 5. INTANGIBLE ASSETS RELATED PARTY TRANSACTIONS NOTE 6. RELATED PARTY TRANSACTIONS NOTE 7. CONVERTIBLE DEBENTURE PAYABLE NOTES PAYABLE NOTE 8. NOTES PAYABLE DERIVATIVE LIABILITY NOTE 9. DERIVATIVE LIABILITY STOCK SUBSCRIPTIONS PAYABLE NOTE 10. STOCK SUBSCRIPTIONS PAYABLE COMMON STOCK NOTE 11. COMMON STOCK PREFERRED STOCK NOTE 12. PREFERRED STOCK STOCK WARRANTS AND STOCK OPTIONS NOTE 13. STOCK WARRANTS AND STOCK OPTIONS COMMITMENTS AND CONTINGENCIES NOTE 14. COMMITMENTS AND CONTINGENCIES SUBSEQUENT EVENTS NOTE 15. SUBSEQUENT EVENTS Basis of Presentation Principles of consolidations Use of Estimates Financial Instruments Cash Cash and Cash Equivalents, Policy [Policy Text Block] Prepaid Expenses Beneficial Conversion Features Debt Issuance Costs Preferred Stock Minority Interest (Noncontrolling Interest) Stock-based compensation Research and Development Advertising and Marketing Costs Depreciation Income tax Net loss per share Concentration of Credit Risk Related Parties New Pronouncements Correction of Error Schedule of assets and liabilities Summary of closing transactions Schedule of prepaid expenses Summary of Intangible Assets Schedule of estimated future amortization expense Schedule of debenture payable Schedule of notes payables - related parties Schedule of notes payables - non related parties Schedule of fair value of non-employee stock/warrants Schedule of fair value of stock options Schedule of outstanding options Financial Instrument Axis Level 1 [Member] Level 2 [Member] Level 3 [Member] Derivative liabilites Fair value assets and liabilities Plan Name [Axis] Annual Meeting of Shareholders [Member] Research and development costs Impairment loss Loss from operation Depreciation [Depreciation] Excess of the FDIC insured limits Advertising and marketing costs Valuation allowance, percentage FDIC insured limit Ownership interest, percentage Common stock, shares authorized Common stock, par value Description of reverse stock split Award Date [Axis] Private Offering [Member] January 15, 2021 [Member] Accumulated deficit Proceeds from convertible debt Debt face amount OID percentage Net cash used in operating activities Additional offering amount Termination date description Offering amount Property and equipment Intangible assets Total assets Net purchase (fair value of stock issued, warrants and notes payable) Business Acquisition [Axis] Asset Purchase Agreement [Member] IDTEC [Member] Liability required Exercise price per share Market price of shares Assets purchase upon shares issued Assets purchase upon shares issued, shares Common stock issuable upon exercise of warrant, shares Asset impairment charges loss Fair value of warrants issued Description of fair value of assets evaluation Common stock, shares issued upon assets purchase Convertible notes, conversion price Interest rate Convertible Notes Payable Consulting services Rent Insurance Prepaid expenses Lease Agreement [Member] Prepaid expenses with common shares Common stock issued Rent [Operating Leases, Rent Expense] Property, Plant and Equipment, Type [Axis] Intellectual Technology [Member] Intangible assets, gross Accumulated amortization Intangible assets, net Amortization Period 2022 2023 2024 2025 2026 Thereafter Amortization and depreciation expense Related Party Transaction [Axis] Title of Individual [Axis] David Gandini [Member] IDTEC [Member] [IDTEC [Member]] Nick Noceti [Member] Charles Bennington [Member] Director [Member] Prakash Gadgil [Member] Stock Purchase Plan One [Member] Devdatt Mishal [Member] Lanphere Law Group [Member] Stock Purchase Plan Three [Member] Vemon Justus [Member] Stock Purchase Plan Two [Member] December 3 2014 [Member] Exercise prices Warrants purchased Convertible notes payable Debt conversion rate Debt amount after debt forgiveness Issuance of convertible notes payable Indirect interest amount recieved Acquired shares Working capital Unseured note interest rate Warrants exercise price Settlement of outstanding judgement Common stock issue for settlement Purchase price of shares issued Reduction in related party debt Common stock, shares issued Gain on related party debt conversion Debt conversion, converted instrument, shares issued, shares Accrued interest Debt amount Debt instrument principal value, after forgivness Due date notes payable Debt Instrument, Forgiveness Acquired additional shares of common stock Purchase price of additional shares of common stock Conversion price Common stock issued price per share Convertible Debenture Payable with Detached Free-standing Warrant Unamortized Debt Discount Net Convertible Debenture Payable Warrants issued to purchase common shares Debenture conversion description Debt face amount Proceeds from financing transition OID percentage Exercise price Adjusted exercise price Partial liquidated damages description unamortized discount and issuance costs Conversion feature debt discount Amortization of interest [Amortization of interest] Outstanding warrants Fair market value of stock warrants Unamortized discount Interest expense [Interest Expense, Debt] Original Issue Discount Debt issuance costs [Payments of Debt Issuance Costs] Interest expense related to the Original Issue Discount and debt issuance costs Related Party Transactions By Related Party Axis Related Party Notes Payable [Member] Convertible Notes Payable with Detached Free-standing Warrants Conventional Non-Convertible Notes Payable Unamortized Debt Discount Net Related Party Notes Payable Current portion [Convertible Notes Payable, Current] Net Long-Term Portion Non-Related Party Notes Payable [Member] Convertible Notes Payable with Detached Free-standing Warrants [Convertible Notes Payable with Detached Free-standing Warrants] Convertible Notes Payable [Convertible Notes Payable, Noncurrent] Conventional Non-Convertible Notes Payable [Conventional Non-Convertible Notes Payable] Notes Payable with Detached Free-standing Warrants Unamortized Debt Discount Net Non-Related Party Notes Payable Short Term Debt Type Axis Range Axis Common Stock Purchase Plans [Member] Six Related Parties [Member] Related Party Convertible Notes Payable [Member] Related Party Notes Payable [Member] Non-Related Party Notes Payable [Member] Non-Convertible Notes Payable [Member] Non-Convertible Notes Payable Two [Member] Minimum [Member] Maximum [Member] Proceed received from commercial bank Interest expenses for related party notes Loan payment, description Gain on loan extinguishment Accrued interest Common stock shares exchanged Convertible notes payable principal Reduction in related party non - convertible notes payable Convertible Notes Payable [Convertible Debt, Current] Convertible non-related party note payable Convertible notes, conversion price Interest rate Beneficial conversion feature debt discount Interest expense Outstanding warrants [Class of Warrant or Right, Outstanding] Fair market value of warrants Unamortized discount [Debt Instrument, Unamortized Discount] Amortization expenses, beneficial conversion feature Stock issued during the period Default interest rate Purchase price of shares issued Convertible Notes Payable with Detached Free-standing Warrants Convertible debt, conversion, principal amount Outstanding note payable Note payable due date Note payable conversion price per share Convertible promissory note agreement [Member] Minimum [Member] Maximum [Member] OID percentage Proceeds from financing transition Debt face amount Risk free interest rate Fair value of embeded derivative liability Volatility Expected life Due To Related Parties [Member] Common stock shares subscriptions, amount Common stock shares subscriptions, shares Non-Related Party [Member] Series A-1 Convertible Preferred stock [Member] Compensation for services [Member] Related Party Two [Member] Convertible promissory note agreement [Member] Related Party One [Member] Non-Related Party One [Member] Related Party Three [Member] Common stock valued Common stock shares issued for services, shares Settle payable balance Additional paid in capital Debt conversion, converted instrument, shares issued Debt conversion price description Debt Conversion, Converted Instrument, Amount Agreement Expiring date Common stock shares issued for cash, shares Common stock shares issued to option exercised Reduction in related party debt Number of warrants outstanding Debt instrument, convertible, conversion price Consolidation Items [Axis] SOBR SAFE, LLC [Member] Asset purchase agreement [Member] Series A-1 Preferred Stock Purchase Agreement [Member] SOBR's Director company [Member] Series A Convertible Preferred Stock [Member] Accrued dividends payable Preferred stock, shares authorized Convertible preferred stock issuable Cumulative dividends rate Conversion of preferred stock shares Converted shares of common stock Preferred stock shares sold Right of dividend Shares issuance price Preferences and rights of preferred stock Preferred stock, par value Preferred stock conversion description Class of Warrant or Right [Axis] Warrants [Member] Dividend yield Exercise Price Life of warrants Risk free interest rate Volatility Warrants [Member] Outstanding at beginning of period [Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number] Warrants Granted Warrants Exercised Warrants Expired Outstanding at ending of periods Warrants outstanding, Granted Warrants outstanding, Exercised Warrants outstanding exercise price per share, end of period Outstanding at beginning of period [Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price] Warrants Exercised [Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price] Outstanding at end of period Weighted Average Remaining Contractual Life Weighted Average Remaining Contractual Life , Beginning balance Weighted Average Remaining Contractual Life, Warrants granted Weighted Average Remaining Contractual Life, Ending balance Weighted Average Exercise Price Per Share Weighted Average Exercise Price Per Share, Beginning balance Weighted Average Exercise Price Per Share, Warrants granted Weighted Average Exercise Price Per Share, Warrants exercised Weighted Average Exercise Price Per Share, ending balance Aggregate Intrinsic Value Aggregate Intrinsic Value, Beginning balance Aggregate Intrinsic Value, Warrants granted Aggregate Intrinsic Value, Ending balance Exercise Price Expected life [Expected life] Expected volatility Risk free interest rate [Risk free interest rate] Stock Options [Member] Options Outstanding Number of Shares Option Granted Options Exercised Options Cancelled Options Expired Option outstanding, exercisable, beginning balance [Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number] Option outstanding, exercisable, ending balance Exercise Price Per Share Exercise Price Per Shares option granted Weighted Average Remaining Contractual Life Weighted Average Remaining Contractual Lifes beginning balance Weighted Average Remaining Contractual Lifes options granted Weighted Average Remaining Contractual Lifes ending balance Weighted Average Remaining Contractual Lifes, Exercisable, Beginning balance Weighted Average Remaining Contractual Lifes, Exercisable, Ending balance Weighted Average Exercise Price Per Share Weighted Average Exercise Price Per Shares beginning balance Weighted Average Exercise Price Per Shares options granted Weighted Average Exercise Price Per Shares ending balance Weighted Average Exercise Price Per Shares exercisable beginning balance Weighted Average Exercise Price Per Shares exercisable ending balance Aggregate Intrinsic Value Aggregate Intrinsic Value beginning balance Aggregate Intrinsic Value options granted Aggregate Intrinsic Value options exercised Aggregate Intrinsic Value options cancelled Aggregate Intrinsic Value options expired Aggregate Intrinsic Value ending balance Aggregate Intrinsic Value exercisable, beginning balance Aggregate Intrinsic Value exercisable ending balance Exercise Price Per Shares exercisable beginning balance [Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price] Exercise Price Per Shares exercisable ending balance STOCK WARRANTS AND STOCK OPTIONS (Details Narrative) Award Type Axis Executive Stock Options [Member] 2019 Equity Incentive Plans [Member] 8% Series A-1 Convertible Preferred Stock Investment agreement [Member] First Capital Ventures "FCV" [Member] Non Employee Stock Warrants [Member] Exercise price of warrants Share-based compensation expenses Expected lives Investor relationship service, description Unrecognized compensation expense Options exercisable per share Warrants purchased Warrants exercise price Common stock authorized shares Stock option vested shares Stock option issued Stock option vested or expected to vest shares Convertible preferred stock shares sold Sale of stock price per share Common stock shares issuable upon exercise of warrants to SPV Detached free-standing stock warrants granted Fair value of detached free-standing stock warrants granted Geographic Distribution [Axis] California [Member] Short Term Lease Agreement [Member] Highland School [Member] Short Term Operating Lease [Member] Rent expense Contract settlement amount Accrued interest Legal fees Due to related party Accrued interest [Debt Instrument, Increase, Accrued Interest] Lease expiration term Operating lease, monthly payment Issuance of common stock Rent payments, monthly Prepaid expenses with common shares [Operating Leases, Rent Expense, Sublease Rentals] Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or mo Amount of increase (decrease) in additional paid in capital (APIC) resulting from recognition of deferred taxes for convertible debt with a beneficial conversion feature. Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer. Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. Date the original debt was scheduled to mature, in CCYY-MM-DD format. Number of share options (or share units) exercised during the current period. Amount of noncash expense for share-based payment arrangement. Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill. The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. The amount of the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period. EX-101.CAL 8 imle-20210930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.PRE 9 imle-20210930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE EX-101.DEF 10 imle-20210930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE XML 11 sobr_10q_htm.xml IDEA: XBRL DOCUMENT 0001425627 2021-01-01 2021-09-30 0001425627 imle:ShortTermOperatingLeaseMember 2021-01-01 2021-09-30 0001425627 srt:MaximumMember imle:HighlandSchoolMember imle:ShortTermLeaseAgreementMember 2019-10-01 2019-10-15 0001425627 srt:MinimumMember imle:HighlandSchoolMember imle:ShortTermLeaseAgreementMember 2019-10-01 2019-10-15 0001425627 imle:HighlandSchoolMember imle:ShortTermLeaseAgreementMember 2019-10-01 2019-10-15 0001425627 2006-12-06 0001425627 imle:CaliforniaMember 2021-09-30 0001425627 imle:CaliforniaMember 2021-01-01 2021-09-30 0001425627 imle:NonEmployeeStockWarrantsMember 2020-01-01 2020-09-30 0001425627 imle:NonEmployeeStockWarrantsMember 2021-01-01 2021-09-30 0001425627 imle:NonEmployeeStockWarrantsMember 2020-12-31 0001425627 imle:NonEmployeeStockWarrantsMember 2021-09-30 0001425627 imle:EightPercentSeriesAOneConvertiblePreferredStockInvestmentAgreementMember imle:FirstCapitalVenturesFcvMember 2020-12-31 0001425627 imle:EightPercentSeriesAOneConvertiblePreferredStockInvestmentAgreementMember imle:FirstCapitalVenturesFcvMember 2021-09-30 0001425627 imle:EightPercentSeriesAOneConvertiblePreferredStockInvestmentAgreementMember imle:FirstCapitalVenturesFcvMember 2019-08-08 0001425627 imle:EightPercentSeriesAOneConvertiblePreferredStockInvestmentAgreementMember imle:FirstCapitalVenturesFcvMember 2019-08-01 2019-08-08 0001425627 imle:TwoThousandNineteenEquityIncentivePlansMemberMember 2020-12-31 0001425627 imle:TwoThousandNineteenEquityIncentivePlansMemberMember 2021-09-30 0001425627 imle:TwoThousandNineteenEquityIncentivePlansMemberMember 2019-10-24 0001425627 imle:TwoThousandNineteenEquityIncentivePlansMemberMember 2020-09-30 0001425627 srt:MaximumMember imle:ExecutiveStockOptionsMember 2021-09-30 0001425627 imle:ExecutiveStockOptionsMember 2020-12-31 0001425627 imle:ExecutiveStockOptionsMember 2021-09-30 0001425627 imle:IdtecMember 2020-06-05 0001425627 imle:IdtecMember 2020-06-01 2020-06-05 0001425627 2020-05-01 2020-05-04 0001425627 srt:MinimumMember imle:ExecutiveStockOptionsMember 2021-09-30 0001425627 srt:MaximumMember imle:StockOptionsMember 2021-09-30 0001425627 srt:MaximumMember imle:StockOptionsMember 2020-09-30 0001425627 srt:MaximumMember imle:StockOptionsMember 2021-01-01 2021-09-30 0001425627 srt:MaximumMember imle:StockOptionsMember 2020-01-01 2020-09-30 0001425627 srt:MaximumMember imle:StockOptionsMember 2020-12-31 0001425627 srt:MaximumMember imle:StockOptionsMember 2019-12-31 0001425627 srt:MinimumMember imle:StockOptionsMember 2021-09-30 0001425627 srt:MinimumMember imle:StockOptionsMember 2020-09-30 0001425627 srt:MinimumMember imle:StockOptionsMember 2020-01-01 2020-09-30 0001425627 srt:MinimumMember imle:StockOptionsMember 2021-01-01 2021-09-30 0001425627 srt:MinimumMember imle:StockOptionsMember 2020-12-31 0001425627 srt:MinimumMember imle:StockOptionsMember 2019-12-31 0001425627 imle:StockOptionsMember 2021-09-30 0001425627 imle:StockOptionsMember 2020-09-30 0001425627 imle:StockOptionsMember 2020-01-01 2020-09-30 0001425627 imle:StockOptionsMember 2021-01-01 2021-09-30 0001425627 imle:StockOptionsMember 2020-12-31 0001425627 imle:StockOptionsMember 2019-12-31 0001425627 srt:MinimumMember 2020-09-30 0001425627 srt:MaximumMember 2020-09-30 0001425627 srt:MaximumMember imle:WarrantsMember 2021-09-30 0001425627 srt:MaximumMember imle:WarrantsMember 2020-09-30 0001425627 srt:MaximumMember imle:WarrantsMember 2020-01-01 2020-09-30 0001425627 srt:MaximumMember imle:WarrantsMember 2021-01-01 2021-09-30 0001425627 srt:MaximumMember imle:WarrantsMember 2020-12-31 0001425627 srt:MaximumMember imle:WarrantsMember 2019-12-31 0001425627 srt:MinimumMember imle:WarrantsMember 2020-09-30 0001425627 srt:MinimumMember imle:WarrantsMember 2021-09-30 0001425627 srt:MinimumMember imle:WarrantsMember 2020-01-01 2020-09-30 0001425627 srt:MinimumMember imle:WarrantsMember 2021-01-01 2021-09-30 0001425627 srt:MinimumMember imle:WarrantsMember 2020-12-31 0001425627 srt:MinimumMember imle:WarrantsMember 2019-12-31 0001425627 imle:WarrantsMember 2021-09-30 0001425627 imle:WarrantsMember 2020-12-31 0001425627 imle:WarrantsMember 2019-12-31 0001425627 srt:MinimumMember 2020-01-01 2020-09-30 0001425627 srt:MinimumMember 2021-01-01 2021-09-30 0001425627 srt:MaximumMember 2020-01-01 2020-09-30 0001425627 imle:WarrantsMember 2020-09-30 0001425627 srt:MaximumMember 2021-01-01 2021-09-30 0001425627 srt:MinimumMember 2021-09-30 0001425627 srt:MaximumMember 2021-09-30 0001425627 imle:WarrantsMember 2021-01-01 2021-09-30 0001425627 imle:WarrantsMember 2020-01-01 2020-09-30 0001425627 imle:SeriesAConvertiblePreferredStockMember 2020-01-01 2020-12-31 0001425627 imle:SeriesAConvertiblePreferredStockMember 2015-11-20 0001425627 imle:SOBRSDirectorCompanyMember imle:SeriesAOnePreferredStockPurchaseAgreementMember imle:SOBRSAFELLCMember imle:SeriesAOneConvertiblePreferredstockMember 2019-07-24 2019-08-08 0001425627 imle:SOBRSDirectorCompanyMember imle:SeriesAOnePreferredStockPurchaseAgreementMember imle:SOBRSAFELLCMember imle:SeriesAOneConvertiblePreferredstockMember 2019-12-09 0001425627 imle:SeriesAOneConvertiblePreferredstockMember 2020-12-01 2020-12-07 0001425627 imle:SeriesAOneConvertiblePreferredstockMember 2019-12-09 0001425627 imle:SeriesAOneConvertiblePreferredstockMember 2020-01-01 2020-09-30 0001425627 imle:AssetPurchaseAgreementMember imle:SOBRSAFELLCMember 2020-05-07 0001425627 2015-11-20 0001425627 imle:RelatedPartyThreeMember 2021-09-30 0001425627 imle:RelatedPartyThreeMember 2021-01-01 2021-09-30 0001425627 imle:NonRelatedPartyOneMember 2021-09-30 0001425627 imle:NonRelatedPartyOneMember 2021-01-01 2021-09-30 0001425627 imle:RelatedPartyOneMember 2021-01-01 2021-09-30 0001425627 imle:ConvertiblePromissoryNoteAgreementMember 2021-01-01 2021-09-30 0001425627 imle:RelatedPartyTwoMember 2021-09-30 0001425627 imle:RelatedPartyTwoMember 2021-01-01 2021-09-30 0001425627 imle:CompensationForServciesMember 2021-01-01 2021-09-30 0001425627 imle:NonRelatedPartyMember 2021-01-01 2021-09-30 0001425627 imle:SeriesAOneConvertiblePreferredstockMember 2021-01-01 2021-09-30 0001425627 imle:NonRelatedPartyMember 2021-09-30 0001425627 imle:DueToRelatedPartiesMember 2020-12-31 0001425627 imle:DueToRelatedPartiesMember 2021-09-30 0001425627 srt:MaximumMember imle:ConvertiblePromissoryNoteAgreementMember 2021-09-01 2021-09-28 0001425627 srt:MinimumMember imle:ConvertiblePromissoryNoteAgreementMember 2021-09-01 2021-09-28 0001425627 imle:ConvertiblePromissoryNoteAgreementMember 2021-09-30 0001425627 imle:ConvertiblePromissoryNoteAgreementMember 2021-09-28 0001425627 imle:ConvertiblePromissoryNoteAgreementMember 2021-09-01 2021-09-28 0001425627 srt:MaximumMember imle:NonRelatedPartyNotesPayableMember 2021-09-30 0001425627 srt:MaximumMember imle:NonRelatedPartyNotesPayableMember 2021-01-01 2021-09-30 0001425627 srt:MinimumMember imle:NonRelatedPartyNotesPayableMember 2021-09-30 0001425627 srt:MinimumMember imle:NonRelatedPartyNotesPayableMember 2021-01-01 2021-09-30 0001425627 srt:MaximumMember imle:NonRelatedPartyNotesPayableMember imle:NonConvertibleNotesPayableMember 2021-01-01 2021-09-30 0001425627 srt:MinimumMember imle:NonRelatedPartyNotesPayableMember imle:NonConvertibleNotesPayableMember 2021-01-01 2021-09-30 0001425627 imle:NonConvertibleNotesPayableTwoMember 2020-01-01 2020-09-30 0001425627 imle:NonConvertibleNotesPayableTwoMember 2021-09-30 0001425627 imle:NonConvertibleNotesPayableTwoMember 2020-12-31 0001425627 imle:NonConvertibleNotesPayableTwoMember 2021-01-01 2021-09-30 0001425627 imle:NonRelatedPartyNotesPayableMember imle:NonConvertibleNotesPayableMember 2021-01-01 2021-09-30 0001425627 imle:NonRelatedPartyNotesPayableMember imle:NonConvertibleNotesPayableMember 2020-12-31 0001425627 imle:NonRelatedPartyNotesPayableMember imle:NonConvertibleNotesPayableMember 2021-09-30 0001425627 imle:RelatedPartyNotesPayableMember 2020-01-01 2020-09-30 0001425627 imle:RelatedPartyNotesPayableMember 2021-01-01 2021-09-30 0001425627 imle:RelatedPartyNotesPayableMember 2020-06-05 0001425627 imle:RelatedPartyConvertibleNotesPayableMember 2020-11-01 2020-11-15 0001425627 imle:RelatedPartyConvertibleNotesPayableMember 2021-09-30 0001425627 imle:RelatedPartyConvertibleNotesPayableMember 2021-01-01 2021-09-30 0001425627 imle:RelatedPartyConvertibleNotesPayableMember 2020-05-01 2020-06-05 0001425627 imle:RelatedPartyConvertibleNotesPayableMember 2020-01-01 2020-09-30 0001425627 imle:RelatedPartyConvertibleNotesPayableMember 2020-01-01 2020-03-31 0001425627 imle:RelatedPartyConvertibleNotesPayableMember 2020-06-05 0001425627 imle:RelatedPartyConvertibleNotesPayableMember 2020-11-15 0001425627 imle:RelatedPartyConvertibleNotesPayableMember 2020-12-31 0001425627 imle:RelatedPartyConvertibleNotesPayableMember 2020-01-01 2020-12-31 0001425627 imle:RelatedPartyConvertibleNotesPayableMember 2020-03-31 0001425627 imle:CommonStockPurchasePlansMember imle:SixRelatedPartiesMember 2020-03-31 0001425627 imle:CommonStockPurchasePlansMember imle:SixRelatedPartiesMember 2020-12-31 0001425627 imle:CommonStockPurchasePlansMember imle:SixRelatedPartiesMember 2020-01-01 2020-12-31 0001425627 imle:CommonStockPurchasePlansMember imle:SixRelatedPartiesMember 2020-01-01 2020-03-31 0001425627 2020-12-07 0001425627 2020-12-01 2020-12-07 0001425627 2020-05-01 2020-05-12 0001425627 imle:NonRelatedPartyNotesPayableMember 2020-12-31 0001425627 imle:NonRelatedPartyNotesPayableMember 2021-09-30 0001425627 imle:RelatedPartyNotesPayableMember 2020-12-31 0001425627 imle:RelatedPartyNotesPayableMember 2021-09-30 0001425627 imle:DecemberThreeTwoThousandFourteenMember imle:LanphereLawGroupMember 2017-03-08 0001425627 imle:StockPurchasePlanOneMember imle:LanphereLawGroupMember 2020-01-01 2020-01-03 0001425627 imle:StockPurchasePlanOneMember imle:LanphereLawGroupMember 2015-06-25 2015-07-02 0001425627 imle:StockPurchasePlanOneMember imle:LanphereLawGroupMember 2020-01-03 0001425627 imle:StockPurchasePlanOneMember imle:LanphereLawGroupMember 2015-07-01 0001425627 imle:StockPurchasePlanTwoMember imle:LanphereLawGroupMember 2020-01-03 0001425627 imle:StockPurchasePlanTwoMember imle:LanphereLawGroupMember 2020-01-01 2020-01-03 0001425627 imle:StockPurchasePlanOneMember imle:VemonJustusMember 2020-01-03 0001425627 imle:StockPurchasePlanOneMember imle:VemonJustusMember 2020-01-01 2020-01-03 0001425627 imle:StockPurchasePlanThreeMember imle:LanphereLawGroupMember 2020-01-16 0001425627 imle:StockPurchasePlanThreeMember imle:LanphereLawGroupMember 2020-01-01 2020-01-16 0001425627 imle:StockPurchasePlanOneMember imle:DevdattMishalMember 2020-01-30 0001425627 imle:StockPurchasePlanOneMember imle:DevdattMishalMember 2020-01-01 2020-01-30 0001425627 imle:StockPurchasePlanOneMember imle:PrakashGadgilMember 2020-03-23 0001425627 imle:StockPurchasePlanOneMember imle:PrakashGadgilMember 2020-03-01 2020-03-23 0001425627 imle:DirectorsMember 2021-05-31 0001425627 2021-05-01 2021-05-31 0001425627 2020-04-07 0001425627 2021-03-01 2021-03-31 0001425627 imle:CharlesBenningtonMember 2020-04-07 0001425627 imle:CharlesBenningtonMember 2021-03-31 0001425627 imle:CharlesBenningtonMember 2020-04-01 2020-04-07 0001425627 2020-04-06 0001425627 imle:NickNocetiMember 2020-04-01 2020-04-06 0001425627 2021-05-31 0001425627 imle:NickNocetiMember 2020-04-06 0001425627 2017-03-08 0001425627 imle:IdtecMember 2021-03-01 2021-03-30 0001425627 imle:IdtecMember 2021-01-01 2021-09-30 0001425627 imle:IdtecMember 2021-03-30 0001425627 imle:DavidGandiniMember 2021-02-12 0001425627 imle:IntellectualTechnologyMember 2021-01-01 2021-09-30 0001425627 imle:IntellectualTechnologyMember 2021-09-30 0001425627 imle:LeaseAgreementMember 2021-01-01 2021-09-30 0001425627 imle:IDTECMember imle:AssetPurchaseAgreementMember 2021-01-01 2021-09-30 0001425627 imle:IDTECMember imle:AssetPurchaseAgreementMember 2021-09-30 0001425627 imle:IDTECMember imle:AssetPurchaseAgreementMember 2020-05-28 2020-06-05 0001425627 2020-05-28 2020-06-05 0001425627 2020-06-05 0001425627 imle:JanuaryFifteenTwoThousandTwentyOneMember imle:PrivateOfferingMember 2021-01-01 2021-09-30 0001425627 imle:JanuaryFifteenTwoThousandTwentyOneMember imle:PrivateOfferingMember 2021-09-30 0001425627 imle:AnnualMeetingOfShareholdersMember 2020-03-01 2020-03-23 0001425627 imle:AnnualMeetingOfShareholdersMember 2020-05-01 2020-05-21 0001425627 imle:AnnualMeetingOfShareholdersMember 2021-09-30 0001425627 imle:AnnualMeetingOfShareholdersMember 2020-03-23 0001425627 2020-01-01 2020-12-31 0001425627 imle:LevelThreeMember 2021-09-30 0001425627 imle:LevelThreeMember 2020-12-31 0001425627 imle:LevelTwoMember 2021-09-30 0001425627 imle:LevelTwoMember 2020-12-31 0001425627 imle:LevelOneMember 2021-09-30 0001425627 imle:LevelOneMember 2020-12-31 0001425627 us-gaap:NoncontrollingInterestMember 2021-09-30 0001425627 imle:StockholdersDeficitSOBRSafeIncMember 2021-09-30 0001425627 us-gaap:RetainedEarningsMember 2021-09-30 0001425627 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001425627 us-gaap:PreferredStockMember 2021-09-30 0001425627 us-gaap:CommonStockMember 2021-09-30 0001425627 us-gaap:NoncontrollingInterestMember 2021-07-01 2021-09-30 0001425627 imle:StockholdersDeficitSOBRSafeIncMember 2021-07-01 2021-09-30 0001425627 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001425627 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0001425627 us-gaap:PreferredStockMember 2021-07-01 2021-09-30 0001425627 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001425627 2021-06-30 0001425627 us-gaap:NoncontrollingInterestMember 2021-06-30 0001425627 imle:StockholdersDeficitSOBRSafeIncMember 2021-06-30 0001425627 us-gaap:RetainedEarningsMember 2021-06-30 0001425627 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001425627 us-gaap:PreferredStockMember 2021-06-30 0001425627 us-gaap:CommonStockMember 2021-06-30 0001425627 2021-04-01 2021-06-30 0001425627 us-gaap:NoncontrollingInterestMember 2021-04-01 2021-06-30 0001425627 imle:StockholdersDeficitSOBRSafeIncMember 2021-04-01 2021-06-30 0001425627 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001425627 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001425627 us-gaap:PreferredStockMember 2021-04-01 2021-06-30 0001425627 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001425627 2021-03-31 0001425627 us-gaap:NoncontrollingInterestMember 2021-03-31 0001425627 imle:StockholdersDeficitSOBRSafeIncMember 2021-03-31 0001425627 us-gaap:RetainedEarningsMember 2021-03-31 0001425627 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001425627 us-gaap:PreferredStockMember 2021-03-31 0001425627 us-gaap:CommonStockMember 2021-03-31 0001425627 2021-01-01 2021-03-31 0001425627 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-03-31 0001425627 imle:StockholdersDeficitSOBRSafeIncMember 2021-01-01 2021-03-31 0001425627 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001425627 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001425627 us-gaap:PreferredStockMember 2021-01-01 2021-03-31 0001425627 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001425627 us-gaap:NoncontrollingInterestMember 2020-12-31 0001425627 imle:StockholdersDeficitSOBRSafeIncMember 2020-12-31 0001425627 us-gaap:RetainedEarningsMember 2020-12-31 0001425627 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001425627 us-gaap:PreferredStockMember 2020-12-31 0001425627 us-gaap:CommonStockMember 2020-12-31 0001425627 2020-09-30 0001425627 us-gaap:NoncontrollingInterestMember 2020-09-30 0001425627 imle:StockholdersDeficitSOBRSafeIncMember 2020-09-30 0001425627 us-gaap:RetainedEarningsMember 2020-09-30 0001425627 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0001425627 us-gaap:PreferredStockMember 2020-09-30 0001425627 us-gaap:CommonStockMember 2020-09-30 0001425627 us-gaap:NoncontrollingInterestMember 2020-07-01 2020-09-30 0001425627 imle:StockholdersDeficitSOBRSafeIncMember 2020-07-01 2020-09-30 0001425627 us-gaap:RetainedEarningsMember 2020-07-01 2020-09-30 0001425627 us-gaap:AdditionalPaidInCapitalMember 2020-07-01 2020-09-30 0001425627 us-gaap:PreferredStockMember 2020-07-01 2020-09-30 0001425627 us-gaap:CommonStockMember 2020-07-01 2020-09-30 0001425627 2020-06-30 0001425627 us-gaap:NoncontrollingInterestMember 2020-06-30 0001425627 imle:StockholdersDeficitSOBRSafeIncMember 2020-06-30 0001425627 us-gaap:RetainedEarningsMember 2020-06-30 0001425627 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001425627 us-gaap:PreferredStockMember 2020-06-30 0001425627 us-gaap:CommonStockMember 2020-06-30 0001425627 2020-04-01 2020-06-30 0001425627 us-gaap:NoncontrollingInterestMember 2020-04-01 2020-06-30 0001425627 imle:StockholdersDeficitSOBRSafeIncMember 2020-04-01 2020-06-30 0001425627 us-gaap:RetainedEarningsMember 2020-04-01 2020-06-30 0001425627 us-gaap:AdditionalPaidInCapitalMember 2020-04-01 2020-06-30 0001425627 us-gaap:PreferredStockMember 2020-04-01 2020-06-30 0001425627 us-gaap:CommonStockMember 2020-04-01 2020-06-30 0001425627 2020-03-31 0001425627 us-gaap:NoncontrollingInterestMember 2020-03-31 0001425627 imle:StockholdersDeficitSOBRSafeIncMember 2020-03-31 0001425627 us-gaap:RetainedEarningsMember 2020-03-31 0001425627 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001425627 us-gaap:PreferredStockMember 2020-03-31 0001425627 us-gaap:CommonStockMember 2020-03-31 0001425627 2020-01-01 2020-03-31 0001425627 us-gaap:NoncontrollingInterestMember 2020-01-01 2020-03-31 0001425627 imle:StockholdersDeficitSOBRSafeIncMember 2020-01-01 2020-03-31 0001425627 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0001425627 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0001425627 us-gaap:PreferredStockMember 2020-01-01 2020-03-31 0001425627 us-gaap:CommonStockMember 2020-01-01 2020-03-31 0001425627 2019-12-31 0001425627 us-gaap:NoncontrollingInterestMember 2019-12-31 0001425627 imle:StockholdersDeficitSOBRSafeIncMember 2019-12-31 0001425627 us-gaap:RetainedEarningsMember 2019-12-31 0001425627 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001425627 us-gaap:PreferredStockMember 2019-12-31 0001425627 us-gaap:CommonStockMember 2019-12-31 0001425627 2020-01-01 2020-09-30 0001425627 2020-07-01 2020-09-30 0001425627 2021-07-01 2021-09-30 0001425627 imle:SeriesAOneConvertiblePreferredstockMember 2020-12-31 0001425627 imle:SeriesAOneConvertiblePreferredstockMember 2021-09-30 0001425627 imle:SeriesAConvertiblePreferredStockMember 2020-12-31 0001425627 imle:SeriesAConvertiblePreferredStockMember 2021-09-30 0001425627 2020-12-31 0001425627 2021-09-30 0001425627 2021-11-12 iso4217:USD shares iso4217:USD shares pure 0001425627 false --12-31 Q3 2021 885 Arapahoe Avenue Boulder CO 2608900 774850 771576 0.00001 100000000 25981203 25922034 0.00001 0.00001 19300000 3000000 0.00001 0 2700000 0 0 0 0 0 0 0 0 0 0 0 260 1934969 1 0.0138 298098 112871 250000 3.326 9656 1.41 108000 847048 833008 14039 0 11810 11810 104183 79183 0.1 0 494759 70000 0.1 12 0.12 0 56683 42500 5000 11810 2013-09-21 2022-06-03 8700 136433 87500 2700000 2.00 P5Y 1.53 1.039375 P3Y11M19D 1253030 1651291 0.26341 P4Y1M6D P8Y1M24D P7Y8M24D 0.4540 0 0 0 3299765 5772880 0.2634 0.2634 3.300 2.00 P2Y 144317 2900 1800 10-Q true 2021-09-30 false 000-53316 SOBR Safe, Inc. DE 26-0731818 80302 844 762-7723 Yes Yes Non-accelerated Filer true false false 25981203 2185233 232842 24899 115230 2210132 348072 513952 224854 3340723 3629821 15826 8680 5566681 3986573 706142 101308 306071 313032 193177 134444 29404 28624 228046 253688 980000 0 2608900 439881 0 11810 11810 104183 79183 2998714 922089 771576 228424 0 774850 230150 25000 3457288 947089 0.00001 19300000 0 0 0.00001 3000000 0 0 0.00001 2700000 0 0 0.00001 100000000 25981203 25922034 260 260 56330450 52693974 -54167685 -49601220 2163025 3093014 -53632 -53530 2109393 3039484 5566681 3986573 0 0 0 0 316329 191589 875378 400127 147163 0 334228 41302 632964 352266 1682557 1103828 566655 152123 1052650 309403 0 0 0 25320555 1663111 695978 3944813 27175215 -1663111 -695978 -3944813 -27175215 0 0 -269144 0 0 0 60650 227475 41622 399381 107253 -130830 0 -222373 -1407675 -358305 -41622 -621754 -1723422 -2021416 -737600 -4566567 -28898637 0 0 0 0 -2021416 -737600 -4566567 -28898637 4 -98 102 -48 -2021412 -737698 -4566465 -28898685 0 161880 0 161880 -2021412 -899578 -4566465 -29060565 -0.08 -0.04 -0.18 -2.23 25981203 20046424 25974042 13030845 6452993 65 0 15971392 -19511168 -3539711 -53410 -3593121 601 0 0 20800 0 20800 0 20800 454097 4 0 65724 0 65728 0 65728 214883 2 0 493072 0 493074 0 493074 38323 0 0 92385 0 92385 0 92385 648739 6 0 826958 0 826964 0 826964 70448 1 0 166525 0 166526 0 166526 0 0 39450 0 39450 0 39450 0 0 124291 0 124291 0 124291 0 0 221557 0 221557 0 221557 0 0 116893 0 116893 0 116893 0 0 174 0 174 0 174 0 0 0 -450023 -450023 149 -449874 7880084 78 0 18139221 -19961191 -1821892 -53261 -1875153 121072 2 0 173290 0 173292 0 173292 45268 1 0 86739 0 86740 0 86740 12000000 120 0 27119880 0 27120000 0 27120000 0 0 1407501 0 1407501 0 1407501 0 0 695454 0 695454 0 695454 0 0 50741 0 50741 0 50741 0 0 273462 0 273462 0 273462 0 0 257482 0 257482 0 257482 0 0 0 -27710964 -27710964 -199 -27711163 20046424 201 0 48203770 -47672155 531816 -53460 478356 0 0 46617 0 46617 0 46617 0 0 0 -161880 -161880 0 -161880 0 0 0 -737698 -737698 98 -737600 20046424 201 0 48250387 -48571733 -321145 -53362 -374507 25922034 260 0 52693974 -49601220 3093014 -53530 3039484 43169 0 0 107880 0 107880 0 107880 0 0 105013 0 105013 0 105013 0 0 619381 0 619381 0 619381 0 0 480619 0 480619 0 480619 0 0 0 -1002340 -1002340 -94 -1002434 25965203 260 0 54006867 -50603560 3403567 -53624 3349943 16000 0 0 49600 0 49600 0 49600 0 0 138010 0 138010 0 138010 0 0 473327 0 473327 0 473327 0 0 428595 0 428595 0 428595 0 0 0 -1542713 -1542713 -4 -1542717 25981203 260 0 55096399 -52146273 2950386 -53628 2896758 0 0 387003 0 387003 0 387003 0 0 847048 0 847048 0 847048 0 0 0 -2021412 -2021412 -4 -2021416 25981203 260 0 56330450 -54167685 2163025 -53632 2109393 -4566567 -28898637 289098 133571 0 269144 0 -60650 222373 1407675 275052 8656 399259 343549 334228 41302 0 25320555 -19361 994 -7146 -8680 604834 140906 -6961 -83495 58733 -6697 780 -51976 138069 0 -2277609 -1443783 1030000 0 -30000 0 1005000 41665 2500000 0 275000 0 0 1700000 4230000 1741665 1952391 297882 232842 681759 2185233 979641 49600 0 107880 0 909214 1407501 1939756 0 823781 0 980000 0 0 272299 0 265677 0 579814 0 65728 0 826964 0 166526 0 124291 0 20800 0 29222955 0 161880 67618 765 0 0 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 1. ORGANIZATION, OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">SOBR Safe, Inc. (“SOBR Safe”), formerly TransBiotec, Inc., was incorporated as Imagine Media LTD. in August 2007 in the State of Delaware. A corporation also named TransBiotec, Inc. (“TransBiotec – CA”) was formed in the state of California July 4, 2004. Effective September 19, 2011, TransBiotec was acquired by TransBiotec - CA in a transaction classified as a reverse acquisition as the shareholders of TransBiotec - CA retained the majority of the outstanding common stock of TransBiotec after the share exchange. The consolidated financial statements represent the activity of TransBiotec - CA from July 4, 2004 forward, and the consolidated activity of SOBR Safe and TransBiotec - CA from September 19, 2011 forward. SOBR Safe and TransBiotec - CA are hereinafter referred to collectively as the “Company” or “We”. The Company has developed and plans to market and sell a non-invasive alcohol sensing system which includes an ignition interlock. The Company has not generated any revenues from its operations. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On March 23, 2020, the Company filed a Definitive 14C providing notice that the Board of Directors has recommended, and that holders of a majority of the voting power of the Company’s outstanding stock voted, to approve the following. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">1. </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">To remove and re-elect four (4) directors to serve until the next Annual Meeting of Shareholders and thereafter until their successors are elected and qualified; and </p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td></tr><tr style="height:15px"><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">2. </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">To approve an amendment to the Company’s Certificate of Incorporation to: (a) change the Company’s name to SOBR SAFE, Inc., (b) decrease the Company’s authorized common stock from 800,000,000 shares, par value $0.00001 to 100,000,000 shares, par value $0.00001, and (c) effect a reverse stock split of the Company’s outstanding common stock at a ratio between 1-for-32 and 1-for-35 (with the exact ratio to be determined by the directors in their sole discretion without further approval by the shareholders). </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The above actions taken by the Company’s stockholders became effective on or about May 21, 2020. The effective dates of the above actions were June 5, 2020 and April 20, 2020, respectively, and the actual reverse stock split ratio was 1-for-33.26. All share and per share amounts have been adjusted in these consolidated financial statements to reflect the effect of the reverse stock split. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Basis of Presentation</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”) as promulgated in the United States of America and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and related notes for the year ended December 31, 2020, included in the Company’s Annual Report on Form 10-K filed with the SEC on March 31, 2021.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In management’s opinion, the unaudited condensed consolidated financial statements reflect all adjustments (including reclassifications and normal recurring adjustments) necessary to present fairly the financial position as of September 30, 2021 and December 31, 2020, and results of operations and cash flows for the three and nine month periods ended September 30, 2021 and 2020.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Principles of Consolidation</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its majority owned subsidiary, TransBiotec-CA. We have eliminated all intercompany transactions and balances between entities consolidated in these unaudited condensed financial statements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Use of Estimates</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of unaudited condensed consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Specifically, such estimates were made by the Company for the recoverability and useful lives of long-lived assets, the intellectual technology, the valuation of the derivative liabilities, beneficial conversion feature expenses, stock-based compensation and the valuation allowance related to deferred tax assets. Actual results could differ from those estimates.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Financial Instruments </span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Pursuant to  Accounting Standards Codification (“ASC”) Topic 820, <em>Fair Value Measurements and Disclosures</em>, and ASC 825, <em>Financial Instruments</em>, an entity is required to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 and 825 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 and 825 prioritizes the inputs into three levels that may be used to measure fair value:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Level </em>1</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Level </em>2</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets: quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Level 3</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company’s financial instruments consist primarily of cash, accounts payable, accrued expenses, accrued interest payable,  related party payables, notes payable, convertible debentures, and other liabilities. Pursuant to ASC 820 and 825, the fair value of our derivative liabilities is determined based on “Level 3” inputs. We believe that the recorded values of all of our other financial instruments approximate their current fair values because of their nature and respective maturity dates or durations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following table presents assets and liabilities that are measured and recognized at fair value as of September 30, 2021 and December 31, 2020: </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>September 30, 2021</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">  </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level 1</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-TOP: medium none; BORDER-BOTTOM: 0.5pt solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level 2</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-TOP: medium none; BORDER-BOTTOM: 0.5pt solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level 3</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Derivative liability</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">980,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">980,000</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>  </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>December 31, 2020</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>    </strong></p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-TOP: medium none; BORDER-BOTTOM: 0.5pt solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level 1</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-TOP: medium none; BORDER-BOTTOM: 0.5pt solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level 2</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-TOP: medium none; BORDER-BOTTOM: 0.5pt solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level 3</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Derivative liability</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Cash</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company considers all highly liquid investments with an original maturity of three months or less as cash equivalents. The Company does not have any cash equivalents as of September 30, 2021 and December 31, 2020.  </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Prepaid Expenses</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Amounts incurred in advance of contractual performance or coverage periods are recorded as prepaid assets and recognized as expense in the period service or coverage is provided.   </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Beneficial Conversion Features</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">From time to time, the Company may issue convertible notes that may contain a beneficial conversion feature. A beneficial conversion feature exists on the date a convertible note is issued when the fair value of the underlying common stock to which the note is convertible into is in excess of the remaining unallocated proceeds of the note after first considering the allocation of a portion of the note proceeds to the fair value of the warrants, if related warrants have been granted. The intrinsic value of the beneficial conversion feature is recorded as a debt discount with a corresponding amount to additional paid-in capital. The debt discount is amortized to interest expense over the life of the note using the effective interest method.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> <span style="text-decoration:underline">Derivative Instruments</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instruments are initially recorded at their fair values and are then re-valued at each reporting date, with changes in the fair value reported in the unaudited condensed consolidated statements of operations under other income (expense). The accounting treatment of derivative financial instruments requires that the Company record the embedded conversion option at its fair value as of the inception date of the agreement and at fair value as of each subsequent balance sheet date. Any change in fair value is recorded as non-operating, non-cash income or expense for each reporting period at each balance sheet date. If the classification changes as a result of events during the period, the contract is reclassified as of the date of the event that caused the reclassification. As a result of entering into warrant agreements, for which such instruments contained a variable conversion feature with no floor, the Company has adopted a sequencing policy in accordance with ASC 815-40-35-12 whereby all future instruments may be classified as a derivative liability with the exception of instruments related to share-based compensation issued to employees or directors. For stock-based derivative financial instruments, the Company uses a Monte Carlo Simulation model to value the derivative instruments at inception and on subsequent valuation dates. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.  </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Debt Issuance Costs</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Debt issuance costs incurred in connection with the issuance of debt are capitalized and amortized to interest expense over the term of the debt using the effective interest method. The unamortized amount is presented as a reduction of debt on the balance sheet.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Preferred Stock</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We apply the guidance enumerated in ASC 480 “Distinguishing Liabilities from Equity” when determining the classification and measurement of preferred stock. Preferred shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. We classify conditionally redeemable preferred shares (if any), which includes preferred shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control, as temporary equity. At all other times, we classified our preferred shares in stockholders’ equity.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Minority Interest (Noncontrolling Interest)</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">A subsidiary of the Company has minority members representing ownership interests of 1.38% at September 30, 2021 and December 31, 2020. The Company accounts for these minority, or noncontrolling interests, pursuant to ASC 810-10-65 whereby gains and losses in a subsidiary with a noncontrolling interest are allocated to the noncontrolling interest based on the ownership percentage of the noncontrolling interest, even if that allocation results in a deficit noncontrolling interest balance.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Stock-based Compensation</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company follows the guidance of the accounting provisions of ASC 718 “Share-based Compensation”, which requires the use of the fair-value based method to determine compensation for all arrangements under which employees and others receive shares of stock or equity instruments (warrants and options). The fair value of each option award is estimated on the date of grant using the Black-Scholes options pricing model that uses assumptions for expected volatility, expected dividends, expected term, and the risk-free interest rate. The Company has not paid common stock dividends historically and does not expect to pay them in the future. Expected volatilities are based on weighted averages of the historical volatility of the Company’s common stock estimated over the expected term of the options. The expected term of options granted is derived using the “simplified method” which computes expected term as the average of the sum of the vesting term plus the contract term as historically the Company had limited activity surrounding its options. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the period of the expected term.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Research and Development</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company accounts for its research and development costs pursuant to ASC 730, whereby it requires the Company to disclose the amounts of costs for company and customer-sponsored research and development activities, if material. Research and development costs are expensed as incurred. The Company incurred research and development costs as it acquired new knowledge to bring about significant improvements in the functionality and design of its SOBR product. Research and development costs were $1,026,679 and $309,403 during the nine month periods ended September 30, 2021 and 2020, respectively.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Advertising and Marketing Costs</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Advertising and marketing costs are charged to operations as incurred.  Advertising and marketing costs were $70,692 and $70,198 during the nine month periods ended September 30, 2021 and 2020, respectively, and are included in general and administrative expenses in the consolidated statements of operations.     </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Depreciation</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Depreciation is computed on a straight-line basis over the assets estimated useful lives of three years. There was no depreciation for the three and nine months ended September 30, 2021. Depreciation for the three and nine months ended September 30, 2020 was $3,978 and $5,083, respectively . </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Income Tax</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company accounts for income taxes pursuant to ASC 740. Under ASC 740 deferred taxes are provided on a liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss carry forwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. The Company has not recorded any deferred tax assets or liabilities at September 30, 2021 and December 31, 2020 as these have been offset by a 100% valuation allowance.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Net Loss Per Share</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Basic net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period.  Diluted  loss per share gives the effect to all dilutive potential common shares outstanding during the period,  including stock options, warrants and convertible instruments.  Diluted net loss per share excludes all potentially issuable shares if their effect is anti-dilutive.  Because the effect of the Company’s dilutive securities is anti-dilutive, diluted net loss per share is the same as basic loss per share for the periods presented.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Concentration of Credit Risk</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Certain financial instruments potentially subject the Company to concentrations of credit risk. Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash deposits. Cash held in operating accounts may exceed the Federal Deposit Insurance Corporation (“FDIC”) insurance limits. Accounts at each institution are insured by the FDIC up to $250,000. While the Company monitors cash balances in our operating accounts on a regular basis and adjust the balances as appropriate, these balances could be impacted if the underlying financial institutions fail. To date, the Company has experienced no loss or lack of access to our cash; however, the Company can provide no assurances that access to our cash will not be impacted by adverse conditions in the financial markets. At September 30, 2021 and December 31, 2020, the Company had $1,934,969 and none, respectively in excess of the FDIC insured limits.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Related Parties</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Related parties are any entities or individuals that, through employment, ownership, or other means, possess the ability to direct or cause the direction of the management and policies of the Company.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">New Pronouncements  </span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In December 2019, the FASB issued ASU No. 2019-12, <em>Simplifying the Accounting for Income Taxes</em> (“ASU 2019-12”), which simplifies the accounting for income taxes, eliminates certain exceptions within ASC 740, <em>Income Taxes</em>,<em> </em>and clarifies certain aspects of the current guidance to promote consistency among reporting entities. ASU 2019-12 is effective for fiscal years beginning after December 15, 2021. Most amendments within the standard are required to be applied on a prospective basis, while certain amendments must be applied on a retrospective or modified retrospective basis. The Company is evaluating the effects, if any, of the adoption of ASU 2019-12 guidance on the Company's financial position, results of operations and cash flows.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In August 2020, the FASB issued ASU No. 2020-06, <em>Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, </em>which address issues identified as a result of the complexity associated with applying generally accepted accounting principles for certain financial instruments with characteristics of liabilities and equity.  This amendment is effective for public business entities that meet the definition of a SEC filer, excluding entities eligible to be smaller reporting companies as defined by the SEC, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company is evaluating the effects, if any, of the adoption of ASU 2020-06 guidance on the Company's financial position, results of operations and cash flows.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In October 2020, the FASB issued ASU No. 2020-08, <em>Codification Improvements to Subtopic 310-20, Receivables-Nonrefundable Fees and Other Costs, </em>amendments the guidance in ASU No. 2017-08, (Subtopic 310-20): <em>Premium Amortization on Purchased Callable Debt Securities</em>, which addresses multiple call dates of a callable debt security.  This amendment is effective for public business entities, for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. Early application is not permitted.  The Company evaluated the adoption of ASU 2020-08 guidance and determined no effects on the Company's financial position, results of operations and cash flows.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In May 2021, the FASB issued ASU No. 2021-04, <em>Earnings Per Share (Topic 260), Debt-Modifications and Extinguishments </em><em>(S</em>ubtopic 470-50), <em>Compensation-Stock Compensation </em><em>(Topic 718), and Derivatives and Hedging-Contracts in Entity’s Own Equity </em><em>(Subtpoic 815-40)</em>, which addresses issuer’s accounting for certain modifications or exchanges of freestanding equity-classified written call options.  This amendment is effective for all entities, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted.  The Company is evaluating the effects, if any, of the adoption of ASU 2021-04 guidance on the Company's financial position, results of operations and cash flows.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Correction of Error</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">While preparing financial statements for periods in 2021, the Company discovered an error in the statement of operations for the year ended December 31, 2020.  The error related to the presentation of the loss on disposal of property and equipment and asset impairment adjustment in accordance with ASC 360-10-45.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Loss on disposal of property and equipment and asset impairment adjustment of  $39,434 and $25,320,555, respectively, were presented as other income/expense-net, instead of as operating expenses.  As a result, loss from operations for the year ended December 31, 2020, was understated by $25,359,989 and other income/expenses-net was overstated by the same amount.  The errors had no affect on the net loss or net loss per share for the year ended December 31, 2020.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As a result of this correction, the statement of operations for the three and nine month periods ended September 30, 2020 in the accompanying financial statements has been retroactively restated.</p> 800000000 0.00001 100000000 0.00001 reverse stock split of the Company’s outstanding common stock at a ratio between 1-for-32 and 1-for-35 (with the exact ratio to be determined by the directors in their sole discretion without further approval by the shareholders The effective dates of the above actions were June 5, 2020 and April 20, 2020, respectively, and the actual reverse stock split ratio was 1-for-33.26 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”) as promulgated in the United States of America and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and related notes for the year ended December 31, 2020, included in the Company’s Annual Report on Form 10-K filed with the SEC on March 31, 2021.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In management’s opinion, the unaudited condensed consolidated financial statements reflect all adjustments (including reclassifications and normal recurring adjustments) necessary to present fairly the financial position as of September 30, 2021 and December 31, 2020, and results of operations and cash flows for the three and nine month periods ended September 30, 2021 and 2020.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instruments are initially recorded at their fair values and are then re-valued at each reporting date, with changes in the fair value reported in the unaudited condensed consolidated statements of operations under other income (expense). The accounting treatment of derivative financial instruments requires that the Company record the embedded conversion option at its fair value as of the inception date of the agreement and at fair value as of each subsequent balance sheet date. Any change in fair value is recorded as non-operating, non-cash income or expense for each reporting period at each balance sheet date. If the classification changes as a result of events during the period, the contract is reclassified as of the date of the event that caused the reclassification. As a result of entering into warrant agreements, for which such instruments contained a variable conversion feature with no floor, the Company has adopted a sequencing policy in accordance with ASC 815-40-35-12 whereby all future instruments may be classified as a derivative liability with the exception of instruments related to share-based compensation issued to employees or directors. For stock-based derivative financial instruments, the Company uses a Monte Carlo Simulation model to value the derivative instruments at inception and on subsequent valuation dates. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.  </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Depreciation is computed on a straight-line basis over the assets estimated useful lives of three years. There was no depreciation for the three and nine months ended September 30, 2021. Depreciation for the three and nine months ended September 30, 2020 was $3,978 and $5,083, respectively . </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its majority owned subsidiary, TransBiotec-CA. We have eliminated all intercompany transactions and balances between entities consolidated in these unaudited condensed financial statements.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of unaudited condensed consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Specifically, such estimates were made by the Company for the recoverability and useful lives of long-lived assets, the intellectual technology, the valuation of the derivative liabilities, beneficial conversion feature expenses, stock-based compensation and the valuation allowance related to deferred tax assets. Actual results could differ from those estimates.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Pursuant to  Accounting Standards Codification (“ASC”) Topic 820, <em>Fair Value Measurements and Disclosures</em>, and ASC 825, <em>Financial Instruments</em>, an entity is required to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 and 825 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 and 825 prioritizes the inputs into three levels that may be used to measure fair value:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Level </em>1</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Level </em>2</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets: quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Level 3</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company’s financial instruments consist primarily of cash, accounts payable, accrued expenses, accrued interest payable,  related party payables, notes payable, convertible debentures, and other liabilities. Pursuant to ASC 820 and 825, the fair value of our derivative liabilities is determined based on “Level 3” inputs. We believe that the recorded values of all of our other financial instruments approximate their current fair values because of their nature and respective maturity dates or durations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following table presents assets and liabilities that are measured and recognized at fair value as of September 30, 2021 and December 31, 2020: </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>September 30, 2021</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">  </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level 1</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-TOP: medium none; BORDER-BOTTOM: 0.5pt solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level 2</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-TOP: medium none; BORDER-BOTTOM: 0.5pt solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level 3</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Derivative liability</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">980,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">980,000</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>  </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>December 31, 2020</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>    </strong></p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-TOP: medium none; BORDER-BOTTOM: 0.5pt solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level 1</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-TOP: medium none; BORDER-BOTTOM: 0.5pt solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level 2</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-TOP: medium none; BORDER-BOTTOM: 0.5pt solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level 3</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Derivative liability</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level 1</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-TOP: medium none; BORDER-BOTTOM: 0.5pt solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level 2</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-TOP: medium none; BORDER-BOTTOM: 0.5pt solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level 3</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Derivative liability</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">980,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">980,000</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-TOP: medium none; BORDER-BOTTOM: 0.5pt solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level 1</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-TOP: medium none; BORDER-BOTTOM: 0.5pt solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level 2</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-TOP: medium none; BORDER-BOTTOM: 0.5pt solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level 3</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Derivative liability</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 0 0 980000 0 0 980000 0 0 0 0 0 0 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company considers all highly liquid investments with an original maturity of three months or less as cash equivalents. The Company does not have any cash equivalents as of September 30, 2021 and December 31, 2020.  </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Amounts incurred in advance of contractual performance or coverage periods are recorded as prepaid assets and recognized as expense in the period service or coverage is provided.   </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">From time to time, the Company may issue convertible notes that may contain a beneficial conversion feature. A beneficial conversion feature exists on the date a convertible note is issued when the fair value of the underlying common stock to which the note is convertible into is in excess of the remaining unallocated proceeds of the note after first considering the allocation of a portion of the note proceeds to the fair value of the warrants, if related warrants have been granted. The intrinsic value of the beneficial conversion feature is recorded as a debt discount with a corresponding amount to additional paid-in capital. The debt discount is amortized to interest expense over the life of the note using the effective interest method.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Debt issuance costs incurred in connection with the issuance of debt are capitalized and amortized to interest expense over the term of the debt using the effective interest method. The unamortized amount is presented as a reduction of debt on the balance sheet.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We apply the guidance enumerated in ASC 480 “Distinguishing Liabilities from Equity” when determining the classification and measurement of preferred stock. Preferred shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. We classify conditionally redeemable preferred shares (if any), which includes preferred shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control, as temporary equity. At all other times, we classified our preferred shares in stockholders’ equity.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">A subsidiary of the Company has minority members representing ownership interests of 1.38% at September 30, 2021 and December 31, 2020. The Company accounts for these minority, or noncontrolling interests, pursuant to ASC 810-10-65 whereby gains and losses in a subsidiary with a noncontrolling interest are allocated to the noncontrolling interest based on the ownership percentage of the noncontrolling interest, even if that allocation results in a deficit noncontrolling interest balance.</p> 0.0138 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company follows the guidance of the accounting provisions of ASC 718 “Share-based Compensation”, which requires the use of the fair-value based method to determine compensation for all arrangements under which employees and others receive shares of stock or equity instruments (warrants and options). The fair value of each option award is estimated on the date of grant using the Black-Scholes options pricing model that uses assumptions for expected volatility, expected dividends, expected term, and the risk-free interest rate. The Company has not paid common stock dividends historically and does not expect to pay them in the future. Expected volatilities are based on weighted averages of the historical volatility of the Company’s common stock estimated over the expected term of the options. The expected term of options granted is derived using the “simplified method” which computes expected term as the average of the sum of the vesting term plus the contract term as historically the Company had limited activity surrounding its options. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the period of the expected term.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company accounts for its research and development costs pursuant to ASC 730, whereby it requires the Company to disclose the amounts of costs for company and customer-sponsored research and development activities, if material. Research and development costs are expensed as incurred. The Company incurred research and development costs as it acquired new knowledge to bring about significant improvements in the functionality and design of its SOBR product. Research and development costs were $1,026,679 and $309,403 during the nine month periods ended September 30, 2021 and 2020, respectively.</p> 309403 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Advertising and marketing costs are charged to operations as incurred.  Advertising and marketing costs were $70,692 and $70,198 during the nine month periods ended September 30, 2021 and 2020, respectively, and are included in general and administrative expenses in the consolidated statements of operations.     </p> 70692 70198 3978 5083 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company accounts for income taxes pursuant to ASC 740. Under ASC 740 deferred taxes are provided on a liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss carry forwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. The Company has not recorded any deferred tax assets or liabilities at September 30, 2021 and December 31, 2020 as these have been offset by a 100% valuation allowance.</p> 1 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Basic net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period.  Diluted  loss per share gives the effect to all dilutive potential common shares outstanding during the period,  including stock options, warrants and convertible instruments.  Diluted net loss per share excludes all potentially issuable shares if their effect is anti-dilutive.  Because the effect of the Company’s dilutive securities is anti-dilutive, diluted net loss per share is the same as basic loss per share for the periods presented.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Certain financial instruments potentially subject the Company to concentrations of credit risk. Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash deposits. Cash held in operating accounts may exceed the Federal Deposit Insurance Corporation (“FDIC”) insurance limits. Accounts at each institution are insured by the FDIC up to $250,000. While the Company monitors cash balances in our operating accounts on a regular basis and adjust the balances as appropriate, these balances could be impacted if the underlying financial institutions fail. To date, the Company has experienced no loss or lack of access to our cash; however, the Company can provide no assurances that access to our cash will not be impacted by adverse conditions in the financial markets. At September 30, 2021 and December 31, 2020, the Company had $1,934,969 and none, respectively in excess of the FDIC insured limits.</p> 250000 1934969 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Related parties are any entities or individuals that, through employment, ownership, or other means, possess the ability to direct or cause the direction of the management and policies of the Company.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In December 2019, the FASB issued ASU No. 2019-12, <em>Simplifying the Accounting for Income Taxes</em> (“ASU 2019-12”), which simplifies the accounting for income taxes, eliminates certain exceptions within ASC 740, <em>Income Taxes</em>,<em> </em>and clarifies certain aspects of the current guidance to promote consistency among reporting entities. ASU 2019-12 is effective for fiscal years beginning after December 15, 2021. Most amendments within the standard are required to be applied on a prospective basis, while certain amendments must be applied on a retrospective or modified retrospective basis. The Company is evaluating the effects, if any, of the adoption of ASU 2019-12 guidance on the Company's financial position, results of operations and cash flows.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In August 2020, the FASB issued ASU No. 2020-06, <em>Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, </em>which address issues identified as a result of the complexity associated with applying generally accepted accounting principles for certain financial instruments with characteristics of liabilities and equity.  This amendment is effective for public business entities that meet the definition of a SEC filer, excluding entities eligible to be smaller reporting companies as defined by the SEC, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company is evaluating the effects, if any, of the adoption of ASU 2020-06 guidance on the Company's financial position, results of operations and cash flows.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In October 2020, the FASB issued ASU No. 2020-08, <em>Codification Improvements to Subtopic 310-20, Receivables-Nonrefundable Fees and Other Costs, </em>amendments the guidance in ASU No. 2017-08, (Subtopic 310-20): <em>Premium Amortization on Purchased Callable Debt Securities</em>, which addresses multiple call dates of a callable debt security.  This amendment is effective for public business entities, for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. Early application is not permitted.  The Company evaluated the adoption of ASU 2020-08 guidance and determined no effects on the Company's financial position, results of operations and cash flows.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In May 2021, the FASB issued ASU No. 2021-04, <em>Earnings Per Share (Topic 260), Debt-Modifications and Extinguishments </em><em>(S</em>ubtopic 470-50), <em>Compensation-Stock Compensation </em><em>(Topic 718), and Derivatives and Hedging-Contracts in Entity’s Own Equity </em><em>(Subtpoic 815-40)</em>, which addresses issuer’s accounting for certain modifications or exchanges of freestanding equity-classified written call options.  This amendment is effective for all entities, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted.  The Company is evaluating the effects, if any, of the adoption of ASU 2021-04 guidance on the Company's financial position, results of operations and cash flows.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">While preparing financial statements for periods in 2021, the Company discovered an error in the statement of operations for the year ended December 31, 2020.  The error related to the presentation of the loss on disposal of property and equipment and asset impairment adjustment in accordance with ASC 360-10-45.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Loss on disposal of property and equipment and asset impairment adjustment of  $39,434 and $25,320,555, respectively, were presented as other income/expense-net, instead of as operating expenses.  As a result, loss from operations for the year ended December 31, 2020, was understated by $25,359,989 and other income/expenses-net was overstated by the same amount.  The errors had no affect on the net loss or net loss per share for the year ended December 31, 2020.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As a result of this correction, the statement of operations for the three and nine month periods ended September 30, 2020 in the accompanying financial statements has been retroactively restated.</p> 39434 25320555 -25359989 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 2. GOING CONCERN</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company has incurred recurring losses from operations and has limited cash liquidity and capital resources. Future capital requirements will depend on many factors, including the Company’s ability to develop products, cash flow from operations, and competing market developments. The Company will need additional capital in the near future. Sources of debt financing may result in high interest expense. Any financing, if available, may be on unfavorable terms. If adequate funds are not obtained, we will be required to reduce or curtail operations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As of September 30, 2021, the Company has an accumulated deficit of approximately $54,200,000. During the nine months ended September 30, 2021, the Company also experienced negative cash flows from operating activities of approximately $2,300,000. It appears these principal conditions or events, considered in the aggregate, indicate it is probable that the Company will be unable to meet its obligations as they become due within one year after the date the financial statements are issued. As such, there is substantial doubt about the entity’s ability to continue as a going concern. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company has identified factors that mitigate the probable conditions that have raised substantial doubt about the entity’s ability to continue as a going concern.  On January 15, 2021, the Company initiated a Private Offering (the “Offering”) of up to 40 Units ($2,000,000) with each Unit consisting of one $50,000 principal amount secured convertible debenture, convertible at $3 per share, and a Warrant to purchase 25,000 shares of the Company’s common stock at $3 per share. The Secured Debentures carry interest at 12% and mature 24 months after issuance. The Warrants are exercisable six months after issuance and expire 24 months after issuance .  The Offering closed on May 31, 2021 and raised $2,005,000, see Note 8. On September 28, 2021 the Company closed the sale of a convertible debenture and issued warrants that raised $2,225,000 of net proceeds after debt issuance costs.  The debenture is for a face amount $3,048,781 with an OID of 18% and due March 27, 2022, if not converted, see Note 7.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We will need additional funds beyond the money raised in this Offering.  As a result, we are planning on additional financings in the future. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On January 30, 2020, the World Health Organization (“WHO”) announced a global health emergency because of a new strain of coronavirus originating in Wuhan, China (the “COVID-19 outbreak”) and the risks to the international community as the virus spreads globally beyond its point of origin. In March 2020, the WHO classified the COVID-19 outbreak as a pandemic, based on the rapid increase in exposure globally. The full impact of the COVID-19 outbreak continues to evolve as of the date of this report. Management is actively monitoring the global situation on its financial condition, liquidity, operations, suppliers, industry, and workforce. Given the daily evolution of the COVID-19 outbreak and the global responses to curb its spread, the Company is not able to estimate the effects of the COVID-19 outbreak on its results of operations, financial condition, or liquidity for fiscal year 2021. However, if the pandemic continues, it may have an adverse effect on the Company’s results of future operations, financial position, and liquidity in fiscal year 2021.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Management believes actions presently being taken to obtain additional funding provide the opportunity for the Company to continue as a going concern; however, these plans are contingent upon actions to be performed by the Company and these conditions have not been met on or before September 30, 2021. Additionally, the COVID-19 outbreak could have a continued material adverse impact on economic and market conditions and trigger a period of global economic slowdown, which would impair the Company’s ability to raise needed funds to continue as a going concern. As such, substantial doubt about the entity’s ability to continue as a going concern was not alleviated as of September 30, 2021.</p> On January 15, 2021, the Company initiated a Private Offering (the “Offering”) of up to 40 Units ($2,000,000) with each Unit consisting of one $50,000 principal amount secured convertible debenture, convertible at $3 per share, and a Warrant to purchase 25,000 shares of the Company’s common stock at $3 per share. The Secured Debentures carry interest at 12% and mature 24 months after issuance. The Warrants are exercisable six months after issuance and expire 24 months after issuance 2000000 2005000 3048781 0.18 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 3. ASSET PURCHASE</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On June 5, 2020, the Company completed a transaction (the “Transaction”) with IDTEC subject to the terms and conditions of the APA and that was accounted for as an asset purchase. Pursuant to the APA, IDTEC provided personnel, experience, and access to funding to assist with the development of the SOBR device, as well as sold to us certain robotics assets, which our management believes are synergistic with our current assets, in exchange for 12,000,000 shares of our common stock after giving effect to the reverse stock split effected in connection with closing the Transaction. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As a result of closing the Transaction, the Company issued a convertible promissory note for all the funds spent or advanced by IDTEC prior to closing. This note totaled $1,485,189(the “APA Note”), with simple interest at 10% per annum, due upon demand, and may be convertible into shares of common stock at $0.50 per share (after giving effect to the reverse stock split and subject to anti-dilution protection against any future securities we may issue at an effective price of less than $0.50 per share) at the discretion of the holder. The repayment of APA Note is secured by a first priority security lien or security interest in the patents, trademarks, tradenames, and other intellectual property of the Company.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At closing, some of the closing conditions under the APA were either waived and/or modified by the parties. In order to document those modifications and waivers, we entered into a Waiver Under Asset Purchase Agreement and Post-Closing Covenant Agreement with IDTEC. One of the closing conditions that was the subject of the Waiver Under Asset Purchase Agreement and Post-Closing Covenant Agreement was the requirement that the Company have under $125,000 in permitted liabilities (not including aged liabilities) after closing of the Transaction. At closing we had approximately $158,000 in non-permitted liabilities under the APA. As a result, the Company issued a Warrant to Purchase Common Stock to IDTEC (the “Warrant”), under which IDTEC will purchase up to 320,000 shares of our common stock (post-split) at an exercise price of $0.50 per share, if either (i) we are forced to pay a non-permitted liability, then we may force IDTEC to exercise the Warrant and pay the exercise price to pay the non-permitted liability, but only in an amount sufficient to pay the non-permitted liability, or (ii) if IDTEC otherwise elects to exercise the Warrant and acquire some or all of the shares underlying the Warrant. The Warrant expires five years after the date of issuance.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Transaction recorded as an asset purchase was valued at $29,222,955, which consists of the market price as of June 5, 2020 of the Company’s 12,000,000 shares of common stock issued totaling $27,120,000, the funds spent by IDTEC and affiliates prior to closing of $1,407,051 and the fair value of the Warrant issued of $695,454.  In determining the fair value of the intangible assets, the Company considered, among other factors, the best use of acquired assets such as the analysis of historical financial performance of the products and estimates of future performance of the products and intellectual properties acquired. The  allocation to identifiable intangible assets required extensive use of financial information and management's best estimate of fair value.   </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following summarizes the transaction closing with IDTEC on June 5, 2020:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Property and equipment</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">47,725</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Intangible assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">29,175,230</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Total assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">29,222,955</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net purchase (fair value of stock issued, warrants and notes payable) </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">29,222,955</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">  </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Subsequent to the Transaction closing, the Company evaluated the fair value of theassets acquired based on market estimates for property and equipment and discounted net cash flow for the SOBR Safe intellectual technology. The present value of the discounted cash flow utilized a 75% discount, which included a 25% risk return premium, over an estimated five-year net revenue stream expected to be derived from the technology acquired. Based on the assessment of fair value, the Company recognized an asset impairment loss of $25,320,555 resulting from the APA during the year ended December 31, 2020. The impairment was due to the increase of the Company's stock price value. The stock price of the Company at closing of the Transaction was significantly higher than expected from the stock price of the Company when the Company signed the APA. The number of shares to be given to IDTEC as consideration for the Transaction would not get updated for any stock price changes.</p> 12000000 1485189 0.10 0.50 125000 158000 320000 0.50 29222955 12000000 27120000 1407051 695454 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Property and equipment</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">47,725</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Intangible assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">29,175,230</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Total assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">29,222,955</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net purchase (fair value of stock issued, warrants and notes payable) </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">29,222,955</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 47725 29175230 29222955 29222955 assets acquired based on market estimates for property and equipment and discounted net cash flow for the SOBR Safe intellectual technology. The present value of the discounted cash flow utilized a 75% discount, which included a 25% risk return premium, over an estimated five-year net revenue stream expected to be derived from the technology acquired 25320555 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 4. PREPAID EXPENSES</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Prepaid expenses consist of the following:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>September 30,</strong></p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2020</strong> </p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Consulting service</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">111,860</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Rent</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">20,667</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Insurance</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">4,232</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">3,370</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Prepaid expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">24,899</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">115,230</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">  </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On February 26, 2021, the Company entered into a new lease agreement for its office facility for a 12-month term beginning March 1, 2021.  In addition to monthly base rent of $6,000, the agreement requires the issuance on 16,000 shares of its common stock valued at $49,600, all of which has been issued as of September 30, 2021.  </p> <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>September 30,</strong></p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2020</strong> </p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Consulting service</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">111,860</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Rent</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">20,667</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Insurance</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">4,232</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">3,370</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Prepaid expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">24,899</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">115,230</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 0 111860 20667 0 4232 3370 24899 115230 6000 16000 49600 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 5. INTANGIBLE ASSETS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Intangible assets consist of the following at September 30, 2021:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Gross Carrying </strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Amount </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Accumulated</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Amortization </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Net Intangible</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Asset </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Amortization </strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Period </strong><strong>(in years)</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">SOBR Safe Intellectual Technology</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,854,675</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">513,952</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,340,723</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">10</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">                                                                            </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Amortization expense for the nine-month period ended September 30, 2021 and 2020 was $298,098 and $128,488, respectively, and is included in general and administrative expenses in the consolidated statements of operations. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Estimated future amortization expense for device technology intangible assets is as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td colspan="2" style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> 2023</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>  2024</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;text-align:center;"><strong>2025</strong></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>   2026</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> Thereafter</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td style="width:14%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">385,467</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:14%;vertical-align:bottom;text-align:right;">385,467</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:14%;vertical-align:bottom;text-align:right;">385,467</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:14%;vertical-align:bottom;text-align:right;">385,467</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:14%;vertical-align:bottom;text-align:right;">385,467</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:13%;vertical-align:bottom;text-align:right;">1,413,388</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Gross Carrying </strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Amount </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Accumulated</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Amortization </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Net Intangible</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Asset </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Amortization </strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Period </strong><strong>(in years)</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">SOBR Safe Intellectual Technology</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,854,675</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">513,952</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,340,723</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">10</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 3854675 513952 3340723 P10Y 128488 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td colspan="2" style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> 2023</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>  2024</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;text-align:center;"><strong>2025</strong></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>   2026</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> Thereafter</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td style="width:14%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">385,467</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:14%;vertical-align:bottom;text-align:right;">385,467</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:14%;vertical-align:bottom;text-align:right;">385,467</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:14%;vertical-align:bottom;text-align:right;">385,467</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:14%;vertical-align:bottom;text-align:right;">385,467</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:13%;vertical-align:bottom;text-align:right;">1,413,388</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 385467 385467 385467 385467 385467 1413388 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 6. RELATED PARTY TRANSACTIONS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On July 1, 2015, the Company amended a December 3, 2014, note payable agreement with Lanphere Law Group, a related party and  shareholder, which forgave $108,000 of a note payable’s principal balance. This debt forgiveness decreased the original principal balance on the note of $214,334 to a new principal balance of $106,335, and a related party gain of $108,000 was recorded to additional paid-in capital. This amendment also extended the note payable’s due date toDecember 2, 2015. The note was converted to common stock during the three months ended March 31, 2020. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On March 8, 2017, Lanphere Law Group irrevocably elected to exercise warrants in order to acquire 969,601 shares of the Company’s common stock in exchange for an aggregate exercise price of $112,871, which was used for the deduction of $74,672 of principal and $38,199 of accrued interest related to the December 3, 2014, note payable agreement with Lanphere Law Group. The forgiveness of the note payable principal of $74,672 was recorded to equity and the $38,199 of related accrued interest was also recorded to equity. The principal balance of the note after the debt deduction was $31,662. On January 3, 2020, the note payable principal balance of $31,662 was converted to 9,520 common shares at a per share price of $3.326.  </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On January 3, 2020, the Company entered into a Debt Conversion and Common Stock Purchase Plan with Michael Lanphere, a beneficial owner of the Company, under which he agreed to exercise warrants and the Company agreed to issue 454,097 shares of its common stock in exchange for a reduction in the amounts owed to Mr. Lanphere under two promissory notes. Mr. Lanphere’s option to acquire the shares was under the terms of certain Loan Agreement with Promissory Note and Stock Fees agreements entered into with the Company and Mr. Lanphere on April 17, 2019 and July 17, 2019. The amount of the debt reduction, and therefore the purchase price of the shares, was approximately $66,000 which was used for the deduction of related party notes payable principal of  approximately $66,000. 180,397 common shares were issued on January 3, 2020, at an effective conversion price of $0.133 and 273,700 common shares were issued on January 3, 2020 at an effective conversion price of $0.153. After this exercise, Lanphere Law Group owns no warrants for shares of our common stock.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On January 3, 2020, the Company entered into another Debt Conversion and Common Stock Purchase Plan with Michael Lanphere, under which the Company agreed to issue 63,225 shares of its common stock in exchange for a reduction in the amounts owed to Mr. Lanphere under numerous other remaining promissory notes. The amount of the debt reduction, and therefore the purchase price of the shares, was $210,285 which was used for the deduction of related party notes payable principal of $169,606 and accrued interest of $40,679. Based on the fair value of the shares issued, the Company recognized a related party gain of approximately $52,000 and accounted for it as additional paid-in capital. The common shares were issued on January 3, 2020 at an effective conversion price of $3.326 per share. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On January 3, 2020, the Company entered into a Debt Conversion and Common Stock Purchase Plan with Vernon Justus, a shareholder, under which the Company agreed to issue 84,963 shares of its common stock in exchange for a reduction in the amounts owed to Mr. Justus under a promissory note. The amount of the debt reduction, and therefore the purchase price of the shares, was $282,588 which was used for the deduction of a related party note payable principal of $180,001 and accrued interest of $102,587. Based on the fair value of the shares issued, the Company recognized a related party gain of approximately $70,000 and accounted for it as additional paid-in capital. The common shares were issued on January 3, 2020 at an effective conversion price of $3.326 per share. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On January 16, 2020, the Company entered into a Accounts Payable Conversion and Common Stock Purchase Plan with Michael Lanphere, under which the Company agreed to issue 214,883 shares of its common stock in exchange for a reduction in the amounts owed to Mr. Lanphere for unpaid legal bills. The amount of the debt reduction, and therefore the purchase price of the shares, was $714,700 which was used for the deduction of related party payables of $714,700. Based on the fair value of the shares issued, the Company recognized a related party gain of approximately $222,000 and accounted for it as additional paid-in capital. The common shares were issued on January 16, 2020 at an effective conversion price of $3.326 per share. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On January 30, 2020, the Company entered into a Debt Conversion and Common Stock Purchase Plan with Devadatt Mishal, one of the Company’s former directors and current shareholder, under which the Company agreed to issue 499,965 shares of its common stock in exchange for a reduction in the amounts owed to Mr. Mishal under numerous promissory notes. The amount of the debt reduction, and therefore the purchase price of the shares, was $456,641 which was used for the deduction of related party notes payable principal of $270,300 and accrued interest of $186,341. The Company also recorded a loss on related party debt extinguishment of approximately $144,000. The common shares were issued on January 30, 2020 at an effective conversion price of $0.91465 per share. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On March 23, 2020, the Company entered into a Debt Conversion and Common Stock Purchase Plan with Prakash Gadgil, one of the Company’s former directors and current shareholder, under which the Company agreed to issue 586 shares of its common stock in exchange for a reduction in the amounts owed to Mr. Gadgil under a promissory note. The amount of the debt reduction, and therefore the purchase price of the shares, was $1,950 which was used for the deduction of a related party note payable principal of $1,950. Based on the fair value of the shares issued, the Company recognized a related party gain of approximately $1,000 and accounted for it as additional paid-in capital. The common shares were issued on March 23, 2020 at an effective conversion price of $3.326 per share. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On April 6, 2020, the Company agreed with Nick Noceti, the Company’s former Chief Financial Officer, to issue 38,437 shares of its common stock in exchange for amounts due for accounting fees. The amount of the debt reduction, and therefore the purchase price of the shares, was $127,840 which was used for the deduction of a related party accounts payable of $127,480. Based on the fair value of the shares issued, the Company recognized a related party gain of approximately $49,000 and accounted for it as additional paid-in capital. The common shares were issued on April 4, 2020 at an effective conversion price of $3.326 per share.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On April 7, 2020, the Company agreed with Charles Bennington, one of the Company’s former directors, to issue 6,831 shares of its common stock in exchange for amounts due for Board of Director fees. The amount of the debt reduction, and therefore the purchase price of the shares, was $9,656 which was used for the deduction of a related party accounts payable of $9,656. Based on the fair value of the shares issued, the Company recognized a related party gain of approximately $2,000 and accounted for it as additional paid-in capital. The common shares were issued on April 7, 2020 at an effective conversion price of $1.41 per share.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On February 12, 2021, the Company entered into a note payable agreement with David Gandini, an officer and shareholder, under which Mr. Gandini advanced the Company $30,000 for working capital purposes.  The  unsecured note carried interest at 0% and was paid in April 2021.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On March 30, 2021, the Company received notification from IDTEC that it was exercising a portion of the 320,000 warrants issued resulting from the Waiver Under Asset Purchase Agreement and Post-Closing Covenant Agreement with IDTEC.  The warrant exercise price is $0.50 per share.  With the proceeds of the exercise we paid $88,469 during the six-month period ended June 30, 2021 to settle an outstanding judgement (see Note 14) against the Company which was considered as a non-permitted liability under the Post-Closing Covenant Agreement.  We will issue 176,938 shares of our common stock for the $88,469 we received from IDTEC to pay the settlement.  As the shares had not been issued by June 30, 2021, the amount received from IDTEC is included in the common stock subscriptions payable balance at June 30, 2021. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On March 3 and 31, 2021, the Company issued convertible notes payable (see Note 8) totaling $450,000 to existing shareholders holding a direct or indirect interest in the Company and $100,000 to a Company’s director and another director’s family member. The principal amount of the secured convertible debentures are convertible at $3 per share, and include warrants to purchase in total 275,000 shares of the Company’s common stock at $3 per share.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On May 31, 2021, the Company issued convertible notes payable (see Note 8) totaling $400,000 to existing shareholders holding a direct or indirect interest in the Company and $50,000 to a Company’s officer. The principal amount of the secured convertible debentures are convertible at $3 per share, and include warrants to purchase in total 225,000 shares of the Company’s common stock at $3 per share.</p> 214334 106335 108000 2015-12-02 969601 74672 38199 31662 31662 9520 3.326 454097 66000 66000 180397 0.133 273700 0.153 63225 210285 169606 40679 52000 3.326 84963 282588 180001 102587 70000 3.326 214883 714700 714700 222000 3.326 499965 456641 270300 186341 144000 0.91465 586 1950 1950 1000 3.326 38437 127840 127480 49000 3.326 6831 9656 2000 1.41 30000 0 320000 0.50 88469 176938 450000 100000 275000 3 400000 50000 3 225000 3 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 7. CONVERTIBLE DEBENTURE PAYABLE</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Convertible debenture payable consists of the following:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>September 30,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2020</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Convertible Debenture Payable with Detached Free-standing Warrant</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,048,781</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Unamortized Debt Discount </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">(2,608,900</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Convertible Debenture Payable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">439,881</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On September 28, 2021, (the “Closing Date”) the Company completed a financing transaction under a Securities Purchase Agreement (the “SPA”) and corresponding 18% Original Issue Discount Convertible Debenture (the “Debenture”), Common Stock Purchase Warrant (the “Warrant”) and Registration Rights Agreement (“RRA”). Under the terms of the SPA, the Company received $2,500,000 from the Purchaser and in exchange issued the Debenture in the principal amount of $3,048,781 and Warrants to purchase up to 1,219,512 shares of the Company’s common stock. The Debenture is convertible voluntarily by the Purchaser at any time into shares of our common stock, at the lesser of $2.50, representing 100% of the closing price of our common stock on the trading day immediately prior to the Closing Date, or 75% of the average VWAP of our common stock during the 5 trading day period immediately prior to the conversion date (the “Conversion Price”), or automatically upon the occurrence of a single public offering of our common stock which results in the listing of our common stock on a national securities exchange as defined in the Exchange Act (the “Qualified Offering”) into shares of our common stock at the lesser of the Conversion Price, or 75% of the offering price of the securities offered in the Qualified Offering. The Debenture matures on March 27, 2022, does not accrue interest unless there is an event of default under the terms of the Debenture. The Warrant is exercisable at any time through September 28, 2026 into shares of our common stock at an exercise price of $2.00 per share, unless an event of default occurs, at which time the exercise price will adjust to $1.00 per share. The Warrant contains a cashless exercise provision but only in the event the Company fails to have an effective registration statement registering the common shares underlying the Warrant at any time beginning six months from the Closing Date.  The RRA requires the Company to register for resale and maintain effectiveness of such Registration Statement for such all of the registrable securities under the terms of the Debenture and Warrant, within defined time frames. Should the Company fail to meet the RRA requirements, until the date causing such event of noncompliance is cured, the Company shall pay to the Purchaser as partial liquidated damages equal to the product of 2% of the principal amount not to exceed 24% of the aggregate principal. If the Company fails to pay of the liquidated damages within seven days after the date payable, the Company will pay interest at 18% until such amounts are paid in full. The Company evaluated the Debenture for derivative embedded and beneficial conversion features and determined that its embedded conversion feature carried a debt discount. The total conversion feature debt discount of $980,000 is amortized over the life of the convertible debenture. The debt discount amortization expense recorded as amortization of interest in the consolidated statements of operations was $16,245 for the nine-month period ended September 30, 2021.  As of September 30, 2021, the debenture carries outstanding warrants of 1,219,512. The relative fair market value of the related stock warrants granted during the nine month period ended September 30, 2021 and 2020 was $847,048 and none, respectively.  The unamortized discount at September 30, 2021 and December 31, 2020 was $833,008 and none, respectively. Stock warrants amortization expense recorded as interest expense was $14,039 for the nine month period ended September 30, 2021. The Company incurred $548,781 of Original Issue Discount and $275,000 of debt issuance costs related to the Debenture which is being amortized to interest expense over the term of the debt using the effective interest method. Interest expense related to the Original Issue Discount and debt issuance costs was $11,645 for the nine month period ended September 30, 2021. The unamortized discount and issuance costs at September 30, 2021 and December 31, 2020 was $812,134 and none, respectively.  </p> <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>September 30,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2020</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Convertible Debenture Payable with Detached Free-standing Warrant</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,048,781</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Unamortized Debt Discount </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">(2,608,900</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Convertible Debenture Payable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">439,881</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 3048781 0 -2608900 0 439881 0 0.18 2500000 3048781 1219512 The Debenture is convertible voluntarily by the Purchaser at any time into shares of our common stock, at the lesser of $2.50, representing 100% of the closing price of our common stock on the trading day immediately prior to the Closing Date, or 75% of the average VWAP of our common stock during the 5 trading day period immediately prior to the conversion date (the “Conversion Price”), or automatically upon the 2.00 1.00 the Company shall pay to the Purchaser as partial liquidated damages equal to the product of 2% of the principal amount not to exceed 24% of the aggregate principal. If the Company fails to pay of the liquidated damages within seven days after the date payable, the Company will pay interest at 18% until such amounts are paid in full 980000 16245 1219512 847048 833008 14039 548781 275000 11645 812134 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 8. NOTES PAYABLE</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>RELATED PARTIES</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Related party notes payable consist of the following:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>    September 30,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>        2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2020</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Convertible Notes Payable with Detached Free-standing Warrants</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,000,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Conventional Non-Convertible Notes Payable </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">11,810</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">11,810</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Unamortized Debt Discount </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(771,576</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Related Party Notes Payable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">240,234</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">11,810</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Current Portion </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(11,810</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(11,810</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Long-Term Portion </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">228,424</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Total interest expense for related party notes was $55,151 and $79,596 for the nine month period ended September 30, 2021 and 2020, respectively.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Related Party Convertible Notes Payable with Warrants</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company has thirteen convertible notes payable to related parties, each with detached free-standing warrants to purchase the Company’s common stock at $3 per share, that have a total principal balance of $1,000,000 as of September 30, 2021. The notes, secured by the Company’s patents and patents applications, include interest at 12%, are convertible at $3 per share of the Company’s common stock and are due 24 months after issuance. The note holders may elect to have the interest paid in cash monthly or have the interest accrue and be payable on the maturity date. Interest elected to be accrued will be paid in cash or may be converted into shares of our common stock under the same terms as the principal amount on the maturity date. The notes contain both voluntary and automatic conversion features. The notes will be convertible at any time, by the holders, beginning on the date of issuance. However, the holders may not convert any outstanding amounts due under the note if at the time of such conversion the amount of common stock issued for the conversion, when added to other shares of Company common stock owned by the holders or which can be acquired by holders upon exercise or conversion of any other instrument, would cause the holder to own more than 4.9% of the Company’s outstanding common stock.  Beginning on the issuance date, the outstanding principal amount of the note, and any accrued interest, will automatically convert into shares of the Company’s common stock if the Company’s common stock closes at or above $6 per share for five (5) consecutive trading days while listed on NASDAQ. The Company evaluated the convertible notes payable for derivative embedded and beneficial conversion features. The Company determined that there were beneficial conversion features to record. The total beneficial conversion feature debt discount of $448,999 is amortized over the life of the convertible notes payable. The debt discount amortization expense recorded as amortization of interest – beneficial conversion feature in the consolidated statements of operations was $101,070for the nine-month period ended September 30, 2021. As of September 30, 2021, these notes carry outstanding warrants of 500,000. The relative fair market value of the related stock warrants granted during the nine-month period ended September 30, 2021 and 2020 was $551,001 and none, respectively.  The unamortized discount at September 30, 2021 and December 31, 2020 is $423,647 and none, respectively. Stock warrants amortization expense recorded as interest expense was $127,354 for the nine-month period ended September 30, 2021.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Related Party Convertible Notes Payable</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On June 5, 2020 the Company issued the convertible APA Note to a related party with a principal balance of  $1,485,189, which included the $70,000 balance of three convertible notes payable to related parties and related accrued interest of $7,689 outstanding at December 31, 2019.  The note includes simple interest at 10% per annum, due upon demand, and may be convertible into shares of common stock at $0.50 per share (after giving effect to the reverse stock split and subject to anti-dilution protection against any future securities we may issue at an effective price of less than $0.50 per share) at the discretion of the holder.  The Company evaluated the convertible note payable for derivative embedded and beneficial  conversion features. The Company determined that there was a  beneficial conversion feature to record. During the year ended December 31, 2020, beneficial conversion feature amortization expense related to this related party convertible note payable of $1,407,675 was accounted for as amortization of interest - beneficial conversion feature expense in the consolidated statements of operations. On November 15, 2020, the related party holder elected to convert the note principal and accrued interest balance of $1,551,514 into 3,103,028 of shares of common stock. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Related Party Non-convertible Notes Payable</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company has one non-convertible note payable to a related party that has a principal balance of  $11,810 as of September 30, 2021 and December 31, 2020. The note carries an interest rate at 0%.  The note payable had a due date of December 31, 2012 and is currently in default.    </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NON-RELATED PARTIES</strong>  </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Non-related party notes payable consist of the following:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>September 30,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2020</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Convertible Notes Payable with Detached Free-standing Warrants</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,005,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Convertible Notes Payable </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">56,683</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">56,683</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Conventional Non-Convertible Notes Payable </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">42,500</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">42,500</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Notes Payable with Detached Free-standing Warrants </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Unamortized Debt Discount </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">(774,850</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Non-Related Party Notes Payable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">334,333</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">104,183</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Current Portion</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">(104,183</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">(79,183</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Long-Term Portion</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">230,150</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">25,000</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Total interest expense for non-related party notes was $65,130 and $14,036 for the nine-month periods ended September 30, 2021 and 2020, respectively.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Convertible Notes Payable with Warrants</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company has sixteen convertible notes payable to non-related parties, each with detached free-standing warrants to purchase the Company’s common stock at $3 per share, that have a total principal balance of $1,005,000 as of September 30, 2021. The notes, secured by the Company’s patents and patents applications, include interest at 12%, are convertible at $3 per share of the Company’s common stock and are due 24 months after issuance.  The note holders may elect to have the interest paid in cash monthly or have the interest accrue and be payable on the maturity date.  Interest elected to be accrued will be paid in cash or may be converted into shares of our common stock under the same terms as the principal amount on the maturity date.  The notes contain both voluntary and automatic conversion features. The notes will be convertible at any time, by the holders, beginning on the date of issuance. However, the holders may not convert any outstanding amounts due under the note if at the time of such conversion the amount of common stock issued for the conversion, when added to other shares of Company common stock owned by the holders or which can be acquired by holders upon exercise or conversion of any other instrument, would cause the holder to own more than 4.9% of the Company’s outstanding common stock.  Beginning on the issuance date, the outstanding principal amount of the note, and any accrued interest, will automatically convert into shares of the Company’s common stock if the Company’s common stock closes at or above $6 per share for five (5) consecutive trading days while listed on NASDAQ. The Company evaluated the convertible notes payable for derivative embedded and beneficial conversion features. The Company determined that there were beneficial conversion features to record. The total beneficial conversion feature debt discount of $460,215 is amortized over the life of the convertible notes payable.  The debt discount recorded as amortization of interest – beneficial conversion feature in the consolidated statements of operations was $105,060 for the nine-month period ended September 30, 2021.  As of September 30, 2021, these notes carry outstanding warrants of 502,500. The relative fair market value of the related stock warrants granted during the nine-month period ended September 30, 2021 and 2020 was $541,707 and none, respectively.  The unamortized discount at September 30, 2021 and December 31, 2020 was $419,695 and none, respectively. Stock warrants amortization expense recorded as interest expense was $122,012 for the nine-month period ended September 30, 2021.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Convertible Notes Payable</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company has three convertible notes payable to non-related parties that have a principal balance of $56,683 as of September 30, 2021 and December 31, 2020. These notes carry interest rates ranging from 5% - 12% and have due dates ranging from February 2013 to March 2022. Two of the three notes are currently in default. These notes carry conversion prices ranging from $1.99- $10.7619 per share. The Company evaluated these convertible notes payable for derivative embedded and beneficial conversion features. The Company determined that there were beneficial conversion features to record. The conversion features were either fully amortized upon grant or over the life of the convertible notes payable. The conversion features were fully amortized prior to 2020. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three months ended March 31, 2020, the Company entered into Debt Conversion and Common Stock Purchase Plans with six non-related parties, under which the Company agreed to issue 50,135 shares of its common stock in exchange for a reduction of eleven convertible notes payable to non-related parties. The amount of the debt reduction, and therefore the purchase price of the shares, was $166,750 which was used for the deduction of non-related party convertible notes payable principal of $83,953 and accrued interest of $82,797. The Company recorded a non-related party gain on loan extinguishment  of approximately $103,000.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three months ended March 31, 2020, the Company entered into a non-related party convertible note payable agreement to convert a high interest rate convertible non-related party note payable with a principal balance of $25,000 and accrued interest due of $22,500 to a non-related party convertible note payable of $47,500 that accrues interest at 5%. The note conversion rate is $2 per common share. The Company recorded a loss on non-related party debt extinguishment of $11,697.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During 2020, the holder of a $25,000 convertible promissory note with interest at 30% and accrued interest of $61,875 replaced the carrying amount of the note and its conversion features with a new non-convertible note totaling $25,000 that bears interest at 5%. The Company recorded a gain on non-related party debt extinguishment of $61,875.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Non-convertible Notes Payable</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company has three non-convertible notes payable to non-related parties that have a principal balance of $42,500 as of September 30, 2021, and December 31, 2020. These notes carry interest rates ranging from  5% - 10% and have due dates ranging from 12/25/2013 - 6/06/2022. Two of the three notes are currently in default.  </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During 2020, the Company entered into a Debt Conversion and Common Stock Purchase Plan with a non-related party, under which the Company agreed to issue 20,313 shares of its common stock in exchange for a reduction of a non-convertible non-related party note payable. The amount of the debt reduction, and therefore the purchase price of the shares, was $67,561 which was used for the deduction of non-related party non-convertible notes payable principal of $3,938 and accrued interest of $63,623. The Company recorded a non-related party gain on loan extinguishment  of approximately $14,000.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On May 12, 2020, the Company received proceeds of $41,665 from a commercial bank under the SBA Payroll Protection Loan Program. The loan requires interest at 1% and 18 monthly payments of principal and interest beginning December 5, 2020. Provisions of the SBA Payroll Protection Loan Program allow for portions or all the loan balance to be forgiven should certain criteria be met.  On December 7, 2020 the Company was notified that the principal balance and accrued interest of $242 was forgiven, and thus the Company  recorded a gain on loan extinguishment of approximately $42,000.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Notes Payable with Warrants</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company has one note payable with detached free-standing warrants to a non-related party that has a principal balance of $5,000 as of  September 30, 2021 and December 31, 2020. This note carries an interest rate of 10% and had a due date of 9/11/2014. This note is currently in default. The detached free-standing warrants for this note payable were not exercised by the note holder and expired on May 16, 2019.</p> <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>    September 30,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>        2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2020</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Convertible Notes Payable with Detached Free-standing Warrants</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,000,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Conventional Non-Convertible Notes Payable </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">11,810</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">11,810</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Unamortized Debt Discount </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(771,576</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Related Party Notes Payable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">240,234</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">11,810</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Current Portion </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(11,810</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(11,810</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Long-Term Portion </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">228,424</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 1000000 0 11810 11810 -771576 0 240234 11810 228424 0 55151 79596 3 1000000 0.12 448999 101070 500000 551001 423647 127354 1485189 70000 7689 0.10 0.50 1407675 1551514 3103028 11810 0 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>September 30,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2020</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Convertible Notes Payable with Detached Free-standing Warrants</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,005,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Convertible Notes Payable </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">56,683</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">56,683</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Conventional Non-Convertible Notes Payable </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">42,500</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">42,500</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Notes Payable with Detached Free-standing Warrants </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Unamortized Debt Discount </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">(774,850</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Non-Related Party Notes Payable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">334,333</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">104,183</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Current Portion</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">(104,183</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">(79,183</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Long-Term Portion</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">230,150</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">25,000</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 1005000 0 56683 56683 42500 42500 5000 5000 -774850 0 334333 104183 230150 25000 65130 14036 1005000 460215 502500 541707 419695 122012 56683 0.05 0.12 1.99 10.7619 50135 166750 83953 82797 103000 25000 22500 47500 0.05 2 11697 25000 25000 0.05 61875 42500 0.05 0.10 12/25/2013 6/06/2022 20313 67561 3938 63623 14000 41665 The loan requires interest at 1% and 18 monthly payments of principal and interest beginning December 5, 2020 242 42000 5000 0.10 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 9. DERIVATIVE LIABILITY</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In September 2021, the Company completed a financing transition and received $2,500,000 from the Purchaser and in exchange issued an 18% Original Issue Discount Convertible Debenture in the principal amount of $3,048,781. The debenture includes voluntary and automatic conversion features at a variable conversion prices convertible into the Company’s common shares at an undetermined future date. The Company analyzed the conversion features of the debenture agreement for derivative accounting consideration under ASU 2017-11 (ASC 815-15, Derivatives and Hedging), and determined the embedded conversion features should be classified as a derivative because the exercise price of the convertible note is subject to a variable conversion rate and should therefore be accounted for at fair value under ASC 820, <em>Fair Value Measurements and Disclosures,</em> and ASC 825, <em>Financial Instruments</em>. In accordance with ASC 815-15, the Company bifurcated the conversion feature of the debenture and recorded a derivative liability. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The embedded derivative for the debenture is carried on the Company’s balance sheet at fair value. The derivative liability is marked to market each measurement period and any unrealized change in fair value is recorded as a component of the consolidated statement of operations and the associated fair value carrying amount on the balance sheet was adjusted by the change. The Company fair valued the embedded derivative using a Monte Carlo simulation model based on the following assumptions: (1) expected volatility of 120%, (2) risk-free interest rate of 0.05%, and (3) expected life from 4 to 6 months. On September 28, 2021, the Closing Date of the transaction, the fair value of the embedded derivative was $980,000 and is amortized to interest expense over the term of the Debenture. Utilizing level 3 inputs, the Company did not record a fair market value gain or loss for the nine months ended September 30, 2021. The fair value of the embedded derivative recorded on the balance sheet as a liability was $980,000 at September 30, 2021.</p> 2500000 0.18 3048781 1.20 0.0005 P4Y P6Y 980000 980000 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 10. STOCK SUBSCRIPTIONS PAYABLE </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company has common stock subscriptions payable due to related parties of $91,613 payable with 193,856 of its common shares at September 30, 2021.  The Company has common stock subscriptions payable due to related parties of $111,024 payable with 60,087 of its common shares at December 31, 2020. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company has common stock subscriptions payable due to non-related parties of $136,433 payable with 87,500 of its common shares at September 30, 2021 and December 31, 2020. </p> 91613 193856 111024 60087 136433 87500 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 11. COMMON STOCK </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company’s common stock transactions for the nine months ended September 30, 2020, consist of the following:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company issued 601 shares of its common stock for compensation for services rendered.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company issued 454,097 shares of its common stock for the conversion of $65,728 of related parties’ debt from $0.1530 to $0.13304 per share pursuant to terms of the convertible promissory notes. 454,097 stock warrants were settled along with the related party debt.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company issued 214,883 shares of its common stock for the settlement of related party payables of $714,700.  A related party gain of approximately $222,000 was recorded as additional paid-in capital from the stock issuance.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">  </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company issued 38,323 shares of its common stock for the settlement of  accounts payables and accrued expenses of approximately $127,000.  The Company recorded a net gain of approximately $27,000 from the stock issuance.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company issued 648,739 shares of its common stock to related parties for the conversion of $622,004 of debt from $0.9146 to $3.326 per share.  The Company recorded $143,660 of loss on debt extinguishment  and a related party gain of $124,291 as additional paid in-capital as a result of the stock issuance.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company issued 70,448 shares of its common stock to non-related parties for the conversion of $65,391 of debt  at $3.326 per share.  The Company recorded $41,665 of loss resulting from the stock issuance. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company agreed to convert 121,072 shares of its common stock at values between $0.5821 to $1.039 per share to non-related parties in exchange for their agreement to settle payable balances of $91,464 owed to them. The conversion was in full satisfaction of all outstanding amounts owed. The Company recorded a non-related party loss of $81,867 as other expense in the consolidated statements of operations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company issued 45,268 shares of its common stock to related parties in exchange for their agreement to settle  related party accounts payable of $137,496 owed to them. The shares were issued at a value of $86,739 and recorded a related party gain of $50,741 to additional paid-in-capital.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company issued 12,000,000 shares of its common stock valued at $2.26 as result of the Transaction with IDTEC (see Note 3).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company’s common stock transactions for the nine months ended September 30, 2021, consist of the following:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company issued 43,169 shares of its common stock to SOBR Safe, LLC, an entity controlled by a beneficial owner of the Company, in full satisfaction of $107,880 of accrued dividends resulting from the December 2020 conversion of the Series A-1 Convertible Preferred Stock into common shares, see Note 11.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company issued 16,000 shares of its common stock valued at $49,600 to its landlord under the terms of a lease agreement expiring in February 2022.  The amount has been recorded as prepaid expense and amortized monthly over the lease term as general and administrative expense in the consolidated statement of operations.   </p> 601 454097 65728 debt from $0.1530 to $0.13304 per share 454097 214883 714700 222000 38323 127000 27000 648739 622004 debt from $0.9146 to $3.326 per share. 143660 124291 70448 65391 3.326 41665 121072 values between $0.5821 to $1.039 per share 91464 81867 45268 137496 86739 12000000 43169 107880 16000 49600 February 2022 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 12. PREFERRED STOCK </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On November 20, 2015, the Company’s Board of Directors authorized a class of stock designated as preferred stock with a par value of $0.00001 per share comprising 25,000,000 shares, 3,000,000 shares of which were classified as Series A Convertible Preferred Stock. In each calendar year, the holders of the Series A Convertible Preferred Stock are entitled to receive, when, as and if, declared by the Board of Directors, out of any funds and assets of the Company legally available, non-cumulative dividends, in an amount equal to any dividends or other Distribution on the common stock in such calendar year (other than a Common Stock Dividend). No dividends (other than a Common Stock Dividend) shall be paid and no distribution shall be made with respect to the common stock unless dividends shall have been paid or declared and set apart for payment to the holders of the Series A Convertible Preferred Stock simultaneously. Dividends on the Series A Convertible Preferred Stock shall not be mandatory or cumulative, and no rights or interest shall accrue to the holders of the Series A Convertible Preferred Stock by reason of the fact that the Company shall fail to declare or pay dividends on the Series A Convertible Preferred Stock, except for such rights or interest that may arise as a result of the Company paying a dividend or making a distribution on the common stock in violation of the terms. The holders of each share of Series A Convertible Preferred Stock then outstanding shall be entitled to be paid, out of the Available Funds and Assets, and prior and in preference to any payment or Distribution (or any setting part of any payment or Distribution) of any Available Funds and Assets on any shares of common stock, and equal in preference to any payment or Distribution (or any setting part of any payment or Distribution)  of any Available Funds and Assets on any shares of any other series of preferred stock that have liquidation preference, an amount per share equal to the Original Issue Price of the Series A Convertible Preferred Stock plus all declared but unpaid dividends on the Series A Convertible Preferred Stock. A reorganization, or any other consolidation or merger of the Company with or into any other corporation, or any other sale of all or substantially all of the assets of the Company, shall not be deemed a liquidation, dissolution, or winding up of the Company. Shares of the Series A Convertible Preferred Stock are convertible at a 35% discount rate to the average closing price per share of the Company’s common stock (either as listed on a national exchange or as quoted over-the-market) for the last 15 trading days immediately prior to conversion. However, no conversions of the Series A Convertible Preferred Stock to shares of common stock can occur unless the average closing price per share of the Company’s common stock (either as listed on a national exchange or as quoted over-the-market) for the last  15 trading days immediately prior to conversion is at least $1.67. The shares of Series A Convertible Preferred Stock vote on a one for one basis. The right of conversion is limited by the fact the holder of the Series A Convertible Preferred Stock may not convert if such conversion would cause the holder to beneficially own more than 4.9% of the Company’s common stock after giving effect to such conversion. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On December 9, 2019, the Company’s Board of Directors created a class of preferred stock designated as 8% Series A-1 Convertible Preferred Stock comprising of 2,000,000 shares. During 2020, the authorized shares were increased to 2,700,000 shares.  The rights and preferences of the 8% Series A-1 Convertible Preferred Stock are as follows: (a) dividend rights of 8% per annum based on the original issuance price of $1 per share, (b) liquidation preference over the Company’s common stock, (c) conversion rights into shares of the Company’s common stock at $1 per share (not to be affected by any reverse stock split in connection with the Asset Purchase Agreement with IDTEC), (d) redemption rights such that we have the right, upon 30 days written notice, at any time after one year from the date of issuance, to redeem all or part of the Series A-1 Convertible Preferred Stock for 150% of the original issuance price, (e) no call rights by the Company, and (f) each share of Series A-1 Convertible Preferred Stock will vote on an “as converted” basis.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On December 12, 2019, the Company entered into a Series A-1 Preferred Stock Purchase Agreement (the “SPA”) with SOBR SAFE, LLC (“SOBR SAFE”), a Delaware limited liability company and an entity controlled by a beneficial owner of the Company, under which SOBR SAFE agreed to acquire 1,000,000 shares of our Series A-1 Convertible Preferred Stock  in exchange for $1,000,000 (the “Purchase Price”). The Company received the Purchase Price on December 12, 2019. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On May 7, 2020, the Company amended a Convertible Preferred Stock Investment Agreement  granting the exclusive right to SOBR SAFE to purchase up to 2,700,000 shares of Series A-1 Convertible Preferred Stock.   </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On July 2, 2020, the Company executed Amendment No. 2 to the Stock Investment Agreement which provides that the full amount of each dividend due on a dividend payment date, even if not declared, shall be paid to any holder regardless of the date on which the holder acquired the stock.  </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Series A-1 Convertible Preferred Stock earns cumulative dividends at a rate of 8% per annum, payable in cash or common stock at the option of the Company on June 30 and December 31 of each year. If paid in common stock, the common stock will be valued at the average of the closing price for the five business days prior to the dividend payment date. The preferred shareholders will participate in any common stock dividends on an as converted basis. Although no dividends were declared as of September 30, 2020, the Company has accrued dividends payable of $161,880 related to the 8% Series A-1 Convertible Preferred Stock as of September 30, 2020.  On December 7, 2020, we sent a Notice of Automatic Conversion and Calculation of Dividend Shares to SOBR SAFE notifying them that under the terms governing the shares of Series A-1 Convertible Preferred Stock the 2,700,000 shares of Series A-1 Convertible Preferred Stock owned by SOBR SAFE automatically converted into 2,700,000 shares of our common stock.  In addition, as a result of the conversion of the Series A-1 Convertible Preferred Stock we owed SOBR SAFE accrued dividends totaling $107,880, which we could pay in cash or in shares of our common stock based on the price of common stock on the applicable dividend dates.  Our management and Board of Directors elected to pay SOBR SAFE the accrued dividends in shares of our common stock.</p> 0.00001 25000000 3000000 Series A Convertible Preferred Stock are convertible at a 35% discount rate to the average closing price per share of the Company’s common stock (either as listed on a national exchange or as quoted over-the-market) for the last 15 trading days immediately prior to conversion. However, no conversions of the Series A Convertible Preferred Stock to shares of common stock can occur unless the average closing price per share 2000000 (a) dividend rights of 8% per annum based on the original issuance price of $1 per share, (b) liquidation preference over the Company’s common stock, (c) conversion rights into shares of the Company’s common stock at $1 per share (not to be affected by any reverse stock split in connection with the Asset Purchase Agreement with IDTEC 1 1000000 2700000 0.08 161880 0.08 2700000 2700000 107880 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 13 STOCK WARRANTS AND STOCK OPTIONS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span style="text-decoration:underline">Stock Warrants</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company accounts for employee stock options and stock warrants under ASC 718 and ASC 505, whereby option costs are recorded based on the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable, utilizing the Black-Scholes pricing model. Unless otherwise provided for, the Company covers option exercises by issuing new shares.  </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On August 8, 2019, the Company entered into an 8% Series A-1 Convertible Preferred Stock Investment agreement with First Capital Ventures, LLC (“FCV”), an entity controlled by a beneficial owner of the Company. FCV set up a special purpose vehicle (“SPV”) or SOBR SAFE, LLC, an entity controlled by a beneficial owner of the Company,  that purchased 1,000,000 of the 8% Series A-1 Convertible Preferred Shares at $1 per share on December 12, 2019. Upon purchase, the Company issued the SPV through FCV a three-year warrant to purchase 144,317 shares of the Company’s common stock at an exercise price of $1.039375 per share. The number of warrants outstanding to the SPV through FCV at September 30, 2021 and December 31, 2020 are 144,317.  </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On May 4, 2020, the Company entered into an agreement with a vendor to provide investor relations services.  Under the terms of the agreement, we issued warrants to purchase up to 120,000 shares of our common stock at an exercise price of $2.00 per share. The warrants expire five years after the date of issuance. Approximately $220,000 of expense was recognized for the warrants issued for the services provide by the vendor.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On June 5, 2020, at closing of the Transaction, the Company entered into a Waiver Under Asset Purchase Agreement and Post-Closing Covenant Agreement under which we issued warrants to IDTEC to purchase up to 320,000 shares of our common stock (post-split) at an exercise price of $0.50 per share. The warrants expire five years after the date of issuance.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During March, April and May 2021, the Company issued through the Offering convertible notes payable with warrants, see Note 8, to purchase up to 1,002,500 shares of our common stock at an exercise price of $3 per share. The warrants expire two years after the date of issuance. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On September 28, 2021, the Closing Date,  the Company issued through the sale of the Debenture warrants, see Note 7, to purchase up to 1,219,512 shares of our common stock at an exercise price of $2 per share. The warrants expire five years after the date of issuance. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The total outstanding balance of all stock warrants in the Company is 2,629,391 and 584,317 at September 30, 2021 and December 31 2020, respectively. There were 2,222,012 detached free-standing stock warrants granted during the nine month period ended September 30, 2021, and 320,000  detached free-standing stock warrants granted during the nine month period ended September 30, 2020. The fair value of these non-employee stock warrants granted during the nine-month periods ended September 30, 2021 and 2020 totaled $1,939,756 and $695,454, respectively, and were determined using the Black-Scholes option pricing model based on the following assumptions: </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>September 30, </strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>  September 30,</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>2020  </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercise Price  </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td>$</td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">3.00-2.00</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.50</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Dividend Yield  </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Volatility  </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">158-120</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">% </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">153</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Risk-free Interest Rate  </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.14%-0.98</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">% </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.29</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Life of Warrants</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">2-5 Years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">   5 Years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following table summarizes the changes in the Company’s outstanding warrants during the nine-month period ended September 30, 2021 and 2020, and as of September 30, 2021 and 2020: </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Warrants</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Outstanding</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number of</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise Price Per</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Share</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted Average Remaining Contractual Life</strong></p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted Average</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise Price Per Share</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Aggregate Intrinsic Value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:38%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance at December 31, 2019</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">598,414</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;">$</td><td style="width:11%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.13304–1.039375</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:11%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">3.97 Years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.3607</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,276,870</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Warrants Granted</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">320,000</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">0.50</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">4.68Years</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">0.50</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">761,000</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Warrants Exercised</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">(454,097</td><td style="vertical-align:bottom;white-space: nowrap;">)</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td>$</td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.13304 - 0.15299</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">0.1451</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Warrants Expired </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance at September 30, 2020</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;vertical-align:bottom;text-align:right;">464,317</td><td style="PADDING-BOTTOM: 3px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td>$</td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.50- 1.039375</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">3.91 Years</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">0.66765</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">1,027,234</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Warrants</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Outstanding</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number of</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise Price Per</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Share</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted Average Remaining Contractual Life</strong></p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted Average</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise Price Per Share</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Aggregate Intrinsic Value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance at December 31, 2020</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">584,317</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td>$</td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.50 – 2.00</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">3.80 Years</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">0.9413</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">1,173,737</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Warrants Granted</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">2,222,012</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td>$</td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">3.00-2.00</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">3.40 Years</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">2.45</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">108,506</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:38%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Warrants Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(176,938</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:11%;vertical-align:bottom;text-align:right;">0.50</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:11%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.50</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Warrants Expired </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance at September 30, 2021</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;vertical-align:bottom;text-align:right;">2,629,391</td><td style="PADDING-BOTTOM: 3px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td>$</td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.50 – 3.00</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">3.30 Years</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">2.25</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">665,424</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span style="text-decoration:underline">Stock Options</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On October 24, 2019, the Company’s 2019 Equity Incentive Plan went effective. The plan was approved by the Company’s Board of Directors and the holders of a majority of the Company’s voting stock on September 9, 2019. The plan’s number of authorized shares is 3,848,467. As of September 30, 2021 and December 31, 2020, the Company has granted stock options to acquire 2,921,861 and 2,521,921 shares of common stock under the plan, respectively. As of September 30, 2021, the plan has 1,893,347 vested shares and 1,028,514 non-vested shares. As of December 31, 2020, the plan had 1,202,724 vested shares and 1,319,197 non-vested shares. As of September 30, 2021 and December 31, 2020 the plan has options available to be issued of 926,606 and 1,326,546, respectively.  The stock options are held by our officers, directors, employees, and certain key consultants.  </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In total for the nine months ended September 30, 2021 and 2020, the Company recorded $630,027 and $343,549, respectively, of share-based compensation expense related to stock options and restricted stock units. The unrecognized compensation expense as of September 30, 2021, was approximately $813,000 for non-vested share-based awards to be recognized over periods of approximately one to three years.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In applying the Black-Scholes options pricing model, assumptions used to compute the fair value of the stock options granted during the nine-month period ended September 30, 2021 and 2020 were as follows: </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>September 30, </strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>2021</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>September 30, </strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>2020</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercise Price</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td>$</td><td class="hdcell" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">2.50 - $3.58</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td>$</td><td class="hdcell" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.26-$3.30</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Dividend Yield</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expected Volatility</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">44% - 185</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">% </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">153%-171</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">% </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Risk-free Interest Rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.16% - 1.69</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">% </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.19%-0.43</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">% </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expected Life</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">1.3 - 7 years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">2.2-5 years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">   </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following table summarizes the changes in the Company’s outstanding stock options during the nine-month period ended September 30, 2021 and 2020, and as of September 30, 2021 and 2020:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Options</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Outstanding</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number of </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise Price Per</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Share </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted Average Remaining Contractual Life</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted Average</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise Price Per Share</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Aggregate </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Intrinsic Value </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance at December 31, 2019</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,381,239</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td>$</td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.2634-1.039</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">8.86 Years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.2948</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,238,080</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Options Granted</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">160,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td>$</td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.26341-3.30</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">4.10 Years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.9454</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">149,532</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Options Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td/><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Options Cancelled</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"/><td class="ffcell" style="width:9%;"/><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Options Expired</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance at September 30, 2020</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">2,541,239</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td>$</td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.2634 – 3.30</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">7.86 Years </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.3987</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">6,305,579</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Options</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Outstanding</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number of </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise Price Per</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Share </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted Average Remaining Contractual Life</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted Average</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise Price Per Share</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Aggregate Intrinsic Value </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance at December 31, 2020</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,572,227</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td>$</td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.2634–3.300</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">7.45 Years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.4999</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">6,302,277</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Options Granted</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">610,526</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td>$</td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">2.50–3.575</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">2.58 Years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3.1783</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(414,147</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Options Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td/><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Options Cancelled</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(210,587</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td>$</td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.2634-3.29</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2.969</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Options Expired</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"/><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance at September 30, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">2,972,166</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td>$</td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.2634–3.575</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">6.15 Years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.8751</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4,829,417</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px;background-color:#cceeff"><td style="width:42%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercisable at December 31, 2020 </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,253,030</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$ </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.2634 – 3.300</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:9%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">7.4 Years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.3165</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,299,765</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercisable at September 30, 2021 </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">1,943,652</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td>$</td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.2634 – 3.575</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">6.3 Years</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">0.6527</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">3,590,430</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Executive Stock Options</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company has 1,553,152 and 981,771 outstanding executive stock options exercisable at $0.2634 to $3.38 per share as of  September 30, 2021, and December 31, 2020, respectively.</p> 1000000 1 144317 1.039375 144317 Under the terms of the agreement, we issued warrants to purchase up to 120,000 shares of our common stock at an exercise price of $2.00 per share. The warrants expire five years after the date of issuance. Approximately $220,000 of expense was recognized for the warrants issued for the services provide by the vendor 320000 0.50 1002500 3 2629391 584317 2222012 1939756 695454 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>September 30, </strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>  September 30,</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>2020  </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercise Price  </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td>$</td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">3.00-2.00</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.50</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Dividend Yield  </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Volatility  </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">158-120</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">% </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">153</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Risk-free Interest Rate  </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.14%-0.98</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">% </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.29</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Life of Warrants</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">2-5 Years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">   5 Years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Warrants</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Outstanding</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number of</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise Price Per</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Share</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted Average Remaining Contractual Life</strong></p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted Average</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise Price Per Share</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Aggregate Intrinsic Value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:38%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance at December 31, 2019</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">598,414</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;">$</td><td style="width:11%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.13304–1.039375</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:11%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">3.97 Years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.3607</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,276,870</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Warrants Granted</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">320,000</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">0.50</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">4.68Years</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">0.50</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">761,000</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Warrants Exercised</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">(454,097</td><td style="vertical-align:bottom;white-space: nowrap;">)</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td>$</td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.13304 - 0.15299</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">0.1451</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Warrants Expired </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance at September 30, 2020</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;vertical-align:bottom;text-align:right;">464,317</td><td style="PADDING-BOTTOM: 3px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td>$</td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.50- 1.039375</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">3.91 Years</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">0.66765</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">1,027,234</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Warrants</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Outstanding</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number of</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise Price Per</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Share</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted Average Remaining Contractual Life</strong></p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted Average</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise Price Per Share</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Aggregate Intrinsic Value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance at December 31, 2020</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">584,317</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td>$</td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.50 – 2.00</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">3.80 Years</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">0.9413</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">1,173,737</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Warrants Granted</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">2,222,012</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td>$</td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">3.00-2.00</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">3.40 Years</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">2.45</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">108,506</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:38%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Warrants Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(176,938</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:11%;vertical-align:bottom;text-align:right;">0.50</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:11%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.50</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Warrants Expired </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance at September 30, 2021</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;vertical-align:bottom;text-align:right;">2,629,391</td><td style="PADDING-BOTTOM: 3px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td>$</td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.50 – 3.00</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">3.30 Years</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">2.25</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">665,424</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 3.00 0.50 0 0 1.58 0.0014 0.0098 0.0029 P2Y P5Y P5Y 598414 0.13304 1.039375 P3Y11M19D 0.3607 1276870 320000 0.50 P4Y8M4D 0.50 761000 -454097 0.13304 0.15299 0.1451 464317 0.50 1.039375 P3Y10M28D 0.66765 1027234 584317 0.50 2 0.9413 1173737 2222012 3 2 P3Y4M24D 2.45 108506 -176938 0.50 0.50 2629391 0.50 3 P3Y3M18D 2.25 665424 3848467 2921861 2521921 1028514 1202724 1319197 926606 1326546 630027 343549 813000 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>September 30, </strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>2021</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>September 30, </strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>2020</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercise Price</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td>$</td><td class="hdcell" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">2.50 - $3.58</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td>$</td><td class="hdcell" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.26-$3.30</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Dividend Yield</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expected Volatility</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">44% - 185</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">% </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">153%-171</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">% </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Risk-free Interest Rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.16% - 1.69</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">% </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.19%-0.43</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">% </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expected Life</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">1.3 - 7 years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">2.2-5 years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 0.26 3.30 0.44 1.53 0.0016 0.0169 0.0019 0.0043 P1Y3M18D P7Y P2Y2M12D P5Y <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Options</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Outstanding</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number of </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise Price Per</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Share </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted Average Remaining Contractual Life</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted Average</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise Price Per Share</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Aggregate </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Intrinsic Value </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance at December 31, 2019</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,381,239</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td>$</td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.2634-1.039</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">8.86 Years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.2948</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,238,080</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Options Granted</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">160,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td>$</td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.26341-3.30</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">4.10 Years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.9454</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">149,532</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Options Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td/><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Options Cancelled</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"/><td class="ffcell" style="width:9%;"/><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Options Expired</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance at September 30, 2020</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">2,541,239</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td>$</td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.2634 – 3.30</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">7.86 Years </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.3987</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">6,305,579</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Options</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Outstanding</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number of </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise Price Per</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Share </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted Average Remaining Contractual Life</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted Average</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise Price Per Share</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Aggregate Intrinsic Value </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance at December 31, 2020</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,572,227</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td>$</td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.2634–3.300</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">7.45 Years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.4999</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">6,302,277</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Options Granted</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">610,526</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td>$</td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">2.50–3.575</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">2.58 Years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3.1783</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(414,147</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Options Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td/><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Options Cancelled</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(210,587</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td>$</td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.2634-3.29</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2.969</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Options Expired</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"/><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance at September 30, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">2,972,166</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td>$</td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.2634–3.575</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">6.15 Years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.8751</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4,829,417</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px;background-color:#cceeff"><td style="width:42%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercisable at December 31, 2020 </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,253,030</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$ </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.2634 – 3.300</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:9%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">7.4 Years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.3165</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,299,765</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercisable at September 30, 2021 </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">1,943,652</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td>$</td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.2634 – 3.575</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">6.3 Years</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">0.6527</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">3,590,430</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 2381239 0.2634 1.039 P8Y10M9D 0.2948 5238080 160000 0.26341 3.30 1.9454 149532 2541239 0.2634 3.30 P7Y10M9D 0.3987 6305579 2572227 0.2634 3.300 P7Y5M12D 0.4999 6302277 610526 2.50 3.575 P2Y6M29D 3.1783 -414147 -210587 0.2634 2972166 0.2634 3.575 P6Y1M24D 0.8751 4829417 1253030 0.2634 3.300 0.3165 3299765 1943652 0.2634 3.575 3590430 1553152 981771 0.2634 3.38 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 14. COMMITMENTS AND CONTINGENCIES</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span style="text-decoration:underline">Operating Leases</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On October 15, 2019, the Company entered into a short-term lease agreement that is between $2,800 - $2,900per month and ended on October 31, 2020. The lease has been renewed for another twelve months under the same general terms and conditions.  The lease was subsequently canceled to accommodate additional space, and a new lease was executed February 26, 2021, effective for a 12-month term beginning March 1, 2021.  The lease requires monthly base rent payments of $6,000 and the issuance of 16,000 shares of the Company’s common stock.  The value of the common stock of $49,600 is amortized to rent expense on a monthly basis over the lease term.  The Company also leases an office space for approximately $3,500 per month on a short-term (month to month) basis through a related party that terminates at any time.  Rent expense under office leases, including CAM charges, was $106,997 and $47,711 for the nine-month period ended September 30, 2021 and 2020, respectively. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span style="text-decoration:underline">Legal Proceedings</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On December 6, 2006, Orange County Valet and Security Patrol, Inc. filed a lawsuit against us in Orange County California State Superior Court for Breach of Contract in the amount of $11,164. A default judgment was taken against us in this matter. In mid-2013 we learned the Plaintiff’s perfected the judgment against us, but we have not heard from the Plaintiffs as of the date of this report.  As of September 30, 2021, and December 31, 2020, the Company has accrued $11,164 plus accrued interest of approximately $18,000.  In the event we pay any money related to this lawsuit, IDTEC agreed, in connection with us closing the asset purchase transaction with IDTEC, to pay the amount for us in exchange for shares of our common stock.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We had one outstanding judgment against us involving a past employee of the Company. The matter was under the purview of the State of California, Franchise Tax Board, Industrial Health and Safety Collections. We owed  $28,786 plus accrued interest of approximately $53,000, which had been accrued as of December 31, 2020, to our ex-employee for unpaid wages under these Orders.  On March 8, 2021 we received an Acknowledgement of Satisfaction of Judgement-Full by the California Court that the judgement has been settled with a payment of approximately $85,000 including accrued interest through settlement date and legal fees of approximately $3,000.  IDTEC agreed, in connection with us closing the asset purchase transaction with IDTEC, to pay the amounts for us in exchange for shares of our common stock.  </p> 2800 2020-10-31 6000 16000 49600 106997 47711 11164 18000 28786 53000 85000 3000 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 15. SUBSEQUENT EVENTS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company has evaluated subsequent events for recognition and disclosure through November 15, 2021, which is the date the condensed consolidated financial statements were available to be issued, and has determined that there are no other material subsequent events that require recognition or disclosure in the accompanying condensed consolidated financial statements.</p> XML 12 R1.htm IDEA: XBRL DOCUMENT v3.21.2
Cover - shares
9 Months Ended
Sep. 30, 2021
Nov. 12, 2021
Cover [Abstract]    
Entity Registrant Name SOBR Safe, Inc.  
Entity Central Index Key 0001425627  
Document Type 10-Q  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Entity Small Business true  
Entity Shell Company false  
Entity Emerging Growth Company false  
Entity Current Reporting Status Yes  
Document Period End Date Sep. 30, 2021  
Entity Filer Category Non-accelerated Filer  
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2021  
Entity Common Stock Shares Outstanding   25,981,203
Document Quarterly Report true  
Document Transition Report false  
Entity Address Address Line 1 885 Arapahoe Avenue  
Entity Address City Or Town Boulder  
Entity Address State Or Province CO  
Entity Interactive Data Current Yes  
Entity File Number 000-53316  
Entity Incorporation State Country Code DE  
Entity Tax Identification Number 26-0731818  
Entity Address Postal Zip Code 80302  
City Area Code 844  
Local Phone Number 762-7723  
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Sep. 30, 2021
Dec. 31, 2020
Current assets    
Cash $ 2,185,233 $ 232,842
Prepaid expenses 24,899 115,230
Total current assets 2,210,132 348,072
SOBR Safe Intellectual Technology, net of accumulated amortization of $513,952 and $224,854 at September 30, 2021 and December 31, 2020, respectively 3,340,723 3,629,821
Other assets 15,826 8,680
Total Assets 5,566,681 3,986,573
Current liabilities    
Accounts payable 706,142 101,308
Accrued expenses 306,071 313,032
Accrued interest payable 193,177 134,444
Related party payables 29,404 28,624
Common stock subscriptions payable 228,046 253,688
Derivative liability 980,000 0
* Includes unamortized debt discount related to detached warrants and convertible debenture of $2,608,900 and none at September 30, 2021 and December 31, 2020, respectively 439,881 0
Current portion notes payable - related parties 11,810 11,810
Current portion notes payable - non-related parties 104,183 79,183
Total current liabilities 2,998,714 922,089
Notes payable -related parties-less current portion    
* Includes unamortized debt discount and beneficial conversion feature related to detached warrants and convertible notes of $771,576 and none at September 30, 2021 and December 31, 2020, respectively 228,424 0
Notes payable -non-related parties-less current portion    
* Includes unamortized debt discount and beneficial conversion feature related to detached warrants and convertible notes of $774,850 and none at September 30, 2021 and December 31, 2020, respectively 230,150 25,000
Total Liabilities 3,457,288 947,089
Stockholders' Equity    
Preferred stock, $0.00001 par value; 19,300,000 shares authorized, no shares issued or outstanding as of September 30, 2021 and December 31, 2020 0 0
Common stock, $0.00001 par value; 100,000,000 shares authorized; 25,981,203 and 25,922,034 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively 260 260
Additional paid-in capital 56,330,450 52,693,974
Accumulated deficit (54,167,685) (49,601,220)
Total SOBR Safe, Inc. stockholders' equity 2,163,025 3,093,014
Noncontrolling interest (53,632) (53,530)
Total Stockholders' Equity 2,109,393 3,039,484
Total Liabilities and Stockholders' Equity 5,566,681 3,986,573
Series A Convertible Preferred Stock [Member]    
Stockholders' Equity    
Common stock, $0.00001 par value; 100,000,000 shares authorized; 25,981,203 and 25,922,034 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively 0 0
Series A-1 Convertible Preferred stock [Member]    
Stockholders' Equity    
Common stock, $0.00001 par value; 100,000,000 shares authorized; 25,981,203 and 25,922,034 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively $ 0 $ 0
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
Sep. 30, 2021
Dec. 31, 2020
SOBR Safe Intellectual Technology, net of accumulated amortization $ 513,952 $ 224,854
Current liabilities    
Notes payable -related parties-less current portion 2,608,900 2,608,900
Notes payable -non-related parties-less current portion 771,576 771,576
Discount beneficial features $ 774,850 $ 774,850
Stockholders' Deficit    
Common stock, shares par value $ 0.00001 $ 0.00001
Common stock, shares authorized 100,000,000 100,000,000
Common stock, shares issued 25,981,203 25,922,034
Common stock, shares outstanding 25,981,203 25,922,034
Preferred stock, shares par value $ 0.00001 $ 0.00001
Preferred stock, shares authorized 19,300,000 19,300,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Series A Convertible Preferred Stock [Member]    
Stockholders' Deficit    
Preferred stock, shares par value $ 0.00001 $ 0.00001
Preferred stock, shares authorized 3,000,000 3,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Series A-1 Convertible Preferred stock [Member]    
Stockholders' Deficit    
Preferred stock, shares par value $ 0.00001 $ 0.00001
Preferred stock, shares authorized 2,700,000 2,700,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)        
Revenues $ 0 $ 0 $ 0 $ 0
Operating expenses:        
General and administrative 316,329 191,589 875,378 400,127
Stock-based compensation expense 147,163 0 334,228 41,302
Management salaries and consulting fees 632,964 352,266 1,682,557 1,103,828
Research and development 566,655 152,123 1,052,650 309,403
Asset impairment adjustment 0 0 0 25,320,555
Total operating expenses 1,663,111 695,978 3,944,813 27,175,215
Loss from operations (1,663,111) (695,978) (3,944,813) (27,175,215)
Other income (expense):        
Loss on extinguishment of debt, net 0 0 86,739 (269,144)
Gain on fair value adjustment - derivatives 0 0 0 60,650
Interest expense (227,475) (41,622) (399,381) (107,253)
Amortization of interest - conversion features (130,830) 0 (222,373) (1,407,675)
Total other expense, net (358,305) (41,622) (621,754) (1,723,422)
Loss before provision for income taxes (2,021,416) (737,600) (4,566,567) (28,898,637)
Provision for income taxes 0 0 0 0
Net loss (2,021,416) (737,600) (4,566,567) (28,898,637)
Net (income) loss attributable to noncontrolling interest 4 (98) 102 (48)
Net loss attributable to SOBR Safe, Inc. (2,021,412) (737,698) (4,566,465) (28,898,685)
Accrued dividends on convertible preferred stock 0 (161,880) 0 (161,880)
Net loss attributable to common stockholders $ (2,021,412) $ (899,578) $ (4,566,465) $ (29,060,565)
Basic and diluted loss per common share $ (0.08) $ (0.04) $ (0.18) $ (2.23)
Weighted average number of common shares outstanding 25,981,203 20,046,424 25,974,042 13,030,845
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (UNAUDITED) - USD ($)
Total
Common Stock [Member]
Preferred Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Stockholders Deficit SOBR Safe Inc [Member]
Noncontrolling Interest
Balance, shares at Dec. 31, 2019   6,452,993          
Balance, amount at Dec. 31, 2019 $ (3,593,121) $ 65 $ 0 $ 15,971,392 $ (19,511,168) $ (3,539,711) $ (53,410)
Common stock issued for compensation, shares   601          
Common stock issued for compensation, amount 20,800 $ 0 0 20,800 0 20,800 0
Common stock issued due to stock warrants exercise, shares   454,097          
Common stock issued due to stock warrants exercise, amount 65,728 $ 4 0 65,724 0 65,728 0
Common stock issued to settle related party payables, shares   214,883          
Common stock issued to settle related party payables, amount 493,074 $ 2 0 493,072 0 493,074 0
Common stock issued to settle accounts payable and accrued expenses, shares   38,323          
Common stock issued to settle accounts payable and accrued expenses, amount 92,385 $ 0 0 92,385 0 92,385 0
Common stock issued to settle related party debt, shares   648,739          
Common stock issued to settle related party debt, amount 826,964 $ 6 0 826,958 0 826,964 0
Common stock issued to settle non-related party debt, shares   70,448          
Common stock issued to settle non-related party debt, amount 166,526 $ 1 0 166,525 0 166,526 0
Paid-in capital - fair value of stock options vested 39,450 0 0 39,450 0 39,450 0
Paid-in capital - gain on related party debt conversion 124,291 0 0 124,291 0 124,291 0
Paid-in capital - gain on related party payables conversion 221,557 0 0 221,557 0 221,557 0
Paid-in capital - loss on debt extinguishment 116,893 0 0 116,893 0 116,893 0
Paid-in capital - beneficial conversion feature 174 0 0 174 0 174 0
Net loss for the period (449,874) $ 0 0 0 (450,023) (450,023) 149
Balance, shares at Mar. 31, 2020   7,880,084          
Balance, amount at Mar. 31, 2020 (1,875,153) $ 78 0 18,139,221 (19,961,191) (1,821,892) (53,261)
Balance, shares at Dec. 31, 2019   6,452,993          
Balance, amount at Dec. 31, 2019 (3,593,121) $ 65 0 15,971,392 (19,511,168) (3,539,711) (53,410)
Net loss for the period (28,898,637)            
Balance, shares at Sep. 30, 2020   20,046,424          
Balance, amount at Sep. 30, 2020 (374,507) $ 201 0 48,250,387 (48,571,733) (321,145) (53,362)
Balance, shares at Mar. 31, 2020   7,880,084          
Balance, amount at Mar. 31, 2020 (1,875,153) $ 78 0 18,139,221 (19,961,191) (1,821,892) (53,261)
Common stock issued to settle related party payables, shares   45,268          
Common stock issued to settle related party payables, amount 86,740 $ 1 0 86,739 0 86,740 0
Common stock issued to settle accounts payable and accrued expenses, shares   121,072          
Common stock issued to settle accounts payable and accrued expenses, amount 173,292 $ 2 0 173,290 0 173,292 0
Paid-in capital - fair value of stock options vested 257,482 0 0 257,482 0 257,482 0
Paid-in capital - gain on related party payables conversion 50,741 0 0 50,741 0 50,741 0
Paid-in capital - beneficial conversion feature 1,407,501 0 0 1,407,501 0 1,407,501 0
Net loss for the period (27,711,163) $ 0 0 0 (27,710,964) (27,710,964) (199)
Common stock issued for asset purchase, shares   12,000,000          
Common stock issued for asset purchase, amount 27,120,000 $ 120 0 27,119,880 0 27,120,000 0
Paid-in capital - fair value of stock warrants granted 695,454 0 0 695,454 0 695,454 0
Paid-in capital - loss on extinguishment of convertible notes 273,462 $ 0 0 273,462 0 273,462 0
Balance, shares at Jun. 30, 2020   20,046,424          
Balance, amount at Jun. 30, 2020 478,356 $ 201 0 48,203,770 (47,672,155) 531,816 (53,460)
Paid-in capital - fair value of stock options vested 46,617 0 0 46,617 0 46,617 0
Net loss for the period (737,600) 0 0 0 (737,698) (737,698) 98
Dividends payable-Series A-1 convertible preferred stock (161,880) $ 0 0 0 (161,880) (161,880) 0
Balance, shares at Sep. 30, 2020   20,046,424          
Balance, amount at Sep. 30, 2020 (374,507) $ 201 0 48,250,387 (48,571,733) (321,145) (53,362)
Balance, shares at Dec. 31, 2020   25,922,034          
Balance, amount at Dec. 31, 2020 3,039,484 $ 260 0 52,693,974 (49,601,220) 3,093,014 (53,530)
Paid-in capital - beneficial conversion feature 480,619 0 0 480,619 0 480,619 0
Net loss for the period (1,002,434) $ 0 0 0 (1,002,340) (1,002,340) (94)
Common stock issued to settle dividends - Series A-1 Convertible Preferred stock, shares   43,169          
Common stock issued to settle dividends - Series A-1 Convertible Preferred stock, amount 107,880 $ 0 0 107,880 0 107,880 0
Paid-in capital - fair value of stock options and RSU vested 105,013 0 0 105,013 0 105,013 0
Paid-in capital - relative fair value of stock warrants granted 619,381 $ 0 0 619,381 0 619,381 0
Balance, shares at Mar. 31, 2021   25,965,203          
Balance, amount at Mar. 31, 2021 3,349,943 $ 260 0 54,006,867 (50,603,560) 3,403,567 (53,624)
Balance, shares at Dec. 31, 2020   25,922,034          
Balance, amount at Dec. 31, 2020 3,039,484 $ 260 0 52,693,974 (49,601,220) 3,093,014 (53,530)
Net loss for the period (4,566,567)            
Balance, shares at Sep. 30, 2021   25,981,203          
Balance, amount at Sep. 30, 2021 2,109,393 $ 260 0 56,330,450 (54,167,685) 2,163,025 (53,632)
Balance, shares at Mar. 31, 2021   25,965,203          
Balance, amount at Mar. 31, 2021 3,349,943 $ 260 0 54,006,867 (50,603,560) 3,403,567 (53,624)
Paid-in capital - beneficial conversion feature 428,595 0 0 428,595 0 428,595 0
Net loss for the period (1,542,717) 0 0 0 (1,542,713) (1,542,713) (4)
Paid-in capital - fair value of stock options and RSU vested 138,010 0 0 138,010 0 138,010 0
Paid-in capital - relative fair value of stock warrants granted 473,327 $ 0 0 473,327 0 473,327 0
Common stock issued for facility lease, shares   16,000          
Common stock issued for facility lease, amount 49,600 $ 0 $ 0 49,600 0 49,600 0
Balance, shares at Jun. 30, 2021   25,981,203 260        
Balance, amount at Jun. 30, 2021 2,896,758 $ 260 $ 0 55,096,399 (52,146,273) 2,950,386 (53,628)
Net loss for the period (2,021,416) 0 0 0 (2,021,412) (2,021,412) (4)
Paid-in capital - fair value of stock options and RSU vested 387,003 0 0 387,003 0 387,003 0
Paid-in capital - relative fair value of stock warrants granted 847,048 $ 0 0 847,048 0 847,048 0
Balance, shares at Sep. 30, 2021   25,981,203          
Balance, amount at Sep. 30, 2021 $ 2,109,393 $ 260 $ 0 $ 56,330,450 $ (54,167,685) $ 2,163,025 $ (53,632)
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Operating Activities:    
Net loss $ (4,566,567) $ (28,898,637)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 289,098 133,571
Loss on debt extinguishment, net 0 269,144
Change in fair value of derivative liability 0 (60,650)
Amortization of interest - conversion feature 222,373 1,407,675
Amortization of interest 275,052 8,656
Stock options expense 399,259 343,549
Stock-based compensation expense 334,228 41,302
Asset impairment adjustment 0 25,320,555
Changes in assets and liabilities:    
Prepaid expenses (19,361) 994
Other assets (7,146) (8,680)
Accounts payable 604,834 140,906
Accrued expenses (6,961) (83,495)
Accrued interest payable 58,733 (6,697)
Related party payables 780 (51,976)
Common stock subscriptions payable 138,069 0
Net cash used in operating activities (2,277,609) (1,443,783)
Financing Activities:    
Proceeds from notes payable - related parties 1,030,000 0
Repayments of notes payable - related parties (30,000) 0
Proceeds from notes payable - non-related parties 1,005,000 41,665
Proceeds from convertible debenture payable 2,500,000 0
Debt issuance costs (275,000) 0
Proceeds from offering of preferred stock - related parties 0 1,700,000
Net cash provided by financing activities 4,230,000 1,741,665
Net Change In Cash 1,952,391 297,882
Cash At The Beginning Of The Period 232,842 681,759
Cash At The End Of The Period 2,185,233 979,641
Schedule Of Non-Cash Investing And Financing Activities:    
Issuance of common shares for rent 49,600 0
Issuance of common stock for prior year accrued dividends 107,880 0
Intrinsic value-beneficial conversion feature 909,214 1,407,501
Relative fair value of stock warrants granted 1,939,756 0
Convertible debenture payable discount 823,781 0
Fair value of embedded conversion feature 980,000 0
Gain on related party payables converted to capital 0 272,299
Accounts payable and accrued expenses converted to capital 0 265,677
Related party payables converted to capital 0 579,814
Related party debt converted to capital after exercise of cashless stock warrants 0 65,728
Related party debt converted to capital 0 826,964
Non-related party debt converted to capital 0 166,526
Gain on related party debt converted to capital 0 124,291
Shares issued for cash received in prior years 0 20,800
Issuance of common stock, stock warrants and convertible note for asset purchase 0 29,222,955
Preferred stock dividend accrued 0 161,880
Supplemental Disclosure:    
Cash paid for interest 67,618 765
Cash paid for income taxes $ 0 $ 0
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.21.2
ORGANIZATION OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
9 Months Ended
Sep. 30, 2021
ORGANIZATION OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  
NOTE 1. ORGANIZATION, OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 1. ORGANIZATION, OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

SOBR Safe, Inc. (“SOBR Safe”), formerly TransBiotec, Inc., was incorporated as Imagine Media LTD. in August 2007 in the State of Delaware. A corporation also named TransBiotec, Inc. (“TransBiotec – CA”) was formed in the state of California July 4, 2004. Effective September 19, 2011, TransBiotec was acquired by TransBiotec - CA in a transaction classified as a reverse acquisition as the shareholders of TransBiotec - CA retained the majority of the outstanding common stock of TransBiotec after the share exchange. The consolidated financial statements represent the activity of TransBiotec - CA from July 4, 2004 forward, and the consolidated activity of SOBR Safe and TransBiotec - CA from September 19, 2011 forward. SOBR Safe and TransBiotec - CA are hereinafter referred to collectively as the “Company” or “We”. The Company has developed and plans to market and sell a non-invasive alcohol sensing system which includes an ignition interlock. The Company has not generated any revenues from its operations.

 

On March 23, 2020, the Company filed a Definitive 14C providing notice that the Board of Directors has recommended, and that holders of a majority of the voting power of the Company’s outstanding stock voted, to approve the following.

 

 

1.

To remove and re-elect four (4) directors to serve until the next Annual Meeting of Shareholders and thereafter until their successors are elected and qualified; and

 

 

 

 

2.

To approve an amendment to the Company’s Certificate of Incorporation to: (a) change the Company’s name to SOBR SAFE, Inc., (b) decrease the Company’s authorized common stock from 800,000,000 shares, par value $0.00001 to 100,000,000 shares, par value $0.00001, and (c) effect a reverse stock split of the Company’s outstanding common stock at a ratio between 1-for-32 and 1-for-35 (with the exact ratio to be determined by the directors in their sole discretion without further approval by the shareholders).

 

The above actions taken by the Company’s stockholders became effective on or about May 21, 2020. The effective dates of the above actions were June 5, 2020 and April 20, 2020, respectively, and the actual reverse stock split ratio was 1-for-33.26. All share and per share amounts have been adjusted in these consolidated financial statements to reflect the effect of the reverse stock split. 

 

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”) as promulgated in the United States of America and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and related notes for the year ended December 31, 2020, included in the Company’s Annual Report on Form 10-K filed with the SEC on March 31, 2021.

 

In management’s opinion, the unaudited condensed consolidated financial statements reflect all adjustments (including reclassifications and normal recurring adjustments) necessary to present fairly the financial position as of September 30, 2021 and December 31, 2020, and results of operations and cash flows for the three and nine month periods ended September 30, 2021 and 2020.

 

Principles of Consolidation

The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its majority owned subsidiary, TransBiotec-CA. We have eliminated all intercompany transactions and balances between entities consolidated in these unaudited condensed financial statements.

Use of Estimates

The preparation of unaudited condensed consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Specifically, such estimates were made by the Company for the recoverability and useful lives of long-lived assets, the intellectual technology, the valuation of the derivative liabilities, beneficial conversion feature expenses, stock-based compensation and the valuation allowance related to deferred tax assets. Actual results could differ from those estimates.

 

Financial Instruments 

Pursuant to  Accounting Standards Codification (“ASC”) Topic 820, Fair Value Measurements and Disclosures, and ASC 825, Financial Instruments, an entity is required to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 and 825 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 and 825 prioritizes the inputs into three levels that may be used to measure fair value:

 

Level 1

Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.

 

Level 2

Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets: quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.

 

Level 3

Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.

 

The Company’s financial instruments consist primarily of cash, accounts payable, accrued expenses, accrued interest payable,  related party payables, notes payable, convertible debentures, and other liabilities. Pursuant to ASC 820 and 825, the fair value of our derivative liabilities is determined based on “Level 3” inputs. We believe that the recorded values of all of our other financial instruments approximate their current fair values because of their nature and respective maturity dates or durations.

 

The following table presents assets and liabilities that are measured and recognized at fair value as of September 30, 2021 and December 31, 2020:

 

September 30, 2021

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

Derivative liability

 

$-

 

 

$-

 

 

$980,000

 

 

 

$-

 

 

$-

 

 

$980,000

 

 

December 31, 2020

   

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

Derivative liability

 

$-

 

 

$-

 

 

$-

 

 

 

$-

 

 

$-

 

 

$-

 

Cash

The Company considers all highly liquid investments with an original maturity of three months or less as cash equivalents. The Company does not have any cash equivalents as of September 30, 2021 and December 31, 2020. 

 

Prepaid Expenses

Amounts incurred in advance of contractual performance or coverage periods are recorded as prepaid assets and recognized as expense in the period service or coverage is provided.  

 

Beneficial Conversion Features

From time to time, the Company may issue convertible notes that may contain a beneficial conversion feature. A beneficial conversion feature exists on the date a convertible note is issued when the fair value of the underlying common stock to which the note is convertible into is in excess of the remaining unallocated proceeds of the note after first considering the allocation of a portion of the note proceeds to the fair value of the warrants, if related warrants have been granted. The intrinsic value of the beneficial conversion feature is recorded as a debt discount with a corresponding amount to additional paid-in capital. The debt discount is amortized to interest expense over the life of the note using the effective interest method.

 

 Derivative Instruments

The Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instruments are initially recorded at their fair values and are then re-valued at each reporting date, with changes in the fair value reported in the unaudited condensed consolidated statements of operations under other income (expense). The accounting treatment of derivative financial instruments requires that the Company record the embedded conversion option at its fair value as of the inception date of the agreement and at fair value as of each subsequent balance sheet date. Any change in fair value is recorded as non-operating, non-cash income or expense for each reporting period at each balance sheet date. If the classification changes as a result of events during the period, the contract is reclassified as of the date of the event that caused the reclassification. As a result of entering into warrant agreements, for which such instruments contained a variable conversion feature with no floor, the Company has adopted a sequencing policy in accordance with ASC 815-40-35-12 whereby all future instruments may be classified as a derivative liability with the exception of instruments related to share-based compensation issued to employees or directors. For stock-based derivative financial instruments, the Company uses a Monte Carlo Simulation model to value the derivative instruments at inception and on subsequent valuation dates.

 

The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date. 

Debt Issuance Costs

Debt issuance costs incurred in connection with the issuance of debt are capitalized and amortized to interest expense over the term of the debt using the effective interest method. The unamortized amount is presented as a reduction of debt on the balance sheet.

 

Preferred Stock

We apply the guidance enumerated in ASC 480 “Distinguishing Liabilities from Equity” when determining the classification and measurement of preferred stock. Preferred shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. We classify conditionally redeemable preferred shares (if any), which includes preferred shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control, as temporary equity. At all other times, we classified our preferred shares in stockholders’ equity.

 

Minority Interest (Noncontrolling Interest)

A subsidiary of the Company has minority members representing ownership interests of 1.38% at September 30, 2021 and December 31, 2020. The Company accounts for these minority, or noncontrolling interests, pursuant to ASC 810-10-65 whereby gains and losses in a subsidiary with a noncontrolling interest are allocated to the noncontrolling interest based on the ownership percentage of the noncontrolling interest, even if that allocation results in a deficit noncontrolling interest balance.

 

Stock-based Compensation

The Company follows the guidance of the accounting provisions of ASC 718 “Share-based Compensation”, which requires the use of the fair-value based method to determine compensation for all arrangements under which employees and others receive shares of stock or equity instruments (warrants and options). The fair value of each option award is estimated on the date of grant using the Black-Scholes options pricing model that uses assumptions for expected volatility, expected dividends, expected term, and the risk-free interest rate. The Company has not paid common stock dividends historically and does not expect to pay them in the future. Expected volatilities are based on weighted averages of the historical volatility of the Company’s common stock estimated over the expected term of the options. The expected term of options granted is derived using the “simplified method” which computes expected term as the average of the sum of the vesting term plus the contract term as historically the Company had limited activity surrounding its options. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the period of the expected term.

 

Research and Development

The Company accounts for its research and development costs pursuant to ASC 730, whereby it requires the Company to disclose the amounts of costs for company and customer-sponsored research and development activities, if material. Research and development costs are expensed as incurred. The Company incurred research and development costs as it acquired new knowledge to bring about significant improvements in the functionality and design of its SOBR product. Research and development costs were $1,026,679 and $309,403 during the nine month periods ended September 30, 2021 and 2020, respectively.

 

Advertising and Marketing Costs

Advertising and marketing costs are charged to operations as incurred.  Advertising and marketing costs were $70,692 and $70,198 during the nine month periods ended September 30, 2021 and 2020, respectively, and are included in general and administrative expenses in the consolidated statements of operations.    

 

Depreciation

Depreciation is computed on a straight-line basis over the assets estimated useful lives of three years. There was no depreciation for the three and nine months ended September 30, 2021. Depreciation for the three and nine months ended September 30, 2020 was $3,978 and $5,083, respectively .

 

Income Tax

The Company accounts for income taxes pursuant to ASC 740. Under ASC 740 deferred taxes are provided on a liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss carry forwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. The Company has not recorded any deferred tax assets or liabilities at September 30, 2021 and December 31, 2020 as these have been offset by a 100% valuation allowance.

Net Loss Per Share

Basic net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period.  Diluted  loss per share gives the effect to all dilutive potential common shares outstanding during the period,  including stock options, warrants and convertible instruments.  Diluted net loss per share excludes all potentially issuable shares if their effect is anti-dilutive.  Because the effect of the Company’s dilutive securities is anti-dilutive, diluted net loss per share is the same as basic loss per share for the periods presented.

 

Concentration of Credit Risk

Certain financial instruments potentially subject the Company to concentrations of credit risk. Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash deposits. Cash held in operating accounts may exceed the Federal Deposit Insurance Corporation (“FDIC”) insurance limits. Accounts at each institution are insured by the FDIC up to $250,000. While the Company monitors cash balances in our operating accounts on a regular basis and adjust the balances as appropriate, these balances could be impacted if the underlying financial institutions fail. To date, the Company has experienced no loss or lack of access to our cash; however, the Company can provide no assurances that access to our cash will not be impacted by adverse conditions in the financial markets. At September 30, 2021 and December 31, 2020, the Company had $1,934,969 and none, respectively in excess of the FDIC insured limits.

 

Related Parties

Related parties are any entities or individuals that, through employment, ownership, or other means, possess the ability to direct or cause the direction of the management and policies of the Company.

 

New Pronouncements 

In December 2019, the FASB issued ASU No. 2019-12, Simplifying the Accounting for Income Taxes (“ASU 2019-12”), which simplifies the accounting for income taxes, eliminates certain exceptions within ASC 740, Income Taxes, and clarifies certain aspects of the current guidance to promote consistency among reporting entities. ASU 2019-12 is effective for fiscal years beginning after December 15, 2021. Most amendments within the standard are required to be applied on a prospective basis, while certain amendments must be applied on a retrospective or modified retrospective basis. The Company is evaluating the effects, if any, of the adoption of ASU 2019-12 guidance on the Company's financial position, results of operations and cash flows.

 

In August 2020, the FASB issued ASU No. 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, which address issues identified as a result of the complexity associated with applying generally accepted accounting principles for certain financial instruments with characteristics of liabilities and equity.  This amendment is effective for public business entities that meet the definition of a SEC filer, excluding entities eligible to be smaller reporting companies as defined by the SEC, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company is evaluating the effects, if any, of the adoption of ASU 2020-06 guidance on the Company's financial position, results of operations and cash flows.

 

In October 2020, the FASB issued ASU No. 2020-08, Codification Improvements to Subtopic 310-20, Receivables-Nonrefundable Fees and Other Costs, amendments the guidance in ASU No. 2017-08, (Subtopic 310-20): Premium Amortization on Purchased Callable Debt Securities, which addresses multiple call dates of a callable debt security.  This amendment is effective for public business entities, for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. Early application is not permitted.  The Company evaluated the adoption of ASU 2020-08 guidance and determined no effects on the Company's financial position, results of operations and cash flows.

In May 2021, the FASB issued ASU No. 2021-04, Earnings Per Share (Topic 260), Debt-Modifications and Extinguishments (Subtopic 470-50), Compensation-Stock Compensation (Topic 718), and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtpoic 815-40), which addresses issuer’s accounting for certain modifications or exchanges of freestanding equity-classified written call options.  This amendment is effective for all entities, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted.  The Company is evaluating the effects, if any, of the adoption of ASU 2021-04 guidance on the Company's financial position, results of operations and cash flows.

 

Correction of Error

While preparing financial statements for periods in 2021, the Company discovered an error in the statement of operations for the year ended December 31, 2020.  The error related to the presentation of the loss on disposal of property and equipment and asset impairment adjustment in accordance with ASC 360-10-45.

 

Loss on disposal of property and equipment and asset impairment adjustment of  $39,434 and $25,320,555, respectively, were presented as other income/expense-net, instead of as operating expenses.  As a result, loss from operations for the year ended December 31, 2020, was understated by $25,359,989 and other income/expenses-net was overstated by the same amount.  The errors had no affect on the net loss or net loss per share for the year ended December 31, 2020.

 

As a result of this correction, the statement of operations for the three and nine month periods ended September 30, 2020 in the accompanying financial statements has been retroactively restated.

XML 19 R8.htm IDEA: XBRL DOCUMENT v3.21.2
GOING CONCERN
9 Months Ended
Sep. 30, 2021
GOING CONCERN  
NOTE 2. GOING CONCERN

NOTE 2. GOING CONCERN

 

The Company has incurred recurring losses from operations and has limited cash liquidity and capital resources. Future capital requirements will depend on many factors, including the Company’s ability to develop products, cash flow from operations, and competing market developments. The Company will need additional capital in the near future. Sources of debt financing may result in high interest expense. Any financing, if available, may be on unfavorable terms. If adequate funds are not obtained, we will be required to reduce or curtail operations.

 

As of September 30, 2021, the Company has an accumulated deficit of approximately $54,200,000. During the nine months ended September 30, 2021, the Company also experienced negative cash flows from operating activities of approximately $2,300,000. It appears these principal conditions or events, considered in the aggregate, indicate it is probable that the Company will be unable to meet its obligations as they become due within one year after the date the financial statements are issued. As such, there is substantial doubt about the entity’s ability to continue as a going concern.

 

The Company has identified factors that mitigate the probable conditions that have raised substantial doubt about the entity’s ability to continue as a going concern.  On January 15, 2021, the Company initiated a Private Offering (the “Offering”) of up to 40 Units ($2,000,000) with each Unit consisting of one $50,000 principal amount secured convertible debenture, convertible at $3 per share, and a Warrant to purchase 25,000 shares of the Company’s common stock at $3 per share. The Secured Debentures carry interest at 12% and mature 24 months after issuance. The Warrants are exercisable six months after issuance and expire 24 months after issuance .  The Offering closed on May 31, 2021 and raised $2,005,000, see Note 8. On September 28, 2021 the Company closed the sale of a convertible debenture and issued warrants that raised $2,225,000 of net proceeds after debt issuance costs.  The debenture is for a face amount $3,048,781 with an OID of 18% and due March 27, 2022, if not converted, see Note 7.

 

We will need additional funds beyond the money raised in this Offering.  As a result, we are planning on additional financings in the future.

On January 30, 2020, the World Health Organization (“WHO”) announced a global health emergency because of a new strain of coronavirus originating in Wuhan, China (the “COVID-19 outbreak”) and the risks to the international community as the virus spreads globally beyond its point of origin. In March 2020, the WHO classified the COVID-19 outbreak as a pandemic, based on the rapid increase in exposure globally. The full impact of the COVID-19 outbreak continues to evolve as of the date of this report. Management is actively monitoring the global situation on its financial condition, liquidity, operations, suppliers, industry, and workforce. Given the daily evolution of the COVID-19 outbreak and the global responses to curb its spread, the Company is not able to estimate the effects of the COVID-19 outbreak on its results of operations, financial condition, or liquidity for fiscal year 2021. However, if the pandemic continues, it may have an adverse effect on the Company’s results of future operations, financial position, and liquidity in fiscal year 2021.

 

Management believes actions presently being taken to obtain additional funding provide the opportunity for the Company to continue as a going concern; however, these plans are contingent upon actions to be performed by the Company and these conditions have not been met on or before September 30, 2021. Additionally, the COVID-19 outbreak could have a continued material adverse impact on economic and market conditions and trigger a period of global economic slowdown, which would impair the Company’s ability to raise needed funds to continue as a going concern. As such, substantial doubt about the entity’s ability to continue as a going concern was not alleviated as of September 30, 2021.

XML 20 R9.htm IDEA: XBRL DOCUMENT v3.21.2
ASSET PURCHASE
9 Months Ended
Sep. 30, 2021
ASSET PURCHASE  
NOTE 3. ASSET PURCHASE

NOTE 3. ASSET PURCHASE

 

On June 5, 2020, the Company completed a transaction (the “Transaction”) with IDTEC subject to the terms and conditions of the APA and that was accounted for as an asset purchase. Pursuant to the APA, IDTEC provided personnel, experience, and access to funding to assist with the development of the SOBR device, as well as sold to us certain robotics assets, which our management believes are synergistic with our current assets, in exchange for 12,000,000 shares of our common stock after giving effect to the reverse stock split effected in connection with closing the Transaction.

 

As a result of closing the Transaction, the Company issued a convertible promissory note for all the funds spent or advanced by IDTEC prior to closing. This note totaled $1,485,189(the “APA Note”), with simple interest at 10% per annum, due upon demand, and may be convertible into shares of common stock at $0.50 per share (after giving effect to the reverse stock split and subject to anti-dilution protection against any future securities we may issue at an effective price of less than $0.50 per share) at the discretion of the holder. The repayment of APA Note is secured by a first priority security lien or security interest in the patents, trademarks, tradenames, and other intellectual property of the Company.

 

At closing, some of the closing conditions under the APA were either waived and/or modified by the parties. In order to document those modifications and waivers, we entered into a Waiver Under Asset Purchase Agreement and Post-Closing Covenant Agreement with IDTEC. One of the closing conditions that was the subject of the Waiver Under Asset Purchase Agreement and Post-Closing Covenant Agreement was the requirement that the Company have under $125,000 in permitted liabilities (not including aged liabilities) after closing of the Transaction. At closing we had approximately $158,000 in non-permitted liabilities under the APA. As a result, the Company issued a Warrant to Purchase Common Stock to IDTEC (the “Warrant”), under which IDTEC will purchase up to 320,000 shares of our common stock (post-split) at an exercise price of $0.50 per share, if either (i) we are forced to pay a non-permitted liability, then we may force IDTEC to exercise the Warrant and pay the exercise price to pay the non-permitted liability, but only in an amount sufficient to pay the non-permitted liability, or (ii) if IDTEC otherwise elects to exercise the Warrant and acquire some or all of the shares underlying the Warrant. The Warrant expires five years after the date of issuance.

 

The Transaction recorded as an asset purchase was valued at $29,222,955, which consists of the market price as of June 5, 2020 of the Company’s 12,000,000 shares of common stock issued totaling $27,120,000, the funds spent by IDTEC and affiliates prior to closing of $1,407,051 and the fair value of the Warrant issued of $695,454.  In determining the fair value of the intangible assets, the Company considered, among other factors, the best use of acquired assets such as the analysis of historical financial performance of the products and estimates of future performance of the products and intellectual properties acquired. The  allocation to identifiable intangible assets required extensive use of financial information and management's best estimate of fair value.  

The following summarizes the transaction closing with IDTEC on June 5, 2020:

 

Property and equipment

 

$47,725

 

Intangible assets

 

 

29,175,230

 

Total assets

 

$29,222,955

 

 

 

 

 

 

Net purchase (fair value of stock issued, warrants and notes payable) 

 

$29,222,955

 

 

Subsequent to the Transaction closing, the Company evaluated the fair value of theassets acquired based on market estimates for property and equipment and discounted net cash flow for the SOBR Safe intellectual technology. The present value of the discounted cash flow utilized a 75% discount, which included a 25% risk return premium, over an estimated five-year net revenue stream expected to be derived from the technology acquired. Based on the assessment of fair value, the Company recognized an asset impairment loss of $25,320,555 resulting from the APA during the year ended December 31, 2020. The impairment was due to the increase of the Company's stock price value. The stock price of the Company at closing of the Transaction was significantly higher than expected from the stock price of the Company when the Company signed the APA. The number of shares to be given to IDTEC as consideration for the Transaction would not get updated for any stock price changes.

XML 21 R10.htm IDEA: XBRL DOCUMENT v3.21.2
PREPAID EXPENSES
9 Months Ended
Sep. 30, 2021
PREPAID EXPENSES  
NOTE 4. PREPAID EXPENSES

NOTE 4. PREPAID EXPENSES

 

Prepaid expenses consist of the following:

 

 

 

September 30,

 

 

December 31,

 

 

 

2021

 

 

2020

 

Consulting service

 

$-

 

 

$111,860

 

Rent

 

 

20,667

 

 

 

-

 

Insurance

 

 

4,232

 

 

 

3,370

 

Prepaid expenses

 

$24,899

 

 

$115,230

 

 

On February 26, 2021, the Company entered into a new lease agreement for its office facility for a 12-month term beginning March 1, 2021.  In addition to monthly base rent of $6,000, the agreement requires the issuance on 16,000 shares of its common stock valued at $49,600, all of which has been issued as of September 30, 2021. 

XML 22 R11.htm IDEA: XBRL DOCUMENT v3.21.2
INTANGIBLE ASSETS
9 Months Ended
Sep. 30, 2021
INTANGIBLE ASSETS  
NOTE 5. INTANGIBLE ASSETS

NOTE 5. INTANGIBLE ASSETS

 

Intangible assets consist of the following at September 30, 2021:

 

 

 

Gross Carrying

Amount

 

 

Accumulated

Amortization

 

 

Net Intangible

Asset

 

 

Amortization

Period (in years)

 

SOBR Safe Intellectual Technology

 

$3,854,675

 

 

$513,952

 

 

$3,340,723

 

 

 

10

 

                                                                           

Amortization expense for the nine-month period ended September 30, 2021 and 2020 was $298,098 and $128,488, respectively, and is included in general and administrative expenses in the consolidated statements of operations.

Estimated future amortization expense for device technology intangible assets is as follows:

 

2022

 

 

 2023

 

 

  2024

 

 

2025

 

 

   2026

 

 

 Thereafter

 

$

385,467

 

 

$385,467

 

 

$385,467

 

 

$385,467

 

 

$385,467

 

 

$1,413,388

 

XML 23 R12.htm IDEA: XBRL DOCUMENT v3.21.2
RELATED PARTY TRANSACTIONS
9 Months Ended
Sep. 30, 2021
RELATED PARTY TRANSACTIONS  
NOTE 6. RELATED PARTY TRANSACTIONS

NOTE 6. RELATED PARTY TRANSACTIONS

 

On July 1, 2015, the Company amended a December 3, 2014, note payable agreement with Lanphere Law Group, a related party and  shareholder, which forgave $108,000 of a note payable’s principal balance. This debt forgiveness decreased the original principal balance on the note of $214,334 to a new principal balance of $106,335, and a related party gain of $108,000 was recorded to additional paid-in capital. This amendment also extended the note payable’s due date toDecember 2, 2015. The note was converted to common stock during the three months ended March 31, 2020.

 

On March 8, 2017, Lanphere Law Group irrevocably elected to exercise warrants in order to acquire 969,601 shares of the Company’s common stock in exchange for an aggregate exercise price of $112,871, which was used for the deduction of $74,672 of principal and $38,199 of accrued interest related to the December 3, 2014, note payable agreement with Lanphere Law Group. The forgiveness of the note payable principal of $74,672 was recorded to equity and the $38,199 of related accrued interest was also recorded to equity. The principal balance of the note after the debt deduction was $31,662. On January 3, 2020, the note payable principal balance of $31,662 was converted to 9,520 common shares at a per share price of $3.326. 

 

On January 3, 2020, the Company entered into a Debt Conversion and Common Stock Purchase Plan with Michael Lanphere, a beneficial owner of the Company, under which he agreed to exercise warrants and the Company agreed to issue 454,097 shares of its common stock in exchange for a reduction in the amounts owed to Mr. Lanphere under two promissory notes. Mr. Lanphere’s option to acquire the shares was under the terms of certain Loan Agreement with Promissory Note and Stock Fees agreements entered into with the Company and Mr. Lanphere on April 17, 2019 and July 17, 2019. The amount of the debt reduction, and therefore the purchase price of the shares, was approximately $66,000 which was used for the deduction of related party notes payable principal of  approximately $66,000. 180,397 common shares were issued on January 3, 2020, at an effective conversion price of $0.133 and 273,700 common shares were issued on January 3, 2020 at an effective conversion price of $0.153. After this exercise, Lanphere Law Group owns no warrants for shares of our common stock.

 

On January 3, 2020, the Company entered into another Debt Conversion and Common Stock Purchase Plan with Michael Lanphere, under which the Company agreed to issue 63,225 shares of its common stock in exchange for a reduction in the amounts owed to Mr. Lanphere under numerous other remaining promissory notes. The amount of the debt reduction, and therefore the purchase price of the shares, was $210,285 which was used for the deduction of related party notes payable principal of $169,606 and accrued interest of $40,679. Based on the fair value of the shares issued, the Company recognized a related party gain of approximately $52,000 and accounted for it as additional paid-in capital. The common shares were issued on January 3, 2020 at an effective conversion price of $3.326 per share.

 

On January 3, 2020, the Company entered into a Debt Conversion and Common Stock Purchase Plan with Vernon Justus, a shareholder, under which the Company agreed to issue 84,963 shares of its common stock in exchange for a reduction in the amounts owed to Mr. Justus under a promissory note. The amount of the debt reduction, and therefore the purchase price of the shares, was $282,588 which was used for the deduction of a related party note payable principal of $180,001 and accrued interest of $102,587. Based on the fair value of the shares issued, the Company recognized a related party gain of approximately $70,000 and accounted for it as additional paid-in capital. The common shares were issued on January 3, 2020 at an effective conversion price of $3.326 per share.

 

On January 16, 2020, the Company entered into a Accounts Payable Conversion and Common Stock Purchase Plan with Michael Lanphere, under which the Company agreed to issue 214,883 shares of its common stock in exchange for a reduction in the amounts owed to Mr. Lanphere for unpaid legal bills. The amount of the debt reduction, and therefore the purchase price of the shares, was $714,700 which was used for the deduction of related party payables of $714,700. Based on the fair value of the shares issued, the Company recognized a related party gain of approximately $222,000 and accounted for it as additional paid-in capital. The common shares were issued on January 16, 2020 at an effective conversion price of $3.326 per share.

On January 30, 2020, the Company entered into a Debt Conversion and Common Stock Purchase Plan with Devadatt Mishal, one of the Company’s former directors and current shareholder, under which the Company agreed to issue 499,965 shares of its common stock in exchange for a reduction in the amounts owed to Mr. Mishal under numerous promissory notes. The amount of the debt reduction, and therefore the purchase price of the shares, was $456,641 which was used for the deduction of related party notes payable principal of $270,300 and accrued interest of $186,341. The Company also recorded a loss on related party debt extinguishment of approximately $144,000. The common shares were issued on January 30, 2020 at an effective conversion price of $0.91465 per share.

 

On March 23, 2020, the Company entered into a Debt Conversion and Common Stock Purchase Plan with Prakash Gadgil, one of the Company’s former directors and current shareholder, under which the Company agreed to issue 586 shares of its common stock in exchange for a reduction in the amounts owed to Mr. Gadgil under a promissory note. The amount of the debt reduction, and therefore the purchase price of the shares, was $1,950 which was used for the deduction of a related party note payable principal of $1,950. Based on the fair value of the shares issued, the Company recognized a related party gain of approximately $1,000 and accounted for it as additional paid-in capital. The common shares were issued on March 23, 2020 at an effective conversion price of $3.326 per share.

 

On April 6, 2020, the Company agreed with Nick Noceti, the Company’s former Chief Financial Officer, to issue 38,437 shares of its common stock in exchange for amounts due for accounting fees. The amount of the debt reduction, and therefore the purchase price of the shares, was $127,840 which was used for the deduction of a related party accounts payable of $127,480. Based on the fair value of the shares issued, the Company recognized a related party gain of approximately $49,000 and accounted for it as additional paid-in capital. The common shares were issued on April 4, 2020 at an effective conversion price of $3.326 per share.

 

On April 7, 2020, the Company agreed with Charles Bennington, one of the Company’s former directors, to issue 6,831 shares of its common stock in exchange for amounts due for Board of Director fees. The amount of the debt reduction, and therefore the purchase price of the shares, was $9,656 which was used for the deduction of a related party accounts payable of $9,656. Based on the fair value of the shares issued, the Company recognized a related party gain of approximately $2,000 and accounted for it as additional paid-in capital. The common shares were issued on April 7, 2020 at an effective conversion price of $1.41 per share.

 

On February 12, 2021, the Company entered into a note payable agreement with David Gandini, an officer and shareholder, under which Mr. Gandini advanced the Company $30,000 for working capital purposes.  The  unsecured note carried interest at 0% and was paid in April 2021.

 

On March 30, 2021, the Company received notification from IDTEC that it was exercising a portion of the 320,000 warrants issued resulting from the Waiver Under Asset Purchase Agreement and Post-Closing Covenant Agreement with IDTEC.  The warrant exercise price is $0.50 per share.  With the proceeds of the exercise we paid $88,469 during the six-month period ended June 30, 2021 to settle an outstanding judgement (see Note 14) against the Company which was considered as a non-permitted liability under the Post-Closing Covenant Agreement.  We will issue 176,938 shares of our common stock for the $88,469 we received from IDTEC to pay the settlement.  As the shares had not been issued by June 30, 2021, the amount received from IDTEC is included in the common stock subscriptions payable balance at June 30, 2021.

 

On March 3 and 31, 2021, the Company issued convertible notes payable (see Note 8) totaling $450,000 to existing shareholders holding a direct or indirect interest in the Company and $100,000 to a Company’s director and another director’s family member. The principal amount of the secured convertible debentures are convertible at $3 per share, and include warrants to purchase in total 275,000 shares of the Company’s common stock at $3 per share.

 

On May 31, 2021, the Company issued convertible notes payable (see Note 8) totaling $400,000 to existing shareholders holding a direct or indirect interest in the Company and $50,000 to a Company’s officer. The principal amount of the secured convertible debentures are convertible at $3 per share, and include warrants to purchase in total 225,000 shares of the Company’s common stock at $3 per share.

XML 24 R13.htm IDEA: XBRL DOCUMENT v3.21.2
CONVERTIBLE DEBENTURE PAYABLE
9 Months Ended
Sep. 30, 2021
RELATED PARTY TRANSACTIONS  
NOTE 7. CONVERTIBLE DEBENTURE PAYABLE

NOTE 7. CONVERTIBLE DEBENTURE PAYABLE

 

Convertible debenture payable consists of the following:

 

 

 

September 30,

2021

 

 

December 31,

2020

 

Convertible Debenture Payable with Detached Free-standing Warrant

 

$3,048,781

 

 

$-

 

Unamortized Debt Discount

 

 

(2,608,900)

 

 

-

 

 

 

 

 

 

 

 

 

 

Net Convertible Debenture Payable

 

$439,881

 

 

$-

 

 

On September 28, 2021, (the “Closing Date”) the Company completed a financing transaction under a Securities Purchase Agreement (the “SPA”) and corresponding 18% Original Issue Discount Convertible Debenture (the “Debenture”), Common Stock Purchase Warrant (the “Warrant”) and Registration Rights Agreement (“RRA”). Under the terms of the SPA, the Company received $2,500,000 from the Purchaser and in exchange issued the Debenture in the principal amount of $3,048,781 and Warrants to purchase up to 1,219,512 shares of the Company’s common stock. The Debenture is convertible voluntarily by the Purchaser at any time into shares of our common stock, at the lesser of $2.50, representing 100% of the closing price of our common stock on the trading day immediately prior to the Closing Date, or 75% of the average VWAP of our common stock during the 5 trading day period immediately prior to the conversion date (the “Conversion Price”), or automatically upon the occurrence of a single public offering of our common stock which results in the listing of our common stock on a national securities exchange as defined in the Exchange Act (the “Qualified Offering”) into shares of our common stock at the lesser of the Conversion Price, or 75% of the offering price of the securities offered in the Qualified Offering. The Debenture matures on March 27, 2022, does not accrue interest unless there is an event of default under the terms of the Debenture. The Warrant is exercisable at any time through September 28, 2026 into shares of our common stock at an exercise price of $2.00 per share, unless an event of default occurs, at which time the exercise price will adjust to $1.00 per share. The Warrant contains a cashless exercise provision but only in the event the Company fails to have an effective registration statement registering the common shares underlying the Warrant at any time beginning six months from the Closing Date.  The RRA requires the Company to register for resale and maintain effectiveness of such Registration Statement for such all of the registrable securities under the terms of the Debenture and Warrant, within defined time frames. Should the Company fail to meet the RRA requirements, until the date causing such event of noncompliance is cured, the Company shall pay to the Purchaser as partial liquidated damages equal to the product of 2% of the principal amount not to exceed 24% of the aggregate principal. If the Company fails to pay of the liquidated damages within seven days after the date payable, the Company will pay interest at 18% until such amounts are paid in full. The Company evaluated the Debenture for derivative embedded and beneficial conversion features and determined that its embedded conversion feature carried a debt discount. The total conversion feature debt discount of $980,000 is amortized over the life of the convertible debenture. The debt discount amortization expense recorded as amortization of interest in the consolidated statements of operations was $16,245 for the nine-month period ended September 30, 2021.  As of September 30, 2021, the debenture carries outstanding warrants of 1,219,512. The relative fair market value of the related stock warrants granted during the nine month period ended September 30, 2021 and 2020 was $847,048 and none, respectively.  The unamortized discount at September 30, 2021 and December 31, 2020 was $833,008 and none, respectively. Stock warrants amortization expense recorded as interest expense was $14,039 for the nine month period ended September 30, 2021. The Company incurred $548,781 of Original Issue Discount and $275,000 of debt issuance costs related to the Debenture which is being amortized to interest expense over the term of the debt using the effective interest method. Interest expense related to the Original Issue Discount and debt issuance costs was $11,645 for the nine month period ended September 30, 2021. The unamortized discount and issuance costs at September 30, 2021 and December 31, 2020 was $812,134 and none, respectively. 

XML 25 R14.htm IDEA: XBRL DOCUMENT v3.21.2
NOTES PAYABLE
9 Months Ended
Sep. 30, 2021
NOTES PAYABLE  
NOTE 8. NOTES PAYABLE

NOTE 8. NOTES PAYABLE

 

RELATED PARTIES

 

Related party notes payable consist of the following:

 

 

 

    September 30,

        2021

 

 

December 31,

2020

 

Convertible Notes Payable with Detached Free-standing Warrants

 

$1,000,000

 

 

$-

 

Conventional Non-Convertible Notes Payable

 

 

11,810

 

 

 

11,810

 

Unamortized Debt Discount

 

 

(771,576)

 

 

-

 

Net Related Party Notes Payable

 

$240,234

 

 

$11,810

 

Current Portion

 

 

(11,810)

 

 

(11,810)

Net Long-Term Portion

 

$228,424

 

 

$-

 

 

Total interest expense for related party notes was $55,151 and $79,596 for the nine month period ended September 30, 2021 and 2020, respectively.

 

Related Party Convertible Notes Payable with Warrants

 

The Company has thirteen convertible notes payable to related parties, each with detached free-standing warrants to purchase the Company’s common stock at $3 per share, that have a total principal balance of $1,000,000 as of September 30, 2021. The notes, secured by the Company’s patents and patents applications, include interest at 12%, are convertible at $3 per share of the Company’s common stock and are due 24 months after issuance. The note holders may elect to have the interest paid in cash monthly or have the interest accrue and be payable on the maturity date. Interest elected to be accrued will be paid in cash or may be converted into shares of our common stock under the same terms as the principal amount on the maturity date. The notes contain both voluntary and automatic conversion features. The notes will be convertible at any time, by the holders, beginning on the date of issuance. However, the holders may not convert any outstanding amounts due under the note if at the time of such conversion the amount of common stock issued for the conversion, when added to other shares of Company common stock owned by the holders or which can be acquired by holders upon exercise or conversion of any other instrument, would cause the holder to own more than 4.9% of the Company’s outstanding common stock.  Beginning on the issuance date, the outstanding principal amount of the note, and any accrued interest, will automatically convert into shares of the Company’s common stock if the Company’s common stock closes at or above $6 per share for five (5) consecutive trading days while listed on NASDAQ. The Company evaluated the convertible notes payable for derivative embedded and beneficial conversion features. The Company determined that there were beneficial conversion features to record. The total beneficial conversion feature debt discount of $448,999 is amortized over the life of the convertible notes payable. The debt discount amortization expense recorded as amortization of interest – beneficial conversion feature in the consolidated statements of operations was $101,070for the nine-month period ended September 30, 2021. As of September 30, 2021, these notes carry outstanding warrants of 500,000. The relative fair market value of the related stock warrants granted during the nine-month period ended September 30, 2021 and 2020 was $551,001 and none, respectively.  The unamortized discount at September 30, 2021 and December 31, 2020 is $423,647 and none, respectively. Stock warrants amortization expense recorded as interest expense was $127,354 for the nine-month period ended September 30, 2021.

Related Party Convertible Notes Payable

 

On June 5, 2020 the Company issued the convertible APA Note to a related party with a principal balance of  $1,485,189, which included the $70,000 balance of three convertible notes payable to related parties and related accrued interest of $7,689 outstanding at December 31, 2019.  The note includes simple interest at 10% per annum, due upon demand, and may be convertible into shares of common stock at $0.50 per share (after giving effect to the reverse stock split and subject to anti-dilution protection against any future securities we may issue at an effective price of less than $0.50 per share) at the discretion of the holder.  The Company evaluated the convertible note payable for derivative embedded and beneficial  conversion features. The Company determined that there was a  beneficial conversion feature to record. During the year ended December 31, 2020, beneficial conversion feature amortization expense related to this related party convertible note payable of $1,407,675 was accounted for as amortization of interest - beneficial conversion feature expense in the consolidated statements of operations. On November 15, 2020, the related party holder elected to convert the note principal and accrued interest balance of $1,551,514 into 3,103,028 of shares of common stock.

 

Related Party Non-convertible Notes Payable

 

The Company has one non-convertible note payable to a related party that has a principal balance of  $11,810 as of September 30, 2021 and December 31, 2020. The note carries an interest rate at 0%.  The note payable had a due date of December 31, 2012 and is currently in default.    

 

NON-RELATED PARTIES 

 

Non-related party notes payable consist of the following:

 

 

 

September 30,

2021

 

 

December 31,

2020

 

Convertible Notes Payable with Detached Free-standing Warrants

 

$1,005,000

 

 

$-

 

Convertible Notes Payable

 

 

56,683

 

 

 

56,683

 

Conventional Non-Convertible Notes Payable

 

 

42,500

 

 

 

42,500

 

Notes Payable with Detached Free-standing Warrants

 

 

5,000

 

 

 

5,000

 

Unamortized Debt Discount

 

 

(774,850)

 

 

-

 

Net Non-Related Party Notes Payable

 

$334,333

 

 

$104,183

 

Current Portion

 

 

(104,183)

 

 

(79,183)

Net Long-Term Portion

 

$230,150

 

 

$25,000

 

 

Total interest expense for non-related party notes was $65,130 and $14,036 for the nine-month periods ended September 30, 2021 and 2020, respectively.

 

Convertible Notes Payable with Warrants

 

The Company has sixteen convertible notes payable to non-related parties, each with detached free-standing warrants to purchase the Company’s common stock at $3 per share, that have a total principal balance of $1,005,000 as of September 30, 2021. The notes, secured by the Company’s patents and patents applications, include interest at 12%, are convertible at $3 per share of the Company’s common stock and are due 24 months after issuance.  The note holders may elect to have the interest paid in cash monthly or have the interest accrue and be payable on the maturity date.  Interest elected to be accrued will be paid in cash or may be converted into shares of our common stock under the same terms as the principal amount on the maturity date.  The notes contain both voluntary and automatic conversion features. The notes will be convertible at any time, by the holders, beginning on the date of issuance. However, the holders may not convert any outstanding amounts due under the note if at the time of such conversion the amount of common stock issued for the conversion, when added to other shares of Company common stock owned by the holders or which can be acquired by holders upon exercise or conversion of any other instrument, would cause the holder to own more than 4.9% of the Company’s outstanding common stock.  Beginning on the issuance date, the outstanding principal amount of the note, and any accrued interest, will automatically convert into shares of the Company’s common stock if the Company’s common stock closes at or above $6 per share for five (5) consecutive trading days while listed on NASDAQ. The Company evaluated the convertible notes payable for derivative embedded and beneficial conversion features. The Company determined that there were beneficial conversion features to record. The total beneficial conversion feature debt discount of $460,215 is amortized over the life of the convertible notes payable.  The debt discount recorded as amortization of interest – beneficial conversion feature in the consolidated statements of operations was $105,060 for the nine-month period ended September 30, 2021.  As of September 30, 2021, these notes carry outstanding warrants of 502,500. The relative fair market value of the related stock warrants granted during the nine-month period ended September 30, 2021 and 2020 was $541,707 and none, respectively.  The unamortized discount at September 30, 2021 and December 31, 2020 was $419,695 and none, respectively. Stock warrants amortization expense recorded as interest expense was $122,012 for the nine-month period ended September 30, 2021.

Convertible Notes Payable

 

The Company has three convertible notes payable to non-related parties that have a principal balance of $56,683 as of September 30, 2021 and December 31, 2020. These notes carry interest rates ranging from 5% - 12% and have due dates ranging from February 2013 to March 2022. Two of the three notes are currently in default. These notes carry conversion prices ranging from $1.99- $10.7619 per share. The Company evaluated these convertible notes payable for derivative embedded and beneficial conversion features. The Company determined that there were beneficial conversion features to record. The conversion features were either fully amortized upon grant or over the life of the convertible notes payable. The conversion features were fully amortized prior to 2020.

 

During the three months ended March 31, 2020, the Company entered into Debt Conversion and Common Stock Purchase Plans with six non-related parties, under which the Company agreed to issue 50,135 shares of its common stock in exchange for a reduction of eleven convertible notes payable to non-related parties. The amount of the debt reduction, and therefore the purchase price of the shares, was $166,750 which was used for the deduction of non-related party convertible notes payable principal of $83,953 and accrued interest of $82,797. The Company recorded a non-related party gain on loan extinguishment  of approximately $103,000.

 

During the three months ended March 31, 2020, the Company entered into a non-related party convertible note payable agreement to convert a high interest rate convertible non-related party note payable with a principal balance of $25,000 and accrued interest due of $22,500 to a non-related party convertible note payable of $47,500 that accrues interest at 5%. The note conversion rate is $2 per common share. The Company recorded a loss on non-related party debt extinguishment of $11,697.

 

During 2020, the holder of a $25,000 convertible promissory note with interest at 30% and accrued interest of $61,875 replaced the carrying amount of the note and its conversion features with a new non-convertible note totaling $25,000 that bears interest at 5%. The Company recorded a gain on non-related party debt extinguishment of $61,875.

 

Non-convertible Notes Payable

 

The Company has three non-convertible notes payable to non-related parties that have a principal balance of $42,500 as of September 30, 2021, and December 31, 2020. These notes carry interest rates ranging from  5% - 10% and have due dates ranging from 12/25/2013 - 6/06/2022. Two of the three notes are currently in default. 

 

During 2020, the Company entered into a Debt Conversion and Common Stock Purchase Plan with a non-related party, under which the Company agreed to issue 20,313 shares of its common stock in exchange for a reduction of a non-convertible non-related party note payable. The amount of the debt reduction, and therefore the purchase price of the shares, was $67,561 which was used for the deduction of non-related party non-convertible notes payable principal of $3,938 and accrued interest of $63,623. The Company recorded a non-related party gain on loan extinguishment  of approximately $14,000.

 

On May 12, 2020, the Company received proceeds of $41,665 from a commercial bank under the SBA Payroll Protection Loan Program. The loan requires interest at 1% and 18 monthly payments of principal and interest beginning December 5, 2020. Provisions of the SBA Payroll Protection Loan Program allow for portions or all the loan balance to be forgiven should certain criteria be met.  On December 7, 2020 the Company was notified that the principal balance and accrued interest of $242 was forgiven, and thus the Company  recorded a gain on loan extinguishment of approximately $42,000.

 

Notes Payable with Warrants

 

The Company has one note payable with detached free-standing warrants to a non-related party that has a principal balance of $5,000 as of  September 30, 2021 and December 31, 2020. This note carries an interest rate of 10% and had a due date of 9/11/2014. This note is currently in default. The detached free-standing warrants for this note payable were not exercised by the note holder and expired on May 16, 2019.

XML 26 R15.htm IDEA: XBRL DOCUMENT v3.21.2
DERIVATIVE LIABILITY
9 Months Ended
Sep. 30, 2021
DERIVATIVE LIABILITY  
NOTE 9. DERIVATIVE LIABILITY

NOTE 9. DERIVATIVE LIABILITY

 

In September 2021, the Company completed a financing transition and received $2,500,000 from the Purchaser and in exchange issued an 18% Original Issue Discount Convertible Debenture in the principal amount of $3,048,781. The debenture includes voluntary and automatic conversion features at a variable conversion prices convertible into the Company’s common shares at an undetermined future date. The Company analyzed the conversion features of the debenture agreement for derivative accounting consideration under ASU 2017-11 (ASC 815-15, Derivatives and Hedging), and determined the embedded conversion features should be classified as a derivative because the exercise price of the convertible note is subject to a variable conversion rate and should therefore be accounted for at fair value under ASC 820, Fair Value Measurements and Disclosures, and ASC 825, Financial Instruments. In accordance with ASC 815-15, the Company bifurcated the conversion feature of the debenture and recorded a derivative liability.

 

The embedded derivative for the debenture is carried on the Company’s balance sheet at fair value. The derivative liability is marked to market each measurement period and any unrealized change in fair value is recorded as a component of the consolidated statement of operations and the associated fair value carrying amount on the balance sheet was adjusted by the change. The Company fair valued the embedded derivative using a Monte Carlo simulation model based on the following assumptions: (1) expected volatility of 120%, (2) risk-free interest rate of 0.05%, and (3) expected life from 4 to 6 months. On September 28, 2021, the Closing Date of the transaction, the fair value of the embedded derivative was $980,000 and is amortized to interest expense over the term of the Debenture. Utilizing level 3 inputs, the Company did not record a fair market value gain or loss for the nine months ended September 30, 2021. The fair value of the embedded derivative recorded on the balance sheet as a liability was $980,000 at September 30, 2021.

XML 27 R16.htm IDEA: XBRL DOCUMENT v3.21.2
STOCK SUBSCRIPTIONS PAYABLE
9 Months Ended
Sep. 30, 2021
STOCK SUBSCRIPTIONS PAYABLE  
NOTE 10. STOCK SUBSCRIPTIONS PAYABLE

NOTE 10. STOCK SUBSCRIPTIONS PAYABLE

 

The Company has common stock subscriptions payable due to related parties of $91,613 payable with 193,856 of its common shares at September 30, 2021.  The Company has common stock subscriptions payable due to related parties of $111,024 payable with 60,087 of its common shares at December 31, 2020.

 

The Company has common stock subscriptions payable due to non-related parties of $136,433 payable with 87,500 of its common shares at September 30, 2021 and December 31, 2020.

XML 28 R17.htm IDEA: XBRL DOCUMENT v3.21.2
COMMON STOCK
9 Months Ended
Sep. 30, 2021
COMMON STOCK  
NOTE 11. COMMON STOCK

NOTE 11. COMMON STOCK

 

The Company’s common stock transactions for the nine months ended September 30, 2020, consist of the following:

 

The Company issued 601 shares of its common stock for compensation for services rendered.

 

The Company issued 454,097 shares of its common stock for the conversion of $65,728 of related parties’ debt from $0.1530 to $0.13304 per share pursuant to terms of the convertible promissory notes. 454,097 stock warrants were settled along with the related party debt.

 

The Company issued 214,883 shares of its common stock for the settlement of related party payables of $714,700.  A related party gain of approximately $222,000 was recorded as additional paid-in capital from the stock issuance.

 

The Company issued 38,323 shares of its common stock for the settlement of  accounts payables and accrued expenses of approximately $127,000.  The Company recorded a net gain of approximately $27,000 from the stock issuance.

 

The Company issued 648,739 shares of its common stock to related parties for the conversion of $622,004 of debt from $0.9146 to $3.326 per share.  The Company recorded $143,660 of loss on debt extinguishment  and a related party gain of $124,291 as additional paid in-capital as a result of the stock issuance.

The Company issued 70,448 shares of its common stock to non-related parties for the conversion of $65,391 of debt  at $3.326 per share.  The Company recorded $41,665 of loss resulting from the stock issuance. 

 

The Company agreed to convert 121,072 shares of its common stock at values between $0.5821 to $1.039 per share to non-related parties in exchange for their agreement to settle payable balances of $91,464 owed to them. The conversion was in full satisfaction of all outstanding amounts owed. The Company recorded a non-related party loss of $81,867 as other expense in the consolidated statements of operations.

 

The Company issued 45,268 shares of its common stock to related parties in exchange for their agreement to settle  related party accounts payable of $137,496 owed to them. The shares were issued at a value of $86,739 and recorded a related party gain of $50,741 to additional paid-in-capital.

 

The Company issued 12,000,000 shares of its common stock valued at $2.26 as result of the Transaction with IDTEC (see Note 3).

 

The Company’s common stock transactions for the nine months ended September 30, 2021, consist of the following:

 

The Company issued 43,169 shares of its common stock to SOBR Safe, LLC, an entity controlled by a beneficial owner of the Company, in full satisfaction of $107,880 of accrued dividends resulting from the December 2020 conversion of the Series A-1 Convertible Preferred Stock into common shares, see Note 11.

 

The Company issued 16,000 shares of its common stock valued at $49,600 to its landlord under the terms of a lease agreement expiring in February 2022.  The amount has been recorded as prepaid expense and amortized monthly over the lease term as general and administrative expense in the consolidated statement of operations.  

XML 29 R18.htm IDEA: XBRL DOCUMENT v3.21.2
PREFERRED STOCK
9 Months Ended
Sep. 30, 2021
PREFERRED STOCK  
NOTE 12. PREFERRED STOCK

NOTE 12. PREFERRED STOCK

 

On November 20, 2015, the Company’s Board of Directors authorized a class of stock designated as preferred stock with a par value of $0.00001 per share comprising 25,000,000 shares, 3,000,000 shares of which were classified as Series A Convertible Preferred Stock. In each calendar year, the holders of the Series A Convertible Preferred Stock are entitled to receive, when, as and if, declared by the Board of Directors, out of any funds and assets of the Company legally available, non-cumulative dividends, in an amount equal to any dividends or other Distribution on the common stock in such calendar year (other than a Common Stock Dividend). No dividends (other than a Common Stock Dividend) shall be paid and no distribution shall be made with respect to the common stock unless dividends shall have been paid or declared and set apart for payment to the holders of the Series A Convertible Preferred Stock simultaneously. Dividends on the Series A Convertible Preferred Stock shall not be mandatory or cumulative, and no rights or interest shall accrue to the holders of the Series A Convertible Preferred Stock by reason of the fact that the Company shall fail to declare or pay dividends on the Series A Convertible Preferred Stock, except for such rights or interest that may arise as a result of the Company paying a dividend or making a distribution on the common stock in violation of the terms. The holders of each share of Series A Convertible Preferred Stock then outstanding shall be entitled to be paid, out of the Available Funds and Assets, and prior and in preference to any payment or Distribution (or any setting part of any payment or Distribution) of any Available Funds and Assets on any shares of common stock, and equal in preference to any payment or Distribution (or any setting part of any payment or Distribution)  of any Available Funds and Assets on any shares of any other series of preferred stock that have liquidation preference, an amount per share equal to the Original Issue Price of the Series A Convertible Preferred Stock plus all declared but unpaid dividends on the Series A Convertible Preferred Stock. A reorganization, or any other consolidation or merger of the Company with or into any other corporation, or any other sale of all or substantially all of the assets of the Company, shall not be deemed a liquidation, dissolution, or winding up of the Company. Shares of the Series A Convertible Preferred Stock are convertible at a 35% discount rate to the average closing price per share of the Company’s common stock (either as listed on a national exchange or as quoted over-the-market) for the last 15 trading days immediately prior to conversion. However, no conversions of the Series A Convertible Preferred Stock to shares of common stock can occur unless the average closing price per share of the Company’s common stock (either as listed on a national exchange or as quoted over-the-market) for the last  15 trading days immediately prior to conversion is at least $1.67. The shares of Series A Convertible Preferred Stock vote on a one for one basis. The right of conversion is limited by the fact the holder of the Series A Convertible Preferred Stock may not convert if such conversion would cause the holder to beneficially own more than 4.9% of the Company’s common stock after giving effect to such conversion. 

On December 9, 2019, the Company’s Board of Directors created a class of preferred stock designated as 8% Series A-1 Convertible Preferred Stock comprising of 2,000,000 shares. During 2020, the authorized shares were increased to 2,700,000 shares.  The rights and preferences of the 8% Series A-1 Convertible Preferred Stock are as follows: (a) dividend rights of 8% per annum based on the original issuance price of $1 per share, (b) liquidation preference over the Company’s common stock, (c) conversion rights into shares of the Company’s common stock at $1 per share (not to be affected by any reverse stock split in connection with the Asset Purchase Agreement with IDTEC), (d) redemption rights such that we have the right, upon 30 days written notice, at any time after one year from the date of issuance, to redeem all or part of the Series A-1 Convertible Preferred Stock for 150% of the original issuance price, (e) no call rights by the Company, and (f) each share of Series A-1 Convertible Preferred Stock will vote on an “as converted” basis.

 

On December 12, 2019, the Company entered into a Series A-1 Preferred Stock Purchase Agreement (the “SPA”) with SOBR SAFE, LLC (“SOBR SAFE”), a Delaware limited liability company and an entity controlled by a beneficial owner of the Company, under which SOBR SAFE agreed to acquire 1,000,000 shares of our Series A-1 Convertible Preferred Stock  in exchange for $1,000,000 (the “Purchase Price”). The Company received the Purchase Price on December 12, 2019.

 

On May 7, 2020, the Company amended a Convertible Preferred Stock Investment Agreement  granting the exclusive right to SOBR SAFE to purchase up to 2,700,000 shares of Series A-1 Convertible Preferred Stock.   

 

On July 2, 2020, the Company executed Amendment No. 2 to the Stock Investment Agreement which provides that the full amount of each dividend due on a dividend payment date, even if not declared, shall be paid to any holder regardless of the date on which the holder acquired the stock. 

 

The Series A-1 Convertible Preferred Stock earns cumulative dividends at a rate of 8% per annum, payable in cash or common stock at the option of the Company on June 30 and December 31 of each year. If paid in common stock, the common stock will be valued at the average of the closing price for the five business days prior to the dividend payment date. The preferred shareholders will participate in any common stock dividends on an as converted basis. Although no dividends were declared as of September 30, 2020, the Company has accrued dividends payable of $161,880 related to the 8% Series A-1 Convertible Preferred Stock as of September 30, 2020.  On December 7, 2020, we sent a Notice of Automatic Conversion and Calculation of Dividend Shares to SOBR SAFE notifying them that under the terms governing the shares of Series A-1 Convertible Preferred Stock the 2,700,000 shares of Series A-1 Convertible Preferred Stock owned by SOBR SAFE automatically converted into 2,700,000 shares of our common stock.  In addition, as a result of the conversion of the Series A-1 Convertible Preferred Stock we owed SOBR SAFE accrued dividends totaling $107,880, which we could pay in cash or in shares of our common stock based on the price of common stock on the applicable dividend dates.  Our management and Board of Directors elected to pay SOBR SAFE the accrued dividends in shares of our common stock.

XML 30 R19.htm IDEA: XBRL DOCUMENT v3.21.2
STOCK WARRANTS AND STOCK OPTIONS
9 Months Ended
Sep. 30, 2021
STOCK WARRANTS AND STOCK OPTIONS  
NOTE 13. STOCK WARRANTS AND STOCK OPTIONS

NOTE 13 STOCK WARRANTS AND STOCK OPTIONS

 

Stock Warrants

 

The Company accounts for employee stock options and stock warrants under ASC 718 and ASC 505, whereby option costs are recorded based on the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable, utilizing the Black-Scholes pricing model. Unless otherwise provided for, the Company covers option exercises by issuing new shares. 

 

On August 8, 2019, the Company entered into an 8% Series A-1 Convertible Preferred Stock Investment agreement with First Capital Ventures, LLC (“FCV”), an entity controlled by a beneficial owner of the Company. FCV set up a special purpose vehicle (“SPV”) or SOBR SAFE, LLC, an entity controlled by a beneficial owner of the Company,  that purchased 1,000,000 of the 8% Series A-1 Convertible Preferred Shares at $1 per share on December 12, 2019. Upon purchase, the Company issued the SPV through FCV a three-year warrant to purchase 144,317 shares of the Company’s common stock at an exercise price of $1.039375 per share. The number of warrants outstanding to the SPV through FCV at September 30, 2021 and December 31, 2020 are 144,317. 

 

On May 4, 2020, the Company entered into an agreement with a vendor to provide investor relations services.  Under the terms of the agreement, we issued warrants to purchase up to 120,000 shares of our common stock at an exercise price of $2.00 per share. The warrants expire five years after the date of issuance. Approximately $220,000 of expense was recognized for the warrants issued for the services provide by the vendor.

 

On June 5, 2020, at closing of the Transaction, the Company entered into a Waiver Under Asset Purchase Agreement and Post-Closing Covenant Agreement under which we issued warrants to IDTEC to purchase up to 320,000 shares of our common stock (post-split) at an exercise price of $0.50 per share. The warrants expire five years after the date of issuance.

 

During March, April and May 2021, the Company issued through the Offering convertible notes payable with warrants, see Note 8, to purchase up to 1,002,500 shares of our common stock at an exercise price of $3 per share. The warrants expire two years after the date of issuance.

 

On September 28, 2021, the Closing Date,  the Company issued through the sale of the Debenture warrants, see Note 7, to purchase up to 1,219,512 shares of our common stock at an exercise price of $2 per share. The warrants expire five years after the date of issuance.

 

The total outstanding balance of all stock warrants in the Company is 2,629,391 and 584,317 at September 30, 2021 and December 31 2020, respectively. There were 2,222,012 detached free-standing stock warrants granted during the nine month period ended September 30, 2021, and 320,000  detached free-standing stock warrants granted during the nine month period ended September 30, 2020. The fair value of these non-employee stock warrants granted during the nine-month periods ended September 30, 2021 and 2020 totaled $1,939,756 and $695,454, respectively, and were determined using the Black-Scholes option pricing model based on the following assumptions:

 

 

 

September 30,

2021

 

 

  September 30,

2020 

 

Exercise Price 

 

$

3.00-2.00

 

 

$0.50

 

Dividend Yield 

 

 

0%

 

 

0%

Volatility 

 

158-120

 

 

153%

Risk-free Interest Rate 

 

0.14%-0.98

 

 

0.29%

Life of Warrants

 

2-5 Years

 

 

   5 Years

 

The following table summarizes the changes in the Company’s outstanding warrants during the nine-month period ended September 30, 2021 and 2020, and as of September 30, 2021 and 2020:

 

 

 

Warrants

Outstanding

Number of

Shares

 

 

Exercise Price Per

Share

 

 

Weighted Average Remaining Contractual Life

 

Weighted Average

Exercise Price Per Share

 

 

Aggregate Intrinsic Value

 

Balance at December 31, 2019

 

 

598,414

 

 

$

0.13304–1.039375

 

 

3.97 Years

 

$0.3607

 

 

$1,276,870

 

Warrants Granted

 

 

320,000

 

 

$0.50

 

 

4.68Years

 

$0.50

 

 

$761,000

 

Warrants Exercised

 

 

(454,097)

 

$

0.13304 - 0.15299

 

 

 

 

$0.1451

 

 

 

 

 

Warrants Expired

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at September 30, 2020

 

 

464,317

 

 

$

0.50- 1.039375

 

 

3.91 Years

 

$0.66765

 

 

$1,027,234

 

 

 

 

Warrants

Outstanding

Number of

Shares

 

 

Exercise Price Per

Share

 

 

Weighted Average Remaining Contractual Life

 

Weighted Average

Exercise Price Per Share

 

 

Aggregate Intrinsic Value

 

Balance at December 31, 2020

 

 

584,317

 

 

$

0.50 – 2.00

 

 

3.80 Years

 

$0.9413

 

 

$1,173,737

 

Warrants Granted

 

 

2,222,012

 

 

$

3.00-2.00

 

 

3.40 Years

 

$2.45

 

 

$108,506

 

Warrants Exercised

 

 

(176,938)

 

$0.50

 

 

 

 

$0.50

 

 

 

 

 

Warrants Expired

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at September 30, 2021

 

 

2,629,391

 

 

$

0.50 – 3.00

 

 

3.30 Years

 

$2.25

 

 

$665,424

 

 

Stock Options

 

On October 24, 2019, the Company’s 2019 Equity Incentive Plan went effective. The plan was approved by the Company’s Board of Directors and the holders of a majority of the Company’s voting stock on September 9, 2019. The plan’s number of authorized shares is 3,848,467. As of September 30, 2021 and December 31, 2020, the Company has granted stock options to acquire 2,921,861 and 2,521,921 shares of common stock under the plan, respectively. As of September 30, 2021, the plan has 1,893,347 vested shares and 1,028,514 non-vested shares. As of December 31, 2020, the plan had 1,202,724 vested shares and 1,319,197 non-vested shares. As of September 30, 2021 and December 31, 2020 the plan has options available to be issued of 926,606 and 1,326,546, respectively.  The stock options are held by our officers, directors, employees, and certain key consultants. 

 

In total for the nine months ended September 30, 2021 and 2020, the Company recorded $630,027 and $343,549, respectively, of share-based compensation expense related to stock options and restricted stock units. The unrecognized compensation expense as of September 30, 2021, was approximately $813,000 for non-vested share-based awards to be recognized over periods of approximately one to three years.

In applying the Black-Scholes options pricing model, assumptions used to compute the fair value of the stock options granted during the nine-month period ended September 30, 2021 and 2020 were as follows:

 

 

 

September 30,

2021

 

 

September 30,

2020

 

Exercise Price

 

$

2.50 - $3.58

 

 

$

0.26-$3.30

 

Dividend Yield

 

 

0%

 

 

0%

Expected Volatility

 

44% - 185

 

153%-171

Risk-free Interest Rate

 

0.16% - 1.69

 

0.19%-0.43

Expected Life

 

1.3 - 7 years

 

 

2.2-5 years

 

  

The following table summarizes the changes in the Company’s outstanding stock options during the nine-month period ended September 30, 2021 and 2020, and as of September 30, 2021 and 2020:

 

 

 

Options

Outstanding

Number of

Shares

 

 

Exercise Price Per

Share

 

 

Weighted Average Remaining Contractual Life

 

Weighted Average

Exercise Price Per Share

 

 

Aggregate

Intrinsic Value

 

Balance at December 31, 2019

 

 

2,381,239

 

 

$

0.2634-1.039

 

 

8.86 Years

 

$0.2948

 

 

$5,238,080

 

Options Granted

 

 

160,000

 

 

$

0.26341-3.30

 

 

4.10 Years

 

$1.9454

 

 

$149,532

 

Options Exercised

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options Cancelled

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

Options Expired

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at September 30, 2020

 

 

2,541,239

 

 

$

0.2634 – 3.30

 

 

7.86 Years

 

$0.3987

 

 

$6,305,579

 

 

 

 

Options

Outstanding

Number of

Shares

 

 

Exercise Price Per

Share

 

 

Weighted Average Remaining Contractual Life

 

Weighted Average

Exercise Price Per Share

 

 

Aggregate Intrinsic Value

 

Balance at December 31, 2020

 

 

2,572,227

 

 

$

0.2634–3.300

 

 

7.45 Years

 

$0.4999

 

 

$6,302,277

 

Options Granted

 

 

610,526

 

 

$

2.50–3.575

 

 

2.58 Years

 

$3.1783

 

 

$(414,147)

Options Exercised

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options Cancelled

 

 

(210,587)

 

$

0.2634-3.29

 

 

 

 

$2.969

 

 

 

 

 

Options Expired

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at September 30, 2021

 

 

2,972,166

 

 

$

0.2634–3.575

 

 

6.15 Years

 

$0.8751

 

 

$4,829,417

 

 

Exercisable at December 31, 2020

 

 

1,253,030

 

 

0.2634 – 3.300

 

 

7.4 Years

 

$0.3165

 

 

$3,299,765

 

Exercisable at September 30, 2021

 

 

1,943,652

 

 

$

0.2634 – 3.575

 

 

6.3 Years

 

$0.6527

 

 

$3,590,430

 

 

Executive Stock Options

 

The Company has 1,553,152 and 981,771 outstanding executive stock options exercisable at $0.2634 to $3.38 per share as of  September 30, 2021, and December 31, 2020, respectively.

XML 31 R20.htm IDEA: XBRL DOCUMENT v3.21.2
COMMITMENTS AND CONTINGENCIES
9 Months Ended
Sep. 30, 2021
COMMITMENTS AND CONTINGENCIES  
NOTE 14. COMMITMENTS AND CONTINGENCIES

NOTE 14. COMMITMENTS AND CONTINGENCIES

 

Operating Leases

On October 15, 2019, the Company entered into a short-term lease agreement that is between $2,800 - $2,900per month and ended on October 31, 2020. The lease has been renewed for another twelve months under the same general terms and conditions.  The lease was subsequently canceled to accommodate additional space, and a new lease was executed February 26, 2021, effective for a 12-month term beginning March 1, 2021.  The lease requires monthly base rent payments of $6,000 and the issuance of 16,000 shares of the Company’s common stock.  The value of the common stock of $49,600 is amortized to rent expense on a monthly basis over the lease term.  The Company also leases an office space for approximately $3,500 per month on a short-term (month to month) basis through a related party that terminates at any time.  Rent expense under office leases, including CAM charges, was $106,997 and $47,711 for the nine-month period ended September 30, 2021 and 2020, respectively.

 

Legal Proceedings

On December 6, 2006, Orange County Valet and Security Patrol, Inc. filed a lawsuit against us in Orange County California State Superior Court for Breach of Contract in the amount of $11,164. A default judgment was taken against us in this matter. In mid-2013 we learned the Plaintiff’s perfected the judgment against us, but we have not heard from the Plaintiffs as of the date of this report.  As of September 30, 2021, and December 31, 2020, the Company has accrued $11,164 plus accrued interest of approximately $18,000.  In the event we pay any money related to this lawsuit, IDTEC agreed, in connection with us closing the asset purchase transaction with IDTEC, to pay the amount for us in exchange for shares of our common stock.

 

We had one outstanding judgment against us involving a past employee of the Company. The matter was under the purview of the State of California, Franchise Tax Board, Industrial Health and Safety Collections. We owed  $28,786 plus accrued interest of approximately $53,000, which had been accrued as of December 31, 2020, to our ex-employee for unpaid wages under these Orders.  On March 8, 2021 we received an Acknowledgement of Satisfaction of Judgement-Full by the California Court that the judgement has been settled with a payment of approximately $85,000 including accrued interest through settlement date and legal fees of approximately $3,000.  IDTEC agreed, in connection with us closing the asset purchase transaction with IDTEC, to pay the amounts for us in exchange for shares of our common stock. 

XML 32 R21.htm IDEA: XBRL DOCUMENT v3.21.2
SUBSEQUENT EVENTS
9 Months Ended
Sep. 30, 2021
SUBSEQUENT EVENTS  
NOTE 15. SUBSEQUENT EVENTS

NOTE 15. SUBSEQUENT EVENTS

 

The Company has evaluated subsequent events for recognition and disclosure through November 15, 2021, which is the date the condensed consolidated financial statements were available to be issued, and has determined that there are no other material subsequent events that require recognition or disclosure in the accompanying condensed consolidated financial statements.

XML 33 R22.htm IDEA: XBRL DOCUMENT v3.21.2
ORGANIZATION OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
9 Months Ended
Sep. 30, 2021
ORGANIZATION OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  
Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”) as promulgated in the United States of America and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and related notes for the year ended December 31, 2020, included in the Company’s Annual Report on Form 10-K filed with the SEC on March 31, 2021.

 

In management’s opinion, the unaudited condensed consolidated financial statements reflect all adjustments (including reclassifications and normal recurring adjustments) necessary to present fairly the financial position as of September 30, 2021 and December 31, 2020, and results of operations and cash flows for the three and nine month periods ended September 30, 2021 and 2020.

The Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instruments are initially recorded at their fair values and are then re-valued at each reporting date, with changes in the fair value reported in the unaudited condensed consolidated statements of operations under other income (expense). The accounting treatment of derivative financial instruments requires that the Company record the embedded conversion option at its fair value as of the inception date of the agreement and at fair value as of each subsequent balance sheet date. Any change in fair value is recorded as non-operating, non-cash income or expense for each reporting period at each balance sheet date. If the classification changes as a result of events during the period, the contract is reclassified as of the date of the event that caused the reclassification. As a result of entering into warrant agreements, for which such instruments contained a variable conversion feature with no floor, the Company has adopted a sequencing policy in accordance with ASC 815-40-35-12 whereby all future instruments may be classified as a derivative liability with the exception of instruments related to share-based compensation issued to employees or directors. For stock-based derivative financial instruments, the Company uses a Monte Carlo Simulation model to value the derivative instruments at inception and on subsequent valuation dates.

 

The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date. 

Depreciation is computed on a straight-line basis over the assets estimated useful lives of three years. There was no depreciation for the three and nine months ended September 30, 2021. Depreciation for the three and nine months ended September 30, 2020 was $3,978 and $5,083, respectively .

Principles of consolidations

The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its majority owned subsidiary, TransBiotec-CA. We have eliminated all intercompany transactions and balances between entities consolidated in these unaudited condensed financial statements.

Use of Estimates

The preparation of unaudited condensed consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Specifically, such estimates were made by the Company for the recoverability and useful lives of long-lived assets, the intellectual technology, the valuation of the derivative liabilities, beneficial conversion feature expenses, stock-based compensation and the valuation allowance related to deferred tax assets. Actual results could differ from those estimates.

Financial Instruments

Pursuant to  Accounting Standards Codification (“ASC”) Topic 820, Fair Value Measurements and Disclosures, and ASC 825, Financial Instruments, an entity is required to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 and 825 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 and 825 prioritizes the inputs into three levels that may be used to measure fair value:

 

Level 1

Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.

 

Level 2

Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets: quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.

 

Level 3

Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.

 

The Company’s financial instruments consist primarily of cash, accounts payable, accrued expenses, accrued interest payable,  related party payables, notes payable, convertible debentures, and other liabilities. Pursuant to ASC 820 and 825, the fair value of our derivative liabilities is determined based on “Level 3” inputs. We believe that the recorded values of all of our other financial instruments approximate their current fair values because of their nature and respective maturity dates or durations.

 

The following table presents assets and liabilities that are measured and recognized at fair value as of September 30, 2021 and December 31, 2020:

 

September 30, 2021

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

Derivative liability

 

$-

 

 

$-

 

 

$980,000

 

 

 

$-

 

 

$-

 

 

$980,000

 

 

December 31, 2020

   

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

Derivative liability

 

$-

 

 

$-

 

 

$-

 

 

 

$-

 

 

$-

 

 

$-

 

Cash

The Company considers all highly liquid investments with an original maturity of three months or less as cash equivalents. The Company does not have any cash equivalents as of September 30, 2021 and December 31, 2020. 

Prepaid Expenses

Amounts incurred in advance of contractual performance or coverage periods are recorded as prepaid assets and recognized as expense in the period service or coverage is provided.  

Beneficial Conversion Features

From time to time, the Company may issue convertible notes that may contain a beneficial conversion feature. A beneficial conversion feature exists on the date a convertible note is issued when the fair value of the underlying common stock to which the note is convertible into is in excess of the remaining unallocated proceeds of the note after first considering the allocation of a portion of the note proceeds to the fair value of the warrants, if related warrants have been granted. The intrinsic value of the beneficial conversion feature is recorded as a debt discount with a corresponding amount to additional paid-in capital. The debt discount is amortized to interest expense over the life of the note using the effective interest method.

Debt Issuance Costs

Debt issuance costs incurred in connection with the issuance of debt are capitalized and amortized to interest expense over the term of the debt using the effective interest method. The unamortized amount is presented as a reduction of debt on the balance sheet.

Preferred Stock

We apply the guidance enumerated in ASC 480 “Distinguishing Liabilities from Equity” when determining the classification and measurement of preferred stock. Preferred shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. We classify conditionally redeemable preferred shares (if any), which includes preferred shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control, as temporary equity. At all other times, we classified our preferred shares in stockholders’ equity.

Minority Interest (Noncontrolling Interest)

A subsidiary of the Company has minority members representing ownership interests of 1.38% at September 30, 2021 and December 31, 2020. The Company accounts for these minority, or noncontrolling interests, pursuant to ASC 810-10-65 whereby gains and losses in a subsidiary with a noncontrolling interest are allocated to the noncontrolling interest based on the ownership percentage of the noncontrolling interest, even if that allocation results in a deficit noncontrolling interest balance.

Stock-based compensation

The Company follows the guidance of the accounting provisions of ASC 718 “Share-based Compensation”, which requires the use of the fair-value based method to determine compensation for all arrangements under which employees and others receive shares of stock or equity instruments (warrants and options). The fair value of each option award is estimated on the date of grant using the Black-Scholes options pricing model that uses assumptions for expected volatility, expected dividends, expected term, and the risk-free interest rate. The Company has not paid common stock dividends historically and does not expect to pay them in the future. Expected volatilities are based on weighted averages of the historical volatility of the Company’s common stock estimated over the expected term of the options. The expected term of options granted is derived using the “simplified method” which computes expected term as the average of the sum of the vesting term plus the contract term as historically the Company had limited activity surrounding its options. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the period of the expected term.

Research and Development

The Company accounts for its research and development costs pursuant to ASC 730, whereby it requires the Company to disclose the amounts of costs for company and customer-sponsored research and development activities, if material. Research and development costs are expensed as incurred. The Company incurred research and development costs as it acquired new knowledge to bring about significant improvements in the functionality and design of its SOBR product. Research and development costs were $1,026,679 and $309,403 during the nine month periods ended September 30, 2021 and 2020, respectively.

Advertising and Marketing Costs

Advertising and marketing costs are charged to operations as incurred.  Advertising and marketing costs were $70,692 and $70,198 during the nine month periods ended September 30, 2021 and 2020, respectively, and are included in general and administrative expenses in the consolidated statements of operations.    

Depreciation  
Income tax

The Company accounts for income taxes pursuant to ASC 740. Under ASC 740 deferred taxes are provided on a liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss carry forwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. The Company has not recorded any deferred tax assets or liabilities at September 30, 2021 and December 31, 2020 as these have been offset by a 100% valuation allowance.

Net loss per share

Basic net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period.  Diluted  loss per share gives the effect to all dilutive potential common shares outstanding during the period,  including stock options, warrants and convertible instruments.  Diluted net loss per share excludes all potentially issuable shares if their effect is anti-dilutive.  Because the effect of the Company’s dilutive securities is anti-dilutive, diluted net loss per share is the same as basic loss per share for the periods presented.

Concentration of Credit Risk

Certain financial instruments potentially subject the Company to concentrations of credit risk. Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash deposits. Cash held in operating accounts may exceed the Federal Deposit Insurance Corporation (“FDIC”) insurance limits. Accounts at each institution are insured by the FDIC up to $250,000. While the Company monitors cash balances in our operating accounts on a regular basis and adjust the balances as appropriate, these balances could be impacted if the underlying financial institutions fail. To date, the Company has experienced no loss or lack of access to our cash; however, the Company can provide no assurances that access to our cash will not be impacted by adverse conditions in the financial markets. At September 30, 2021 and December 31, 2020, the Company had $1,934,969 and none, respectively in excess of the FDIC insured limits.

Related Parties

Related parties are any entities or individuals that, through employment, ownership, or other means, possess the ability to direct or cause the direction of the management and policies of the Company.

New Pronouncements

In December 2019, the FASB issued ASU No. 2019-12, Simplifying the Accounting for Income Taxes (“ASU 2019-12”), which simplifies the accounting for income taxes, eliminates certain exceptions within ASC 740, Income Taxes, and clarifies certain aspects of the current guidance to promote consistency among reporting entities. ASU 2019-12 is effective for fiscal years beginning after December 15, 2021. Most amendments within the standard are required to be applied on a prospective basis, while certain amendments must be applied on a retrospective or modified retrospective basis. The Company is evaluating the effects, if any, of the adoption of ASU 2019-12 guidance on the Company's financial position, results of operations and cash flows.

 

In August 2020, the FASB issued ASU No. 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, which address issues identified as a result of the complexity associated with applying generally accepted accounting principles for certain financial instruments with characteristics of liabilities and equity.  This amendment is effective for public business entities that meet the definition of a SEC filer, excluding entities eligible to be smaller reporting companies as defined by the SEC, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company is evaluating the effects, if any, of the adoption of ASU 2020-06 guidance on the Company's financial position, results of operations and cash flows.

 

In October 2020, the FASB issued ASU No. 2020-08, Codification Improvements to Subtopic 310-20, Receivables-Nonrefundable Fees and Other Costs, amendments the guidance in ASU No. 2017-08, (Subtopic 310-20): Premium Amortization on Purchased Callable Debt Securities, which addresses multiple call dates of a callable debt security.  This amendment is effective for public business entities, for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. Early application is not permitted.  The Company evaluated the adoption of ASU 2020-08 guidance and determined no effects on the Company's financial position, results of operations and cash flows.

In May 2021, the FASB issued ASU No. 2021-04, Earnings Per Share (Topic 260), Debt-Modifications and Extinguishments (Subtopic 470-50), Compensation-Stock Compensation (Topic 718), and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtpoic 815-40), which addresses issuer’s accounting for certain modifications or exchanges of freestanding equity-classified written call options.  This amendment is effective for all entities, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted.  The Company is evaluating the effects, if any, of the adoption of ASU 2021-04 guidance on the Company's financial position, results of operations and cash flows.

While preparing financial statements for periods in 2021, the Company discovered an error in the statement of operations for the year ended December 31, 2020.  The error related to the presentation of the loss on disposal of property and equipment and asset impairment adjustment in accordance with ASC 360-10-45.

 

Loss on disposal of property and equipment and asset impairment adjustment of  $39,434 and $25,320,555, respectively, were presented as other income/expense-net, instead of as operating expenses.  As a result, loss from operations for the year ended December 31, 2020, was understated by $25,359,989 and other income/expenses-net was overstated by the same amount.  The errors had no affect on the net loss or net loss per share for the year ended December 31, 2020.

 

As a result of this correction, the statement of operations for the three and nine month periods ended September 30, 2020 in the accompanying financial statements has been retroactively restated.

Correction of Error  
XML 34 R23.htm IDEA: XBRL DOCUMENT v3.21.2
ORGANIZATION OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
9 Months Ended
Sep. 30, 2021
ORGANIZATION OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  
Schedule of assets and liabilities

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

Derivative liability

 

$-

 

 

$-

 

 

$980,000

 

 

 

$-

 

 

$-

 

 

$980,000

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

Derivative liability

 

$-

 

 

$-

 

 

$-

 

 

 

$-

 

 

$-

 

 

$-

 

XML 35 R24.htm IDEA: XBRL DOCUMENT v3.21.2
ASSET PURCHASE (Tables)
9 Months Ended
Sep. 30, 2021
ASSET PURCHASE  
Summary of closing transactions

Property and equipment

 

$47,725

 

Intangible assets

 

 

29,175,230

 

Total assets

 

$29,222,955

 

 

 

 

 

 

Net purchase (fair value of stock issued, warrants and notes payable) 

 

$29,222,955

 

XML 36 R25.htm IDEA: XBRL DOCUMENT v3.21.2
PREPAID EXPENSES (Tables)
9 Months Ended
Sep. 30, 2021
PREPAID EXPENSES  
Schedule of prepaid expenses

 

 

September 30,

 

 

December 31,

 

 

 

2021

 

 

2020

 

Consulting service

 

$-

 

 

$111,860

 

Rent

 

 

20,667

 

 

 

-

 

Insurance

 

 

4,232

 

 

 

3,370

 

Prepaid expenses

 

$24,899

 

 

$115,230

 

XML 37 R26.htm IDEA: XBRL DOCUMENT v3.21.2
INTANGIBLE ASSETS (Tables)
9 Months Ended
Sep. 30, 2021
INTANGIBLE ASSETS  
Summary of Intangible Assets

 

 

Gross Carrying

Amount

 

 

Accumulated

Amortization

 

 

Net Intangible

Asset

 

 

Amortization

Period (in years)

 

SOBR Safe Intellectual Technology

 

$3,854,675

 

 

$513,952

 

 

$3,340,723

 

 

 

10

 

Schedule of estimated future amortization expense

2022

 

 

 2023

 

 

  2024

 

 

2025

 

 

   2026

 

 

 Thereafter

 

$

385,467

 

 

$385,467

 

 

$385,467

 

 

$385,467

 

 

$385,467

 

 

$1,413,388

 

XML 38 R27.htm IDEA: XBRL DOCUMENT v3.21.2
CONVERTIBLE DEBENTURE PAYABLE (Tables)
9 Months Ended
Sep. 30, 2021
RELATED PARTY TRANSACTIONS  
Schedule of debenture payable

 

 

September 30,

2021

 

 

December 31,

2020

 

Convertible Debenture Payable with Detached Free-standing Warrant

 

$3,048,781

 

 

$-

 

Unamortized Debt Discount

 

 

(2,608,900)

 

 

-

 

 

 

 

 

 

 

 

 

 

Net Convertible Debenture Payable

 

$439,881

 

 

$-

 

XML 39 R28.htm IDEA: XBRL DOCUMENT v3.21.2
NOTES PAYABLE (Tables)
9 Months Ended
Sep. 30, 2021
NOTES PAYABLE  
Schedule of notes payables - related parties

 

 

    September 30,

        2021

 

 

December 31,

2020

 

Convertible Notes Payable with Detached Free-standing Warrants

 

$1,000,000

 

 

$-

 

Conventional Non-Convertible Notes Payable

 

 

11,810

 

 

 

11,810

 

Unamortized Debt Discount

 

 

(771,576)

 

 

-

 

Net Related Party Notes Payable

 

$240,234

 

 

$11,810

 

Current Portion

 

 

(11,810)

 

 

(11,810)

Net Long-Term Portion

 

$228,424

 

 

$-

 

Schedule of notes payables - non related parties

 

 

September 30,

2021

 

 

December 31,

2020

 

Convertible Notes Payable with Detached Free-standing Warrants

 

$1,005,000

 

 

$-

 

Convertible Notes Payable

 

 

56,683

 

 

 

56,683

 

Conventional Non-Convertible Notes Payable

 

 

42,500

 

 

 

42,500

 

Notes Payable with Detached Free-standing Warrants

 

 

5,000

 

 

 

5,000

 

Unamortized Debt Discount

 

 

(774,850)

 

 

-

 

Net Non-Related Party Notes Payable

 

$334,333

 

 

$104,183

 

Current Portion

 

 

(104,183)

 

 

(79,183)

Net Long-Term Portion

 

$230,150

 

 

$25,000

 

XML 40 R29.htm IDEA: XBRL DOCUMENT v3.21.2
STOCK WARRANTS AND STOCK OPTIONS (Tables)
9 Months Ended
Sep. 30, 2021
STOCK WARRANTS AND STOCK OPTIONS  
Schedule of fair value of non-employee stock/warrants

 

 

September 30,

2021

 

 

  September 30,

2020 

 

Exercise Price 

 

$

3.00-2.00

 

 

$0.50

 

Dividend Yield 

 

 

0%

 

 

0%

Volatility 

 

158-120

 

 

153%

Risk-free Interest Rate 

 

0.14%-0.98

 

 

0.29%

Life of Warrants

 

2-5 Years

 

 

   5 Years

 

 

 

Warrants

Outstanding

Number of

Shares

 

 

Exercise Price Per

Share

 

 

Weighted Average Remaining Contractual Life

 

Weighted Average

Exercise Price Per Share

 

 

Aggregate Intrinsic Value

 

Balance at December 31, 2019

 

 

598,414

 

 

$

0.13304–1.039375

 

 

3.97 Years

 

$0.3607

 

 

$1,276,870

 

Warrants Granted

 

 

320,000

 

 

$0.50

 

 

4.68Years

 

$0.50

 

 

$761,000

 

Warrants Exercised

 

 

(454,097)

 

$

0.13304 - 0.15299

 

 

 

 

$0.1451

 

 

 

 

 

Warrants Expired

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at September 30, 2020

 

 

464,317

 

 

$

0.50- 1.039375

 

 

3.91 Years

 

$0.66765

 

 

$1,027,234

 

 

 

Warrants

Outstanding

Number of

Shares

 

 

Exercise Price Per

Share

 

 

Weighted Average Remaining Contractual Life

 

Weighted Average

Exercise Price Per Share

 

 

Aggregate Intrinsic Value

 

Balance at December 31, 2020

 

 

584,317

 

 

$

0.50 – 2.00

 

 

3.80 Years

 

$0.9413

 

 

$1,173,737

 

Warrants Granted

 

 

2,222,012

 

 

$

3.00-2.00

 

 

3.40 Years

 

$2.45

 

 

$108,506

 

Warrants Exercised

 

 

(176,938)

 

$0.50

 

 

 

 

$0.50

 

 

 

 

 

Warrants Expired

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at September 30, 2021

 

 

2,629,391

 

 

$

0.50 – 3.00

 

 

3.30 Years

 

$2.25

 

 

$665,424

 

Schedule of fair value of stock options

 

 

September 30,

2021

 

 

September 30,

2020

 

Exercise Price

 

$

2.50 - $3.58

 

 

$

0.26-$3.30

 

Dividend Yield

 

 

0%

 

 

0%

Expected Volatility

 

44% - 185

 

153%-171

Risk-free Interest Rate

 

0.16% - 1.69

 

0.19%-0.43

Expected Life

 

1.3 - 7 years

 

 

2.2-5 years

 

Schedule of outstanding options

 

 

Options

Outstanding

Number of

Shares

 

 

Exercise Price Per

Share

 

 

Weighted Average Remaining Contractual Life

 

Weighted Average

Exercise Price Per Share

 

 

Aggregate

Intrinsic Value

 

Balance at December 31, 2019

 

 

2,381,239

 

 

$

0.2634-1.039

 

 

8.86 Years

 

$0.2948

 

 

$5,238,080

 

Options Granted

 

 

160,000

 

 

$

0.26341-3.30

 

 

4.10 Years

 

$1.9454

 

 

$149,532

 

Options Exercised

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options Cancelled

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

Options Expired

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at September 30, 2020

 

 

2,541,239

 

 

$

0.2634 – 3.30

 

 

7.86 Years

 

$0.3987

 

 

$6,305,579

 

 

 

Options

Outstanding

Number of

Shares

 

 

Exercise Price Per

Share

 

 

Weighted Average Remaining Contractual Life

 

Weighted Average

Exercise Price Per Share

 

 

Aggregate Intrinsic Value

 

Balance at December 31, 2020

 

 

2,572,227

 

 

$

0.2634–3.300

 

 

7.45 Years

 

$0.4999

 

 

$6,302,277

 

Options Granted

 

 

610,526

 

 

$

2.50–3.575

 

 

2.58 Years

 

$3.1783

 

 

$(414,147)

Options Exercised

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options Cancelled

 

 

(210,587)

 

$

0.2634-3.29

 

 

 

 

$2.969

 

 

 

 

 

Options Expired

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at September 30, 2021

 

 

2,972,166

 

 

$

0.2634–3.575

 

 

6.15 Years

 

$0.8751

 

 

$4,829,417

 

Exercisable at December 31, 2020

 

 

1,253,030

 

 

0.2634 – 3.300

 

 

7.4 Years

 

$0.3165

 

 

$3,299,765

 

Exercisable at September 30, 2021

 

 

1,943,652

 

 

$

0.2634 – 3.575

 

 

6.3 Years

 

$0.6527

 

 

$3,590,430

 

XML 41 R30.htm IDEA: XBRL DOCUMENT v3.21.2
ORGANIZATION, OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)
Sep. 30, 2021
Dec. 31, 2020
Level 1 [Member]    
Derivative liabilites $ 0 $ 0
Fair value assets and liabilities 0 0
Level 2 [Member]    
Derivative liabilites 0 0
Fair value assets and liabilities 0 0
Level 3 [Member]    
Derivative liabilites 980,000 0
Fair value assets and liabilities $ 980,000 $ 0
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.21.2
ORGANIZATION, OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
May 21, 2020
Mar. 23, 2020
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Research and development costs     $ 566,655 $ 152,123 $ 1,052,650 $ 309,403  
Impairment loss         39,434 25,320,555  
Loss from operation     (1,663,111) $ (695,978) (3,944,813) (27,175,215) $ (25,359,989)
Depreciation         3,978 5,083  
Excess of the FDIC insured limits     1,934,969   1,934,969   $ 1,934,969
Advertising and marketing costs         $ 70,692 $ 70,198  
Valuation allowance, percentage         100.00%   100.00%
FDIC insured limit     $ 250,000   $ 250,000    
Ownership interest, percentage     1.38%   1.38%   1.38%
Common stock, shares authorized     100,000,000   100,000,000   100,000,000
Common stock, par value     $ 0.00001   $ 0.00001   $ 0.00001
Annual Meeting of Shareholders [Member]              
Common stock, shares authorized   100,000,000 800,000,000   800,000,000    
Common stock, par value   $ 0.00001 $ 0.00001   $ 0.00001    
Description of reverse stock split The effective dates of the above actions were June 5, 2020 and April 20, 2020, respectively, and the actual reverse stock split ratio was 1-for-33.26 reverse stock split of the Company’s outstanding common stock at a ratio between 1-for-32 and 1-for-35 (with the exact ratio to be determined by the directors in their sole discretion without further approval by the shareholders          
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.21.2
GOING CONCERN (Details Narrative) - USD ($)
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Accumulated deficit $ (54,167,685)   $ (49,601,220)
Proceeds from convertible debt 275,000 $ 0  
Debt face amount $ 3,048,781    
OID percentage 18.00%    
Net cash used in operating activities $ (2,277,609) $ (1,443,783)  
Private Offering [Member] | January 15, 2021 [Member]      
Additional offering amount $ 2,005,000    
Termination date description On January 15, 2021, the Company initiated a Private Offering (the “Offering”) of up to 40 Units ($2,000,000) with each Unit consisting of one $50,000 principal amount secured convertible debenture, convertible at $3 per share, and a Warrant to purchase 25,000 shares of the Company’s common stock at $3 per share. The Secured Debentures carry interest at 12% and mature 24 months after issuance. The Warrants are exercisable six months after issuance and expire 24 months after issuance    
Offering amount $ 2,000,000    
XML 44 R33.htm IDEA: XBRL DOCUMENT v3.21.2
ASSET PURCHASE (Details)
Jun. 05, 2020
USD ($)
ASSET PURCHASE  
Property and equipment $ 47,725
Intangible assets 29,175,230
Total assets 29,222,955
Net purchase (fair value of stock issued, warrants and notes payable) $ 29,222,955
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.21.2
ASSET PURCHASE (Details Narrative) - USD ($)
9 Months Ended
Jun. 05, 2020
Sep. 30, 2021
May 31, 2021
Mar. 31, 2021
Liability required $ 125,000 $ 158,000    
Exercise price per share $ 0.50      
Market price of shares $ 27,120,000      
Assets purchase upon shares issued $ 29,222,955 $ 1,407,051    
Assets purchase upon shares issued, shares 12,000,000      
Common stock issuable upon exercise of warrant, shares   320,000    
Asset impairment charges loss   $ 25,320,555    
Fair value of warrants issued   $ 695,454    
Description of fair value of assets evaluation   assets acquired based on market estimates for property and equipment and discounted net cash flow for the SOBR Safe intellectual technology. The present value of the discounted cash flow utilized a 75% discount, which included a 25% risk return premium, over an estimated five-year net revenue stream expected to be derived from the technology acquired    
Convertible Notes Payable     $ 225,000 $ 275,000
Asset Purchase Agreement [Member] | IDTEC [Member]        
Common stock, shares issued upon assets purchase 12,000,000      
Convertible notes, conversion price   $ 0.50    
Interest rate   10.00%    
Convertible Notes Payable   $ 1,485,189    
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.21.2
PREPAID EXPENSES (Details) - USD ($)
Sep. 30, 2021
Dec. 31, 2020
ASSET PURCHASE    
Consulting services $ 0 $ 111,860
Rent 20,667 0
Insurance 4,232 3,370
Prepaid expenses $ 24,899 $ 115,230
XML 47 R36.htm IDEA: XBRL DOCUMENT v3.21.2
PREPAID EXPENSES (Details Narrative) - USD ($)
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Rent $ 106,997 $ 47,711
Lease Agreement [Member]    
Prepaid expenses with common shares $ 49,600  
Common stock issued 16,000  
Rent $ 6,000  
XML 48 R37.htm IDEA: XBRL DOCUMENT v3.21.2
INTANGIBLE ASSETS (Details) - USD ($)
9 Months Ended
Sep. 30, 2021
Dec. 31, 2020
Intangible assets, net $ 3,340,723 $ 3,629,821
Intellectual Technology [Member]    
Intangible assets, gross 3,854,675  
Accumulated amortization 513,952  
Intangible assets, net $ 3,340,723  
Amortization Period 10 years  
XML 49 R38.htm IDEA: XBRL DOCUMENT v3.21.2
INTANGIBLE ASSETS (Details 1)
Sep. 30, 2021
USD ($)
INTANGIBLE ASSETS  
2022 $ 385,467
2023 385,467
2024 385,467
2025 385,467
2026 385,467
Thereafter $ 1,413,388
XML 50 R39.htm IDEA: XBRL DOCUMENT v3.21.2
INTANGIBLE ASSETS (Details Narrative) - USD ($)
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
INTANGIBLE ASSETS    
Amortization and depreciation expense $ 298,098 $ 128,488
XML 51 R40.htm IDEA: XBRL DOCUMENT v3.21.2
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Dec. 07, 2020
Jun. 05, 2020
Apr. 07, 2020
Apr. 06, 2020
Jan. 03, 2020
Jul. 02, 2015
May 31, 2021
Mar. 31, 2021
Mar. 30, 2021
Mar. 23, 2020
Jan. 30, 2020
Jan. 16, 2020
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Feb. 12, 2021
Dec. 31, 2020
Mar. 08, 2017
Jul. 01, 2015
Dec. 06, 2006
Exercise prices                                     $ 112,871    
Warrants purchased                             250,000            
Convertible notes payable             $ 225,000 $ 275,000                          
Debt conversion rate     $ 1.41 $ 3.326     $ 3 $ 3                          
Debt amount after debt forgiveness                                     $ 31,662    
Issuance of convertible notes payable               450,000                          
Indirect interest amount recieved             $ 50,000 $ 100,000                          
Acquired shares                                     969,601    
Common stock, shares issued                         25,981,203   25,981,203     25,922,034      
Gain on related party debt conversion $ 42,000                       $ 0 $ 0 $ 86,739 $ (269,144)          
Debt conversion, converted instrument, shares issued, shares                             45,268            
Accrued interest                         $ 306,071   $ 306,071     $ 313,032     $ 18,000
Director [Member]                                          
Convertible notes payable             $ 400,000                            
David Gandini [Member]                                          
Working capital                                 $ 30,000        
Unseured note interest rate                                 0.00%        
IDTEC [Member]                                          
Warrants purchased   320,000             320,000                        
Warrants exercise price   $ 0.50             $ 0.50                        
Settlement of outstanding judgement                             $ 88,469            
Common stock issue for settlement                             176,938            
Debt conversion, converted instrument, shares issued, shares                             12,000,000            
Nick Noceti [Member]                                          
Debt conversion rate       $ 3.326                                  
Purchase price of shares issued       $ 127,480                                  
Reduction in related party debt       $ 127,840                                  
Common stock, shares issued       38,437                                  
Gain on related party debt conversion       $ 49,000                                  
Charles Bennington [Member]                                          
Debt conversion rate     $ 1.41                                    
Purchase price of shares issued     $ 9,656         $ 3                          
Reduction in related party debt     $ 9,656                                    
Common stock, shares issued     6,831                                    
Gain on related party debt conversion     $ 2,000                                    
Prakash Gadgil [Member] | Stock Purchase Plan One [Member]                                          
Debt conversion rate                   $ 3.326                      
Purchase price of shares issued                   $ 1,950                      
Reduction in related party debt                   1,950                      
Gain on related party debt conversion                   $ 1,000                      
Debt conversion, converted instrument, shares issued, shares                   586                      
Devdatt Mishal [Member] | Stock Purchase Plan One [Member]                                          
Debt conversion rate                     $ 0.91465                    
Purchase price of shares issued                     $ 456,641                    
Reduction in related party debt                     270,300                    
Gain on related party debt conversion                     $ 144,000                    
Debt conversion, converted instrument, shares issued, shares                     499,965                    
Accrued interest                     $ 186,341                    
Lanphere Law Group [Member] | December 3 2014 [Member]                                          
Accrued interest                                     $ 38,199    
Debt amount                                     $ 74,672    
Lanphere Law Group [Member] | Stock Purchase Plan One [Member]                                          
Debt conversion rate         $ 3.326                                
Common stock issue for settlement         180,397                                
Reduction in related party debt         $ 66,000                                
Common stock, shares issued         273,700                                
Gain on related party debt conversion           $ 108,000                              
Debt conversion, converted instrument, shares issued, shares         9,520                                
Debt amount                                       $ 214,334  
Debt instrument principal value, after forgivness         $ 31,662                             106,335  
Due date notes payable           Dec. 02, 2015                              
Debt Instrument, Forgiveness                                       $ 108,000  
Acquired additional shares of common stock         454,097                                
Purchase price of additional shares of common stock         $ 66,000                                
Conversion price         $ 0.133                                
Common stock issued price per share         0.153                                
Lanphere Law Group [Member] | Stock Purchase Plan Three [Member]                                          
Debt conversion rate                       $ 3.326                  
Purchase price of shares issued                       $ 714,700                  
Reduction in related party debt                       714,700                  
Gain on related party debt conversion                       $ 222,000                  
Debt conversion, converted instrument, shares issued, shares                       214,883                  
Lanphere Law Group [Member] | Stock Purchase Plan Two [Member]                                          
Debt conversion rate         $ 3.326                                
Purchase price of shares issued         $ 210,285                                
Reduction in related party debt         169,606                                
Gain on related party debt conversion         $ 52,000                                
Debt conversion, converted instrument, shares issued, shares         63,225                                
Accrued interest         $ 40,679                                
Vemon Justus [Member] | Stock Purchase Plan One [Member]                                          
Debt conversion rate         $ 3.326                                
Purchase price of shares issued         $ 282,588                                
Reduction in related party debt         180,001                                
Gain on related party debt conversion         $ 70,000                                
Debt conversion, converted instrument, shares issued, shares         84,963                                
Accrued interest         $ 102,587                                
XML 52 R41.htm IDEA: XBRL DOCUMENT v3.21.2
CONVERTIBLE DEBENTURE PAYABLE (Details) - USD ($)
Sep. 30, 2021
Dec. 31, 2020
INTANGIBLE ASSETS    
Convertible Debenture Payable with Detached Free-standing Warrant $ 3,048,781 $ 0
Unamortized Debt Discount (2,608,900) 0
Net Convertible Debenture Payable $ 439,881 $ 0
XML 53 R42.htm IDEA: XBRL DOCUMENT v3.21.2
CONVERTIBLE DEBENTURE PAYABLE (Details Narrative) - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
INTANGIBLE ASSETS      
Warrants issued to purchase common shares 1,219,512    
Debenture conversion description The Debenture is convertible voluntarily by the Purchaser at any time into shares of our common stock, at the lesser of $2.50, representing 100% of the closing price of our common stock on the trading day immediately prior to the Closing Date, or 75% of the average VWAP of our common stock during the 5 trading day period immediately prior to the conversion date (the “Conversion Price”), or automatically upon the    
Debt face amount $ 3,048,781    
Proceeds from financing transition $ 2,500,000    
OID percentage 18.00%    
Exercise price $ 2.00    
Adjusted exercise price $ 1.00    
Partial liquidated damages description the Company shall pay to the Purchaser as partial liquidated damages equal to the product of 2% of the principal amount not to exceed 24% of the aggregate principal. If the Company fails to pay of the liquidated damages within seven days after the date payable, the Company will pay interest at 18% until such amounts are paid in full    
unamortized discount and issuance costs $ 812,134   $ 0
Conversion feature debt discount 980,000    
Amortization of interest $ 16,245    
Outstanding warrants 1,219,512    
Fair market value of stock warrants $ 847,048 $ 847,048  
Unamortized discount 833,008   $ 833,008
Interest expense 14,039 $ 14,039  
Original Issue Discount 548,781    
Debt issuance costs 275,000    
Interest expense related to the Original Issue Discount and debt issuance costs $ 11,645    
XML 54 R43.htm IDEA: XBRL DOCUMENT v3.21.2
NOTES PAYABLE (Details) - USD ($)
Sep. 30, 2021
May 31, 2021
Mar. 31, 2021
Dec. 31, 2020
Unamortized Debt Discount $ (2,608,900)     $ 0
Net Related Party Notes Payable 11,810     11,810
Net Long-Term Portion   $ 225,000 $ 275,000  
Related Party Notes Payable [Member]        
Convertible Notes Payable with Detached Free-standing Warrants 1,000,000     0
Conventional Non-Convertible Notes Payable 11,810     11,810
Unamortized Debt Discount (771,576)     0
Net Related Party Notes Payable 240,234     11,810
Current portion (11,810)     (11,810)
Net Long-Term Portion $ 228,424     $ 0
XML 55 R44.htm IDEA: XBRL DOCUMENT v3.21.2
NOTES PAYABLE (Details 1) - USD ($)
Sep. 30, 2021
May 31, 2021
Mar. 31, 2021
Dec. 31, 2020
Unamortized Debt Discount $ (2,608,900)     $ 0
Net Long-Term Portion   $ 225,000 $ 275,000  
Non-Related Party Notes Payable [Member]        
Convertible Notes Payable with Detached Free-standing Warrants 1,005,000     0
Convertible Notes Payable 56,683     56,683
Conventional Non-Convertible Notes Payable 42,500     42,500
Notes Payable with Detached Free-standing Warrants 5,000     5,000
Unamortized Debt Discount (774,850)     0
Net Non-Related Party Notes Payable 334,333     104,183
Current portion (104,183)     (79,183)
Net Long-Term Portion $ 230,150     $ 25,000
XML 56 R45.htm IDEA: XBRL DOCUMENT v3.21.2
NOTES PAYABLE (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Dec. 07, 2020
May 12, 2020
Nov. 15, 2020
Jun. 05, 2020
Sep. 30, 2021
Sep. 30, 2020
Mar. 31, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
May 31, 2021
Mar. 31, 2021
Apr. 07, 2020
Apr. 06, 2020
Proceed received from commercial bank   $ 41,665                        
Interest expenses for related party notes               $ 55,151 $ 79,596          
Loan payment, description   The loan requires interest at 1% and 18 monthly payments of principal and interest beginning December 5, 2020                        
Gain on loan extinguishment $ 42,000       $ 0 $ 0   86,739 (269,144)          
Accrued interest $ 242       193,177     193,177   $ 134,444        
Interest expense         $ 227,475 $ 41,622   $ 399,381 107,253          
Outstanding warrants         1,002,500     1,002,500            
Note payable conversion price per share                     $ 3 $ 3 $ 1.41 $ 3.326
Non-Convertible Notes Payable Two [Member]                            
Interest rate               0.00%            
Interest expense               $ 65,130 $ 14,036          
Convertible debt, conversion, principal amount                   11,810        
Outstanding note payable         $ 11,810     11,810            
Related Party Convertible Notes Payable [Member]                            
Gain on loan extinguishment             $ 11,697     61,875        
Accrued interest     $ 1,551,514       22,500              
Convertible notes payable principal       $ 1,485,189                    
Convertible Notes Payable       $ 70,000     25,000     25,000        
Convertible non-related party note payable             $ 47,500     $ 25,000        
Convertible notes, conversion price       $ 0.50     $ 2              
Interest rate       10.00%     5.00%   10.00% 5.00%        
Beneficial conversion feature debt discount       $ 1,407,675       $ 460,215            
Interest expense       7,689                    
Outstanding warrants         500,000     500,000            
Fair market value of warrants               $ 551,001 $ 0          
Unamortized discount         $ 494,759     494,759   $ 423,647        
Amortization expenses, beneficial conversion feature               $ 127,354            
Stock issued during the period     3,103,028         502,500            
Related Party Notes Payable [Member]                            
Convertible notes payable principal         11,810     $ 11,810   11,810        
Convertible Notes Payable       $ 70,000 $ 56,683     56,683   56,683        
Beneficial conversion feature debt discount               448,999            
Interest expense               $ 122,012            
Outstanding warrants         1,000,000     1,000,000            
Fair market value of warrants               $ 541,707 $ 0          
Unamortized discount         $ 419,695     419,695            
Amortization expenses, beneficial conversion feature               $ 101,070            
Default interest rate       10.00% 12.00%     12.00%            
Purchase price of shares issued         $ 12     $ 12            
Non-Related Party Notes Payable [Member]                            
Convertible notes payable principal         $ 104,183     $ 104,183   79,183        
Default interest rate         12.00%     12.00%            
Purchase price of shares issued         $ 3     $ 3            
Convertible Notes Payable with Detached Free-standing Warrants         $ 1,005,000     $ 1,005,000   0        
Non-Related Party Notes Payable [Member] | Minimum [Member]                            
Interest rate               5.00%            
Note payable due date               Sep. 21, 2013            
Note payable conversion price per share         $ 1.99     $ 1.99            
Non-Related Party Notes Payable [Member] | Maximum [Member]                            
Interest rate               12.00%            
Note payable due date               Jun. 03, 2022            
Note payable conversion price per share         $ 10.7619     $ 10.7619            
Non-Related Party Notes Payable [Member] | Non-Convertible Notes Payable [Member]                            
Convertible notes payable principal         $ 42,500     $ 42,500   42,500        
Convertible Notes Payable         $ 5,000     $ 5,000   5,000        
Interest rate               10.00%            
Non-Related Party Notes Payable [Member] | Non-Convertible Notes Payable [Member] | Minimum [Member]                            
Interest rate               5.00%            
Note payable due date               12/25/2013            
Non-Related Party Notes Payable [Member] | Non-Convertible Notes Payable [Member] | Maximum [Member]                            
Interest rate               10.00%            
Note payable due date               6/06/2022            
Common Stock Purchase Plans [Member] | Six Related Parties [Member]                            
Gain on loan extinguishment             $ 103,000     14,000        
Accrued interest             $ 82,797     $ 63,623        
Common stock shares exchanged             50,135     20,313        
Convertible notes payable principal             $ 83,953     $ 3,938        
Reduction in related party non - convertible notes payable             $ 166,750     $ 67,561        
XML 57 R46.htm IDEA: XBRL DOCUMENT v3.21.2
DERIVATIVE LIABILITY (Details Narrative) - USD ($)
1 Months Ended 9 Months Ended
Sep. 28, 2021
Sep. 30, 2021
Sep. 30, 2020
OID percentage   18.00%  
Proceeds from financing transition   $ 2,500,000  
Debt face amount   $ 3,048,781  
Minimum [Member]      
Risk free interest rate   0.98%  
Volatility   44.00% 153.00%
Maximum [Member]      
Risk free interest rate   0.14%  
Volatility   158.00% 153.00%
Convertible promissory note agreement [Member]      
Risk free interest rate 0.05%    
Fair value of embeded derivative liability $ 980,000 $ 8,700  
Volatility 120.00%    
Convertible promissory note agreement [Member] | Minimum [Member]      
Expected life 4 years    
Convertible promissory note agreement [Member] | Maximum [Member]      
Expected life 6 years    
XML 58 R47.htm IDEA: XBRL DOCUMENT v3.21.2
STOCK SUBSCRIPTIONS PAYABLE (Details Narrative) - USD ($)
Sep. 30, 2021
Dec. 31, 2020
Common stock shares subscriptions, amount $ 228,046 $ 253,688
Due To Related Parties [Member]    
Common stock shares subscriptions, amount $ 91,613 $ 111,024
Common stock shares subscriptions, shares 193,856 60,087
Non-Related Party Notes Payable [Member]    
Common stock shares subscriptions, amount $ 136,433 $ 136,433
Common stock shares subscriptions, shares 87,500 87,500
XML 59 R48.htm IDEA: XBRL DOCUMENT v3.21.2
COMMON STOCK (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Dec. 07, 2020
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
May 31, 2021
Mar. 31, 2021
Dec. 31, 2020
Apr. 07, 2020
Apr. 06, 2020
Common stock valued   $ 260   $ 260       $ 260    
Common stock shares issued for services, shares       43,169            
Gain on loan extinguishment $ 42,000 0 $ 0 $ 86,739 $ (269,144)          
Settle payable balance   137,496   137,496            
Additional paid in capital   $ 56,330,450   $ 56,330,450       52,693,974    
Debt conversion, converted instrument, shares issued       45,268            
Number of warrants outstanding   1,002,500   1,002,500            
Debt instrument, convertible, conversion price           $ 3 $ 3   $ 1.41 $ 3.326
Lease Agreement [Member]                    
Debt conversion, converted instrument, shares issued       16,000            
Debt Conversion, Converted Instrument, Amount       $ 49,600            
Agreement Expiring date       February 2022            
Common stock shares issued for cash, shares       16,000            
Convertible promissory note agreement [Member]                    
Debt conversion price description       debt from $0.1530 to $0.13304 per share            
Common stock shares issued to option exercised       454,097            
Reduction in related party debt   $ 65,728   $ 65,728            
Number of warrants outstanding   454,097   454,097            
IDTEC [Member]                    
Debt conversion, converted instrument, shares issued       12,000,000            
Common stock shares issued for cash, shares       176,938            
Related Party Two [Member]                    
Additional paid in capital   $ 222,000   $ 222,000            
Debt conversion, converted instrument, shares issued       214,883            
Debt Conversion, Converted Instrument, Amount       $ 714,700            
Related Party One [Member]                    
Gain on loan extinguishment       $ 27,000            
Debt conversion, converted instrument, shares issued       38,323            
Debt Conversion, Converted Instrument, Amount       $ 127,000            
Related Party Three [Member]                    
Gain on loan extinguishment       143,660            
Additional paid in capital   124,291   $ 124,291            
Debt conversion, converted instrument, shares issued       648,739            
Debt conversion price description       debt from $0.9146 to $3.326 per share.            
Debt Conversion, Converted Instrument, Amount       $ 622,004            
Series A-1 Convertible Preferred stock [Member]                    
Common stock valued   0   0       $ 0    
Debt Conversion, Converted Instrument, Amount       107,880            
Non-Related Party [Member]                    
Gain on loan extinguishment       81,867            
Settle payable balance   $ 91,464   $ 91,464            
Debt conversion, converted instrument, shares issued       121,072            
Debt conversion price description       values between $0.5821 to $1.039 per share            
Compensation for services [Member]                    
Common stock shares issued for cash, shares       601            
Non-Related Party One [Member]                    
Gain on loan extinguishment       $ 41,665            
Debt conversion, converted instrument, shares issued       70,448            
Debt Conversion, Converted Instrument, Amount       $ 65,391            
Debt instrument, convertible, conversion price   $ 3.326   $ 3.326            
XML 60 R49.htm IDEA: XBRL DOCUMENT v3.21.2
PREFERRED STOCK (Details Narratve) - USD ($)
1 Months Ended 9 Months Ended 12 Months Ended
Dec. 07, 2020
Aug. 08, 2019
Sep. 30, 2020
Dec. 31, 2020
Sep. 30, 2021
May 07, 2020
Dec. 09, 2019
Nov. 20, 2015
Accrued dividends payable       $ 107,880        
Preferred stock, shares authorized       19,300,000 19,300,000     25,000,000
Preferred stock, par value       $ 0.00001 $ 0.00001      
Series A-1 Convertible Preferred stock [Member]                
Accrued dividends payable     $ 161,880          
Preferred stock, shares authorized       2,700,000 2,700,000   1,000,000  
Cumulative dividends rate     8.00%          
Conversion of preferred stock shares 2,700,000              
Converted shares of common stock 2,700,000              
Preferred stock shares sold       2,700,000        
Preferred stock, par value       $ 0.00001 $ 0.00001      
Series A Convertible Preferred Stock [Member]                
Preferred stock, shares authorized       3,000,000 3,000,000     3,000,000
Preferred stock, par value       $ 0.00001 $ 0.00001     $ 0.00001
Preferred stock conversion description       Series A Convertible Preferred Stock are convertible at a 35% discount rate to the average closing price per share of the Company’s common stock (either as listed on a national exchange or as quoted over-the-market) for the last 15 trading days immediately prior to conversion. However, no conversions of the Series A Convertible Preferred Stock to shares of common stock can occur unless the average closing price per share        
SOBR SAFE, LLC [Member] | Asset purchase agreement [Member]                
Convertible preferred stock issuable           2,700,000    
SOBR SAFE, LLC [Member] | Series A-1 Preferred Stock Purchase Agreement [Member] | Series A-1 Convertible Preferred stock [Member] | SOBR's Director company [Member]                
Preferred stock, shares authorized             2,000,000  
Right of dividend             8.00%  
Shares issuance price             $ 1  
Preferences and rights of preferred stock   (a) dividend rights of 8% per annum based on the original issuance price of $1 per share, (b) liquidation preference over the Company’s common stock, (c) conversion rights into shares of the Company’s common stock at $1 per share (not to be affected by any reverse stock split in connection with the Asset Purchase Agreement with IDTEC            
XML 61 R50.htm IDEA: XBRL DOCUMENT v3.21.2
STOCK WARRANTS AND STOCK OPTIONS (Details) - $ / shares
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Maximum [Member]    
Exercise Price $ 3.00 $ 3.30
Life of warrants 5 years  
Risk free interest rate 0.14%  
Volatility 158.00% 153.00%
Minimum [Member]    
Exercise Price $ 2.00 $ 0.26
Life of warrants 5 years  
Risk free interest rate 0.98%  
Volatility 44.00% 153.00%
Warrants [Member]    
Dividend yield 0.00% 0.00%
Exercise Price   $ 0.50
Life of warrants 2 years 5 years
Risk free interest rate   0.29%
XML 62 R51.htm IDEA: XBRL DOCUMENT v3.21.2
STOCK WARRANTS AND STOCK OPTIONS (Details 1) - Warrants [Member] - USD ($)
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Outstanding at beginning of period 584,317 598,414
Warrants Granted 2,222,012 320,000
Warrants Exercised (176,938) (454,097)
Outstanding at ending of periods 2,629,391 464,317
Warrants outstanding, Granted   $ 0.50
Warrants outstanding, Exercised $ 0.50  
Warrants outstanding exercise price per share, end of period   1.039375
Minimum [Member]    
Warrants outstanding, Granted 3  
Outstanding at beginning of period 0.50 0.13304
Warrants Exercised   0.13304
Outstanding at end of period 0.50 0.50
Maximum [Member]    
Warrants outstanding, Granted 2  
Outstanding at beginning of period 2 1.039375
Warrants Exercised   0.15299
Outstanding at end of period $ 3 $ 1.039375
Weighted Average Remaining Contractual Life    
Weighted Average Remaining Contractual Life , Beginning balance 3 years 11 months 19 days 3 years 11 months 19 days
Weighted Average Remaining Contractual Life, Warrants granted 3 years 4 months 24 days 4 years 8 months 4 days
Weighted Average Remaining Contractual Life, Ending balance 3 years 3 months 18 days 3 years 10 months 28 days
Weighted Average Exercise Price Per Share    
Weighted Average Exercise Price Per Share, Beginning balance $ 0.9413 $ 0.3607
Weighted Average Exercise Price Per Share, Warrants granted 2.45 0.50
Weighted Average Exercise Price Per Share, Warrants exercised 0.50 0.1451
Weighted Average Exercise Price Per Share, ending balance $ 2.25 $ 0.66765
Aggregate Intrinsic Value    
Aggregate Intrinsic Value, Beginning balance $ 1,173,737 $ 1,276,870
Aggregate Intrinsic Value, Warrants granted 108,506 761,000
Aggregate Intrinsic Value, Ending balance $ 665,424 $ 1,027,234
XML 63 R52.htm IDEA: XBRL DOCUMENT v3.21.2
STOCK WARRANTS AND STOCK OPTIONS (Details 2) - $ / shares
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Maximum [Member]    
Exercise Price $ 3.00 $ 3.30
Expected life 7 years 5 years
Expected volatility 158.00% 153.00%
Risk free interest rate 1.69% 0.43%
Minimum [Member]    
Exercise Price $ 2.00 $ 0.26
Expected life 1 year 3 months 18 days 2 years 2 months 12 days
Expected volatility 44.00% 153.00%
Risk free interest rate 0.16% 0.19%
XML 64 R53.htm IDEA: XBRL DOCUMENT v3.21.2
STOCK WARRANTS AND STOCK OPTIONS (Details 3) - Stock Options [Member] - USD ($)
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Options Outstanding Number of Shares    
Outstanding at beginning of period 2,572,227 2,381,239
Option Granted 610,526 160,000
Options Cancelled (210,587)  
Outstanding at ending of periods 2,972,166 2,541,239
Option outstanding, exercisable, beginning balance 1,253,030 1,253,030
Option outstanding, exercisable, ending balance 1,943,652 1,651,291
Exercise Price Per Share    
Exercise Price Per Shares option granted $ 0.2634 $ 0.26341
Weighted Average Remaining Contractual Life    
Weighted Average Remaining Contractual Lifes beginning balance 7 years 5 months 12 days 8 years 10 months 9 days
Weighted Average Remaining Contractual Lifes options granted 2 years 6 months 29 days 4 years 1 month 6 days
Weighted Average Remaining Contractual Lifes ending balance 7 years 10 months 9 days 8 years 1 month 24 days
Weighted Average Remaining Contractual Lifes, Exercisable, Beginning balance   7 years 8 months 24 days
Weighted Average Remaining Contractual Lifes, Exercisable, Ending balance   6 years 1 month 24 days
Weighted Average Exercise Price Per Share    
Weighted Average Exercise Price Per Shares beginning balance $ 0.4999 $ 0.2948
Weighted Average Exercise Price Per Shares options granted 3.1783 1.9454
Weighted Average Exercise Price Per Shares ending balance $ 0.8751 0.3987
Weighted Average Exercise Price Per Shares exercisable beginning balance   0.3165
Weighted Average Exercise Price Per Shares exercisable ending balance   $ 0.4540
Aggregate Intrinsic Value    
Aggregate Intrinsic Value beginning balance $ 6,302,277 $ 5,238,080
Aggregate Intrinsic Value options granted (414,147) 149,532
Aggregate Intrinsic Value options exercised   0
Aggregate Intrinsic Value options cancelled   0
Aggregate Intrinsic Value options expired   0
Aggregate Intrinsic Value ending balance 4,829,417 6,305,579
Aggregate Intrinsic Value exercisable, beginning balance 3,299,765 3,299,765
Aggregate Intrinsic Value exercisable ending balance $ 3,590,430 $ 5,772,880
Minimum [Member]    
Exercise Price Per Share    
Exercise Price Per Shares option granted $ 2.50 $ 0.26341
Aggregate Intrinsic Value    
Outstanding at beginning of period 0.2634 0.2634
Outstanding at end of period 0.2634 0.2634
Exercise Price Per Shares exercisable beginning balance 0.2634 0.2634
Exercise Price Per Shares exercisable ending balance 0.2634 0.2634
Maximum [Member]    
Exercise Price Per Share    
Exercise Price Per Shares option granted 3.575 3.30
Aggregate Intrinsic Value    
Outstanding at beginning of period 3.300 1.039
Outstanding at end of period 3.575 3.30
Exercise Price Per Shares exercisable beginning balance 3.300 3.300
Exercise Price Per Shares exercisable ending balance $ 3.575 $ 2.00
XML 65 R54.htm IDEA: XBRL DOCUMENT v3.21.2
STOCK WARRANTS AND STOCK OPTIONS (Details Narrative) - USD ($)
1 Months Ended 9 Months Ended
Jun. 05, 2020
May 04, 2020
Aug. 08, 2019
Mar. 30, 2021
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Oct. 24, 2019
Number of warrants outstanding         1,002,500      
Exercise price of warrants         $ 3      
Share-based compensation expenses         $ 630,027 $ 343,549    
Expected lives         2 years      
Investor relationship service, description   Under the terms of the agreement, we issued warrants to purchase up to 120,000 shares of our common stock at an exercise price of $2.00 per share. The warrants expire five years after the date of issuance. Approximately $220,000 of expense was recognized for the warrants issued for the services provide by the vendor            
Unrecognized compensation expense         $ 813,000      
Warrants purchased         250,000      
Non Employee Stock Warrants [Member]                
Number of warrants outstanding         2,629,391   584,317  
Detached free-standing stock warrants granted         2,222,012      
Fair value of detached free-standing stock warrants granted         $ 1,939,756 $ 695,454    
2019 Equity Incentive Plans [Member]                
Common stock authorized shares           2,921,861   3,848,467
Stock option vested shares         1,202,724   1,319,197  
Stock option issued         $ 926,606   $ 1,326,546  
Stock option vested or expected to vest shares         1,028,514   2,521,921  
8% Series A-1 Convertible Preferred Stock Investment agreement [Member] | First Capital Ventures "FCV" [Member]                
Number of warrants outstanding         144,317   144,317  
Exercise price of warrants     $ 1.039375          
Convertible preferred stock shares sold     1,000,000          
Sale of stock price per share     $ 1          
Common stock shares issuable upon exercise of warrants to SPV     144,317          
IDTEC [Member]                
Warrants purchased 320,000     320,000        
Warrants exercise price $ 0.50     $ 0.50        
Executive Stock Options [Member]                
Number of warrants outstanding         1,553,152   981,771  
Executive Stock Options [Member] | Minimum [Member]                
Options exercisable per share         $ 0.2634      
Executive Stock Options [Member] | Maximum [Member]                
Options exercisable per share         $ 3.38      
XML 66 R55.htm IDEA: XBRL DOCUMENT v3.21.2
COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)
9 Months Ended
Oct. 15, 2019
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Dec. 06, 2006
Rent expense   $ 106,997 $ 47,711    
Contract settlement amount         $ 11,164
Accrued interest   306,071   $ 313,032 $ 18,000
Due to related party   29,404   $ 28,624  
Short Term Lease Agreement [Member] | Highland School [Member]          
Lease expiration term Oct. 31, 2020        
Short Term Lease Agreement [Member] | Highland School [Member] | Minimum [Member]          
Operating lease, monthly payment $ 2,800        
Short Term Lease Agreement [Member] | Highland School [Member] | Maximum [Member]          
Operating lease, monthly payment $ 2,900        
Short Term Operating Lease [Member]          
Operating lease, monthly payment   $ 1,800      
Issuance of common stock   16,000      
Rent payments, monthly   $ 6,000      
Prepaid expenses with common shares   49,600      
California [Member]          
Contract settlement amount   85,000      
Legal fees   3,000      
Due to related party   28,786      
Accrued interest   $ 53,000      
EXCEL 67 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 68 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 69 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 70 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.2 html 293 471 1 false 62 0 false 4 false false R1.htm 000001 - Document - Cover Sheet http://imle.com/role/Cover Cover Cover 1 false false R2.htm 000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://imle.com/role/CondensedConsolidatedBalanceSheets CONDENSED CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://imle.com/role/CondensedConsolidatedBalanceSheetsParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) Sheet http://imle.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) Statements 4 false false R5.htm 000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (UNAUDITED) Sheet http://imle.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficitUnaudited CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (UNAUDITED) Statements 5 false false R6.htm 000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) Sheet http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) Statements 6 false false R7.htm 000007 - Disclosure - ORGANIZATION OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPolicies ORGANIZATION OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 7 false false R8.htm 000008 - Disclosure - GOING CONCERN Sheet http://imle.com/role/GoingConcern GOING CONCERN Notes 8 false false R9.htm 000009 - Disclosure - ASSET PURCHASE Sheet http://imle.com/role/AssetPurchase ASSET PURCHASE Notes 9 false false R10.htm 000010 - Disclosure - PREPAID EXPENSES Sheet http://imle.com/role/PrepaidExpenses PREPAID EXPENSES Notes 10 false false R11.htm 000011 - Disclosure - INTANGIBLE ASSETS Sheet http://imle.com/role/IntangibleAssets INTANGIBLE ASSETS Notes 11 false false R12.htm 000012 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://imle.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 12 false false R13.htm 000013 - Disclosure - CONVERTIBLE DEBENTURE PAYABLE Sheet http://imle.com/role/ConvertibleDebenturePayable CONVERTIBLE DEBENTURE PAYABLE Notes 13 false false R14.htm 000014 - Disclosure - NOTES PAYABLE Notes http://imle.com/role/NotesPayable NOTES PAYABLE Notes 14 false false R15.htm 000015 - Disclosure - DERIVATIVE LIABILITY Sheet http://imle.com/role/DerivativeLiability DERIVATIVE LIABILITY Notes 15 false false R16.htm 000016 - Disclosure - STOCK SUBSCRIPTIONS PAYABLE Sheet http://imle.com/role/StockSubscriptionsPayable STOCK SUBSCRIPTIONS PAYABLE Notes 16 false false R17.htm 000017 - Disclosure - COMMON STOCK Sheet http://imle.com/role/CommonStock COMMON STOCK Notes 17 false false R18.htm 000018 - Disclosure - PREFERRED STOCK Sheet http://imle.com/role/PreferredStock PREFERRED STOCK Notes 18 false false R19.htm 000019 - Disclosure - STOCK WARRANTS AND STOCK OPTIONS Sheet http://imle.com/role/StockWarrantsAndStockOptions STOCK WARRANTS AND STOCK OPTIONS Notes 19 false false R20.htm 000020 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://imle.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 20 false false R21.htm 000021 - Disclosure - SUBSEQUENT EVENTS Sheet http://imle.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 21 false false R22.htm 000022 - Disclosure - ORGANIZATION OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPoliciesPolicies ORGANIZATION OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 22 false false R23.htm 000023 - Disclosure - ORGANIZATION OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPoliciesTables ORGANIZATION OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPolicies 23 false false R24.htm 000024 - Disclosure - ASSET PURCHASE (Tables) Sheet http://imle.com/role/AssetPurchaseTables ASSET PURCHASE (Tables) Tables http://imle.com/role/AssetPurchase 24 false false R25.htm 000025 - Disclosure - PREPAID EXPENSES (Tables) Sheet http://imle.com/role/PrepaidExpensesTables PREPAID EXPENSES (Tables) Tables http://imle.com/role/PrepaidExpenses 25 false false R26.htm 000026 - Disclosure - INTANGIBLE ASSETS (Tables) Sheet http://imle.com/role/IntangibleAssetsTables INTANGIBLE ASSETS (Tables) Tables http://imle.com/role/IntangibleAssets 26 false false R27.htm 000027 - Disclosure - CONVERTIBLE DEBENTURE PAYABLE (Tables) Sheet http://imle.com/role/ConvertibleDebenturePayableTables CONVERTIBLE DEBENTURE PAYABLE (Tables) Tables http://imle.com/role/ConvertibleDebenturePayable 27 false false R28.htm 000028 - Disclosure - NOTES PAYABLE (Tables) Notes http://imle.com/role/NotesPayableTables NOTES PAYABLE (Tables) Tables http://imle.com/role/NotesPayable 28 false false R29.htm 000029 - Disclosure - STOCK WARRANTS AND STOCK OPTIONS (Tables) Sheet http://imle.com/role/StockWarrantsAndStockOptionsTables STOCK WARRANTS AND STOCK OPTIONS (Tables) Tables http://imle.com/role/StockWarrantsAndStockOptions 29 false false R30.htm 000030 - Disclosure - ORGANIZATION, OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Sheet http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPoliciesDetails ORGANIZATION, OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Details 30 false false R31.htm 000031 - Disclosure - ORGANIZATION, OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPoliciesDetailsNarrative ORGANIZATION, OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Details 31 false false R32.htm 000032 - Disclosure - GOING CONCERN (Details Narrative) Sheet http://imle.com/role/GoingConcernDetailsNarrative GOING CONCERN (Details Narrative) Details http://imle.com/role/GoingConcern 32 false false R33.htm 000033 - Disclosure - ASSET PURCHASE (Details) Sheet http://imle.com/role/AssetPurchaseDetails ASSET PURCHASE (Details) Details http://imle.com/role/AssetPurchaseTables 33 false false R34.htm 000034 - Disclosure - ASSET PURCHASE (Details Narrative) Sheet http://imle.com/role/AssetPurchaseDetailsNarrative ASSET PURCHASE (Details Narrative) Details http://imle.com/role/AssetPurchaseTables 34 false false R35.htm 000035 - Disclosure - PREPAID EXPENSES (Details) Sheet http://imle.com/role/PrepaidExpensesDetails PREPAID EXPENSES (Details) Details http://imle.com/role/PrepaidExpensesTables 35 false false R36.htm 000036 - Disclosure - PREPAID EXPENSES (Details Narrative) Sheet http://imle.com/role/PrepaidExpensesDetailsNarrative PREPAID EXPENSES (Details Narrative) Details http://imle.com/role/PrepaidExpensesTables 36 false false R37.htm 000037 - Disclosure - INTANGIBLE ASSETS (Details) Sheet http://imle.com/role/IntangibleAssetsDetails INTANGIBLE ASSETS (Details) Details http://imle.com/role/IntangibleAssetsTables 37 false false R38.htm 000038 - Disclosure - INTANGIBLE ASSETS (Details 1) Sheet http://imle.com/role/IntangibleAssetsDetails1 INTANGIBLE ASSETS (Details 1) Details http://imle.com/role/IntangibleAssetsTables 38 false false R39.htm 000039 - Disclosure - INTANGIBLE ASSETS (Details Narrative) Sheet http://imle.com/role/IntangibleAssetsDetailsNarrative INTANGIBLE ASSETS (Details Narrative) Details http://imle.com/role/IntangibleAssetsTables 39 false false R40.htm 000040 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) Sheet http://imle.com/role/RelatedPartyTransactionsDetailsNarrative RELATED PARTY TRANSACTIONS (Details Narrative) Details http://imle.com/role/RelatedPartyTransactions 40 false false R41.htm 000041 - Disclosure - CONVERTIBLE DEBENTURE PAYABLE (Details) Sheet http://imle.com/role/ConvertibleDebenturePayableDetails CONVERTIBLE DEBENTURE PAYABLE (Details) Details http://imle.com/role/ConvertibleDebenturePayableTables 41 false false R42.htm 000042 - Disclosure - CONVERTIBLE DEBENTURE PAYABLE (Details Narrative) Sheet http://imle.com/role/ConvertibleDebenturePayableDetailsNarrative CONVERTIBLE DEBENTURE PAYABLE (Details Narrative) Details http://imle.com/role/ConvertibleDebenturePayableTables 42 false false R43.htm 000043 - Disclosure - NOTES PAYABLE (Details) Notes http://imle.com/role/NotesPayableDetails NOTES PAYABLE (Details) Details http://imle.com/role/NotesPayableTables 43 false false R44.htm 000044 - Disclosure - NOTES PAYABLE (Details 1) Notes http://imle.com/role/NotesPayableDetails1 NOTES PAYABLE (Details 1) Details http://imle.com/role/NotesPayableTables 44 false false R45.htm 000045 - Disclosure - NOTES PAYABLE (Details Narrative) Notes http://imle.com/role/NotesPayableDetailsNarrative NOTES PAYABLE (Details Narrative) Details http://imle.com/role/NotesPayableTables 45 false false R46.htm 000046 - Disclosure - DERIVATIVE LIABILITY (Details Narrative) Sheet http://imle.com/role/DerivativeLiabilityDetailsNarrative DERIVATIVE LIABILITY (Details Narrative) Details http://imle.com/role/DerivativeLiability 46 false false R47.htm 000047 - Disclosure - STOCK SUBSCRIPTIONS PAYABLE (Details Narrative) Sheet http://imle.com/role/StockSubscriptionsPayableDetailsNarrative STOCK SUBSCRIPTIONS PAYABLE (Details Narrative) Details http://imle.com/role/StockSubscriptionsPayable 47 false false R48.htm 000048 - Disclosure - COMMON STOCK (Details Narrative) Sheet http://imle.com/role/CommonStockDetailsNarrative COMMON STOCK (Details Narrative) Details http://imle.com/role/CommonStock 48 false false R49.htm 000049 - Disclosure - PREFERRED STOCK (Details Narratve) Sheet http://imle.com/role/PreferredStockDetailsNarratve PREFERRED STOCK (Details Narratve) Details http://imle.com/role/PreferredStock 49 false false R50.htm 000050 - Disclosure - STOCK WARRANTS AND STOCK OPTIONS (Details) Sheet http://imle.com/role/StockWarrantsAndStockOptionsDetails STOCK WARRANTS AND STOCK OPTIONS (Details) Details http://imle.com/role/StockWarrantsAndStockOptionsTables 50 false false R51.htm 000051 - Disclosure - STOCK WARRANTS AND STOCK OPTIONS (Details 1) Sheet http://imle.com/role/StockWarrantsAndStockOptionsDetails1 STOCK WARRANTS AND STOCK OPTIONS (Details 1) Details http://imle.com/role/StockWarrantsAndStockOptionsTables 51 false false R52.htm 000052 - Disclosure - STOCK WARRANTS AND STOCK OPTIONS (Details 2) Sheet http://imle.com/role/StockWarrantsAndStockOptionsDetails2 STOCK WARRANTS AND STOCK OPTIONS (Details 2) Details http://imle.com/role/StockWarrantsAndStockOptionsTables 52 false false R53.htm 000053 - Disclosure - STOCK WARRANTS AND STOCK OPTIONS (Details 3) Sheet http://imle.com/role/StockWarrantsAndStockOptionsDetails3 STOCK WARRANTS AND STOCK OPTIONS (Details 3) Details http://imle.com/role/StockWarrantsAndStockOptionsTables 53 false false R54.htm 000054 - Disclosure - STOCK WARRANTS AND STOCK OPTIONS (Details Narrative) Sheet http://imle.com/role/StockWarrantsAndStockOptionsDetailsNarrative STOCK WARRANTS AND STOCK OPTIONS (Details Narrative) Details http://imle.com/role/StockWarrantsAndStockOptionsTables 54 false false R55.htm 000055 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative) Sheet http://imle.com/role/CommitmentsAndContingenciesDetailsNarrative COMMITMENTS AND CONTINGENCIES (Details Narrative) Details http://imle.com/role/CommitmentsAndContingencies 55 false false All Reports Book All Reports sobr_10q.htm imle-20210930.xsd imle-20210930_cal.xml imle-20210930_def.xml imle-20210930_lab.xml imle-20210930_pre.xml sobr_ex311.htm sobr_ex312.htm sobr_ex321.htm sobr_ex322.htm http://xbrl.sec.gov/dei/2020-01-31 http://fasb.org/srt/2020-01-31 http://fasb.org/us-gaap/2020-01-31 true true JSON 73 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "sobr_10q.htm": { "axisCustom": 0, "axisStandard": 16, "contextCount": 293, "dts": { "calculationLink": { "local": [ "imle-20210930_cal.xml" ] }, "definitionLink": { "local": [ "imle-20210930_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml", "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml" ] }, "inline": { "local": [ "sobr_10q.htm" ] }, "labelLink": { "local": [ "imle-20210930_lab.xml" ] }, "presentationLink": { "local": [ "imle-20210930_pre.xml" ] }, "schema": { "local": [ "imle-20210930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd", "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd", "https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 539, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2020-01-31": 59, "http://imle.com/20210930": 30, "http://xbrl.sec.gov/dei/2020-01-31": 8, "total": 97 }, "keyCustom": 182, "keyStandard": 289, "memberCustom": 55, "memberStandard": 7, "nsprefix": "imle", "nsuri": "http://imle.com/20210930", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "strong", "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000001 - Document - Cover", "role": "http://imle.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "strong", "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherCurrentAssetsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000010 - Disclosure - PREPAID EXPENSES", "role": "http://imle.com/role/PrepaidExpenses", "shortName": "PREPAID EXPENSES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherCurrentAssetsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000011 - Disclosure - INTANGIBLE ASSETS", "role": "http://imle.com/role/IntangibleAssets", "shortName": "INTANGIBLE ASSETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000012 - Disclosure - RELATED PARTY TRANSACTIONS", "role": "http://imle.com/role/RelatedPartyTransactions", "shortName": "RELATED PARTY TRANSACTIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000013 - Disclosure - CONVERTIBLE DEBENTURE PAYABLE", "role": "http://imle.com/role/ConvertibleDebenturePayable", "shortName": "CONVERTIBLE DEBENTURE PAYABLE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000014 - Disclosure - NOTES PAYABLE", "role": "http://imle.com/role/NotesPayable", "shortName": "NOTES PAYABLE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativesAndFairValueTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000015 - Disclosure - DERIVATIVE LIABILITY", "role": "http://imle.com/role/DerivativeLiability", "shortName": "DERIVATIVE LIABILITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativesAndFairValueTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "imle:Note12StockSubscriptionsPayableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000016 - Disclosure - STOCK SUBSCRIPTIONS PAYABLE", "role": "http://imle.com/role/StockSubscriptionsPayable", "shortName": "STOCK SUBSCRIPTIONS PAYABLE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "imle:Note12StockSubscriptionsPayableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000017 - Disclosure - COMMON STOCK", "role": "http://imle.com/role/CommonStock", "shortName": "COMMON STOCK", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PreferredStockTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000018 - Disclosure - PREFERRED STOCK", "role": "http://imle.com/role/PreferredStock", "shortName": "PREFERRED STOCK", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PreferredStockTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "imle:StockWarrantsAndStockOptionsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000019 - Disclosure - STOCK WARRANTS AND STOCK OPTIONS", "role": "http://imle.com/role/StockWarrantsAndStockOptions", "shortName": "STOCK WARRANTS AND STOCK OPTIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "imle:StockWarrantsAndStockOptionsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "AsOf2021-09-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS", "role": "http://imle.com/role/CondensedConsolidatedBalanceSheets", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "AsOf2021-09-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000020 - Disclosure - COMMITMENTS AND CONTINGENCIES", "role": "http://imle.com/role/CommitmentsAndContingencies", "shortName": "COMMITMENTS AND CONTINGENCIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000021 - Disclosure - SUBSEQUENT EVENTS", "role": "http://imle.com/role/SubsequentEvents", "shortName": "SUBSEQUENT EVENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000022 - Disclosure - ORGANIZATION OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "role": "http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPoliciesPolicies", "shortName": "ORGANIZATION OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "us-gaap:FairValueOfFinancialInstrumentsPolicy", "ix:continuation", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000023 - Disclosure - ORGANIZATION OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "role": "http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPoliciesTables", "shortName": "ORGANIZATION OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:FairValueOfFinancialInstrumentsPolicy", "ix:continuation", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "imle:SummaryOfClosingTransactionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000024 - Disclosure - ASSET PURCHASE (Tables)", "role": "http://imle.com/role/AssetPurchaseTables", "shortName": "ASSET PURCHASE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "imle:SummaryOfClosingTransactionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "us-gaap:OtherCurrentAssetsTextBlock", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000025 - Disclosure - PREPAID EXPENSES (Tables)", "role": "http://imle.com/role/PrepaidExpensesTables", "shortName": "PREPAID EXPENSES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:OtherCurrentAssetsTextBlock", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000026 - Disclosure - INTANGIBLE ASSETS (Tables)", "role": "http://imle.com/role/IntangibleAssetsTables", "shortName": "INTANGIBLE ASSETS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConvertibleDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000027 - Disclosure - CONVERTIBLE DEBENTURE PAYABLE (Tables)", "role": "http://imle.com/role/ConvertibleDebenturePayableTables", "shortName": "CONVERTIBLE DEBENTURE PAYABLE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConvertibleDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShortTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000028 - Disclosure - NOTES PAYABLE (Tables)", "role": "http://imle.com/role/NotesPayableTables", "shortName": "NOTES PAYABLE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShortTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "imle:StockWarrantsAndStockOptionsTextBlock", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000029 - Disclosure - STOCK WARRANTS AND STOCK OPTIONS (Tables)", "role": "http://imle.com/role/StockWarrantsAndStockOptionsTables", "shortName": "STOCK WARRANTS AND STOCK OPTIONS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "imle:StockWarrantsAndStockOptionsTextBlock", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "AsOf2021-09-30", "decimals": "0", "first": true, "lang": null, "name": "imle:SobrSafeIntellectualTechnologyNetOfAccumulatedAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)", "role": "http://imle.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "AsOf2021-09-30", "decimals": "0", "first": true, "lang": null, "name": "imle:SobrSafeIntellectualTechnologyNetOfAccumulatedAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock", "us-gaap:FairValueOfFinancialInstrumentsPolicy", "ix:continuation", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "AsOf2021-09-30_imle_LevelOneMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DerivativeLiabilities", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000030 - Disclosure - ORGANIZATION, OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)", "role": "http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPoliciesDetails", "shortName": "ORGANIZATION, OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock", "us-gaap:FairValueOfFinancialInstrumentsPolicy", "ix:continuation", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "AsOf2021-09-30_imle_LevelOneMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DerivativeLiabilities", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ResearchAndDevelopmentExpense", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000031 - Disclosure - ORGANIZATION, OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "role": "http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "shortName": "ORGANIZATION, OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": "0", "lang": null, "name": "us-gaap:ImpairmentOfIntangibleAssetsFinitelived", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "AsOf2021-09-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RetainedEarningsAccumulatedDeficit", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000032 - Disclosure - GOING CONCERN (Details Narrative)", "role": "http://imle.com/role/GoingConcernDetailsNarrative", "shortName": "GOING CONCERN (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "AsOf2021-09-30_imle_PrivateOfferingMember_imle_JanuaryFifteenTwoThousandTwentyOneMember", "decimals": "0", "lang": null, "name": "imle:AdditionalOfferingAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "imle:SummaryOfClosingTransactionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "AsOf2020-06-05", "decimals": "0", "first": true, "lang": null, "name": "imle:PropertyAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000033 - Disclosure - ASSET PURCHASE (Details)", "role": "http://imle.com/role/AssetPurchaseDetails", "shortName": "ASSET PURCHASE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "imle:SummaryOfClosingTransactionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "AsOf2020-06-05", "decimals": "0", "first": true, "lang": null, "name": "imle:PropertyAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "p", "us-gaap:RestrictedAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "AsOf2020-06-05", "decimals": "0", "first": true, "lang": null, "name": "imle:LiabilityRequired", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000034 - Disclosure - ASSET PURCHASE (Details Narrative)", "role": "http://imle.com/role/AssetPurchaseDetailsNarrative", "shortName": "ASSET PURCHASE (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:RestrictedAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "AsOf2020-06-05", "decimals": "0", "first": true, "lang": null, "name": "imle:LiabilityRequired", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "us-gaap:OtherCurrentAssetsTextBlock", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "AsOf2021-09-30", "decimals": "0", "first": true, "lang": null, "name": "imle:ConsultingServices", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000035 - Disclosure - PREPAID EXPENSES (Details)", "role": "http://imle.com/role/PrepaidExpensesDetails", "shortName": "PREPAID EXPENSES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "us-gaap:OtherCurrentAssetsTextBlock", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "AsOf2021-09-30", "decimals": "0", "first": true, "lang": null, "name": "imle:ConsultingServices", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LeaseAndRentalExpense", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000036 - Disclosure - PREPAID EXPENSES (Details Narrative)", "role": "http://imle.com/role/PrepaidExpensesDetailsNarrative", "shortName": "PREPAID EXPENSES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:OtherCurrentAssetsTextBlock", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30_imle_LeaseAgreementMember", "decimals": "0", "lang": null, "name": "imle:PrepaidExpensesWithCommonShares", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "AsOf2021-09-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsNet", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000037 - Disclosure - INTANGIBLE ASSETS (Details)", "role": "http://imle.com/role/IntangibleAssetsDetails", "shortName": "INTANGIBLE ASSETS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "AsOf2021-09-30_imle_IntellectualTechnologyMember", "decimals": "0", "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "tbody", "table", "imle:ScheduleOfEstimatedFutureAmortizationExpenseTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "AsOf2021-09-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000038 - Disclosure - INTANGIBLE ASSETS (Details 1)", "role": "http://imle.com/role/IntangibleAssetsDetails1", "shortName": "INTANGIBLE ASSETS (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "tbody", "table", "imle:ScheduleOfEstimatedFutureAmortizationExpenseTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "AsOf2021-09-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "p", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2020-01-01to2020-09-30", "decimals": "0", "first": true, "lang": null, "name": "imle:AmortizationAndDepreciationExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000039 - Disclosure - INTANGIBLE ASSETS (Details Narrative)", "role": "http://imle.com/role/IntangibleAssetsDetailsNarrative", "shortName": "INTANGIBLE ASSETS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2020-01-01to2020-09-30", "decimals": "0", "first": true, "lang": null, "name": "imle:AmortizationAndDepreciationExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)", "role": "http://imle.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "AsOf2021-05-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ConvertibleNotesPayable", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000040 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)", "role": "http://imle.com/role/RelatedPartyTransactionsDetailsNarrative", "shortName": "RELATED PARTY TRANSACTIONS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "AsOf2017-03-08", "decimals": "0", "lang": null, "name": "imle:DebtAfterForgaveAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ConvertibleDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "AsOf2021-09-30", "decimals": "0", "first": true, "lang": null, "name": "imle:ConvertibleDebenturePayableWithDetachedFreeStandingWarrant", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000041 - Disclosure - CONVERTIBLE DEBENTURE PAYABLE (Details)", "role": "http://imle.com/role/ConvertibleDebenturePayableDetails", "shortName": "CONVERTIBLE DEBENTURE PAYABLE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ConvertibleDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "AsOf2021-09-30", "decimals": "0", "first": true, "lang": null, "name": "imle:ConvertibleDebenturePayableWithDetachedFreeStandingWarrant", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "p", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": "0", "first": true, "lang": null, "name": "imle:WarrantsIssuedToPurchaseCommonShares", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000042 - Disclosure - CONVERTIBLE DEBENTURE PAYABLE (Details Narrative)", "role": "http://imle.com/role/ConvertibleDebenturePayableDetailsNarrative", "shortName": "CONVERTIBLE DEBENTURE PAYABLE (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": "0", "first": true, "lang": null, "name": "imle:WarrantsIssuedToPurchaseCommonShares", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ConvertibleDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "AsOf2021-09-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000043 - Disclosure - NOTES PAYABLE (Details)", "role": "http://imle.com/role/NotesPayableDetails", "shortName": "NOTES PAYABLE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfShortTermDebtTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "AsOf2021-09-30_imle_RelatedPartyNotesPayableMember", "decimals": "0", "lang": null, "name": "imle:NotesPayableWithDetachedFreestandingWarrants", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ConvertibleDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "AsOf2021-09-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000044 - Disclosure - NOTES PAYABLE (Details 1)", "role": "http://imle.com/role/NotesPayableDetails1", "shortName": "NOTES PAYABLE (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "imle:ScheduleOfNotesPayablesNonRelatedParties", "ix:continuation", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "AsOf2021-09-30_imle_NonRelatedPartyNotesPayableMember", "decimals": "0", "lang": null, "name": "us-gaap:ConvertibleLongTermNotesPayable", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2020-05-01to2020-05-12", "decimals": "0", "first": true, "lang": null, "name": "imle:ProceedReceivedFromCommercialBank", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000045 - Disclosure - NOTES PAYABLE (Details Narrative)", "role": "http://imle.com/role/NotesPayableDetailsNarrative", "shortName": "NOTES PAYABLE (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2020-05-01to2020-05-12", "decimals": "0", "first": true, "lang": null, "name": "imle:ProceedReceivedFromCommercialBank", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "p", "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": "INF", "first": true, "lang": null, "name": "imle:OidPercentage", "reportCount": 1, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000046 - Disclosure - DERIVATIVE LIABILITY (Details Narrative)", "role": "http://imle.com/role/DerivativeLiabilityDetailsNarrative", "shortName": "DERIVATIVE LIABILITY (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:DerivativesAndFairValueTextBlock", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-09-01to2021-09-28_imle_ConvertiblePromissoryNoteAgreementMember", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "AsOf2021-09-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesSubscriptions", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000047 - Disclosure - STOCK SUBSCRIPTIONS PAYABLE (Details Narrative)", "role": "http://imle.com/role/StockSubscriptionsPayableDetailsNarrative", "shortName": "STOCK SUBSCRIPTIONS PAYABLE (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "imle:Note12StockSubscriptionsPayableTextBlock", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "AsOf2021-09-30_imle_DueToRelatedPartiesMember", "decimals": "0", "lang": null, "name": "us-gaap:CommonStockSharesSubscriptions", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "AsOf2021-09-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CommonStockValue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000048 - Disclosure - COMMON STOCK (Details Narrative)", "role": "http://imle.com/role/CommonStockDetailsNarrative", "shortName": "COMMON STOCK (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": "0", "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesIssuedForServices", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2020-01-01to2020-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DividendsPreferredStock", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000049 - Disclosure - PREFERRED STOCK (Details Narratve)", "role": "http://imle.com/role/PreferredStockDetailsNarratve", "shortName": "PREFERRED STOCK (Details Narratve)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2020-01-01to2020-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DividendsPreferredStock", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "strong", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "AsOf2019-12-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:SharesIssued", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (UNAUDITED)", "role": "http://imle.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficitUnaudited", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (UNAUDITED)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2020-01-01to2020-03-31_us-gaap_CommonStockMember", "decimals": "0", "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "tbody", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "imle:StockWarrantsAndStockOptionsTextBlock", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "AsOf2021-09-30_srt_MaximumMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000050 - Disclosure - STOCK WARRANTS AND STOCK OPTIONS (Details)", "role": "http://imle.com/role/StockWarrantsAndStockOptionsDetails", "shortName": "STOCK WARRANTS AND STOCK OPTIONS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "tbody", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "imle:StockWarrantsAndStockOptionsTextBlock", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30_srt_MinimumMember", "decimals": null, "lang": "en-US", "name": "imle:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm3", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "AsOf2020-12-31_imle_WarrantsMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000051 - Disclosure - STOCK WARRANTS AND STOCK OPTIONS (Details 1)", "role": "http://imle.com/role/StockWarrantsAndStockOptionsDetails1", "shortName": "STOCK WARRANTS AND STOCK OPTIONS (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "AsOf2020-12-31_imle_WarrantsMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "tbody", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "imle:StockWarrantsAndStockOptionsTextBlock", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "AsOf2021-09-30_srt_MaximumMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000052 - Disclosure - STOCK WARRANTS AND STOCK OPTIONS (Details 2)", "role": "http://imle.com/role/StockWarrantsAndStockOptionsDetails2", "shortName": "STOCK WARRANTS AND STOCK OPTIONS (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "tbody", "table", "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30_srt_MaximumMember", "decimals": null, "lang": "en-US", "name": "imle:ExpectedLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "AsOf2020-12-31_imle_StockOptionsMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000053 - Disclosure - STOCK WARRANTS AND STOCK OPTIONS (Details 3)", "role": "http://imle.com/role/StockWarrantsAndStockOptionsDetails3", "shortName": "STOCK WARRANTS AND STOCK OPTIONS (Details 3)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "AsOf2020-12-31_imle_StockOptionsMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "p", "imle:StockWarrantsAndStockOptionsTextBlock", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "AsOf2021-09-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000054 - Disclosure - STOCK WARRANTS AND STOCK OPTIONS (Details Narrative)", "role": "http://imle.com/role/StockWarrantsAndStockOptionsDetailsNarrative", "shortName": "STOCK WARRANTS AND STOCK OPTIONS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "imle:StockWarrantsAndStockOptionsTextBlock", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "AsOf2021-09-30", "decimals": "INF", "lang": null, "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LeaseAndRentalExpense", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000055 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)", "role": "http://imle.com/role/CommitmentsAndContingenciesDetailsNarrative", "shortName": "COMMITMENTS AND CONTINGENCIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "AsOf2006-12-06", "decimals": "0", "lang": null, "name": "us-gaap:SettlementLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)", "role": "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": "0", "lang": null, "name": "us-gaap:DepreciationDepletionAndAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000007 - Disclosure - ORGANIZATION OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "role": "http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPolicies", "shortName": "ORGANIZATION OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000008 - Disclosure - GOING CONCERN", "role": "http://imle.com/role/GoingConcern", "shortName": "GOING CONCERN", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestrictedAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000009 - Disclosure - ASSET PURCHASE", "role": "http://imle.com/role/AssetPurchase", "shortName": "ASSET PURCHASE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sobr_10q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestrictedAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 62, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imle.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imle.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imle.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imle.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imle.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imle.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r363" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imle.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r364" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imle.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imle.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address Address Line 1" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imle.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address City Or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imle.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imle.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address State Or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imle.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r365" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imle.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imle.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imle.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r365" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imle.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imle.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r365" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imle.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imle.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r366" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imle.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r365" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imle.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r365" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imle.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r365" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imle.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r365" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imle.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imle.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "imle_AccountsPayableAndAccruedExpensesConvertedToCapital": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Accounts payable and accrued expenses converted to capital" } } }, "localname": "AccountsPayableAndAccruedExpensesConvertedToCapital", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "imle_AcquiredAdditionalSharesOfCommonStock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Acquired additional shares of common stock" } } }, "localname": "AcquiredAdditionalSharesOfCommonStock", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "imle_AcquiredShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Acquired shares" } } }, "localname": "AcquiredShares", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "imle_AdditionalOfferingAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Additional offering amount" } } }, "localname": "AdditionalOfferingAmount", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/GoingConcernDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "imle_AdjustedExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjusted exercise price" } } }, "localname": "AdjustedExercisePrice", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/ConvertibleDebenturePayableDetailsNarrative" ], "xbrltype": "perShareItemType" }, "imle_AggregateIntrinsicBeginningBalanceValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Aggregate Intrinsic Value, Beginning balance" } } }, "localname": "AggregateIntrinsicBeginningBalanceValue", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetails1" ], "xbrltype": "monetaryItemType" }, "imle_AggregateIntrinsicValueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Aggregate Intrinsic Value", "verboseLabel": "Aggregate Intrinsic Value" } } }, "localname": "AggregateIntrinsicValueAbstract", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetails1", "http://imle.com/role/StockWarrantsAndStockOptionsDetails3" ], "xbrltype": "stringItemType" }, "imle_AggregateIntrinsicValueBeginningBalance": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Aggregate Intrinsic Value beginning balance" } } }, "localname": "AggregateIntrinsicValueBeginningBalance", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetails3" ], "xbrltype": "monetaryItemType" }, "imle_AggregateIntrinsicValueEndingBalance": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Aggregate Intrinsic Value, Ending balance", "verboseLabel": "Aggregate Intrinsic Value ending balance" } } }, "localname": "AggregateIntrinsicValueEndingBalance", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetails1", "http://imle.com/role/StockWarrantsAndStockOptionsDetails3" ], "xbrltype": "monetaryItemType" }, "imle_AggregateIntrinsicValueExercisableBeginningBalance": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Aggregate Intrinsic Value exercisable, beginning balance" } } }, "localname": "AggregateIntrinsicValueExercisableBeginningBalance", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetails3" ], "xbrltype": "monetaryItemType" }, "imle_AggregateIntrinsicValueExercisableEndingBalance": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Aggregate Intrinsic Value exercisable ending balance" } } }, "localname": "AggregateIntrinsicValueExercisableEndingBalance", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetails3" ], "xbrltype": "monetaryItemType" }, "imle_AggregateIntrinsicValueOptionsCancelled": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Aggregate Intrinsic Value options cancelled" } } }, "localname": "AggregateIntrinsicValueOptionsCancelled", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetails3" ], "xbrltype": "monetaryItemType" }, "imle_AggregateIntrinsicValueOptionsExercised": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Aggregate Intrinsic Value options exercised" } } }, "localname": "AggregateIntrinsicValueOptionsExercised", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetails3" ], "xbrltype": "monetaryItemType" }, "imle_AggregateIntrinsicValueOptionsExpired": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Aggregate Intrinsic Value options expired" } } }, "localname": "AggregateIntrinsicValueOptionsExpired", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetails3" ], "xbrltype": "monetaryItemType" }, "imle_AggregateIntrinsicValueOptionsGranted": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Aggregate Intrinsic Value options granted" } } }, "localname": "AggregateIntrinsicValueOptionsGranted", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetails3" ], "xbrltype": "monetaryItemType" }, "imle_AggregateIntrinsicValueWarrantsGranted": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Aggregate Intrinsic Value, Warrants granted" } } }, "localname": "AggregateIntrinsicValueWarrantsGranted", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetails1" ], "xbrltype": "monetaryItemType" }, "imle_AgreementExpiringDate": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Agreement Expiring date" } } }, "localname": "AgreementExpiringDate", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CommonStockDetailsNarrative" ], "xbrltype": "stringItemType" }, "imle_AmortizationAndDepreciationExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Amortization and depreciation expense" } } }, "localname": "AmortizationAndDepreciationExpense", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/IntangibleAssetsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "imle_AmortizationOfInterest": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "[Amortization of interest]", "verboseLabel": "Amortization of interest" } } }, "localname": "AmortizationOfInterest", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/ConvertibleDebenturePayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "imle_AmortizationOfInterestBeneficialConversionFeatur": { "auth_ref": [], "calculation": { "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Amortization of interest" } } }, "localname": "AmortizationOfInterestBeneficialConversionFeatur", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "imle_AmortizationOfInterestConversionFeature": { "auth_ref": [], "calculation": { "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Amortization of interest - conversion feature" } } }, "localname": "AmortizationOfInterestConversionFeature", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "imle_AmortizationOfInterestConversionFeatures": { "auth_ref": [], "calculation": { "http://imle.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": { "order": 9.0, "parentTag": "us-gaap_OtherNoncashIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Amortization of interest - conversion features" } } }, "localname": "AmortizationOfInterestConversionFeatures", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "monetaryItemType" }, "imle_AnnualMeetingOfShareholdersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Annual Meeting of Shareholders [Member]" } } }, "localname": "AnnualMeetingOfShareholdersMember", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "imle_AssetImpairmentAdjustment": { "auth_ref": [], "calculation": { "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "[Asset impairment adjustment]", "verboseLabel": "Asset impairment adjustment" } } }, "localname": "AssetImpairmentAdjustment", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "imle_AssetImpairmentChargesLoss": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.", "label": "Asset impairment charges loss" } } }, "localname": "AssetImpairmentChargesLoss", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/AssetPurchaseDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "imle_AssetPurchaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Asset Purchase Agreement [Member]", "verboseLabel": "Asset purchase agreement [Member]" } } }, "localname": "AssetPurchaseAgreementMember", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/AssetPurchaseDetailsNarrative", "http://imle.com/role/PreferredStockDetailsNarratve" ], "xbrltype": "domainItemType" }, "imle_AssetsPurchaseUponSharaesIssue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Assets purchase upon shares issued" } } }, "localname": "AssetsPurchaseUponSharaesIssue", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/AssetPurchaseDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "imle_AssetsPurchaseUponSharesIssuedShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or mo", "label": "Assets purchase upon shares issued, shares" } } }, "localname": "AssetsPurchaseUponSharesIssuedShares", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/AssetPurchaseDetailsNarrative" ], "xbrltype": "sharesItemType" }, "imle_BeneficialConversionFeatureDebtDiscount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Beneficial conversion feature debt discount" } } }, "localname": "BeneficialConversionFeatureDebtDiscount", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "imle_BeneficialConversionFeaturesPoliciesTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Beneficial Conversion Features" } } }, "localname": "BeneficialConversionFeaturesPoliciesTextBlock", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "imle_CaliforniaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "California [Member]" } } }, "localname": "CaliforniaMember", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "imle_CharlesBenningtonMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Charles Bennington [Member]" } } }, "localname": "CharlesBenningtonMember", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "imle_CommonStockIssuedDueToStockWarrantsExerciseAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Common stock issued due to stock warrants exercise, amount" } } }, "localname": "CommonStockIssuedDueToStockWarrantsExerciseAmount", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficitUnaudited" ], "xbrltype": "monetaryItemType" }, "imle_CommonStockIssuedDueToStockWarrantsExerciseShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock issued due to stock warrants exercise, shares" } } }, "localname": "CommonStockIssuedDueToStockWarrantsExerciseShares", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficitUnaudited" ], "xbrltype": "sharesItemType" }, "imle_CommonStockIssuedForAssetPurchaseAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Common stock issued for asset purchase, amount" } } }, "localname": "CommonStockIssuedForAssetPurchaseAmount", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficitUnaudited" ], "xbrltype": "monetaryItemType" }, "imle_CommonStockIssuedForAssetPurchaseShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock issued for asset purchase, shares" } } }, "localname": "CommonStockIssuedForAssetPurchaseShares", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficitUnaudited" ], "xbrltype": "sharesItemType" }, "imle_CommonStockIssuedForFacilityLeaseAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Common stock issued for facility lease, amount" } } }, "localname": "CommonStockIssuedForFacilityLeaseAmount", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficitUnaudited" ], "xbrltype": "monetaryItemType" }, "imle_CommonStockIssuedForFacilityLeaseShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock issued for facility lease, shares" } } }, "localname": "CommonStockIssuedForFacilityLeaseShares", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficitUnaudited" ], "xbrltype": "sharesItemType" }, "imle_CommonStockIssuedToSettleAccountsPayableAndAccruedExpensesAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Common stock issued to settle accounts payable and accrued expenses, amount" } } }, "localname": "CommonStockIssuedToSettleAccountsPayableAndAccruedExpensesAmount", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficitUnaudited" ], "xbrltype": "monetaryItemType" }, "imle_CommonStockIssuedToSettleAccountsPayableAndAccruedExpensesShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock issued to settle accounts payable and accrued expenses, shares" } } }, "localname": "CommonStockIssuedToSettleAccountsPayableAndAccruedExpensesShares", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficitUnaudited" ], "xbrltype": "sharesItemType" }, "imle_CommonStockIssuedToSettleDividendsSeriesA1ConvertiblePreferredStockAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Common stock issued to settle dividends - Series A-1 Convertible Preferred stock, amount" } } }, "localname": "CommonStockIssuedToSettleDividendsSeriesA1ConvertiblePreferredStockAmount", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficitUnaudited" ], "xbrltype": "monetaryItemType" }, "imle_CommonStockIssuedToSettleDividendsSeriesA1ConvertiblePreferredStockShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock issued to settle dividends - Series A-1 Convertible Preferred stock, shares" } } }, "localname": "CommonStockIssuedToSettleDividendsSeriesA1ConvertiblePreferredStockShares", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficitUnaudited" ], "xbrltype": "sharesItemType" }, "imle_CommonStockIssuedToSettleNonRelatedPartyDebtAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Common stock issued to settle non-related party debt, amount" } } }, "localname": "CommonStockIssuedToSettleNonRelatedPartyDebtAmount", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficitUnaudited" ], "xbrltype": "monetaryItemType" }, "imle_CommonStockIssuedToSettleNonRelatedPartyDebtShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock issued to settle non-related party debt, shares" } } }, "localname": "CommonStockIssuedToSettleNonRelatedPartyDebtShares", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficitUnaudited" ], "xbrltype": "sharesItemType" }, "imle_CommonStockIssuedToSettleRelatedPartyDebtAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Common stock issued to settle related party debt, amount" } } }, "localname": "CommonStockIssuedToSettleRelatedPartyDebtAmount", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficitUnaudited" ], "xbrltype": "monetaryItemType" }, "imle_CommonStockIssuedToSettleRelatedPartyDebtShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock issued to settle related party debt, shares" } } }, "localname": "CommonStockIssuedToSettleRelatedPartyDebtShares", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficitUnaudited" ], "xbrltype": "sharesItemType" }, "imle_CommonStockIssuedToSettleRelatedPartyPayablesAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Common stock issued to settle related party payables, amount" } } }, "localname": "CommonStockIssuedToSettleRelatedPartyPayablesAmount", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficitUnaudited" ], "xbrltype": "monetaryItemType" }, "imle_CommonStockIssuedToSettleRelatedPartyPayablesShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock issued to settle related party payables, shares" } } }, "localname": "CommonStockIssuedToSettleRelatedPartyPayablesShares", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficitUnaudited" ], "xbrltype": "sharesItemType" }, "imle_CommonStockPurchasePlansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock Purchase Plans [Member]" } } }, "localname": "CommonStockPurchasePlansMember", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "imle_CommonStockSharesExchange": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock shares exchanged" } } }, "localname": "CommonStockSharesExchange", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "sharesItemType" }, "imle_CommonStockSharesIssuableUponExerciseOfWarrantsToSpv": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock shares issuable upon exercise of warrants to SPV" } } }, "localname": "CommonStockSharesIssuableUponExerciseOfWarrantsToSpv", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "imle_CommonStockSharesSubscriptionsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock shares subscriptions, shares" } } }, "localname": "CommonStockSharesSubscriptionsShares", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockSubscriptionsPayableDetailsNarrative" ], "xbrltype": "sharesItemType" }, "imle_CommonStockSubscriptionsPayable": { "auth_ref": [], "calculation": { "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "[Common stock subscriptions payable]", "verboseLabel": "Common stock subscriptions payable" } } }, "localname": "CommonStockSubscriptionsPayable", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "imle_CommonStocksAuthorizedShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock authorized shares" } } }, "localname": "CommonStocksAuthorizedShares", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "imle_CompensationForServciesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Compensation for services [Member]" } } }, "localname": "CompensationForServciesMember", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CommonStockDetailsNarrative" ], "xbrltype": "domainItemType" }, "imle_ConsultingServices": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Consulting services" } } }, "localname": "ConsultingServices", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/PrepaidExpensesDetails" ], "xbrltype": "monetaryItemType" }, "imle_ConventionalNonConvertibleNotePayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "[Conventional Non-Convertible Notes Payable]", "verboseLabel": "Conventional Non-Convertible Notes Payable" } } }, "localname": "ConventionalNonConvertibleNotePayable", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/NotesPayableDetails1" ], "xbrltype": "monetaryItemType" }, "imle_ConventionalNonConvertibleNotesPayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Conventional Non-Convertible Notes Payable" } } }, "localname": "ConventionalNonConvertibleNotesPayable", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/NotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "imle_ConversionFeatureDebtDiscount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Conversion feature debt discount" } } }, "localname": "ConversionFeatureDebtDiscount", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/ConvertibleDebenturePayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "imle_ConversionPrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Conversion price" } } }, "localname": "ConversionPrice", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "imle_ConvertedSharesOfCommonStock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Converted shares of common stock" } } }, "localname": "ConvertedSharesOfCommonStock", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/PreferredStockDetailsNarratve" ], "xbrltype": "sharesItemType" }, "imle_ConvertibleDebenturePayableWithDetachedFreeStandingWarrant": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Convertible Debenture Payable with Detached Free-standing Warrant" } } }, "localname": "ConvertibleDebenturePayableWithDetachedFreeStandingWarrant", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/ConvertibleDebenturePayableDetails" ], "xbrltype": "monetaryItemType" }, "imle_ConvertibleNonRelatedPartyNotePayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Convertible non-related party note payable" } } }, "localname": "ConvertibleNonRelatedPartyNotePayable", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "imle_ConvertibleNotesPayableWithDetachedFreeStandingWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "[Convertible Notes Payable with Detached Free-standing Warrants]", "terseLabel": "Convertible Notes Payable with Detached Free-standing Warrants", "verboseLabel": "Convertible Notes Payable with Detached Free-standing Warrants" } } }, "localname": "ConvertibleNotesPayableWithDetachedFreeStandingWarrants", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/NotesPayableDetails1", "http://imle.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "imle_ConvertiblePreferredStockIssuable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Convertible preferred stock issuable" } } }, "localname": "ConvertiblePreferredStockIssuable", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/PreferredStockDetailsNarratve" ], "xbrltype": "sharesItemType" }, "imle_ConvertiblePromissoryNoteAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Convertible promissory note agreement [Member]", "verboseLabel": "Convertible promissory note agreement [Member]" } } }, "localname": "ConvertiblePromissoryNoteAgreementMember", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CommonStockDetailsNarrative", "http://imle.com/role/DerivativeLiabilityDetailsNarrative" ], "xbrltype": "domainItemType" }, "imle_CorrectionOfErrorpolicytextblock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Correction of Error" } } }, "localname": "CorrectionOfErrorpolicytextblock", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "imle_CumulativeDividendsRate": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cumulative dividends rate" } } }, "localname": "CumulativeDividendsRate", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/PreferredStockDetailsNarratve" ], "xbrltype": "percentItemType" }, "imle_CurrentPortionNotesPayableNonRelatedParties": { "auth_ref": [], "calculation": { "http://imle.com/role/CondensedConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.", "label": "Current portion notes payable - non-related parties" } } }, "localname": "CurrentPortionNotesPayableNonRelatedParties", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "imle_DavidGandiniMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "David Gandini [Member]" } } }, "localname": "DavidGandiniMember", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "imle_DebentureConversionDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debenture conversion description" } } }, "localname": "DebentureConversionDescription", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/ConvertibleDebenturePayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "imle_DebtAfterForgaveAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Debt amount after debt forgiveness" } } }, "localname": "DebtAfterForgaveAmount", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "imle_DebtFaceAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Debt face amount", "terseLabel": "Debt face amount", "verboseLabel": "Debt face amount" } } }, "localname": "DebtFaceAmount", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/ConvertibleDebenturePayableDetailsNarrative", "http://imle.com/role/DerivativeLiabilityDetailsNarrative", "http://imle.com/role/GoingConcernDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "imle_DebtInstrumentCafdgfhrryingAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Outstanding note payable" } } }, "localname": "DebtInstrumentCafdgfhrryingAmount", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "imle_DebtInstrumentForgiveness": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Debt Instrument, Forgiveness" } } }, "localname": "DebtInstrumentForgiveness", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "imle_DecemberThreeTwoThousandFourteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "December 3 2014 [Member]" } } }, "localname": "DecemberThreeTwoThousandFourteenMember", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "imle_DerivativeInstrumentspolicytextblock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Issuance Costs" } } }, "localname": "DerivativeInstrumentspolicytextblock", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "imle_DescriptionOfFairValueEvaluation": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Description of fair value of assets evaluation" } } }, "localname": "DescriptionOfFairValueEvaluation", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/AssetPurchaseDetailsNarrative" ], "xbrltype": "stringItemType" }, "imle_DevdattMishalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Devdatt Mishal [Member]" } } }, "localname": "DevdattMishalMember", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "imle_DirectorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Director [Member]" } } }, "localname": "DirectorsMember", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "imle_DiscountBeneficialFeatures": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Discount beneficial features" } } }, "localname": "DiscountBeneficialFeatures", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "imle_DividendsPayableSeriesA1ConvertiblePreferredStock": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Dividends payable-Series A-1 convertible preferred stock" } } }, "localname": "DividendsPayableSeriesA1ConvertiblePreferredStock", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficitUnaudited" ], "xbrltype": "monetaryItemType" }, "imle_DueToRelatedPartiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Due To Related Parties [Member]" } } }, "localname": "DueToRelatedPartiesMember", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockSubscriptionsPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "imle_EightPercentSeriesAOneConvertiblePreferredStockInvestmentAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "8% Series A-1 Convertible Preferred Stock Investment agreement [Member]" } } }, "localname": "EightPercentSeriesAOneConvertiblePreferredStockInvestmentAgreementMember", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "imle_ExecutiveStockOptionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Executive Stock Options [Member]" } } }, "localname": "ExecutiveStockOptionsMember", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "imle_ExercisePricePerShareOutstandingEndOfPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants outstanding exercise price per share, end of period" } } }, "localname": "ExercisePricePerShareOutstandingEndOfPeriod", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetails1" ], "xbrltype": "perShareItemType" }, "imle_ExercisePrices": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise prices" } } }, "localname": "ExercisePrices", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "imle_ExpectedLife": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[Expected life]", "verboseLabel": "Expected life" } } }, "localname": "ExpectedLife", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetails2" ], "xbrltype": "durationItemType" }, "imle_FairMarketValueOfStockWarrants": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Fair market value of stock warrants" } } }, "localname": "FairMarketValueOfStockWarrants", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/ConvertibleDebenturePayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "imle_FairMarketValueOfWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Fair market value of warrants" } } }, "localname": "FairMarketValueOfWarrants", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "imle_FairValueOfDetachedFreeStandingStockWarrantsGranted": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Fair value of detached free-standing stock warrants granted" } } }, "localname": "FairValueOfDetachedFreeStandingStockWarrantsGranted", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "imle_FairValueOfEmbeddedConversionFeature": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Fair value of embedded conversion feature" } } }, "localname": "FairValueOfEmbeddedConversionFeature", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "imle_FairValueOfWarrantsIssued": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Fair value of warrants issued" } } }, "localname": "FairValueOfWarrantsIssued", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/AssetPurchaseDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "imle_FirstCapitalVenturesFcvMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "First Capital Ventures \"FCV\" [Member]" } } }, "localname": "FirstCapitalVenturesFcvMember", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "imle_GainOnRelatedPartyDebtConvertedToCapital": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Gain on related party debt converted to capital" } } }, "localname": "GainOnRelatedPartyDebtConvertedToCapital", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "imle_GainOnRelatedPartyPayablesConvertedToCapital": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Gain on related party payables converted to capital" } } }, "localname": "GainOnRelatedPartyPayablesConvertedToCapital", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "imle_HighlandSchoolMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Highland School [Member]" } } }, "localname": "HighlandSchoolMember", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "imle_IDTECMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "IDTEC [Member]" } } }, "localname": "IDTECMember", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/AssetPurchaseDetailsNarrative" ], "xbrltype": "domainItemType" }, "imle_IdtecMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[IDTEC [Member]]", "verboseLabel": "IDTEC [Member]" } } }, "localname": "IdtecMember", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CommonStockDetailsNarrative", "http://imle.com/role/RelatedPartyTransactionsDetailsNarrative", "http://imle.com/role/StockWarrantsAndStockOptionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "imle_IncludesUnamortizedDebtDiscountAndBeneficialConversionFeatureRelatedToDetachedWarrantsAndConvertibleNotesOf771576AndNoneAtSeptember302021AndDecember312020Respectively": { "auth_ref": [], "calculation": { "http://imle.com/role/CondensedConsolidatedBalanceSheets": { "order": 18.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "* Includes unamortized debt discount and beneficial conversion feature related to detached warrants and convertible notes of $771,576 and none at September 30, 2021 and December 31, 2020, respectively" } } }, "localname": "IncludesUnamortizedDebtDiscountAndBeneficialConversionFeatureRelatedToDetachedWarrantsAndConvertibleNotesOf771576AndNoneAtSeptember302021AndDecember312020Respectively", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "imle_IncludesUnamortizedDebtDiscountAndBeneficialConversionFeatureRelatedToDetachedWarrantsAndConvertibleNotesOf774850AndNoneAtSeptember302021AndDecember312020Respectively": { "auth_ref": [], "calculation": { "http://imle.com/role/CondensedConsolidatedBalanceSheets": { "order": 17.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "* Includes unamortized debt discount and beneficial conversion feature related to detached warrants and convertible notes of $774,850 and none at September 30, 2021 and December 31, 2020, respectively" } } }, "localname": "IncludesUnamortizedDebtDiscountAndBeneficialConversionFeatureRelatedToDetachedWarrantsAndConvertibleNotesOf774850AndNoneAtSeptember302021AndDecember312020Respectively", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "imle_IncludesUnamortizedDebtDiscountRelatedToDetachedWarrantsAndConvertibleDebentureOf2608900AndNoneAtSeptember302021AndDecember312020Respectively": { "auth_ref": [], "calculation": { "http://imle.com/role/CondensedConsolidatedBalanceSheets": { "order": 9.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "* Includes unamortized debt discount related to detached warrants and convertible debenture of $2,608,900 and none at September 30, 2021 and December 31, 2020, respectively" } } }, "localname": "IncludesUnamortizedDebtDiscountRelatedToDetachedWarrantsAndConvertibleDebentureOf2608900AndNoneAtSeptember302021AndDecember312020Respectively", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "imle_IndirectInterestAmountRecieved": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Indirect interest amount recieved" } } }, "localname": "IndirectInterestAmountRecieved", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "imle_IntangibleAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Intangible assets" } } }, "localname": "IntangibleAssets", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/AssetPurchaseDetails" ], "xbrltype": "monetaryItemType" }, "imle_IntellectualTechnologyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Intellectual Technology [Member]" } } }, "localname": "IntellectualTechnologyMember", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/IntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "imle_InterestExpenseRelatedToTheOriginalIssueDiscountAndDebtIssuanceCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Interest expense related to the Original Issue Discount and debt issuance costs" } } }, "localname": "InterestExpenseRelatedToTheOriginalIssueDiscountAndDebtIssuanceCosts", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/ConvertibleDebenturePayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "imle_IntrinsicValueBeneficialConversionFeature": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Intrinsic value-beneficial conversion feature" } } }, "localname": "IntrinsicValueBeneficialConversionFeature", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "imle_InvestorRelationshipServiceDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investor relationship service, description" } } }, "localname": "InvestorRelationshipServiceDescription", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "imle_IssuanceOfCommonSharesForRent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Issuance of common shares for rent" } } }, "localname": "IssuanceOfCommonSharesForRent", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "imle_IssuanceOfCommonStockForPriorYearAccruedDividends": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Issuance of common stock for prior year accrued dividends" } } }, "localname": "IssuanceOfCommonStockForPriorYearAccruedDividends", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "imle_IssuanceOfCommonStockStockWarrantsAndConvertibleNoteForAssetPurchase": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.", "label": "Issuance of common stock, stock warrants and convertible note for asset purchase" } } }, "localname": "IssuanceOfCommonStockStockWarrantsAndConvertibleNoteForAssetPurchase", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "imle_IssuanceOfConvertibleNotesPayable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Issuance of convertible notes payable" } } }, "localname": "IssuanceOfConvertibleNotesPayable", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "imle_JanuaryFifteenTwoThousandTwentyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "January 15, 2021 [Member]" } } }, "localname": "JanuaryFifteenTwoThousandTwentyOneMember", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/GoingConcernDetailsNarrative" ], "xbrltype": "domainItemType" }, "imle_LanphereLawGroupMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lanphere Law Group [Member]" } } }, "localname": "LanphereLawGroupMember", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "imle_LeaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lease Agreement [Member]" } } }, "localname": "LeaseAgreementMember", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CommonStockDetailsNarrative", "http://imle.com/role/PrepaidExpensesDetailsNarrative" ], "xbrltype": "domainItemType" }, "imle_LevelOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Level 1 [Member]" } } }, "localname": "LevelOneMember", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "imle_LevelThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Level 3 [Member]" } } }, "localname": "LevelThreeMember", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "imle_LevelTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Level 2 [Member]" } } }, "localname": "LevelTwoMember", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "imle_LiabilityRequired": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Liability required" } } }, "localname": "LiabilityRequired", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/AssetPurchaseDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "imle_LoanPaymentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Loan payment, description" } } }, "localname": "LoanPaymentDescription", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "imle_LossOnDebtExtinguishmentNet": { "auth_ref": [], "calculation": { "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Loss on debt extinguishment, net" } } }, "localname": "LossOnDebtExtinguishmentNet", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "imle_MinorityInterestNoncontrollingInterestPolicYTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Minority Interest (Noncontrolling Interest)" } } }, "localname": "MinorityInterestNoncontrollingInterestPolicYTextBlock", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "imle_NetLossAttributableToCommonStockholders": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Net loss attributable to common stockholders" } } }, "localname": "NetLossAttributableToCommonStockholders", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "monetaryItemType" }, "imle_NetPurchase": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Net purchase (fair value of stock issued, warrants and notes payable)" } } }, "localname": "NetPurchase", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/AssetPurchaseDetails" ], "xbrltype": "monetaryItemType" }, "imle_NickNocetiMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nick Noceti [Member]" } } }, "localname": "NickNocetiMember", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "imle_NonConvertibleNotesPayableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non-Convertible Notes Payable [Member]" } } }, "localname": "NonConvertibleNotesPayableMember", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "imle_NonConvertibleNotesPayableTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non-Convertible Notes Payable Two [Member]" } } }, "localname": "NonConvertibleNotesPayableTwoMember", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "imle_NonEmployeeStockWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non Employee Stock Warrants [Member]" } } }, "localname": "NonEmployeeStockWarrantsMember", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "imle_NonRelatedPartyDebtConvertedToCapital": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Non-related party debt converted to capital" } } }, "localname": "NonRelatedPartyDebtConvertedToCapital", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "imle_NonRelatedPartyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non-Related Party [Member]" } } }, "localname": "NonRelatedPartyMember", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CommonStockDetailsNarrative" ], "xbrltype": "domainItemType" }, "imle_NonRelatedPartyNotesPayableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non-Related Party Notes Payable [Member]", "verboseLabel": "Non-Related Party Notes Payable [Member]" } } }, "localname": "NonRelatedPartyNotesPayableMember", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/NotesPayableDetails1", "http://imle.com/role/NotesPayableDetailsNarrative", "http://imle.com/role/StockSubscriptionsPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "imle_NonRelatedPartyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non-Related Party One [Member]" } } }, "localname": "NonRelatedPartyOneMember", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CommonStockDetailsNarrative" ], "xbrltype": "domainItemType" }, "imle_Note12StockSubscriptionsPayableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NOTE 10. STOCK SUBSCRIPTIONS PAYABLE" } } }, "localname": "Note12StockSubscriptionsPayableTextBlock", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockSubscriptionsPayable" ], "xbrltype": "textBlockItemType" }, "imle_NotePayableDueDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date the original debt was scheduled to mature, in CCYY-MM-DD format.", "label": "Note payable due date" } } }, "localname": "NotePayableDueDate", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "imle_NotesPayableNonRelatedPartiesLessCurrentPortion": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "[Notes payable -non-related parties-less current portion]", "verboseLabel": "Notes payable -non-related parties-less current portion" } } }, "localname": "NotesPayableNonRelatedPartiesLessCurrentPortion", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "imle_NotesPayableNonRelatedPartiesLessCurrentPortionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Notes payable -non-related parties-less current portion" } } }, "localname": "NotesPayableNonRelatedPartiesLessCurrentPortionAbstract", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "imle_NotesPayableRelatedPartiesLessCurrentPortion": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "[Notes payable -related parties-less current portion]", "verboseLabel": "Notes payable -related parties-less current portion" } } }, "localname": "NotesPayableRelatedPartiesLessCurrentPortion", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "imle_NotesPayableRelatedPartiesLessCurrentPortionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Notes payable -related parties-less current portion" } } }, "localname": "NotesPayableRelatedPartiesLessCurrentPortionAbstract", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "imle_NotesPayableWithDetachedFreeStandingWarrants": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Notes Payable with Detached Free-standing Warrants" } } }, "localname": "NotesPayableWithDetachedFreeStandingWarrants", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/NotesPayableDetails1" ], "xbrltype": "monetaryItemType" }, "imle_NotesPayableWithDetachedFreestandingWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Convertible Notes Payable with Detached Free-standing Warrants" } } }, "localname": "NotesPayableWithDetachedFreestandingWarrants", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/NotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "imle_OfferingAmounts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Offering amount" } } }, "localname": "OfferingAmounts", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/GoingConcernDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "imle_OidPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OID percentage", "terseLabel": "OID percentage", "verboseLabel": "OID percentage" } } }, "localname": "OidPercentage", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/ConvertibleDebenturePayableDetailsNarrative", "http://imle.com/role/DerivativeLiabilityDetailsNarrative", "http://imle.com/role/GoingConcernDetailsNarrative" ], "xbrltype": "percentItemType" }, "imle_OptionsCancelled": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Options Cancelled" } } }, "localname": "OptionsCancelled", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetails3" ], "xbrltype": "sharesItemType" }, "imle_OptionsExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Options Exercised" } } }, "localname": "OptionsExercised", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetails3" ], "xbrltype": "sharesItemType" }, "imle_OptionsOutstandingNumberOfSharesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Options Outstanding Number of Shares" } } }, "localname": "OptionsOutstandingNumberOfSharesAbstract", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetails3" ], "xbrltype": "stringItemType" }, "imle_OriginalIssueDiscount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Original Issue Discount" } } }, "localname": "OriginalIssueDiscount", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/ConvertibleDebenturePayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "imle_OutstandingWarrants": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Outstanding warrants" } } }, "localname": "OutstandingWarrants", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/ConvertibleDebenturePayableDetailsNarrative" ], "xbrltype": "sharesItemType" }, "imle_OutstandingWarrantsWeightedAverageExercisePricePerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price Per Share", "verboseLabel": "Weighted Average Exercise Price Per Share" } } }, "localname": "OutstandingWarrantsWeightedAverageExercisePricePerShareAbstract", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetails1", "http://imle.com/role/StockWarrantsAndStockOptionsDetails3" ], "xbrltype": "stringItemType" }, "imle_OutstandingwarrantsWeightedaverageremainingcontractuallifeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Remaining Contractual Life", "verboseLabel": "Weighted Average Remaining Contractual Life" } } }, "localname": "OutstandingwarrantsWeightedaverageremainingcontractuallifeAbstract", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetails1", "http://imle.com/role/StockWarrantsAndStockOptionsDetails3" ], "xbrltype": "stringItemType" }, "imle_PaidInCapitalBeneficialConversionFeature": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in additional paid in capital (APIC) resulting from recognition of deferred taxes for convertible debt with a beneficial conversion feature.", "label": "Paid-in capital - beneficial conversion feature" } } }, "localname": "PaidInCapitalBeneficialConversionFeature", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficitUnaudited" ], "xbrltype": "monetaryItemType" }, "imle_PaidInCapitalFairValueOfStockOptionsAndRsuVested": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Paid-in capital - fair value of stock options and RSU vested" } } }, "localname": "PaidInCapitalFairValueOfStockOptionsAndRsuVested", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficitUnaudited" ], "xbrltype": "monetaryItemType" }, "imle_PaidInCapitalFairValueOfStockOptionsVested": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Paid-in capital - fair value of stock options vested" } } }, "localname": "PaidInCapitalFairValueOfStockOptionsVested", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficitUnaudited" ], "xbrltype": "monetaryItemType" }, "imle_PaidInCapitalFairValueOfStockWarrantsGranted": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Paid-in capital - fair value of stock warrants granted" } } }, "localname": "PaidInCapitalFairValueOfStockWarrantsGranted", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficitUnaudited" ], "xbrltype": "monetaryItemType" }, "imle_PaidInCapitalGainOnRelatedPartyDebtConversion": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Paid-in capital - gain on related party debt conversion" } } }, "localname": "PaidInCapitalGainOnRelatedPartyDebtConversion", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficitUnaudited" ], "xbrltype": "monetaryItemType" }, "imle_PaidInCapitalGainOnRelatedPartyPayablesConversion": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Paid-in capital - gain on related party payables conversion" } } }, "localname": "PaidInCapitalGainOnRelatedPartyPayablesConversion", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficitUnaudited" ], "xbrltype": "monetaryItemType" }, "imle_PaidInCapitalLossOnDebtExtinguishment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Paid-in capital - loss on debt extinguishment" } } }, "localname": "PaidInCapitalLossOnDebtExtinguishment", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficitUnaudited" ], "xbrltype": "monetaryItemType" }, "imle_PaidInCapitalLossOnExtinguishmentOfConvertibleNotes": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Paid-in capital - loss on extinguishment of convertible notes" } } }, "localname": "PaidInCapitalLossOnExtinguishmentOfConvertibleNotes", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficitUnaudited" ], "xbrltype": "monetaryItemType" }, "imle_PaidInCapitalRelativeFairValueOfStockWarrantsGranted": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Paid-in capital - relative fair value of stock warrants granted" } } }, "localname": "PaidInCapitalRelativeFairValueOfStockWarrantsGranted", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficitUnaudited" ], "xbrltype": "monetaryItemType" }, "imle_PartialLiquidatedDamagesDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Partial liquidated damages description" } } }, "localname": "PartialLiquidatedDamagesDescription", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/ConvertibleDebenturePayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "imle_PrakashGadgilMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Prakash Gadgil [Member]" } } }, "localname": "PrakashGadgilMember", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "imle_PreferencesAndRightsOfPreferredStock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Preferences and rights of preferred stock" } } }, "localname": "PreferencesAndRightsOfPreferredStock", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/PreferredStockDetailsNarratve" ], "xbrltype": "stringItemType" }, "imle_PreferredStockPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Preferred Stock" } } }, "localname": "PreferredStockPolicyTextBlock", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "imle_PreferredStockSharesSold": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred stock shares sold" } } }, "localname": "PreferredStockSharesSold", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/PreferredStockDetailsNarratve" ], "xbrltype": "sharesItemType" }, "imle_PrepaidExpensesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.", "label": "Prepaid Expenses" } } }, "localname": "PrepaidExpensesPolicyTextBlock", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "imle_PrepaidExpensesWithCommonShares": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Prepaid expenses with common shares" } } }, "localname": "PrepaidExpensesWithCommonShares", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/PrepaidExpensesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "imle_PrivateOfferingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Private Offering [Member]" } } }, "localname": "PrivateOfferingMember", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/GoingConcernDetailsNarrative" ], "xbrltype": "domainItemType" }, "imle_ProceedReceivedFromCommercialBank": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Proceed received from commercial bank" } } }, "localname": "ProceedReceivedFromCommercialBank", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "imle_ProceedsFromFinancingTransition": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Proceeds from financing transition", "verboseLabel": "Proceeds from financing transition" } } }, "localname": "ProceedsFromFinancingTransition", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/ConvertibleDebenturePayableDetailsNarrative", "http://imle.com/role/DerivativeLiabilityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "imle_PropertyAndEquipmentGross": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Property and equipment" } } }, "localname": "PropertyAndEquipmentGross", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/AssetPurchaseDetails" ], "xbrltype": "monetaryItemType" }, "imle_PurchasePriceOfAdditionalSharesOfCommonStock": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Purchase price of additional shares of common stock" } } }, "localname": "PurchasePriceOfAdditionalSharesOfCommonStock", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "imle_PurchasePriceOfSharesIssued": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Purchase price of shares issued", "verboseLabel": "Purchase price of shares issued" } } }, "localname": "PurchasePriceOfSharesIssued", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/NotesPayableDetailsNarrative", "http://imle.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "imle_ReductionInRelatedPartyNonConvertibleNotesPayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Reduction in related party non - convertible notes payable" } } }, "localname": "ReductionInRelatedPartyNonConvertibleNotesPayable", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "imle_ReductionOnRelatedPartyDebt": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Reduction in related party debt", "verboseLabel": "Reduction in related party debt" } } }, "localname": "ReductionOnRelatedPartyDebt", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CommonStockDetailsNarrative", "http://imle.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "imle_RelatedPartiesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Parties" } } }, "localname": "RelatedPartiesPolicyTextBlock", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "imle_RelatedPartyConvertibleNotesPayableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Convertible Notes Payable [Member]" } } }, "localname": "RelatedPartyConvertibleNotesPayableMember", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "imle_RelatedPartyDebtConvertedToCapital": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Related party debt converted to capital" } } }, "localname": "RelatedPartyDebtConvertedToCapital", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "imle_RelatedPartyDebtConvertedToCapitalAfterExerciseOfCashlessStockWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Related party debt converted to capital after exercise of cashless stock warrants" } } }, "localname": "RelatedPartyDebtConvertedToCapitalAfterExerciseOfCashlessStockWarrants", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "imle_RelatedPartyNotesPayableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Notes Payable [Member]", "verboseLabel": "Related Party Notes Payable [Member]" } } }, "localname": "RelatedPartyNotesPayableMember", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/NotesPayableDetails", "http://imle.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "imle_RelatedPartyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party One [Member]" } } }, "localname": "RelatedPartyOneMember", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CommonStockDetailsNarrative" ], "xbrltype": "domainItemType" }, "imle_RelatedPartyPayablesConvertedToCapital": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Related party payables converted to capital" } } }, "localname": "RelatedPartyPayablesConvertedToCapital", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "imle_RelatedPartyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Three [Member]" } } }, "localname": "RelatedPartyThreeMember", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CommonStockDetailsNarrative" ], "xbrltype": "domainItemType" }, "imle_RelatedPartyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Two [Member]" } } }, "localname": "RelatedPartyTwoMember", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CommonStockDetailsNarrative" ], "xbrltype": "domainItemType" }, "imle_RelativeFairValueOfStockWarrantsGranted": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Relative fair value of stock warrants granted" } } }, "localname": "RelativeFairValueOfStockWarrantsGranted", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "imle_RentPaymentsMonthly": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Rent payments, monthly" } } }, "localname": "RentPaymentsMonthly", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "imle_RightOfDividend": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Right of dividend" } } }, "localname": "RightOfDividend", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/PreferredStockDetailsNarratve" ], "xbrltype": "percentItemType" }, "imle_RiskFreeInterestRates": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[Risk free interest rate]", "verboseLabel": "Risk free interest rate" } } }, "localname": "RiskFreeInterestRates", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetails2" ], "xbrltype": "percentItemType" }, "imle_SOBRSAFELLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SOBR SAFE, LLC [Member]" } } }, "localname": "SOBRSAFELLCMember", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/PreferredStockDetailsNarratve" ], "xbrltype": "domainItemType" }, "imle_SOBRSDirectorCompanyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SOBR's Director company [Member]" } } }, "localname": "SOBRSDirectorCompanyMember", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/PreferredStockDetailsNarratve" ], "xbrltype": "domainItemType" }, "imle_ScheduleOfEstimatedFutureAmortizationExpenseTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of estimated future amortization expense" } } }, "localname": "ScheduleOfEstimatedFutureAmortizationExpenseTableTextBlock", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/IntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "imle_ScheduleOfNotesPayablesNonRelatedParties": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of notes payables - non related parties" } } }, "localname": "ScheduleOfNotesPayablesNonRelatedParties", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/NotesPayableTables" ], "xbrltype": "textBlockItemType" }, "imle_SeriesAConvertiblePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Series A Convertible Preferred Stock [Member]", "verboseLabel": "Series A Convertible Preferred Stock [Member]" } } }, "localname": "SeriesAConvertiblePreferredStockMember", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedBalanceSheets", "http://imle.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://imle.com/role/PreferredStockDetailsNarratve" ], "xbrltype": "domainItemType" }, "imle_SeriesAOneConvertiblePreferredstockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Series A-1 Convertible Preferred stock [Member]", "verboseLabel": "Series A-1 Convertible Preferred stock [Member]" } } }, "localname": "SeriesAOneConvertiblePreferredstockMember", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CommonStockDetailsNarrative", "http://imle.com/role/CondensedConsolidatedBalanceSheets", "http://imle.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://imle.com/role/PreferredStockDetailsNarratve" ], "xbrltype": "domainItemType" }, "imle_SeriesAOnePreferredStockPurchaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Series A-1 Preferred Stock Purchase Agreement [Member]" } } }, "localname": "SeriesAOnePreferredStockPurchaseAgreementMember", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/PreferredStockDetailsNarratve" ], "xbrltype": "domainItemType" }, "imle_SettlePayableBalance": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Settle payable balance" } } }, "localname": "SettlePayableBalance", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CommonStockDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "imle_ShareBasedCompensationExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based compensation expenses" } } }, "localname": "ShareBasedCompensationExpenses", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "imle_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm3": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Life of warrants" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm3", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetails" ], "xbrltype": "durationItemType" }, "imle_SharesIssuedForCashReceivedInPriorYears": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Shares issued for cash received in prior years" } } }, "localname": "SharesIssuedForCashReceivedInPriorYears", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "imle_ShortTermLeaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Short Term Lease Agreement [Member]" } } }, "localname": "ShortTermLeaseAgreementMember", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "imle_ShortTermOperatingLeaseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Short Term Operating Lease [Member]" } } }, "localname": "ShortTermOperatingLeaseMember", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "imle_SixRelatedPartiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Six Related Parties [Member]" } } }, "localname": "SixRelatedPartiesMember", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "imle_SobrSafeIntellectualTechnologyNetOfAccumulatedAmortization": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "SOBR Safe Intellectual Technology, net of accumulated amortization" } } }, "localname": "SobrSafeIntellectualTechnologyNetOfAccumulatedAmortization", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "imle_StockIssuedDuringPeriodSharesStockOptionExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Warrants Exercised" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionExercised", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetails1" ], "xbrltype": "sharesItemType" }, "imle_StockIssuedDuringThePeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock issued during the period" } } }, "localname": "StockIssuedDuringThePeriod", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "sharesItemType" }, "imle_StockOptionExercisePricePerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Price Per Share" } } }, "localname": "StockOptionExercisePricePerShareAbstract", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetails3" ], "xbrltype": "stringItemType" }, "imle_StockOptionIssued": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Stock option issued" } } }, "localname": "StockOptionIssued", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "imle_StockOptionVestedOrExpectedToVestShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock option vested or expected to vest shares" } } }, "localname": "StockOptionVestedOrExpectedToVestShares", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "imle_StockOptionVestedShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock option vested shares" } } }, "localname": "StockOptionVestedShares", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "imle_StockOptionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock Options [Member]" } } }, "localname": "StockOptionsMember", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetails3" ], "xbrltype": "domainItemType" }, "imle_StockPurchasePlanOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock Purchase Plan One [Member]" } } }, "localname": "StockPurchasePlanOneMember", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "imle_StockPurchasePlanThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock Purchase Plan Three [Member]" } } }, "localname": "StockPurchasePlanThreeMember", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "imle_StockPurchasePlanTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock Purchase Plan Two [Member]" } } }, "localname": "StockPurchasePlanTwoMember", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "imle_StockWarrantsAndStockOptionsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NOTE 13. STOCK WARRANTS AND STOCK OPTIONS" } } }, "localname": "StockWarrantsAndStockOptionsTextBlock", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptions" ], "xbrltype": "textBlockItemType" }, "imle_StockholdersDeficitSOBRSafeIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders Deficit SOBR Safe Inc [Member]" } } }, "localname": "StockholdersDeficitSOBRSafeIncMember", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficitUnaudited" ], "xbrltype": "domainItemType" }, "imle_SummaryOfClosingTransactionsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Summary of closing transactions" } } }, "localname": "SummaryOfClosingTransactionsTableTextBlock", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/AssetPurchaseTables" ], "xbrltype": "textBlockItemType" }, "imle_TotalAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Total assets" } } }, "localname": "TotalAssets", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/AssetPurchaseDetails" ], "xbrltype": "monetaryItemType" }, "imle_TwoThousandNineteenEquityIncentivePlansMemberMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "2019 Equity Incentive Plans [Member]" } } }, "localname": "TwoThousandNineteenEquityIncentivePlansMemberMember", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "imle_UnamortizedDiscount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Unamortized discount" } } }, "localname": "UnamortizedDiscount", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/ConvertibleDebenturePayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "imle_UnamortizedDiscountAndIssuanceCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "unamortized discount and issuance costs" } } }, "localname": "UnamortizedDiscountAndIssuanceCosts", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/ConvertibleDebenturePayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "imle_UnrecognizedCompensationExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Unrecognized compensation expense" } } }, "localname": "UnrecognizedCompensationExpense", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "imle_ValuationAllowancePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Valuation allowance, percentage" } } }, "localname": "ValuationAllowancePercentage", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "imle_VemonJustusMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Vemon Justus [Member]" } } }, "localname": "VemonJustusMember", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "imle_WarrantsExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants exercise price", "verboseLabel": "Warrants exercise price" } } }, "localname": "WarrantsExercisePrice", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/RelatedPartyTransactionsDetailsNarrative", "http://imle.com/role/StockWarrantsAndStockOptionsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "imle_WarrantsIssuedToPurchaseCommonShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants issued to purchase common shares" } } }, "localname": "WarrantsIssuedToPurchaseCommonShares", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/ConvertibleDebenturePayableDetailsNarrative" ], "xbrltype": "sharesItemType" }, "imle_WarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants [Member]", "verboseLabel": "Warrants [Member]" } } }, "localname": "WarrantsMember", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetails", "http://imle.com/role/StockWarrantsAndStockOptionsDetails1" ], "xbrltype": "domainItemType" }, "imle_WarrantsOutstandingExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants outstanding, Exercised" } } }, "localname": "WarrantsOutstandingExercised", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetails1" ], "xbrltype": "perShareItemType" }, "imle_WarrantsPurchased": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants purchased", "verboseLabel": "Warrants purchased" } } }, "localname": "WarrantsPurchased", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/RelatedPartyTransactionsDetailsNarrative", "http://imle.com/role/StockWarrantsAndStockOptionsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "imle_WeightedAverageExercisePricePerShareBeginningBalance": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price Per Share, Beginning balance" } } }, "localname": "WeightedAverageExercisePricePerShareBeginningBalance", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetails1" ], "xbrltype": "perShareItemType" }, "imle_WeightedAverageExercisePricePerShareEndingBalance": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price Per Share, ending balance" } } }, "localname": "WeightedAverageExercisePricePerShareEndingBalance", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetails1" ], "xbrltype": "perShareItemType" }, "imle_WeightedAverageExercisePricePerShareWarrantsExercisedPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price Per Share, Warrants exercised" } } }, "localname": "WeightedAverageExercisePricePerShareWarrantsExercisedPerShare", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetails1" ], "xbrltype": "perShareItemType" }, "imle_WeightedAverageExercisePricePerShareWarrantsGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price Per Share, Warrants granted" } } }, "localname": "WeightedAverageExercisePricePerShareWarrantsGranted", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetails1" ], "xbrltype": "perShareItemType" }, "imle_WeightedAverageExercisePricePerSharesBeginningBalance": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price Per Shares beginning balance" } } }, "localname": "WeightedAverageExercisePricePerSharesBeginningBalance", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetails3" ], "xbrltype": "perShareItemType" }, "imle_WeightedAverageExercisePricePerSharesEndingBalance": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price Per Shares ending balance" } } }, "localname": "WeightedAverageExercisePricePerSharesEndingBalance", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetails3" ], "xbrltype": "perShareItemType" }, "imle_WeightedAverageExercisePricePerSharesExercisableBeginningBalance": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price Per Shares exercisable beginning balance" } } }, "localname": "WeightedAverageExercisePricePerSharesExercisableBeginningBalance", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetails3" ], "xbrltype": "perShareItemType" }, "imle_WeightedAverageExercisePricePerSharesExercisableEndingBalance": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price Per Shares exercisable ending balance" } } }, "localname": "WeightedAverageExercisePricePerSharesExercisableEndingBalance", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetails3" ], "xbrltype": "perShareItemType" }, "imle_WeightedAverageExercisePricePerSharesOptionsGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price Per Shares options granted" } } }, "localname": "WeightedAverageExercisePricePerSharesOptionsGranted", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetails3" ], "xbrltype": "perShareItemType" }, "imle_WeightedAverageRemainingContractualLifeBeginningBalance": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Remaining Contractual Life , Beginning balance" } } }, "localname": "WeightedAverageRemainingContractualLifeBeginningBalance", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetails1" ], "xbrltype": "durationItemType" }, "imle_WeightedAverageRemainingContractualLifeEndingBalance": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Remaining Contractual Life, Ending balance" } } }, "localname": "WeightedAverageRemainingContractualLifeEndingBalance", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetails1" ], "xbrltype": "durationItemType" }, "imle_WeightedAverageRemainingContractualLifeWarrantsGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Remaining Contractual Life, Warrants granted" } } }, "localname": "WeightedAverageRemainingContractualLifeWarrantsGranted", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetails1" ], "xbrltype": "durationItemType" }, "imle_WeightedAverageRemainingContractualLifesBeginningBalance": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Remaining Contractual Lifes beginning balance" } } }, "localname": "WeightedAverageRemainingContractualLifesBeginningBalance", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetails3" ], "xbrltype": "durationItemType" }, "imle_WeightedAverageRemainingContractualLifesEndingBalance": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Remaining Contractual Lifes ending balance" } } }, "localname": "WeightedAverageRemainingContractualLifesEndingBalance", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetails3" ], "xbrltype": "durationItemType" }, "imle_WeightedAverageRemainingContractualLifesExercisableBeginningBalance": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Remaining Contractual Lifes, Exercisable, Beginning balance" } } }, "localname": "WeightedAverageRemainingContractualLifesExercisableBeginningBalance", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetails3" ], "xbrltype": "durationItemType" }, "imle_WeightedAverageRemainingContractualLifesExercisableEndingBalance": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Remaining Contractual Lifes, Exercisable, Ending balance" } } }, "localname": "WeightedAverageRemainingContractualLifesExercisableEndingBalance", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetails3" ], "xbrltype": "durationItemType" }, "imle_WeightedAverageRemainingContractualLifesOptionsGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Remaining Contractual Lifes options granted" } } }, "localname": "WeightedAverageRemainingContractualLifesOptionsGranted", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetails3" ], "xbrltype": "durationItemType" }, "imle_WorkingCapital": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Working capital" } } }, "localname": "WorkingCapital", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "imle_ccvfh": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Settlement of outstanding judgement" } } }, "localname": "ccvfh", "nsuri": "http://imle.com/20210930", "presentation": [ "http://imle.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "srt_ConsolidationItemsAxis": { "auth_ref": [ "r113", "r118", "r119", "r120", "r121", "r122", "r124", "r127" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Axis]" } } }, "localname": "ConsolidationItemsAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://imle.com/role/PreferredStockDetailsNarratve" ], "xbrltype": "stringItemType" }, "srt_ConsolidationItemsDomain": { "auth_ref": [ "r113", "r118", "r119", "r120", "r121", "r122", "r124", "r127" ], "localname": "ConsolidationItemsDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://imle.com/role/PreferredStockDetailsNarratve" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r181", "r183", "r281", "r282", "r283", "r284", "r285", "r286", "r305", "r351", "r352" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "verboseLabel": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://imle.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://imle.com/role/DerivativeLiabilityDetailsNarrative", "http://imle.com/role/NotesPayableDetailsNarrative", "http://imle.com/role/StockWarrantsAndStockOptionsDetails", "http://imle.com/role/StockWarrantsAndStockOptionsDetails1", "http://imle.com/role/StockWarrantsAndStockOptionsDetails2", "http://imle.com/role/StockWarrantsAndStockOptionsDetails3", "http://imle.com/role/StockWarrantsAndStockOptionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r181", "r183", "r281", "r282", "r283", "r284", "r285", "r286", "r305", "r351", "r352" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "verboseLabel": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://imle.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://imle.com/role/DerivativeLiabilityDetailsNarrative", "http://imle.com/role/NotesPayableDetailsNarrative", "http://imle.com/role/StockWarrantsAndStockOptionsDetails", "http://imle.com/role/StockWarrantsAndStockOptionsDetails1", "http://imle.com/role/StockWarrantsAndStockOptionsDetails2", "http://imle.com/role/StockWarrantsAndStockOptionsDetails3", "http://imle.com/role/StockWarrantsAndStockOptionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r178", "r181", "r183", "r281", "r282", "r283", "r284", "r285", "r286", "r305", "r351", "r352" ], "lang": { "en-us": { "role": { "label": "Range Axis" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://imle.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://imle.com/role/DerivativeLiabilityDetailsNarrative", "http://imle.com/role/NotesPayableDetailsNarrative", "http://imle.com/role/StockWarrantsAndStockOptionsDetails", "http://imle.com/role/StockWarrantsAndStockOptionsDetails1", "http://imle.com/role/StockWarrantsAndStockOptionsDetails2", "http://imle.com/role/StockWarrantsAndStockOptionsDetails3", "http://imle.com/role/StockWarrantsAndStockOptionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r178", "r181", "r183", "r281", "r282", "r283", "r284", "r285", "r286", "r305", "r351", "r352" ], "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://imle.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://imle.com/role/DerivativeLiabilityDetailsNarrative", "http://imle.com/role/NotesPayableDetailsNarrative", "http://imle.com/role/StockWarrantsAndStockOptionsDetails", "http://imle.com/role/StockWarrantsAndStockOptionsDetails1", "http://imle.com/role/StockWarrantsAndStockOptionsDetails2", "http://imle.com/role/StockWarrantsAndStockOptionsDetails3", "http://imle.com/role/StockWarrantsAndStockOptionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r131", "r269" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://imle.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://imle.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://imle.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://imle.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ORGANIZATION OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": { "auth_ref": [ "r29" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.", "label": "NOTE 8. NOTES PAYABLE" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/NotesPayable" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r28" ], "calculation": { "http://imle.com/role/CondensedConsolidatedBalanceSheets": { "order": 15.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r33" ], "calculation": { "http://imle.com/role/CondensedConsolidatedBalanceSheets": { "order": 14.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued expenses", "terseLabel": "Accrued interest", "verboseLabel": "Accrued interest" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://imle.com/role/CondensedConsolidatedBalanceSheets", "http://imle.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r20", "r210" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.", "label": "Additional paid-in capital", "verboseLabel": "Additional paid in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CommonStockDetailsNarrative", "http://imle.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r79", "r80", "r81", "r207", "r208", "r209" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficitUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_AdvertisingCostsPolicyTextBlock": { "auth_ref": [ "r212" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for advertising cost.", "label": "Advertising and Marketing Costs" } } }, "localname": "AdvertisingCostsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax": { "auth_ref": [], "calculation": { "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of expense for award under share-based payment arrangement.", "label": "[Share-based Payment Arrangement, Expense, after Tax]", "verboseLabel": "Stock-based compensation expense" } } }, "localname": "AllocatedShareBasedCompensationExpenseNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfDebtDiscountPremium": { "auth_ref": [ "r54", "r63", "r256" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.", "label": "Amortization expenses, beneficial conversion feature" } } }, "localname": "AmortizationOfDebtDiscountPremium", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetImpairmentCharges": { "auth_ref": [ "r63", "r157" ], "calculation": { "http://imle.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.", "label": "Asset impairment adjustment" } } }, "localname": "AssetImpairmentCharges", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r74", "r117", "r120", "r126", "r136", "r231", "r234", "r247", "r329", "r343" ], "calculation": { "http://imle.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "[Assets]", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r7", "r9", "r39", "r74", "r136", "r231", "r234", "r247" ], "calculation": { "http://imle.com/role/CondensedConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "[Assets, Current]", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AwardDateAxis": { "auth_ref": [ "r186", "r206" ], "lang": { "en-us": { "role": { "documentation": "Information by date or year award under share-based payment arrangement is granted.", "label": "Award Date [Axis]" } } }, "localname": "AwardDateAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/GoingConcernDetailsNarrative", "http://imle.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AwardDateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date or year award under share-based payment arrangement is granted." } } }, "localname": "AwardDateDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/GoingConcernDetailsNarrative", "http://imle.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r186", "r206" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type Axis" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r180", "r182" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/AssetPurchaseDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r180", "r182", "r226", "r227" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/AssetPurchaseDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_Cash": { "auth_ref": [ "r25", "r358", "r359" ], "calculation": { "http://imle.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r3", "r25", "r65" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "[Cash and Cash Equivalents, at Carrying Value]", "periodEndLabel": "Cash At The End Of The Period", "periodStartLabel": "Cash At The Beginning Of The Period" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r12", "r66", "r71" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "verboseLabel": "Cash" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashFDICInsuredAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.", "label": "FDIC insured limit" } } }, "localname": "CashFDICInsuredAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Non-Cash Investing And Financing Activities:" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_CashPeriodIncreaseDecrease": { "auth_ref": [], "calculation": { "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash. Cash is the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Includes effect from exchange rate changes.", "label": "[Cash, Period Increase (Decrease)]", "totalLabel": "Net Change In Cash" } } }, "localname": "CashPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r72", "r74", "r91", "r92", "r93", "r95", "r97", "r101", "r102", "r103", "r136", "r247" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CommonStockDetailsNarrative", "http://imle.com/role/CondensedConsolidatedBalanceSheets", "http://imle.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://imle.com/role/PreferredStockDetailsNarratve", "http://imle.com/role/StockWarrantsAndStockOptionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightAxis": { "auth_ref": [ "r176", "r184" ], "lang": { "en-us": { "role": { "documentation": "Information by type of warrant or right issued.", "label": "Class of Warrant or Right [Axis]" } } }, "localname": "ClassOfWarrantOrRightAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetails", "http://imle.com/role/StockWarrantsAndStockOptionsDetails1" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months." } } }, "localname": "ClassOfWarrantOrRightDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetails", "http://imle.com/role/StockWarrantsAndStockOptionsDetails1" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r173" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Exercise price of warrants" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights outstanding.", "label": "[Class of Warrant or Right, Outstanding]", "terseLabel": "Number of warrants outstanding", "verboseLabel": "Outstanding warrants" } } }, "localname": "ClassOfWarrantOrRightOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CommonStockDetailsNarrative", "http://imle.com/role/NotesPayableDetailsNarrative", "http://imle.com/role/StockWarrantsAndStockOptionsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r161", "r162", "r163", "r164" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "NOTE 14. COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r79", "r80" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficitUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "COMMON STOCK" } } }, "localname": "CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, shares par value", "verboseLabel": "Common stock, par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, shares authorized", "verboseLabel": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, shares issued", "verboseLabel": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://imle.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r19", "r172" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesSubscriptions": { "auth_ref": [ "r19", "r171" ], "calculation": { "http://imle.com/role/CondensedConsolidatedBalanceSheets": { "order": 11.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Monetary value of common stock allocated to investors to buy shares of a new issue of common stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds.", "label": "Common stock subscriptions payable", "verboseLabel": "Common stock shares subscriptions, amount" } } }, "localname": "CommonStockSharesSubscriptions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedBalanceSheets", "http://imle.com/role/StockSubscriptionsPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r19" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock, $0.00001 par value; 100,000,000 shares authorized; 25,981,203 and 25,922,034 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively", "verboseLabel": "Common stock valued" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CommonStockDetailsNarrative", "http://imle.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r43", "r45", "r50", "r230", "r237", "r334", "r349" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Net (income) loss attributable to noncontrolling interest" } } }, "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskDisclosureTextBlock": { "auth_ref": [ "r111" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.", "label": "Concentration of Credit Risk" } } }, "localname": "ConcentrationRiskDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r71", "r233" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Principles of consolidations" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractTerminationClaimsDescription": { "auth_ref": [ "r306", "r307", "r308", "r309", "r310", "r311", "r312" ], "lang": { "en-us": { "role": { "documentation": "General description of claims, deemed to be reimbursable and included in accounts receivable, relating to the termination of long-term government contracts and programs. Includes claims associated with terminated war and defense contracts. If a reasonable estimate of a termination claim is undeterminable or impossible to make, disclosure is made to discuss the status and circumstances related to the undeterminable claim.", "label": "Termination date description" } } }, "localname": "ContractTerminationClaimsDescription", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/GoingConcernDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConversionOfStockSharesConverted1": { "auth_ref": [ "r68", "r69", "r70" ], "lang": { "en-us": { "role": { "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Conversion of preferred stock shares" } } }, "localname": "ConversionOfStockSharesConverted1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/PreferredStockDetailsNarratve" ], "xbrltype": "sharesItemType" }, "us-gaap_ConvertibleDebtCurrent": { "auth_ref": [ "r15" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "[Convertible Debt, Current]", "verboseLabel": "Convertible Notes Payable" } } }, "localname": "ConvertibleDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of borrowings which can be exchanged for a specified number of another security at the option of the issuer or the holder. Disclosures include, but are not limited to, principal amount, amortized premium or discount, and amount of liability and equity components.", "label": "Schedule of debenture payable" } } }, "localname": "ConvertibleDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/ConvertibleDebenturePayableTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConvertibleLongTermNotesPayable": { "auth_ref": [ "r36" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.", "label": "[Convertible Notes Payable, Noncurrent]", "verboseLabel": "Convertible Notes Payable" } } }, "localname": "ConvertibleLongTermNotesPayable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/NotesPayableDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleNotesPayable": { "auth_ref": [ "r16", "r330", "r344", "r360" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.", "label": "Convertible Notes Payable", "terseLabel": "Net Long-Term Portion", "verboseLabel": "Convertible notes payable" } } }, "localname": "ConvertibleNotesPayable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/AssetPurchaseDetailsNarrative", "http://imle.com/role/NotesPayableDetails", "http://imle.com/role/NotesPayableDetails1", "http://imle.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleNotesPayableCurrent": { "auth_ref": [ "r33" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.", "label": "[Convertible Notes Payable, Current]", "negatedLabel": "Current portion", "verboseLabel": "Convertible notes payable principal" } } }, "localname": "ConvertibleNotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/NotesPayableDetails", "http://imle.com/role/NotesPayableDetails1", "http://imle.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtConversionConvertedInstrumentAmount1": { "auth_ref": [ "r68", "r70" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Debt Conversion, Converted Instrument, Amount" } } }, "localname": "DebtConversionConvertedInstrumentAmount1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CommonStockDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": { "auth_ref": [ "r68", "r70" ], "lang": { "en-us": { "role": { "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period.", "label": "Debt conversion, converted instrument, shares issued, shares", "verboseLabel": "Debt conversion, converted instrument, shares issued" } } }, "localname": "DebtConversionConvertedInstrumentSharesIssued1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CommonStockDetailsNarrative", "http://imle.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_DebtConversionDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The name of the original debt issue that has been converted in a noncash (or part noncash) transaction during the accounting period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Debt conversion price description" } } }, "localname": "DebtConversionDescription", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CommonStockDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtConversionOriginalDebtInterestRateOfDebt": { "auth_ref": [ "r68", "r70" ], "lang": { "en-us": { "role": { "documentation": "The rate of interest that was being paid on the original debt issue that is being converted in the noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Interest rate", "verboseLabel": "Interest rate" } } }, "localname": "DebtConversionOriginalDebtInterestRateOfDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/AssetPurchaseDetailsNarrative", "http://imle.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r170" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "NOTE 7. CONVERTIBLE DEBENTURE PAYABLE" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/ConvertibleDebenturePayable" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentCarryingAmount": { "auth_ref": [ "r16", "r165", "r330", "r341" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.", "label": "Net Convertible Debenture Payable" } } }, "localname": "DebtInstrumentCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/ConvertibleDebenturePayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r166" ], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Debt conversion rate", "terseLabel": "Debt instrument, convertible, conversion price", "verboseLabel": "Note payable conversion price per share" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CommonStockDetailsNarrative", "http://imle.com/role/NotesPayableDetailsNarrative", "http://imle.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r257", "r260" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt amount", "verboseLabel": "Convertible debt, conversion, principal amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/NotesPayableDetailsNarrative", "http://imle.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFairValue": { "auth_ref": [ "r246" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.", "label": "Debt instrument principal value, after forgivness" } } }, "localname": "DebtInstrumentFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentIncreaseAccruedInterest": { "auth_ref": [ "r76" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase for accrued, but unpaid interest on the debt instrument for the period.", "label": "[Debt Instrument, Increase, Accrued Interest]", "verboseLabel": "Accrued interest" } } }, "localname": "DebtInstrumentIncreaseAccruedInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentMaturityDate": { "auth_ref": [ "r35", "r242" ], "lang": { "en-us": { "role": { "documentation": "Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.", "label": "Due date notes payable" } } }, "localname": "DebtInstrumentMaturityDate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [ "r256", "r260" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount.", "label": "[Debt Instrument, Unamortized Discount]", "verboseLabel": "Unamortized discount" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet": { "auth_ref": [ "r256", "r257", "r258", "r259", "r260" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount (premium).", "label": "Unamortized Debt Discount", "terseLabel": "Unamortized Debt Discount", "verboseLabel": "Unamortized Debt Discount" } } }, "localname": "DebtInstrumentUnamortizedDiscountPremiumNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/ConvertibleDebenturePayableDetails", "http://imle.com/role/NotesPayableDetails", "http://imle.com/role/NotesPayableDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCompensationArrangementWithIndividualExercisePrice": { "auth_ref": [ "r189" ], "lang": { "en-us": { "role": { "documentation": "The per share price that the individual must pay to acquire shares under the deferred compensation arrangement.", "label": "Exercise price per share" } } }, "localname": "DeferredCompensationArrangementWithIndividualExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/AssetPurchaseDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r63", "r158" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "[Depreciation]", "verboseLabel": "Depreciation" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r63", "r115" ], "calculation": { "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortizationPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for depreciation, depletion, and amortization of property and equipment costs, including methods used and estimated useful lives and how impairment of such assets is assessed and recognized.", "label": "Depreciation" } } }, "localname": "DepreciationDepletionAndAmortizationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet": { "auth_ref": [ "r239" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair values as of the balance sheet date of the net amount of all assets and liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments.", "label": "Fair value assets and liabilities" } } }, "localname": "DerivativeAssetsLiabilitiesAtFairValueNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeFixedInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fixed interest rate related to the interest rate derivative.", "label": "Unseured note interest rate", "verboseLabel": "Default interest rate" } } }, "localname": "DerivativeFixedInterestRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/NotesPayableDetailsNarrative", "http://imle.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DerivativeGainLossOnDerivativeNet": { "auth_ref": [ "r240" ], "calculation": { "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.", "label": "Change in fair value of derivative liability" } } }, "localname": "DerivativeGainLossOnDerivativeNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilities": { "auth_ref": [ "r40", "r41", "r246" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative liabilites", "verboseLabel": "Fair value of embeded derivative liability" } } }, "localname": "DerivativeLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/DerivativeLiabilityDetailsNarrative", "http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "DERIVATIVE LIABILITY" } } }, "localname": "DerivativeLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_DerivativeLiabilitiesCurrent": { "auth_ref": [ "r40" ], "calculation": { "http://imle.com/role/CondensedConsolidatedBalanceSheets": { "order": 10.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative liability" } } }, "localname": "DerivativeLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativesAndFairValueTextBlock": { "auth_ref": [ "r241", "r244" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for derivatives and fair value of assets and liabilities.", "label": "NOTE 9. DERIVATIVE LIABILITY" } } }, "localname": "DerivativesAndFairValueTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/DerivativeLiability" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "STOCK SUBSCRIPTIONS PAYABLE" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_DividendsPreferredStock": { "auth_ref": [ "r174", "r339" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).", "label": "Accrued dividends payable" } } }, "localname": "DividendsPreferredStock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/PreferredStockDetailsNarratve" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsPreferredStockStock": { "auth_ref": [ "r174", "r339" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in stock.", "label": "Preferred stock dividend accrued" } } }, "localname": "DividendsPreferredStockStock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueToRelatedPartiesCurrent": { "auth_ref": [ "r28", "r78", "r267" ], "calculation": { "http://imle.com/role/CondensedConsolidatedBalanceSheets": { "order": 12.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).", "label": "Related party payables", "verboseLabel": "Due to related party" } } }, "localname": "DueToRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://imle.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareBasicAndDiluted": { "auth_ref": [ "r96" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Basic and diluted loss per common share" } } }, "localname": "EarningsPerShareBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r71", "r98", "r99" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Net loss per share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "PREFERRED STOCK" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r79", "r80", "r81", "r83", "r88", "r90", "r100", "r137", "r172", "r174", "r207", "r208", "r209", "r221", "r222", "r249", "r250", "r251", "r252", "r253", "r254", "r353", "r354", "r355" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficitUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentQuotedMarketValue": { "auth_ref": [ "r135" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This item represents the aggregate value of each identified investment accounted for under the equity method of accounting based on the quoted market price for those investments in common stock for which a quoted market price is available.", "label": "Market price of shares" } } }, "localname": "EquityMethodInvestmentQuotedMarketValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/AssetPurchaseDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r71", "r243", "r245" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueOptionChangesInFairValueGainLoss1": { "auth_ref": [ "r248" ], "calculation": { "http://imle.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": { "order": 11.0, "parentTag": "us-gaap_OtherNoncashIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "For each line item in the statement of financial position, the amounts of gains and losses from fair value changes included in earnings.", "label": "Gain on fair value adjustment - derivatives" } } }, "localname": "FairValueOptionChangesInFairValueGainLoss1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r133", "r134", "r138", "r139", "r140", "r141", "r142", "r144", "r145", "r146", "r147", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument Axis" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/GoingConcernDetailsNarrative", "http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPoliciesDetails", "http://imle.com/role/StockWarrantsAndStockOptionsDetails3" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Amortization Period" } } }, "localname": "FiniteLivedIntangibleAssetUsefulLife", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/IntangibleAssetsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r154" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Accumulated amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/IntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the next rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "2022" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/IntangibleAssetsDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized after the fifth rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Thereafter" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/IntangibleAssetsDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the fifth rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "2026" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/IntangibleAssetsDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the fourth rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/IntangibleAssetsDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the third rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/IntangibleAssetsDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the second rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/IntangibleAssetsDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r154", "r315" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Intangible assets, gross" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/IntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r154", "r314" ], "calculation": { "http://imle.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "SOBR Safe Intellectual Technology, net of accumulated amortization of $513,952 and $224,854 at September 30, 2021 and December 31, 2020, respectively", "verboseLabel": "Intangible assets, net" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedBalanceSheets", "http://imle.com/role/IntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "auth_ref": [ "r63", "r168", "r169" ], "calculation": { "http://imle.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": { "order": 12.0, "parentTag": "us-gaap_OtherNoncashIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Loss on extinguishment of debt, net", "terseLabel": "Gain on loan extinguishment", "verboseLabel": "Gain on related party debt conversion" } } }, "localname": "GainsLossesOnExtinguishmentOfDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CommonStockDetailsNarrative", "http://imle.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited", "http://imle.com/role/NotesPayableDetailsNarrative", "http://imle.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r53" ], "calculation": { "http://imle.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": { "order": 6.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeographicDistributionAxis": { "auth_ref": [ "r143", "r337", "r338" ], "lang": { "en-us": { "role": { "documentation": "Information by geographic distribution of business activity identified as either domestic or foreign. Excludes names of countries, states and provinces, and cities.", "label": "Geographic Distribution [Axis]" } } }, "localname": "GeographicDistributionAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_GeographicDistributionDomain": { "auth_ref": [ "r337", "r338" ], "lang": { "en-us": { "role": { "documentation": "Allocation of business activity identified as domestic or foreign. Excludes names of countries, states and provinces, and cities." } } }, "localname": "GeographicDistributionDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSET PURCHASE" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r156" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for goodwill and intangible assets.", "label": "NOTE 5. INTANGIBLE ASSETS" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/IntangibleAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": { "auth_ref": [ "r63", "r155" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.", "label": "Impairment loss" } } }, "localname": "ImpairmentOfIntangibleAssetsFinitelived", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossAttributableToParent": { "auth_ref": [ "r51" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of income (loss) attributable to parent. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments.", "label": "Net loss attributable to SOBR Safe, Inc." } } }, "localname": "IncomeLossAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": { "auth_ref": [ "r77", "r224" ], "calculation": { "http://imle.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": { "order": 16.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.", "label": "[Income (Loss) from Continuing Operations before Income Taxes, Domestic]", "totalLabel": "Loss before provision for income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r75", "r89", "r90", "r116", "r216", "r223", "r225", "r350" ], "calculation": { "http://imle.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": { "order": 15.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Provision for income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r46", "r71", "r214", "r215", "r217", "r218", "r219", "r220", "r361" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income tax" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r67" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Cash paid for income taxes" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r62" ], "calculation": { "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "[Increase (Decrease) in Accounts Payable]", "verboseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r62" ], "calculation": { "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "[Increase (Decrease) in Accrued Liabilities]", "verboseLabel": "Accrued expenses" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDueToRelatedParties": { "auth_ref": [ "r62" ], "calculation": { "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families; affiliates; or other parties with the ability to exert significant influence.", "label": "[Increase (Decrease) in Due to Related Parties]", "verboseLabel": "Related party payables" } } }, "localname": "IncreaseDecreaseInDueToRelatedParties", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInterestPayableNet": { "auth_ref": [ "r62" ], "calculation": { "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity.", "label": "[Increase (Decrease) in Interest Payable, Net]", "verboseLabel": "Accrued interest payable" } } }, "localname": "IncreaseDecreaseInInterestPayableNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInNotesPayableCurrent": { "auth_ref": [ "r62" ], "calculation": { "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 22.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in current portion (due within one year or one business cycle) of obligations evidenced by formal promissory notes.", "label": "Repayments of notes payable - related parties" } } }, "localname": "IncreaseDecreaseInNotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": { "auth_ref": [ "r62" ], "calculation": { "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.", "label": "[Increase (Decrease) in Other Noncurrent Assets]", "verboseLabel": "Other assets" } } }, "localname": "IncreaseDecreaseInOtherNoncurrentAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "auth_ref": [ "r62" ], "calculation": { "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.", "label": "[Increase (Decrease) in Prepaid Expense]", "verboseLabel": "Prepaid expenses" } } }, "localname": "IncreaseDecreaseInPrepaidExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "INTANGIBLE ASSETS" } } }, "localname": "IntangibleAssetsNetExcludingGoodwillAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r47", "r114", "r255", "r258", "r336" ], "calculation": { "http://imle.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": { "order": 10.0, "parentTag": "us-gaap_OtherNoncashIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "[Interest Expense]", "negatedLabel": "Interest expense", "verboseLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited", "http://imle.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseDebt": { "auth_ref": [ "r54", "r167" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.", "label": "[Interest Expense, Debt]", "verboseLabel": "Interest expense" } } }, "localname": "InterestExpenseDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/ConvertibleDebenturePayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseRelatedParty": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of interest expense incurred on a debt or other obligation to related party.", "label": "Interest expenses for related party notes" } } }, "localname": "InterestExpenseRelatedParty", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseSubordinatedNotesAndDebentures": { "auth_ref": [ "r335" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Interest expense incurred during the reporting period on subordinated notes and debentures. Includes amortization of expenses incurred in the issuance of subordinated notes and debentures.", "label": "Convertible debenture payable discount" } } }, "localname": "InterestExpenseSubordinatedNotesAndDebentures", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r58", "r60", "r67" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Cash paid for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrent": { "auth_ref": [ "r10", "r11", "r33" ], "calculation": { "http://imle.com/role/CondensedConsolidatedBalanceSheets": { "order": 13.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued interest payable", "verboseLabel": "Accrued interest" } } }, "localname": "InterestPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedBalanceSheets", "http://imle.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseAndRentalExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "[Operating Leases, Rent Expense]", "terseLabel": "Rent expense", "verboseLabel": "Rent" } } }, "localname": "LeaseAndRentalExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://imle.com/role/PrepaidExpensesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseExpirationDate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date which lease or group of leases is set to expire, in CCYY-MM-DD format.", "label": "Lease expiration term" } } }, "localname": "LeaseExpirationDate1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "PREPAID EXPENSES" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_LegalFees": { "auth_ref": [ "r52" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.", "label": "Legal fees" } } }, "localname": "LegalFees", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r32", "r74", "r121", "r136", "r232", "r234", "r235", "r247" ], "calculation": { "http://imle.com/role/CondensedConsolidatedBalanceSheets": { "order": 19.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "[Liabilities]", "totalLabel": "Total Liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r24", "r74", "r136", "r247", "r332", "r347" ], "calculation": { "http://imle.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "[Liabilities and Equity]", "totalLabel": "Total Liabilities and Stockholders' Equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES & STOCKHOLDERS' EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r34", "r74", "r136", "r232", "r234", "r235", "r247" ], "calculation": { "http://imle.com/role/CondensedConsolidatedBalanceSheets": { "order": 16.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "[Liabilities, Current]", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current liabilities", "verboseLabel": "Current liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedBalanceSheets", "http://imle.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "STOCK WARRANTS AND STOCK OPTIONS (Details Narrative)" } } }, "localname": "LineOfCreditFacilityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_ManagementFeeExpense": { "auth_ref": [ "r268" ], "calculation": { "http://imle.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": { "order": 4.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses related to the managing member or general partner for management of the day-to-day business functions of the limited liability company (LLC) or limited partnership (LP).", "label": "Management salaries and consulting fees" } } }, "localname": "ManagementFeeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_MarketingAndAdvertisingExpense": { "auth_ref": [ "r53" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The total expense recognized in the period for promotion, public relations, and brand or product advertising.", "label": "Advertising and marketing costs" } } }, "localname": "MarketingAndAdvertisingExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r38", "r74", "r136", "r247", "r331", "r346" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).", "label": "Noncontrolling interest" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestOwnershipPercentageByParent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.", "label": "Ownership interest, percentage" } } }, "localname": "MinorityInterestOwnershipPercentageByParent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r59" ], "calculation": { "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 24.0, "parentTag": "us-gaap_CashPeriodIncreaseDecrease", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "[Net Cash Provided by (Used in) Financing Activities]", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Financing Activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r59", "r61", "r64" ], "calculation": { "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 25.0, "parentTag": "us-gaap_CashPeriodIncreaseDecrease", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "[Net Cash Provided by (Used in) Operating Activities]", "totalLabel": "Net cash used in operating activities", "verboseLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://imle.com/role/GoingConcernDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r0", "r42", "r44", "r49", "r64", "r74", "r82", "r84", "r85", "r86", "r87", "r89", "r90", "r94", "r117", "r119", "r122", "r125", "r127", "r136", "r247", "r333", "r348" ], "calculation": { "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://imle.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "[Net Income (Loss) Attributable to Parent]", "terseLabel": "Net loss", "totalLabel": "Net loss", "verboseLabel": "Net loss for the period" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://imle.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficitUnaudited", "http://imle.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r79", "r80", "r81", "r174", "r228" ], "lang": { "en-us": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficitUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_NotesPayableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NOTES PAYABLE" } } }, "localname": "NotesPayableAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_NotesPayableCurrent": { "auth_ref": [ "r31" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.", "label": "Net Non-Related Party Notes Payable" } } }, "localname": "NotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/NotesPayableDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayableRelatedPartiesClassifiedCurrent": { "auth_ref": [ "r27", "r78", "r268" ], "calculation": { "http://imle.com/role/CondensedConsolidatedBalanceSheets": { "order": 8.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Current portion notes payable - related parties", "verboseLabel": "Net Related Party Notes Payable" } } }, "localname": "NotesPayableRelatedPartiesClassifiedCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedBalanceSheets", "http://imle.com/role/NotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://imle.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": { "order": 7.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "[Operating Expenses]", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r117", "r119", "r122", "r125", "r127" ], "calculation": { "http://imle.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": { "order": 14.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "[Operating Income (Loss)]", "totalLabel": "Loss from operations", "verboseLabel": "Loss from operation" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited", "http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r262", "r263" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating lease, monthly payment" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesRentExpenseSubleaseRentals1": { "auth_ref": [ "r261" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The total amount of sublease rental income recognized during the period that reduces the entity's rent expense incurred under operating leases.", "label": "[Operating Leases, Rent Expense, Sublease Rentals]", "verboseLabel": "Prepaid expenses with common shares" } } }, "localname": "OperatingLeasesRentExpenseSubleaseRentals1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r2", "r238" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "NOTE 1. ORGANIZATION, OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssets": { "auth_ref": [ "r14", "r328", "r342" ], "calculation": { "http://imle.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets classified as other.", "label": "Other assets" } } }, "localname": "OtherAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCurrentAssetsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for other current assets.", "label": "NOTE 4. PREPAID EXPENSES" } } }, "localname": "OtherCurrentAssetsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/PrepaidExpenses" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherIncomeAndExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other income (expense):" } } }, "localname": "OtherIncomeAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_OtherNoncashIncomeExpense": { "auth_ref": [ "r64" ], "calculation": { "http://imle.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": { "order": 13.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.", "label": "[Other Noncash Income (Expense)]", "totalLabel": "Total other expense, net" } } }, "localname": "OtherNoncashIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDebtIssuanceCosts": { "auth_ref": [ "r57" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.", "label": "[Payments of Debt Issuance Costs]", "verboseLabel": "Debt issuance costs" } } }, "localname": "PaymentsOfDebtIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/ConvertibleDebenturePayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r186", "r206" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/AssetPurchaseDetailsNarrative", "http://imle.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://imle.com/role/CommonStockDetailsNarrative", "http://imle.com/role/DerivativeLiabilityDetailsNarrative", "http://imle.com/role/NotesPayableDetailsNarrative", "http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://imle.com/role/PreferredStockDetailsNarratve", "http://imle.com/role/PrepaidExpensesDetailsNarrative", "http://imle.com/role/RelatedPartyTransactionsDetailsNarrative", "http://imle.com/role/StockWarrantsAndStockOptionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement." } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/AssetPurchaseDetailsNarrative", "http://imle.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://imle.com/role/CommonStockDetailsNarrative", "http://imle.com/role/DerivativeLiabilityDetailsNarrative", "http://imle.com/role/NotesPayableDetailsNarrative", "http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://imle.com/role/PreferredStockDetailsNarratve", "http://imle.com/role/PrepaidExpensesDetailsNarrative", "http://imle.com/role/RelatedPartyTransactionsDetailsNarrative", "http://imle.com/role/StockWarrantsAndStockOptionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockConversionBasis": { "auth_ref": [ "r18", "r173" ], "lang": { "en-us": { "role": { "documentation": "Describe the conversion features of preferred stock if preferred stock is convertible. That is, shares of preferred stock into which another convertible security was converted, or shares of preferred stock into which another class of preferred stock was converted.", "label": "Preferred stock conversion description" } } }, "localname": "PreferredStockConversionBasis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/PreferredStockDetailsNarratve" ], "xbrltype": "stringItemType" }, "us-gaap_PreferredStockDividendsIncomeStatementImpact": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.", "label": "[Preferred Stock Dividends, Income Statement Impact]", "negatedLabel": "Accrued dividends on convertible preferred stock" } } }, "localname": "PreferredStockDividendsIncomeStatementImpact", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficitUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred stock, shares par value", "verboseLabel": "Preferred stock, par value" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://imle.com/role/PreferredStockDetailsNarratve" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred stock, shares authorized", "verboseLabel": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://imle.com/role/PreferredStockDetailsNarratve" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockTextBlock": { "auth_ref": [ "r177" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock.", "label": "NOTE 12. PREFERRED STOCK" } } }, "localname": "PreferredStockTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/PreferredStock" ], "xbrltype": "textBlockItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r18" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred stock, $0.00001 par value; 19,300,000 shares authorized, no shares issued or outstanding as of September 30, 2021 and December 31, 2020" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r4", "r8", "r150", "r151" ], "calculation": { "http://imle.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid expenses", "verboseLabel": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedBalanceSheets", "http://imle.com/role/PrepaidExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidInsurance": { "auth_ref": [ "r5", "r8", "r148", "r151" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Insurance" } } }, "localname": "PrepaidInsurance", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/PrepaidExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidRent": { "auth_ref": [ "r6", "r8", "r149", "r151" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for rent that provides economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Rent" } } }, "localname": "PrepaidRent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/PrepaidExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromConvertibleDebt": { "auth_ref": [ "r56" ], "calculation": { "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 20.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "Proceeds from convertible debenture payable" } } }, "localname": "ProceedsFromConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfDebt": { "auth_ref": [ "r56" ], "calculation": { "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 19.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.", "label": "[Proceeds from Issuance of Debt]", "negatedLabel": "Debt issuance costs", "verboseLabel": "Proceeds from convertible debt" } } }, "localname": "ProceedsFromIssuanceOfDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://imle.com/role/GoingConcernDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock": { "auth_ref": [ "r55" ], "calculation": { "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation.", "label": "Proceeds from offering of preferred stock - related parties" } } }, "localname": "ProceedsFromIssuanceOfPreferredStockAndPreferenceStock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromNotesPayable": { "auth_ref": [ "r56" ], "calculation": { "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 21.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation.", "label": "Proceeds from notes payable - non-related parties" } } }, "localname": "ProceedsFromNotesPayable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRelatedPartyDebt": { "auth_ref": [ "r56" ], "calculation": { "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 23.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.", "label": "Proceeds from notes payable - related parties" } } }, "localname": "ProceedsFromRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r26", "r160" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Property, Plant and Equipment, Type [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/IntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r13", "r159" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/IntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r179", "r266", "r267" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CommonStockDetailsNarrative", "http://imle.com/role/NotesPayableDetails", "http://imle.com/role/NotesPayableDetails1", "http://imle.com/role/NotesPayableDetailsNarrative", "http://imle.com/role/StockSubscriptionsPayableDetailsNarrative", "http://imle.com/role/StockWarrantsAndStockOptionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r179", "r266", "r267", "r270" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CommonStockDetailsNarrative", "http://imle.com/role/NotesPayableDetailsNarrative", "http://imle.com/role/PreferredStockDetailsNarratve", "http://imle.com/role/RelatedPartyTransactionsDetailsNarrative", "http://imle.com/role/StockWarrantsAndStockOptionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r179" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party." } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CommonStockDetailsNarrative", "http://imle.com/role/NotesPayableDetailsNarrative", "http://imle.com/role/PreferredStockDetailsNarratve", "http://imle.com/role/RelatedPartyTransactionsDetailsNarrative", "http://imle.com/role/StockWarrantsAndStockOptionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RELATED PARTY TRANSACTIONS" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r179", "r266", "r270", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party Transactions By Related Party Axis" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CommonStockDetailsNarrative", "http://imle.com/role/NotesPayableDetails", "http://imle.com/role/NotesPayableDetails1", "http://imle.com/role/NotesPayableDetailsNarrative", "http://imle.com/role/StockSubscriptionsPayableDetailsNarrative", "http://imle.com/role/StockWarrantsAndStockOptionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r264", "r265", "r267", "r271", "r272" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "NOTE 6. RELATED PARTY TRANSACTIONS" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r213", "r362" ], "calculation": { "http://imle.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and development", "verboseLabel": "Research and development costs" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited", "http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "auth_ref": [ "r71", "r213" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.", "label": "Research and Development" } } }, "localname": "ResearchAndDevelopmentExpensePolicy", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestrictedAssetsDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for assets that are restricted in their use, generally by contractual agreements or regulatory requirements. This would include, but not limited to, a description of the restricted assets and the terms of the restriction.", "label": "NOTE 3. ASSET PURCHASE" } } }, "localname": "RestrictedAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/AssetPurchase" ], "xbrltype": "textBlockItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r21", "r174", "r210", "r345", "r356", "r357" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated deficit", "verboseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedBalanceSheets", "http://imle.com/role/GoingConcernDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r79", "r80", "r81", "r83", "r88", "r90", "r137", "r207", "r208", "r209", "r221", "r222", "r353", "r355" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated Deficit [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficitUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r48", "r74", "r112", "r113", "r118", "r123", "r124", "r128", "r129", "r130", "r136", "r247", "r338" ], "calculation": { "http://imle.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": { "order": 8.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_RisksAndUncertaintiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "GOING CONCERN" } } }, "localname": "RisksAndUncertaintiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.", "label": "Convertible preferred stock shares sold" } } }, "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_SaleOfStockPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.", "label": "Sale of stock price per share" } } }, "localname": "SaleOfStockPricePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r152", "r153" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.", "label": "Summary of Intangible Assets" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/IntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets and liabilities, classified as other.", "label": "Schedule of assets and liabilities" } } }, "localname": "ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amounts of other current assets.", "label": "Schedule of prepaid expenses" } } }, "localname": "ScheduleOfOtherCurrentAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/PrepaidExpensesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r189", "r197", "r199" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Schedule of outstanding options" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [ "r201" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule of fair value of non-employee stock/warrants" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShortTermDebtTextBlock": { "auth_ref": [ "r30" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.", "label": "Schedule of notes payables - related parties" } } }, "localname": "ScheduleOfShortTermDebtTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/NotesPayableTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the change in stock options.", "label": "Schedule of fair value of stock options" } } }, "localname": "ScheduleOfStockOptionsRollForwardTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SettlementLiabilitiesCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amounts payable for money transfers, money orders, and consumer payment service arrangements. Settlement liabilities include amounts payable to intermediaries for global payment transfers.", "label": "Contract settlement amount" } } }, "localname": "SettlementLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r62" ], "calculation": { "http://imle.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": { "order": 5.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Stock-based compensation expense" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r196" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Common stock issuable upon exercise of warrant, shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/AssetPurchaseDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.", "label": "Exercise Price", "verboseLabel": "Exercise Price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetails", "http://imle.com/role/StockWarrantsAndStockOptionsDetails2" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r204" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Dividend yield" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r203" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Volatility", "terseLabel": "Expected volatility", "verboseLabel": "Volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/DerivativeLiabilityDetailsNarrative", "http://imle.com/role/StockWarrantsAndStockOptionsDetails", "http://imle.com/role/StockWarrantsAndStockOptionsDetails2" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r205" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Risk free interest rate", "verboseLabel": "Risk free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/DerivativeLiabilityDetailsNarrative", "http://imle.com/role/StockWarrantsAndStockOptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r192" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "[Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number]", "periodEndLabel": "Option outstanding, exercisable, ending balance", "periodStartLabel": "Option outstanding, exercisable, beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetails3" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r192" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "[Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price]", "periodEndLabel": "Exercise Price Per Shares exercisable ending balance", "periodStartLabel": "Exercise Price Per Shares exercisable beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetails3" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": { "auth_ref": [ "r195" ], "lang": { "en-us": { "role": { "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.", "label": "Warrants Expired", "verboseLabel": "Options Expired" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetails1", "http://imle.com/role/StockWarrantsAndStockOptionsDetails3" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": { "auth_ref": [ "r193" ], "lang": { "en-us": { "role": { "documentation": "Net number of share options (or share units) granted during the period.", "label": "Warrants Granted", "terseLabel": "Detached free-standing stock warrants granted", "verboseLabel": "Option Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetails1", "http://imle.com/role/StockWarrantsAndStockOptionsDetails3", "http://imle.com/role/StockWarrantsAndStockOptionsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r191", "r206" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "[Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number]", "periodEndLabel": "Outstanding at ending of periods", "periodStartLabel": "Outstanding at beginning of period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetails1", "http://imle.com/role/StockWarrantsAndStockOptionsDetails3" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Change in the weighted average exercise price of options outstanding.", "label": "Exercise price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/ConvertibleDebenturePayableDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r190" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "[Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price]", "periodEndLabel": "Outstanding at end of period", "periodStartLabel": "Outstanding at beginning of period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetails1", "http://imle.com/role/StockWarrantsAndStockOptionsDetails3" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r184", "r187" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "[Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price]", "verboseLabel": "Warrants Exercised" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetails1" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Warrants outstanding, Granted", "verboseLabel": "Exercise Price Per Shares option granted" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetails1", "http://imle.com/role/StockWarrantsAndStockOptionsDetails3" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r71", "r186", "r188" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Stock-based compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Shares issuance price" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/PreferredStockDetailsNarratve" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r202", "r211" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Expected life" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/DerivativeLiabilityDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r200" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Expected lives" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1": { "auth_ref": [ "r192" ], "lang": { "en-us": { "role": { "documentation": "Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.", "label": "Options exercisable per share" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/StockWarrantsAndStockOptionsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesIssued": { "auth_ref": [ "r172" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "[Shares, Issued]", "periodEndLabel": "Balance, shares", "periodStartLabel": "Balance, shares" } } }, "localname": "SharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficitUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Convertible notes, conversion price", "terseLabel": "Convertible notes, conversion price", "verboseLabel": "Common stock issued price per share" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/AssetPurchaseDetailsNarrative", "http://imle.com/role/NotesPayableDetailsNarrative", "http://imle.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ShortTermDebtTypeAxis": { "auth_ref": [ "r30" ], "lang": { "en-us": { "role": { "documentation": "Information by type of short-term debt arrangement.", "label": "Short Term Debt Type Axis" } } }, "localname": "ShortTermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermDebtTypeDomain": { "auth_ref": [ "r28" ], "lang": { "en-us": { "role": { "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing." } } }, "localname": "ShortTermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r17", "r18", "r19", "r72", "r74", "r91", "r92", "r93", "r95", "r97", "r101", "r102", "r103", "r136", "r172", "r247" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Statement Class Of Stock Axis" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CommonStockDetailsNarrative", "http://imle.com/role/CondensedConsolidatedBalanceSheets", "http://imle.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://imle.com/role/PreferredStockDetailsNarratve", "http://imle.com/role/StockWarrantsAndStockOptionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r37", "r79", "r80", "r81", "r83", "r88", "r90", "r100", "r137", "r172", "r174", "r207", "r208", "r209", "r221", "r222", "r249", "r250", "r251", "r252", "r253", "r254", "r353", "r354", "r355" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficitUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/AssetPurchaseDetailsNarrative", "http://imle.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://imle.com/role/CommonStockDetailsNarrative", "http://imle.com/role/CondensedConsolidatedBalanceSheets", "http://imle.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://imle.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficitUnaudited", "http://imle.com/role/DerivativeLiabilityDetailsNarrative", "http://imle.com/role/GoingConcernDetailsNarrative", "http://imle.com/role/IntangibleAssetsDetails", "http://imle.com/role/NotesPayableDetails", "http://imle.com/role/NotesPayableDetails1", "http://imle.com/role/NotesPayableDetailsNarrative", "http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPoliciesDetails", "http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://imle.com/role/PreferredStockDetailsNarratve", "http://imle.com/role/PrepaidExpensesDetailsNarrative", "http://imle.com/role/RelatedPartyTransactionsDetailsNarrative", "http://imle.com/role/StockSubscriptionsPayableDetailsNarrative", "http://imle.com/role/StockWarrantsAndStockOptionsDetails", "http://imle.com/role/StockWarrantsAndStockOptionsDetails1", "http://imle.com/role/StockWarrantsAndStockOptionsDetails2", "http://imle.com/role/StockWarrantsAndStockOptionsDetails3", "http://imle.com/role/StockWarrantsAndStockOptionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONDENSED CONSOLIDATED BALANCE SHEETS" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (UNAUDITED)" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r79", "r80", "r81", "r100", "r313" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/AssetPurchaseDetailsNarrative", "http://imle.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://imle.com/role/CommonStockDetailsNarrative", "http://imle.com/role/CondensedConsolidatedBalanceSheets", "http://imle.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://imle.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficitUnaudited", "http://imle.com/role/DerivativeLiabilityDetailsNarrative", "http://imle.com/role/GoingConcernDetailsNarrative", "http://imle.com/role/IntangibleAssetsDetails", "http://imle.com/role/NotesPayableDetails", "http://imle.com/role/NotesPayableDetails1", "http://imle.com/role/NotesPayableDetailsNarrative", "http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPoliciesDetails", "http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://imle.com/role/PreferredStockDetailsNarratve", "http://imle.com/role/PrepaidExpensesDetailsNarrative", "http://imle.com/role/RelatedPartyTransactionsDetailsNarrative", "http://imle.com/role/StockSubscriptionsPayableDetailsNarrative", "http://imle.com/role/StockWarrantsAndStockOptionsDetails", "http://imle.com/role/StockWarrantsAndStockOptionsDetails1", "http://imle.com/role/StockWarrantsAndStockOptionsDetails2", "http://imle.com/role/StockWarrantsAndStockOptionsDetails3", "http://imle.com/role/StockWarrantsAndStockOptionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "Common stock shares issued for services, shares" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CommonStockDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r18", "r19", "r172", "r174" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Common stock issued", "terseLabel": "Common stock shares issued for cash, shares", "verboseLabel": "Common stock issue for settlement" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CommonStockDetailsNarrative", "http://imle.com/role/PrepaidExpensesDetailsNarrative", "http://imle.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesOther": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued attributable to transactions classified as other.", "label": "Issuance of common stock" } } }, "localname": "StockIssuedDuringPeriodSharesOther", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.", "label": "Common stock, shares issued upon assets purchase" } } }, "localname": "StockIssuedDuringPeriodSharesPurchaseOfAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/AssetPurchaseDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "auth_ref": [ "r18", "r19", "r172", "r174" ], "lang": { "en-us": { "role": { "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).", "label": "Common stock issued for compensation, shares" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficitUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r18", "r19", "r172", "r174", "r194" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Common stock shares issued to option exercised" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CommonStockDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "auth_ref": [ "r18", "r19", "r174", "r185", "r198" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Common stock issued for compensation, amount" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficitUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockOptionPlanExpense": { "auth_ref": [ "r63" ], "calculation": { "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for option under share-based payment arrangement.", "label": "Stock options expense" } } }, "localname": "StockOptionPlanExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r19", "r22", "r23", "r74", "r132", "r136", "r247" ], "calculation": { "http://imle.com/role/CondensedConsolidatedBalanceSheets": { "order": 20.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Total Stockholders' Equity", "periodEndLabel": "Balance, amount", "periodStartLabel": "Balance, amount" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedBalanceSheets", "http://imle.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficitUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity", "verboseLabel": "Stockholders' Deficit" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedBalanceSheets", "http://imle.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r74", "r79", "r80", "r81", "r83", "r88", "r136", "r137", "r174", "r207", "r208", "r209", "r221", "r222", "r228", "r229", "r236", "r247", "r249", "r250", "r254", "r354", "r355" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Total SOBR Safe, Inc. stockholders' equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r73", "r174", "r177" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "NOTE 11. COMMON STOCK" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CommonStock" ], "xbrltype": "textBlockItemType" }, "us-gaap_StockholdersEquityReverseStockSplit": { "auth_ref": [ "r175" ], "lang": { "en-us": { "role": { "documentation": "Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.", "label": "Description of reverse stock split" } } }, "localname": "StockholdersEquityReverseStockSplit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r273", "r274" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "NOTE 15. SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.", "label": "NOTE 2. GOING CONCERN" } } }, "localname": "SubstantialDoubtAboutGoingConcernTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/GoingConcern" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowElementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Disclosure:" } } }, "localname": "SupplementalCashFlowElementsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_TimeDepositsAtOrAboveFDICInsuranceLimit": { "auth_ref": [ "r340" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of time deposit liabilities, including certificates of deposit, in denominations that meet or exceed the Federal Deposit Insurance Corporation (FDIC) insurance limit.", "label": "Excess of the FDIC insured limits" } } }, "localname": "TimeDepositsAtOrAboveFDICInsuranceLimit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r133", "r134", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms." } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/GoingConcernDetailsNarrative", "http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPoliciesDetails", "http://imle.com/role/StockWarrantsAndStockOptionsDetails3" ], "xbrltype": "domainItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r104", "r105", "r106", "r107", "r108", "r109", "r110" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/OrganizationOperationsAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WarrantsAndRightsNoteDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "STOCK WARRANTS AND STOCK OPTIONS" } } }, "localname": "WarrantsAndRightsNoteDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).", "label": "Weighted average number of common shares outstanding" } } }, "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://imle.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "sharesItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r1": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "40", "Topic": "205", "URI": "http://asc.fasb.org/subtopic&trid=51888271" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70229-108054" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e7018-107765" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r111": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4647-111522" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL120269820-111563" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919244-210447" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919253-210447" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919258-210447" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919230-210447" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121647567&loc=SL82921835-210448" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922895-210455" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922900-210455" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275" }, "r156": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "http://asc.fasb.org/topic&trid=2144416" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2420-110228" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308" }, "r163": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r164": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031898-161870" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6036836-161870" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12317-112629" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12355-112629" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.C)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187143-122770" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775" }, "r177": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b),(f)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)-(4)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r2": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(a)", "Topic": "720", "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32247-109318" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32280-109318" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r238": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "http://asc.fasb.org/topic&trid=2197479" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=117331979&loc=d3e41228-113958" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959" }, "r241": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "815", "URI": "http://asc.fasb.org/topic&trid=2229140" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260" }, "r244": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "820", "URI": "http://asc.fasb.org/topic&trid=2155941" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13279-108611" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13433-108611" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14172-108612" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28567-108399" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(Note 3)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=121580752&loc=d3e38371-112697" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a)(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r272": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/topic&trid=2122745" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r274": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "http://asc.fasb.org/topic&trid=2122774" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a),20,24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "275", "Topic": "912", "URI": "http://asc.fasb.org/extlink&oid=84167019&loc=d3e54658-109401" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "275", "Topic": "912", "URI": "http://asc.fasb.org/extlink&oid=84167019&loc=d3e54672-109401" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "275", "Topic": "912", "URI": "http://asc.fasb.org/extlink&oid=84167019&loc=d3e54708-109401" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "912", "URI": "http://asc.fasb.org/extlink&oid=84167097&loc=d3e55538-109407" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "912", "URI": "http://asc.fasb.org/extlink&oid=84167097&loc=d3e55541-109407" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "405", "Topic": "912", "URI": "http://asc.fasb.org/extlink&oid=84167112&loc=d3e56414-109416" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "405", "Topic": "912", "URI": "http://asc.fasb.org/extlink&oid=84167112&loc=d3e56417-109416" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(24))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.8)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "405", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "405", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=116652737&loc=d3e64164-112818" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(10))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(20))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "740", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r363": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r364": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r365": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r366": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)(1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(22))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.20)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.3)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)(3)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4273-108586" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4313-108586" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(h)(1)(i))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(k)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6787-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1278-109256" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2626-109256" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257" } }, "version": "2.1" } ZIP 74 0001477932-21-008406-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001477932-21-008406-xbrl.zip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

L;,0V_S/(-K +Y3$9!.T2LNH4$]ZC26_WH':_PG%MM4QV>^3Z MAF("\3]^_VV]1BB=@L%[NB2N\H^3@)VU9S_BHJ:7X/K7Z#O(-PE6@)@2WG]: MM!16*9H>Z00-S3^I+I!K5!*D>COS'MOA?22 M[/GQBNS^MR2IO0= O7E)_AO("&S#!&)??O^]I86@ND7+#S5'[A-"UT10JWC4 M]42F[X0*$!_D%NQ(LLP!70JB_RA[1U&T?)MD L^W3\$3AN0'D*.[>@C$ZV.X M62+&7@K6_R"3Y2QA3Y-I,!+B0@^R!PI3#;[U2 T< MZB?1+M: KUB<>>2R>B$E, B4C%"=B6X"N)2L89+;@+PS2!^N<_2$#0+\P2XG M+>"WSBNQ66=1O##GS'44X]COQ^U2\"U$3,O#0$RL \\A&3' J#^X]@D)TFLJ MG_-$7WSN1;V087J!#<2+I@,[3+:E@$,H6EB=WGF"@/TA>+FSO311$AG=D1J8 M6@C$K-DWT\TD *'287ENEL;P$Q'0[)* \WA!J*Y7%F\7<4+5F$\IR>]D&:XWO5?(T?CU(.[%): M#$E-W-UIXC%YRL[ML75Q-L2S_ ]QL/L+0O^1EU)'*+*Z[R&LA@:4NH#O,XND M1=(MW<9[W]CZN*DA6W/#X(-J="W$4,K8,<';?HXVC^,]5V;YV2R=6G?9AQP)#A593ZJW6Z34B]K;GKEY%AJ:;_00T:O0FGE 2FOU?+H]Z]?YC+ MT\]X[2#=\DU1BCCX^M]*"*?CN-8KZ)MXD49Q&?GXB-2\%(=T?$=U5 M72"YSX?DM[% "EY[3??;+1VD;$Y$3?,T!\A[WX"<-A5'P6B[,.F^7@%W7G![ ME_S'K4='1>5 QYD_?5"Q7!&/BG7+SBMY> MK\!D4.KJ"/_;YW$DNQ<3H-;2Z M-"OG+QX)@CQSFM3N+=,5$0M.2:P!%WDC611$]IK/MZYJUR;+([WW4.$0VN03 MB*@FP1]?XVHEDX+@7K/\UA9PEN:YQ9>024S-_/CKN(MHBCQ%O>8-[K2@):=M MJ!,_ /*4-[0B)B^-@LY>*T6Q:V*6?W\64MU@_H,D?I2276I'.L[T1&64H+O] MQQ$Q T7YC6#U8VP]%9!BZX;Z\7?T!I(H*.S5)L:H,RW-HE1? MY!G8A^)T-R"1S811<-FKO4M4U[B5?LT!X=LX]#[^TFPLCX+47HU=Y;SVU^LD MP_M ?!)]RQY7#H95WIDKV1N%EA7\"2AM*HZ"T5YS C*MY">G=O:Z>EH"[[PD M99.7B8:?1F9@N02(0\Q[/U:TE54Q4<;TJ3L6Y3LMNR;VKQ3U0IJO$15(%.6P M-D\I,10LCYH]KPK-(GG!<9(_=AKR"^YI)7BZ]WRYN[SQ?WB]N; MRYOYXVC5>:JH)0I5,N7'VDN[M/[WI6FU"/?'"EX=RS(= MB5W26?9I)52H^OXEI+JN"J44I03%S'U@,*&<5_QYOTWD\SJ+J:=J"4EBUH[@ MG.\(GQ?9RKY83M<;5B.A2Z M6=-Y<[7>>IN9M]YNR@Q)+%SY;R#7):8&Y U"CAF.^ML8\7CKC6G_*"\X]WS! MS1X?Y\N+^Z\/EW^?/[1:48ZHWHKCI\R:L,L/V<19O-%G4$"P M5LU_])[[#%7/D\C?D.!\C!)+4:(SLK%AA4!*%+7CAKDFFT ?;S&>YL1E:<2J M?G/4\Q>EO/+RJBC M_$Y(-1T%BELZ1]AL;5("TWAKXWP'8"T.]7QQW-PM9W>?;S[=SG?'UGBKXWSX M],X^_^&OM@%5"P[[G$16>?FO(&QXNE=1IZ =T1*+K=EWD$Y,U082-M"*,.;J M;"F$\19L^8EWF> XI1 S@Q!KX6KG"_=A?IO76KZ?/2Q_OU@^S.X>9Y>YJ6>\ M*QX'C\0MKZ8G,MW0;OD:.BRVANJE]$>0;GHAE'HZTO1P-,OFJ,=;E*<9CW;! M!F>9O\KK4C]?EY>+NU_G#\O\1+V:?YK?+;\^S.DJ_7U&_^8C+DW+4_5J_.A[ MOC\3;]-H&7(Z(,,N+E4FOO)Z,\_5TMUC.'T=?/^5A M2^1R9;1&MJ=8X9BV2JX3?RGS?Z-UU/*#2%%#MQJN-5+V !%5S+75%?5X:^]8 M?K88ZAMK"9KG2_!J_G#SZVQY\^O\XO9F]NGF]F;Y^V@KL0I"ZAU!V W92J#J MXYYAQ? RD_HA;$[J,!/W1*ZNNQ:0>&(Y%CA'FB3.\=97;2V!\BJSSE?9XW)Q M^>\7CU\_/5X^W-SO'NW'/O:. \R]%0_U+/?:R>4ZW:2Y;ZN75;RD:"7=P;I] M%[E.@*N%Y;OXQF;'@*IQ"12MPYT3OEQWI%JACP,@B[$?$DY7:RMIC'G;.[C@ MLA9IQ;OF2;(MT@@2:[++ M5Y$5NJXUIB4U'_?S>D4G4IIE!]N\9;.PD3HK_0GD!XH5 /&5ZX4V]BM]8WF, M^BY8\IYF+>6*6\S]P_QZ_O POQIY->]$6[\^3]O1.XKCMTQ3U5?"Y;+()=87 MIP,*B&)A( _J'"$SUT<=GI$5T5(T2:EH/?-QH>+!LM-%?YL]/,SNEGO?T?RO M%O?C/C&40#U$3\^;]'1+JE]%DA] IN<;0:^)*D2DU.F74GT1T36M^IPYSD)J M*N>J%MD,\[@J9+0K"+X+W,J\5$G,<=C6*NXIF4IYL_PR+Q;:Y2)WQ9[?C>J' M+4#5*--HD\\@U0T=>\PS36JX$D==L^_02>R;&I!B<.T88QZ0+:4PXKE);ZOD M'UOZJ?DW$C,]:+2*!TUFL9G_QU>Z?B_FOV:K>+0U>SY\F; \=@]DAX9133HW M(A9)/VIF%Q3220HG"*U&Y.R[6"VV\59-QZ@F07235O%ZZ2>ZZ>*OQ8_^RT<) M=%*(:CAC^EU_PFF4+L*S(;[M_K_$ZI7KCU138YA^P04E%70P%W-#J.Q2] MJ!0Z)4VIJ!=2])"X0#)_M"52"F!1Z&1$^KYF>;KFZ29ZP1M18MK3=BAT+3< M$H_?EB(.I"(5Y8BDE'*C'F(/;V**:9MKS+OIQ.=*JCOR#=4R@;A:M*6P&=(B M6P*X2B_RVZ9,=Q2JBJ$">4ELO7\V0EH$[K][@7F.0>\L%JF>WZR7N!/2-:S: M4]UR&^#;<]EK?BM!78##):..GD;?0*$1$GNJ:[ ]W#UYO29[?A]D!'J)IFJ]U)+7Z%G*($53=F2=$7C?8 MQ:5\5!MIYN?Q*7/.*KMO[9[(\B XGXJ.;ACW*QS7WB=:? Q9?@@F^WU;';0+ M[F(2C&F:>:#"IH)ZSHNC?".K]6MV,NSUKSK2)3HCK 4:%&_]MB0WP5F0.J;! M9A;D,6AIGA$E;7!WK.F( D_SIKYB93$61(YIY+DB5+94O\XD2_^\(OMM9?:R MIA#^VVN)C2%=U; ')I-J6\"ZXBTDPICWHD(Q0FFE>#Z29EJT >_+*Q$E,D:7W),DU!&GJ:CJBT/2(,O'C5!9C0>28@?MY1C&JUN]" M&Z+TCX:.//6]D6-;2@ DG4:'IRQYH 6OO5J 2A'/D:PU5=@'Z=C5JEF3)\*+ M/+R"C3%CB^_(]Q+"9!W3/_JD]#XCO7\V_1(*B.%4Z[Q.A.6NH ON>S4N7:X3 MJF_MTJ+.DV2=R-EAZ[HAV\#V9!\C&R$LWOP/UJ')>&,M\_IO+%^L2J:3OGRQ M=C_Y83RQ#%.W6A:C[PCK MH36!FV=!%]LXV TZD*2U_#5=R;9RFKIV_+4Y2@Y;W<1JRXQ&O-B?8N^]I#]% M9V$YHT_M,LR#8:0_@$P:;:\==?RY2U MCN6[]I@I:\\V[M.W./<$W4&"[Q +R&,JA0N9\DX$()[\M?V%5\=10(G MC/RK_ 57299SDH5U_ 760SI6G9B&.V; Y'$;?WRF^_:2)"_YC&FB^;![(LT+ M0P=(%(%0^#7J3 V\8767\L#3NW5\^AA7JZF(NZ- P6ZU3A)XBEIA'$_;$.:0 MX>Y^C=,AC;\AOE]>),4+@C'].IZG6306DPAF0^AP#8- M"TC)C[[G2",! B99TWO&"D]9C\B 3F<#LC75%>?($-U>"J^A".0E-M!0Y+D9QE)OM$] M(7YBIV-9TK&D['^Z6K_@*.8SV^>O("W$(93@\CJ*F?-B$&ETFTPDA2&#@IAQ0WH9-:SXAQJS M.<*:$GA M'V!BL@\F,2( !CPC@/<^5F4:XUM#MGD[HA4N;B:3Z#0MRTH#B;M MF91%.=Y33C^VE;O,5I4!9AE9*JF]^S:R7!Q^_L.86RS+-4?-?]+2W.*1T'&! M7 \DQ"MC;BD@?01S"]%<7P&2YIDC9EES2P$%AKDE2V-TAU^(V,92;H4\<]7V0R8V,)2ZG1R)5J]1\K"ZV2#>(9&9R&-6T UAW=0QD,NSX&Q@ MKAPY9,?[UCMG1>XI#.;EE=XS,F"+\-P_?A?-L,JB&?C\2WX >9;FNQ.="4TQ M O"?V%_1LD2:6;:GVW4J4#<8C9'IA4$(Y+1KRI<(S]$[89+KM9R+360^.;9" M/E8P%%^5IDPR@1Q+#$R2PF5$=0?RNDZC33K;+)*9M_Y&KJ]N+F_B=)O@V">W MT4LD, =(?@ %CFH[0')N-R6^*<9C<8+1>/V"DS]R52]+C7C,D5FK08G[T4-% MT:&4)&C*HB2T(:H1''U>5ZOU]VS"W),D2[&&GUA<9'U$71"=9L0#8K"2ID$: M5:>2 OU5;3DL<)(E%]W&HLJFK.8($T7'0/+K-ETL8D2=2@KTM,&=96Q??(_I M5?8Y>CU.J$]O][EH!+N=_$=0Z*JF/5$VV^#L5*F@OPJ\>V_?W%Z1SK:;9PKD MGZ([H* 3"CTC=">J?)YG9$96+Y2 M,6Q-;@+4XBL5(YCD1,A1[LV3636PS=L#R4H2[0K!/[ZN1%<2BE)_J>$DL\^)>J>_[>9$]G%\N[B[G#W>@WLVSG,B9 MN\'7#!P=5;R1>CH7=D/8I=>&";Z>6]@."9 [H9R$91[0"U0?X0'==W2L5RZT M(!YM"S'+/J 74& \H/<6KX!=)_2AZ242#-7A@5 9:X+Q"HZO6RZ0X-\ZBMD6 MTR&D 6$RY>'L5W2!B-?Y23/D&XKF0;MV2JQN-HKBT0H$#77+\JQAEKE2@9+T MCRU>,1-G,+IQP2WNF3D"DT5(%S!=MD)O&69;1%Q/PT F_"!;4=6R+19$P5.O M<3W_&\=;G+Q=1^&&D'CY?;U\7F]3' ?+[W3(;W5!6++=D1?:!(K/'V\A5 EI M#*_@:$Q/B8?LCAN3H"BJ-//][W89@[&2S((@R(>-5H=4*]S1><^2[6*V6?01.HQ2B3KY" MO:5@SHW;6694>F_)AGNYPM%+>D52/XE>Q;Z9,KV1XI@VE(3,39=A(X"='(]X MQ];)S.&EBCUKA12BXW"*"@$/R+G'T$C5KP19U2HE[<[+7XV>'&V4^E>6J;JX MG<[!-2^MZ2&X>:._G[U>YX$LGQ-V3,#.LL)IC[#OZ0H08UX[J;+L2'5HA\AT M?3YD#A7GS9"B66HUXGO:#'!!=HJDX0A^N=[@E5#FI1;(L>E)!2132%_B9N$; MXOYX=SP%.)(NM4"FHP35S#+3EC0+W_FE@?5%N?$I"#T"A'-5%MK%;L M'? =B'P/&\8D=[5"XLRK!P?E1W H;3-R$).X0.)#F+(5LG & @(/G[8I7:5I.O/I/2C-#7'B9<'I M@'S7#;P)KI Z/! <<5ACS/Z8D-KU4]L5*0;6J_5EQB&NC@QI!MD0!W'D.5&Q M9T_T5[.9)\Y^(^B"B$5\!4C:#,[&Q3#BRR :Q#_GYFHYOQ1*N]0"^=BWH#QV MR<];AOF$@:F;:PTOA^X^0>7; \F'QHH)S!/(GK=#JA-X@-.)%"II5;9\*" R MK>[>+,N56F99-9BG'-]OT>;Y)@ZB;U&PQ:OY#Y+X49JYS?F"FV+[;Z)0"5P3 M[A,*F^3^8 -(^[.+3?M"-L]K>IG^1M)--OC_V*XW)-@E8\B#%_GL2WX *;YM M:G#=VH14-\4XA&ET9]\HSLBOK^LXBR;%),UD!TMT9[K"2N M3MXXC7C8_W*P^W,C-DZ[HM +/7!11NTYX: #D'V'7;:LM(-_>F,72MSM!B6_ M\\7FF23+9QP7U1/I!I'Y$=V3)%H+LB"\UPB0HUBV"T1M;;KWOKN0AL@ME*^- M8U+ 2SK@)Y)RV3;IJU,;1G)0>J4+(CK9'WPWEJ$AR',OQ7II3CRK^N&#$VWK"F>D-+( *3U MR=-4[";)U39S%MOMDKMCO#CD%R'7*^(@GP:?09[A$0^N,[CXG&J%%((-OZRF MY??3^C0^W"Y(#0T5W$M7$U5#B*J4LF=$$XZWN5S'63*9;"-)HJ&YP. MR+1TBP!Y]&S*7AVF@J@1:D??)X2JLL$^-:FH%K1Y[A1U_S"_G]U<7Z+AAA^((@%$ &\#^V$=$FC7N?]XX8/LL#S"V_B'TSK:D%9$_K7\V M-@SLC)DSNZ5_MFG8I@'$*-9.XARK"A/E1_#/=KTPL($9,]<^M;O(P:.F%[(-1[6 ^.8*MO$J ;+ -@4 MA.\P=^1[_D]M7ZP._9&CN8$)]Q6>364[B L$;L-(,XM))DS94V!+&9SI#A^ MH #9^II2)D;49XG"][O 5NX&? NZ?7YQO;E;SNX^WWRZG>\BC"&8T,_QW)'- M_(>_V@9TA1VN1+77U29?0:H>J"WC(4:]K7JNIT%YZ&\E<)G+:@'R(UQ652NP MJV81$!>D0LRRE]4""I#+ZCZ53*8+;\KY9#Z]99F.:^ZP]9WIS46EVMGTF&N" MK5MM^H&)S$9;>PVN[TSGK>%70P]'NKDU(*<9NPS W=CE)U,BJQ7Q-UN\6A+_ M.5ZOUD]OXD! 01=DFX[A \FFWD2XU;N>%,R"DS%UCUTA]=NLD/KY&;Z)\U)" M'FFN@PO@0B\8/=6_6Y%,^R%#]5TH+CP]$EJ&UN=='Q3Q7U,2;E>W42BX1LKT M1K:M6!X0'X;^)@$#X'AYX3BFF^/%N&2[<>1M-Q?JG\IZ@PDA[IA!'J(SI'1P M[,V-=W2"/*Q7=!1/R^]D]8U\6<>;YW9JEOSGD6NY+A3-NA6]C8_OYK(!KLI5 M >W!_$YPLOR^[FL*G7X5&2:V3""FC[%F#D^V^"2#, U?X3+,M%U5ZGD#^OR!%2>4;,XN")T OA1>8)Q'H+J.R)+ M]PP"Q*&XE9BK[T(-4)]?1]]O[3V0W.Q]CY/-6UY4F&+*UC^?K%\F-T]SBZ7-XL[6(N1A[E^ =;U1(:EJUZ[;#RC^A?IOJM: M0&Q&TD(6.["< OL(/D66ISE0%&".F,645*' \"GBS#BQ+Y&@$PH4NJU#>U:3 M8$H&$P3?(OR_4\IMK> M&W=1L:")/X)"Q3&4L5^::RFI9U 2Y@#<-G>S;![<2733JI['@!>9"$1A&8/ M057$D],ZN-D2^@1T3 MR%274V2K5C_=;#"3;$%[O!'UO0G=,+,9"+85L)L_ 4HM7>WKNG<6ZV"_P'3I\_X^ I6@D%SVB)#%_S52!O76WGN@A7(?)>*T+D.1B*M.#9 M'6,1$Z'D^1V0Z6+?&GOVBZ]+58E+X"D$WVLYB"OR+<";S9<#R1C05O U MT K9MXL(D-UGKZ^_DI=U_+^WZ68K M5F@J[9#B>ZXS<05/(?A>J[Q> MT8]GOY(O*_J;R^?U-L5QD/D!;P@17Z'D.B.B!@H!DAJ09P%CG;6-P!7L]'JC M/:D]RDM==]H(J5YHA$"FO\#?HBIP#HY. 5(-OF0_QEEF48'=6LAHCQ\$: ?**TVBS MK,'3*<:%]WJ3IMNL+L4BE-\,\S>0NGY(U4,;<.I:/@ORT(8H_)I9@C-#;E%K M;#<''H@?D6]>SS&V=)=A.5BR#QG 'X/A%4W#(&\23=:>S*@"NYZO2L_D&";/ZLL MXO)["Z>,<]9%T -9CJ7:4[PURX JY#]F?HA]_9-LT=768"J*LB9H;/^,H3F_7:4K213S_D=71W4;IP%K!;68*6-6WYSY?D(' M=1MA+UI%FXBDM85TN5T0L36MZIT_#0[K415TN1->V,8U]_NL$\TWEV ,% MCN*84U-V94%!") _'V24_(I76Z%MB]D!6?1[@NB53YY@@U&0X'>,7O*$W M8:J\U]@A>7T0-BT5 PFCZ$87$U;!6,_.6"?3A(*-OI&8,.MA%,^4S/9(\573 MFYKTY2 5DN_5T:IX=YD%091)!Z]VBD[V]'BX)]6\/0G[(ASHV)CBTTDS> 4[ MO=I7S@P[;4AJ\@EZ?H::.37MKS7*@K)>W1G.?%4XK)RUHK/(<$T@\4B-!,\# M4LBVG6="3P\ I2M;/KI[DN1_)[#Y\[H@+= 49VHOZ]*H"KIZL7B\7^K$DGL, M/3_I%[<)V;O(\"NS&NIYTL3+Q=VO\X=EGKGT:OYI?K?\^C"_N)_]/LO^YD]9 MI=7R#-^KG-K=-T8F5UG$:29D_YD$UPDA='YGR0.>]B^TPCVTS0=1Z*H.E$"5 M5K3P-N).T@!0D>-4"_X:XUT"5Q)DZS6[XM\GY"7:O@@+;C7X"#)TK)E [@L] MS(0.$@#@#7_F $RGYUN6*[N1B>NT%U)MGU3OJA^+7P[D\\(7D(YE85)CK=WY M#"&O\0@GM1.8C,B//GS"=@KC M(K#KL,Z.%[(KDOI)])K)DV]&$W1"JJ]K 1!_C)YXDD3U$R +X6@Q7MST,FN?+M?TFHKA.HIQ[&=U[+(X\DBPH&IZ(=_7 M=2AI9WKB4Q;R$*%:BRBX)XF?R>Z)9VD[:8,\TU.#*5[\^ 2P 1XCM2;YT)V? MF)^R:%UZ@F:%.O;WW)U+ZTWL M)X0VOB*[__V-1$_/6;%I"IC*K<[]O6Q(&VM8R+0UOUI[=;*3%Y1,APBDFP7_ M=YO2'Y:)K6"V11[1-15(!J&>MBLQT"'BZ#)?W BO;J-_;*,@<\Z]PB]T'J3U M^K%$3Q1H"O$_UF6F">PA O08]JI9'!1!L9?K=,.[?DKT1%C7//]CZ=1-8'>* M_*M]\[PFF<](KN07(ZE] 67T0:&C^<;'VOCD \2Y%$"\T/HZBL1(2Q& ,.ZD)4VGL#?Q+CW5ELA7'762E<4%5Q\!S&X1B!P& M,@?&+SCY@VQR-\9%F#N4U) A[H240%&-RK5XTKQ((BZ%$PZJ/,@K"_24]#WG M8QEH1#"[!07V]F22[[O[@ISB""5&8^2'IH8_S@*20%J*)01R,B714Q3C5?[\ M4;/LF&V1ZQJ&\K$4/C'04ICA>$61=M:4=!?^5G?!VO<2=$+8453EX^@8#1"/ M%S+(S>)TLG_LXY*7Z^4S>V+FY9'K)\$N)U+W3R/B*6$U/?UDITKO?WLK_TJJ>-.,;*##5L&JD@\]C M"X@0@FE/TJHT*#%=U"RR3.P!\61JP4 MDVF\ Y!*J;J^PH0"ZE@Z*+!_-"J=I%$8DJ$W1T^ C2'$4%THQO:;SHPW.HR_I).<'9XNK MG1+B?LAU--4"XMC2=!9(0FOLU>KNB(_)4S:Q@!+?F'%D!8Y*)GH@U&$Z>F(V M6]P;DHP6A\ZPF![2ZI5-IH:>YBE3]4,'4]TY\:J\WA00O>[V%C;[2Y^;;B 2ZZRJ>Y M%Z@WSZH2."YU357GT30CJ'Q?^ZW#\-6+&-J5R=)3,=H^DF_?0BS^YF2;R MLOGU\!9B8,5QQU256KZ%!*KI$B N!4+!RKR%%& ^PEN(HJB*#M.&7HA9]BVD M@ +C+>1^A>,[_$+$KQWE5D@/;(*!6,B;<,$$ >'%HAA8W6O%:3MD:)IJ ^&! M*5LA"V<@(/# >6YI]1"8"\)4?"6 IK1)K!093-#B(TKC;/+J5^F&-,7S0R!& M#QDBFC!X!A$PAT,]QNO8#:%$W/>P)$40"_LT%'9;/,:[AAE"*0+8@@'9Q_@" M)@3&'I_7R29[S,H,J$OZ:^*EQVR.+-,A-C3#E(RZ+D13F(=!T5.WJC@=D.'H M%JEDG!R)(J'8Y9@Z@S4 5VFR*?%$_^N<(_I7Z"'+W\I9,O3?#_^,?.PH!&8H M+7N),$=?F&='$3/7EZ@8ZMZSQO.L8/3\XTSQL25\-NQN,N9Z 1PJ QZJ"-*; M62KTSQ)W0@'52 F08#S.-;/Z&"R)J2"A5Z^LQ^C':?"/4/JP_)@.6\4TF'>PO[(P)H!Q1 @T#^KO#2'6##5:WK#(:+PC= ( M R#11*TY$> JB'C_>,%W]PI6'1U, K9&5,I#*]@$D_R0'[1>1Z9X'PEL1?.! MG&9UEPPFH7+P"CY[+;W __7E]W5+6@X]D6]KN@LDG4R?S%01%N2T*\C0_E;S M)8JCE^V+Z%YSTH1>$:A6._83$.?:4KG;L(=>R+I=+84.LL8_:F5=;H("TZ+0 MIB)KYM +6?=:!F%?"NN!^"3ZECG1KE^R.U56YP2O/N'X#\Z64]L/$MB-D:.I7C7G%G"Y2^ YK^@[PAKY3'6+]':=IB1=Q/,?FRA^VD;I;'>OKVK0SS_X3]GFE.]:?NT/;("U_" &!<:;:OUD#YN9 2]!+KF1'4026B- M(R,&7G$/)-CFQOZ;,YM6P\R/C;^#G- @'I2G["8KM#W43@4(>U^YV4'?9,66 MVB-"7 W#C3J37:DL2,>B@S!6Z,FDJAB>)2*_Z_HBQU8L!9K?C]Q9V00>!&?E MW9&>5]8(\FJR]R3)_T[D"L3I@A3;:>2/U"!U5U#FWP%80MC'QLTK;5A&Q3=-Z7"K (UN*8G4GRL:5-5B&7!@:OE6"G>VK2\[2%AC.%J@3FUPU,. M$H3JC;5Y7<0ZD+ KPK[AF%!<'%HH/G+HQJO:V,\4.*U@7C[P]SE]^%.@MBO" MNF+;T +$)*> /+I*G<5>W)DS4_/N(G:U3>AVOWS.+F/1.N!LHOP.R',L#W#Y M'?XN*H&I$'X[-XR^MM$D^I8G&KF.?I"@?#<2;:#<3D@W J4:N :VA-&VM])6?S3UYF>]*KO?"3Z!0NRYX=34GM8H"WH;5YEB M[8COEVOQJ)[?1MB+5M'F32;EHG6>9J-ZD,D90Q5WX?F M9'H*-$U>@@LF" C^-2V3,NJ6YSE 'FN9LA6R< 9B ![Z M3:*CN88^J1V(.?H!TO#UGT1'"T-S])1>3/&Q)7PV[&XRKC?CW=,Q1FFZ3G*' MP=E30O*Y4)-.1ZX[UF:;I]R0/?TX<9=A_SBR-&('@'W^WFV?J9$/@+#]'(M7#]=K C?+YR9XU1WN-Y$: M.)8%S8[89.8-*Y9CJH'W?OK=9:_8>H>L0$UJ[MGG#\"/R\7EOU\\?OWT>/EP M<[^\6=Q]V I\6'.(/J:#<@0(H,DULMI%*.C"ED?-<,QPNFR(0\M/%R4O25 M'^HL_=R)&L_?!<7]$'9,TP%L)-CK%LR=3Q):VR>F=\NE>#+LW5]Q71SJNR+% M-PF84F2RE#9&=YXV^/TNT:5ARER;G?-K\^7BRY?%W?[V#.F>//_'-J(:1^T- M^;0=4G0/XPG>C3636%"408Y(96[%!8R/<"LV;-MVH>5N/A6S[*VX@/*GO!7K M)C8,:$>0!(\M('Z 6[%J8BL $KC<@@'96W$!$P)CATFY3_&4:Q,UI8%Y79!J M6;H/,UA!;M?D(H)04;T\N+K%56V+5$^%EPF"*W#V/8N/"@)!G"VCU6&VJY2L M^UHUFPS\]22#"4)-=&%5T\:4%9[SNJXI0+1Y&2*:,'@&$0*'+6+J L/VP.5' MD5A63!"%>QH$#AK&U&F>%D)Y>F3*5LC"&8AN//#*1Q&<2@8=L9HBUW5]%8B' M)T=N5>N;$$DAYE[?,VZ"#?&%TBVU0*YN@PF/EMNGJS)FX2E$"\9[_NQ-IMC^R M0\_&0!:0X$I19:4YQ((I,,6ZR[Z$U^N$(OKFUSV<"_L@7]%:S;[#C)U M55?P-*="2ZB=*K/W0_:@E<*QX]M0S'1-*95'-U(B *ZY8[-9%?ER/V&J(_N\ MO">LIB@@BF9#>YNKXZP6#8!@]UD0Y$D]\.H>1\%-?(E?HPU>\=<7IP-20I] M233:=%7589IXR/MI,6_@PQ?5Z!$%S2=$2VA'F/* M/\!$N2('+VS9.5'J@FQ,? ^(I;(;_2Q4Y\'=@TYO_>(TR55Q0)8'9%AF>XEG0W"AD-" QG&-U=Y@WRSOR M/?^GMC?*0W_D8!)X$UU##2&67&VGF(5,!#;_QT61YH,D?I0R*X7)"([Y+>01 MUZ\&D'Z >2*&.TCH[ ,)MKE%\?YM?SAX?Y%3MB=X(!NY8;&MZ8%]:6 ;NJ$5A0\H5P1,I1 MAI@P/D+ KFXIN@'M1#P5LYB2*A30 ;OM@YJ(;?@.M/S6$DS)8((0T3E(4!.] MQSC5V#I0+B(G1#1A\ PB! Y;!#4YKDT(M#=DB67%! $AFK-E4!-6-0T#V=Z8 MLA6R< 8" @^]1JB'BNZX0/:Q5FH"%Q&$6,R.$>H*]EP/R-*I%[C(N,%"-0!! M4N65Z#4Z7:^B(!=@KF'R*_"QVZ+0-$UP:;1%JZ8>R@#^H"W9X"X4)HC"$=8P M]6#LIYMZ*4NP<@:H&R\\7Z_%IX?'V?7\]O92',)VW@YAK+KJ),)L"O6U:FOG MHRJ$W>L+QRQ-R>9^F_C/TK'+HBZ(.+:C ;G9<]0DQA.S#*)"_& ";M\O!-2S MB.4 .5$$9S9C,36&6+ ,IM3?$<*I3;K9FFWX%61H8:@"B>R17L9M01:8W;W;@M MGB+8#[/9\$Y&MG/ZF6TWS^LD^J?(24K<#[F&I7IC[YXM69.$!JV2 M*G=GR7R[.(^WE9AV5C]DF[9>C\,,^P*DTF(^5 MW1HIID&@:(7-A%\#"$ @U=%_9G^*[Q;[P=]8;%= M5#/"SVLOA<2V*NR+5 M"505B%V@Q4XCB0Z$Y\VIG0\GBR0''.2I2^Y)DL\HV9LCKS_R3)/84SNTVT$L MA=%,TM9S"O>H.W["J= Y2]0-&6[H0WG_Z,8_#UDI>N>]7>WS<>WC2[)MIQSF MM?>9/T [.MR;"KNL]&^SAX?9W?+Q8G97>-XO]C6F"P_\\1SO2RAWFVN6KN\( MHMXC7_(#]$9D!UHEZ] 8;F#-7/6)IWH.D-C%IK)F:S1L?!_!AU\Q'%>'INN? MBEE,214*#!]^9LB=V(62VP71:[EKAM-CJ1X1!&]7YB@E?2E9G9!J8"L$0E<] M!?+,G<$;@#LI?[X''#_QW/3IOQ_^&6%'\<%=X43+ACGZL9Q8\Y%P7]B+H>Y? MF:D":E731K^_(O^$?TLGT1S>.3)@@33:UZ9XXTD\^F:64NLX=>R!I(%@PN)9',4\T@OXD\Q; ,()>'D><=2RR=\E+SW$RS,7GUP_:: M+)2>9=/+) KA9/43I']<)(3?QAE""-^]X9+)^ M&F%+M5VX:?+?;^L22N?HIO9?2E^Q3G]=9XY]JVCS-H+:=_KC*#!=XL!ULWM_ MQ8\CGS[SH8-ZJ#R:Y4HOE6KKE\H+]4_P5AG8=EA-3#R!MTK=!I.>OJFLI=XJ M]_@^Q%NEZ?M :X@78I9^J]Q#^8!OE40--0>:FY4$2_6((/C*]?Y6Z85.8 (Q M<]53T/BMLH W '?]OE7:+E'PV,\.398-<_2C/@G+OE6JEJ-I8^]03/$)WRJ+ M87>3<8]OE8;A.-[8\WY6#+W@ M:5+OG$W?HVW/--6QC6K2/#&'7O#TIWOGW-L52IGV[[8;J<_*S_G1=Q/OJK,,-R5/?P>YAJ;ZT&[Q M[S0?.:(8Y$U3L@B/J'Q1_BS7]#O(I_H6 :(62A/<#>J4'Q;W4_-ZG80DVFR3 M/&HPK]*6?^$=-HC:GT9&:%F 4U8,NF?(2P= _HM):TJZIEH^-!/,:)I2(8VV MSWP[36D>!^#UI+31J?T;R4P+))C1RPE^(GTYC/4W"*1B-<" 78 ZS>,!Y#1$ MOI/"LE1:5W6:EJA+E@$=VT#>*1LI55*HALA]=? M(9FQ]95&XT"6J:B $ZH-J[*T$U7K\MH?SZ@.>P=73?/CJN,]RZAUXJ(>;IL< M/;($X?M>ERV@X!V4A&3/S/3?_76<>^AM\6H5A2+ORNS+W3^,#,=U(;LJ<[7. M'K%7DA[U^]YHDNJRMG<%EJ2V$ND3_HVWP5!<2TO+%? MS >?#7U)J9@8_9IS)4;23AF0^A0R5$O#8SOK]/MC- ],'YXQ1 D*&X*LO)-9&,#!V,;QN#, KZ MBOG0:XYQF:&U4 +KOX,"S_3LL$/.%-%K2?1'$:^;MX M:+%N5],+.;:C*A][_,3A5,J>=3%>DJJIECUWA9!":V#@+ MD@Y6'5 I+XYY4DLI+[3V*2^T/T'*"X<85MA.W1PUY84=!AX45Z6FLF8_4K+Q M?824%X9G^A8TE^13,8LIJ4(9).5%O['XEJ,Y0-/MLZ7.'/VH*0]D8_'MP/&, ML=4 IOC8$CX;]E@R;AQ%[&BVK8W]E,P18D72[*$#*VHU5%2^ZNECO_5(\\0< M>LDA P)/8R+6"K$<.+I6T@^%!%UXNDB]G+-S<>'FI(]3V]OS]/_!/8\UU:M M8-1"%NWL>;II./[8SH(M92UCSROP?01[GN>ZV!_[&BX6LZP]KX "(X7M=13C MV(_PZB:F4VR;G]W"!+:<#H@XMCOZ\V$+ANKP0$A>NZ1[0TJ/V?S0(LFWR(_B MIT7(&'JZI&-)V?]4E^VVSU]!Q+<Q4S M1S^);+J*[AK6V!LF4WQ""WXQ[$%\RT@12 MZ.8T]HZ&>SJ=*$ @R^!LCM<8[HNA_RG2Z1I84]2Q'6NE>6(.?;QTNKRP*4X. ML46XRYU8%Q\EV1VY1JA4"PB#L4(5-Z+J!M<8X93+:D)(Y:.O9,_5J52?P0S-D![[N?X 30 CNF)MULKLOZ+S3OJMH[G_M MT?2?4/#UO!_3=IZ 1VSSG[4S-9RB0!'-*Q_G6 MLSC&BW7JEKDR[3=S;>5S*'0]5QO; :=GLJLSJ;-XQLQ=FY:WSJZY:\\^AG17 M25AHFAY'Y'[%M(MWP61:ZXOCFOWE8:"&2UY;JL[B,R7 MD(*=D(R=%P$ YQRQ#!+V(#6@OO(EGRG68:!@"X0)?ER^V5(9)/>NW'BZWC4: M?Q:IMAK8P"X:HTP%"1D-DN:WZ>CZVQ)X6C/6=.6_- ) ;UG+N&.J=5-K#@P M7&H'XU16!*7DPC!T?L[ )4\ R=[T+FR3 ()GABQ/T@QSH19,]VHWY Q"2C>7 MZHM<1R$JA.> WIGB "UXZM5T)QY"74R"9&]D$">P(3S=#<55%6K!5J_&-/$@ MZ@(:)'LC7]7UX".OK"K4@JU>2S_539G7*&F]LO*^2--U0_,^,%/G0 N>>K4J M#5V7PG(4RQX[QG@0EM@XBP"[]R\CWY#@QG:$YA]"-@XM N&EH7_R)5 74V'@ M DWGX^FR='G764,GXV=Y&)I(-N2"Q786'1C^_N4;]3"NN/T, #EV8!O3G62*N8XHTMR\;25K%!#?_Q'OX9*:X8FH$A.OE)*9X(:UBBC?.8L#>PT$EB+_+_G43?3L6 MMBPEBC?:)XH_?'>\A/%4-?;]5%K@3)X$J,!G6@]M M+PC&MH U61O,T4\CTWJ@DW!L43/%QY;PV; 'D''CO>:!K.@4H9>#9/.6)S>G MRD 81 M H?W*QS?X1?><;)O5FZ%B&N3<.QL^BV6%1-$D185 @=U"^>T';(\XE;#3\?A M@2E;(0MG("#PP%FUZ:>W\K^T.H\8WT &)I8Y=E1,?\>3"&*1"Q<*NTV.J/U$ M-<- "\=.ZM2>@5HFSV!"8"RW#V>U:\1+[J09L@/74\;V.V^QJM@HBC2HT\S? M=L04![*'W!"_A@C1- 7(5LLFNMVC2A=9=)M:'(^R^0_B;[,G!NDJ6X(>B&A& M,'ID6+T=Z)0[65"%_,%7SU)"WQX]@2;';E$Q;K"'7L@:3"JXFV!#?.&Z*+5 M#@[&#YIM=+6M+@D6GH*6]Z\@\HY%S6Q?"4?L<5+K,67T*:9CKNV$%8XNMT=?UU M 5KPWVM@XSSS\K@G2?;KCR2)2#I;Q.1R'=-)LXFHOGQ?3+7\$+VA?Y]N<@7G M*2&Y]B/6*WKZ//(-PP_'#N)JRG;OZ(LIT&O,Y'64I)M+_!IM\.I7^IM9\9)K M_YN05V$?A$W5,8'<_@2WZRIA).2#,5 M."^/0]ZBJDQ*2J:@LEV@9*^O^_L1+I*';-5/7OO5S>R(M\-P B+E,X!## MO'9+@SM6 FVF%FU(,GX=)2;*$V?+PS^F^W]-U88SHNYS2"6!"D65ZF6:2",^ M%O?LL:0&;_\C^2%@6U*R7N!/RE-"VH/E7U3'4 ->QB.6X!E:OWG?::QS_ MPDIANB3)B\9?QR,,)E>+H&AM37>!,>4U1$W/W55@G>3::S; Y^B5WB"^T>WL MBJ1^$N7#YAFMI#HCQ[)U=XI[2D-\G4J R FQ M%0)Q1F_$B"RP8]%+8-O\OO;3=O.\3C(07V,ZT-*S06Z5.=$J*5YFOY&( MPF8$>MN8HT*N$@;5V W@TPZ2X(YE,GO,$+G76>^WB?^,^3FK*NU0J(7:)/=U M/I2V!1X'2]B]'VE=$&,9U7F)+>(K0!PL6Y'$AM.VP.%01-%-X85N!]G*+VT' MN^V!PY>H"](#U\=3TY&E474+I>!=AX_;[J]4;:N1/J7YM=@&L ME6KL#2+SFS3=<@^/2CL48I<84S,%B:&4*M -.*L72:;L^O1/RW7V-\UF.;LW M,GS3\Z:FF;4!V*W*6T\W TS5OIUKT6E)V-U\NHE+CA8"3;[!5Y#G!_KH)1C: M:MYM@':KY]8[SR?9IJ4X/>F! LW _M@5F;KSQP8U2 &VDAYRG"W9A>OKZ[%< MZ=%BOUP_OGZK5]2D/X4"U],L(.$:;16XYFB[E4F#D4KFM'YQ!]?E1K^#=(OX MSM0N:L.*HE18[5U?7'G^*SA*=DEVPRS'BO],@NLD>_;?V?-/GO_%F=I;? EI M81@X4WMB[PJV5$'MO3/W9/M@E#M)97E[LD<9.E@2^Q&12MQCGB?NN5Q\^7*S M_#(OLO9<+NZ6-W>?YW>7-W-867M$R ^(ZM/X-/H,,BU%K=Y WO/8:)?7A]AJ MH 'Q%VPG!2_5 !8OMFRE;(PAF( 7B0BLQ:9LKV M(KRAEXAO4;#%*WZ*+&931"Q?';V\2)/54(MD@*P:[:CX+=H\EYVFENLYU44% MB1A8T,0?0:ZC:A#B5,64U#,H"7,L;N6SSRG8 YK?A+NLDCK PD.F\&?)\G9"Q9=E$]V18['F8"D'W M^^3_O*:[&$E>;@E.B5QTIK /TBR,H63>Y2@YC(=G*4@% [VZ!/P]>GJFPPP> M_>?U>B44/*LITC5=4\;VV^MP%%;)$,(L..CQR7^8S!N>X@;5F3)NZH!BSZYL M[.RA%[)^_]0![YCBP?>#T "P?N1X8@Z]X*EQR9"A_"8!O?JH((17LC?G*OCOVXN AD^:*'XZR;\]LCC335D979.O- MZTQSB!C1I&.%'\F&GLP[66 O*P\1D?1RFV12%#RU"'HAW[5#$[!W@XAI*6"= M GQ[2J#H^\F6SK,&G'&[(,>T LBAVB+"ZE$=PX GN#QOR1->71.FT^]A<]HW M06YH*Y#=1L1;[#F*3B&P_4C_:DN6ZU*R%YEEQN^#=&)K&I#+;U-^)& =8V(A MW >:DTV\S4V<;I)M)I:;V$_R4W^WO]S$=#L@J8AWF>[(4G2CFI=S(E.@$<)C M6.XD9T.N\E%-+TIR5JZHJ 2AMJS66FO9NI MX)!DMT>ZJQ,H)2F:4E0#Z1C>.J+S5I: +H_?7&,;PP6B);L507B+E% M6O!U8"#49#M=TFDVW+VQX7'KK;*_VUD@1-FZY+^!3-,G#A!_UFZ[GQ3,4E1L M=Y6$[YR^_Y?L_V4Y)/[G_P]02P,$% @ NH9O4T+M0@F^6 $ ;284 P M !S;V)R7S$P<2YH=&WL??M[FTC2[K_"\9BS^%/VDZ%_J/7\YF MKKNX^/#A^_?OYS^>;>/O YW88JKYXS7MHV[MW;^D%> M:U9/6KV+OZA(#4G>?'%+\'?5:[_/^Z B2?*'?WV]>QK/ MT%QKZ*;C:N88K;^%F__'?@'DW=5'(Y\,#;ZD?B!O/VO.YLGX73WA\Y&6X'Q]@_#=COK9T[;T-ZWW M[ZX^Z-ANPWU;Q+5J_5;,\_%[L5^(:XK3>-&T16ROR1LQ7]'G!EI_GOQR/K;F MY'.RU%.E,TP'2)M\_N3JKH$^.]:S_;LL_7F.3>'3!_^U3_^GT;BVQLLY,EWA MRD::BR;"\YM K/2KYKC(;C0^?YHC5Q.(E ;ZP65S8H"^>+6Q# MFCG5#$Q!G[U_4HN_\JC7O=6=L6;\AC3[QIQ<8]2D[W.C(2L8PJDEKN#IBWS M[UJ36_R:DU[D/]26YL.G/YG8R'&"?^[P)"FGE]?MMH2^K2VT MF86$_BLRE^F5N27^"O\XM$?6=S.]\$MK:6!3R2?PR<6X&=H/MO6J>Y-;6JE7 MPST";VUM3!R*0"(AQ(M[RT7.@_:F/1OH$1F$X!XTV]61&T[ )+4W=?^/;T_69,$%C?8Y-YYL: XS,2I?( M1%-]K&O&+6;?)1Z8V%9(OM4DMJ+3:79;F1H1'IQ[R\PU/NE:)KWF('/)4+" M^9OF/[>_=&>6K?\735(V*=H71?8.IS>V;=D+3R:1\ER(S#U*&>ESA+MM.;KK]-VA MW7^V7M'M]>!J8#I+F^QIW.ESWXF/04FA88BVZ6%)7/8=ESJK,_U5-[''ZKX-L'!L">[PNXE1/-,7FZ9= MON$% _XQY2P0VRSLZIH;=_, C MHSN86?1Q?,A,[C0DM2%UTRV"9%GI=M*JS6O!/S4; ]AU\$B/9YJSZQ.E&HD] M88X<*XEK].QBFW)M+WH=HE[_1[)I[ V5O,?4I";FQ71#I9ZK2MI8GC=2CVBR M]+DG'&%\(TU.:$W'GTRN<",,Y%PBT\23CVN9*5BZUVYE#386,7Z=E% [;V8" MVG;3;BW[17]%)G+B4=_"[<" \P?O3C,7,\PH=]KW+[:U7/AC%\S27A B .^# MH6'MH!1C*TO=].CTVG^KZ?97S?X#N5Z<8SCU)*_,)P7E'N:/;K,C-3/QQS?\ MLT=M:+**Q.<@_YB6J*HDI6W)"GPKV@\H-6H8.8=%;DIJIKDQ9E0PZY,E'YDG MKRQG5U\9INKL0>VU#8:W*8(=BS!]#6W_13R!3K-8O!1M.P9 METB?]KB$F>:B")=GI?'\S3^>4;8GTH,SP"%2R=_P9J_9::4EYACX>[A*A#U> MXTJM(IO63VOHK7BO@%9_^ TW"F,_6;.JP7KM!Q,7##DJF\.PQ/*A0'M)\ M#=TWI&E;2XLJ*/-#!@LK"@"M=KN,>3#;U+W^V!$,1Q:Q)0U_&?UI';LBO]7& MJ#_?.\GL.BI[6CKZ;AWK#\8$!XF$0,#U$F7)YDNK ,=V?_^JF_I\.0_:_YED MH9.'I,R6*[.AVH_MABJ*-S'M2R(\2-5WNO:L&SK)J3J,YJVHN377'<>RO9;V M7VR$")12(*#;.3Z'Z&GY[(QM?4$^F[CJ*V1!H+:;:EHB#"+:2>U=A5Z*;'5L ML*[;R4MTWI)@&NI H'DTB<_^]-H=CD2L(F0GSF'P'G5) J!8)21^X0>+R5S_ MXN'U\FWS$3RVY*7^=\V>$ ?!FC]EHV+"M:1WXU?+6PXA-?>HNYG@E<7 M[<^AS93S5E87*7=_AWX70]N=_T3DI ":]+%E:2_H,$"WO->5S[MW>DD9,9;4 MGMII90#N3K,?T5S320"=G-P@WUYJQIT^19?H1?<"ZY>:H>U+PM[KFQ_LW><' M]3=9_BKWKDO"ZW"+1KRTYJ4_SC&A\M[6IC7AR>#KZ>A25EJJI)9&EUFZMJVF M'%UKMV2EEW47\V#7G -]^^*A:6#ZASS26]XAG"8.0&)FI-)6]V_6Y#<[)]SA M/3N'67KS^:'YF_RUO<_*CFCHC4>"N=@AMIU=W$ZE2:.A&[LXCM1BF]WYK9O0 M[-CMX03TKE)]PXTN=J!3PKO9:F;:RNN_X$7("Y[M!WCP==/1QWYL9]MY.Q[/ M141U4C3XBHRU8?#38.QZZ38'S]UT_*UP.*EKD;9>IT ME&ZW;(_B"&?WD N5=Y7F3[S\C,-._B/?XQ""/AT\9%\ J>=J>7&)XX?A$ GD M'8;TP8NM0<@3OSAH$W&.& EL*.E321^4C&&,*T-SG/5&TM!^)"W*E)I\0[X1 M)%4FQ\T\K0WPZX[K#I6)&=J^Q]'WIG[U6_ZA/P^U9$M>&)1;*F> MJ\'_;A>GV/WRY]5+VT]?> OWU6_8+&V7[-)\WC1Q];W->^MF3D(?)3W8B/#? M6?V^$O)A:SBRC4X:L% >P& ED.; 4_6+\#H?MXT:OV@X)V\G=Q)_M$, M?6K9IJZQ;0M?D/5B:XN9/K[6'=?6GY=>6&$#T=V.% G/C3)V_?R+?Q.J.F)*N"1/0"A@%#6.%3ND1LGI"X@%!!:#$)7B"HJ&A$\;Q59!;0" M6HL.[7KX2A?:W8)VL0N_T7=K-+.6CF9.[G43N0B9?@&_@4ETJ;]ZY8D"#YT[ M6.;H'8\^'BBQ'"46[P;)4D-I@A)+5.)JT N,!X EGH!.BPWJ;"^9?Z#QDO0F M5?8PH^KS;C?PZBGZB;M>7\(>V_Y.'K=[7E8F46DAOOT#52?=,^S^@(:8M*%0 M0;'!Q$5CMC6R9]T8TDFH$_1F-3)FA:54^,];;\:#/O)LNK?3;[J'E5=$)D4K MI#S\%N/'S0!JM>-VBF M$IXPJ)%;[Q14QY+'"-HHU8O;ND&)93^=]WAS9%W"KE\-U2;.D@ ML49YB'U2UAMA5>=4UT*@"'LK@I825#?-S M$*PJ0%'L>?2'+(KE^&^M=O0.!V]94P]+4U IQ4O 8%ABMITU#$P[Y5;R F,X M\:V;,#DP3E#9MFE @H[+U$A6W%'BIGF:YW;"A\*_QPK$LA MMQJRW% D4#(-)8?"1L$X%S55DGMX.@VE&;T2:G/AT7;O'I;V>!:]G#[XTO#R M\:E_>W-W=[7UX>/X!5I9_$NXAQJY+&CMY>5RO$ZT>G MO03K< 8NKZ$1'(C+==L"SPSKC'>L[^D0[WL"KF M4I/[+RG?UT'>+1 45P63S,*SO*IX#\O64Z%;"QUKKCN.9;_=6RXOWGV,HYVV M2Y72\T'G];O%MB(SND2K[O ^;8*..#.TPX0Z7^!Q\^+YMY;]A.S7L8X8S]W) M[ PE]K)6^MYQ"RNFY]C>U4J_$/2F'O1FQ5\"4V;.?8H[]WJ]1",KU)7JS:Y[ M>TAMGX#B<7%0%[/6M9G[>EMSG]+-%AQ@_XP'S7#!0>&G/&W5RS*Q*@5DY!6+ M*9;/:3&'J;+.)I>.J;AI!0*7S$XK875E-7M05R9U;:SK]%X J(X_%MU9%)(A M(G#[<,7#JH!U7/%44:(@.@+8 ML N;D]/1\1A;?2SD7,+$6 P2UWM9,\MV1\B>7Z-G=_2V0-OB$T<>IF7V[ 8 MF7<[J/I\L/0LA\@9_RS'*+$>LWWJ'E.D;#D]97NZHA-) M!-WS[G.EFH%!M=6=ES>^=ROD>\?/T8"#TCSR5GJ//#S-T]L/!!RG6IGM MX$!=1Q*X\;BY YQ,%=YJYF"$;W6G?O]C6%/UMHP%2/Q8TD'0 M2N.40B7D9S4)(<&R=7>Y5X'[H3)J\9@U\_[A8V312E!0U(I%;I%]>Z5%$$9^ MQ@!6 &&50]A*S2D0MD)!D7N$P%N50=7V5E*8B@JXU)@ 3P:@5 PH*\46N4V= MDU&8+V?!-E#H%SPIB%$*=9\!-.R!YN3N,NG:I/5Y&N5F*F M*H^ "I<0H4IVI';>28S$I#C'5(GGK[LPTH^H37$QG.9[B=HF(7MDD@$L%X'(4_11;KD=M*(%W_6!K M?VC.[(LV>=$KCZ>8SG*,I]VC"DJABS%U*Q<8X,(]7';I1\V2^ZL4MR"32:KD M^EYLW49CU[(9S1$):KOYE*P[&+'"K%L.I=X& MSV8M]59.GWJ[,SI%3(]--E*UMPF^661NNAPB>-E/[F>@P[L02$M1_( M"W6"&BEF7LV44) ?E,=P#=^MY0XH+/NRIKCCH/AY2D,.#GM<:Z_ZY(MF3G23 M^RDWVA=Z&E%"Q^/I53@?X(\:!AJ[2\T8H?',M SKY8UM/3W8%AX ]XU$_MV^ M.;GY0T9YAS0']5]LA$@S&==8='LNKOF5 MLK9#^NL[#G)7^Y,[ Q'8YO7HYHH[Q2;U:Z^"4PN\7#JZB1RG/\9&[^B[7M!F MQ"J%I3CF!OQP@Q^Z-P&V&DHW>AL)P(,;>$3+8RG=-/1"X4:372PQ$( [^>AL MW^_ P(A0O+MNK[?R8.NO>/B&TRE^I/D2YI&_:^92L]]N]2DIK!*JM3+ZCGOQ MQGS*VJUN:N98UXP!'CU[2;Z]E:X6T_'CB2:N9DW:@:R\:P-@JR;8Z/I!\;FU M?1/WT_B*D(L'=#A]FFDVFEG&!+&:'9GD^QSJ"TVOI/3,UGTE3149-%NPOYFA M'*M27$+@]G(6M,D.J<:=:0$%,7FB9/OO1_'+W?H%1D\$-D81*_X(F,C$&Q5J^?A]8KRZ41@^4ZT*58 ^@!09L@?/PP78?N+4%T,+I M;"'H(KE>@7S*M@P#N\@DC\)&#N-9!D\N=A?)=TA""+D0<;ZP3/RKXRMG];&D MKG%B,UO,Y1UT#E8OUVA*6OTTO'Q\TJ9H8#*>V'A 99N#W ?ZQYG>5E;VB%Q- M-]'D1K/)B2?&%](I[2N^4YQJJ#^9>+O FO&@Z9.!>:4M='=5-H5S127VC5-] M/=AHBFP;33S6J(2:XKK$J79"UP%60C61_K"NE\TV?V=WFQ\\O\(TM[NIWCE= M[FE$S> REG"NB26%@Z]9>=6"DUH318-W6TFU@EO,DT(W:YLV?AX#^^W;"X5V MP0NX-BP.*"[KJ&@+?'SJ86&J5@:N.NL: H^;+WV!X\RR=L#_/;%>-FN49FB- MPHA[N^OPIRV#MS,Z1:S@=D<'_&)ZZSJ6U P.=0E!E8&KSKJ&P./F M2U_@.+.L'?!_V;B>::=D&B/N[1%UO8JY]&W_Z(!?3&]=QY*:P:%FZP:-TNP: M//'*JA9<^)HH&GS_2JH5%@T\*72G0@KXS336@T574MFJ9P/N+W=Z R^6%PV! M,\J7OL"G9%D[X!JRHA?OG"(#,>3MPL5%5Y:&HB,TRTQ3T1:XM+1=6KI6!BXM MZQH"EY8O?8%+R[)VP*4]L5XVUU2L:Y^ YTM>"DUD31X-U64JW@%O.DT/#UTPR&A0LM#"-!60VZRSHJV@(?GWI8 MF*J5@:O.NH; X^9+7^ XLZP=\']/K)?-&J496J,PXM[N.OQI2V5(!=<^B1D= M\(OIK>M84C,XU"4$S5E2.'CBE5%+H9N7'2#V.[654 MH85A)"BK07?12T5;X.-3#YI3M3)PU5G7$'C6M0/^[XGULEFCR*$U M"B/N[:[#G[94AE1P[9.8T0&_F-ZZCB4U@T-=0M"<)86#)UYYU8(+7Q-%@^]? M2;7"HH$GA?HK/[GG%S1A8%6Q64:M&E74\G;U/%@<%(??$K0%/C[5H#EU*P-7 MG74-@'PTSXKS.#HG.HDM1P:'9G-T9'3 MCXY<^+'DL&>.OXV<_M!$5Y;YBFQ7?S;0FLX=CFCPRM =H.4MM, M++;6J+Q5I0>T1_WFL8++G45M+ZYG//D?R:H[T#N.K0[TQHV],3#[TPGZW6WYDASEC;ZK#M64Y$[%_B]U==7;ZU^ M)]^//.MIIMG(B3PN,$KOS4S/P_(?=IXYT5_QB(4_>;^<(UMS+3MG+R+?)R]> M(].:ZV;<8]/V9NL1'[9;G]3I!_R@/4.XP#\F#^ '_<<%;I>UM,?(\7^=(6WB M@0L+__QI(3CNFX$1>CN\'S6>!O^^N1!D:>%^%+P7;OM?!W>_70@NIFY',-%W M 2]J-/.C\+7_^&5P?R%(BQ\?!0*DAF;H+^;%?Y8.1N_;Q[//__,7N2U]]/__ MZ"J9%):H+TBVMKO"2^ MTNAM@?=7L/P2\ 'Q? M2F^$*&\^6S9F[P8>VC%&](7T,:1>(CGT- --W3"S"F-D& MM,L%?_.5,"C/M MZNDSI+_,W L9T^M9F$G]IS3_2C"VB $6D>S].M7FNO%VL=OCN6:_Z.:%Y#WV M$/3^L=1LC&?C[1$M+-M-C4)ABI&MN;^[WX3'FX?AXTAX^/;X]*U_/Q)&0P$3XPBS MGR"KPO!1D%OO)N^%X:TP^MN-$.+,-5_VKT;D;;FG-C>-#.:Y?1H[O@: 36.,&(8]?SI0SBG2)F5!P9TCX1!61.T&1%IH>Y\L'[UHT? M"LT%UXL)60;C[\TFVML;PJZD>?;Y"2U%1#DX7*\YQ7MKB>%DMQ'U?\X*[!L"*(*7Z$\/OV M'\&U=E\ZY]?GB?B49.M6=TCT3ICJV!\QEX2:+K97>6O_,_AWGYG=>!&-6_R< M>^\QZ3U-29(:+565V\E<6,J8'^68^?;:(#]?:$O76KU@>USGO>)[7>WC7+>= M1?!?).^/((<7PZ==D!Q R2-ZT1UB@NX]?B<]4DC.FT"2WD1A8([/4RU/,LX^ M10_7NYL?VMCU1D"PIH*][KF@.8*S0&,2%YP(NBGHKB.,9Y[;\OYDK%R *:P> MEMH:NBVZUA"L=%I__>AM.(PU(VBI:RU*,95@4)-M @/:LK%?HI%)R=M#N;*6 MIFN_75F3?!ZHYZLXY$D+VWHE\H@+>HT,[;M&@HP''<_=Q:(L%;):C+J;_*CR M@!)'VH]!$.P?>XK,.A6NW-VKG_R>=>')T[^_I+F;HCNK@_/'\Z5RXF2\,ZXWLA-(< MQFVX"O?6^>[DHY(#_ MI;4DQQ]$X6H8.U6==%XJ62NE;CPDSWC]R<1&CO-@84?#^+>^R.2M?.Y*JJ04 M&@(KG(V##A+G?6'C24=?:(: ?J#QTM5?B4^/N1,Y7$\X6&T"T1L3RXYR%Z[> M!R=H'/@1%TL3\D\9;7E'=H:Q9TYP)0J:3V5XW*@!DI+N&%\%$VG@FC$EJ M[_Y 4>NO9;F_R8YZVG$K:7-Z9&O>9/?T-G^VC'?;3F-51K!)L]WW01C= R'Z MX?.I@"GE^TS'KVQX)_/"NV1SNL=NT$GC$=L9&=1'8?U7EL];Y)O,#TJ3_J D M-8J,11678SG]A9?3^ O49/BGI@7OP(LH_"2=DX"2+"PT6WC5C"42*#NHZ^G< MF\FKX'X.S D)8B/A^0W[V6C\AS GB9W?9\C;FR#0"6V^OI/?"S/-\?(>)H)F M&($C3K#XYU(G2,0 ?$;!!_ SUV!4R6:#GV(30#*$Y)O5G(1A2MXF*3;"!+^+ MIWWRT86-QLAS F1%\++#'.$=?MX4_W66> IS9A;9 5YEI;@SS=UM^W=MNY5> M[H;WY: /[_%2SYP([Q2_C\\(F?C]Y__@'I#/>Q_%7R*M")Y#\J,(\G" MI"<)$^W-.=\?HO #@%=+V\;?]G.J\"/)GM#221^N^(T$:?=QB3_9E%H$OX_H96GX6T-/C9'PC@Q&YZ.@J,IY\ EW MIGMY"PN2MT ;ZGZ#UPA&SOOSE)OKZ]$@@Q%@%D!*$Z08%II@X/4Q$K0Q7@J3 M$UA8BT1M-B&HV%<%/,*-V#><.48WEF*OB 8K;XX]M3>1\#%^'"8QLA9_$5YL MZ[L[6[V].AGRA)#7P@F:ZJ:7^>?%]$ET4I$^[FNG][;\T^+5)W73-T59>6XHJ[DF/,&4DXM8P(F%LL(FFS5J 6DJ=_&0$/8OVI6B M\F,VC!$KIZ .]AGHVNG2PC?YJO85'H(7RW[+GV7E'^?U!G$P>,\3M@E,GGO;16L&-/Z MKQF72TQ3SZ$%$E#F 4\-=?ST:=S"Q%N.8+(S+6\U ML71\OPN+]'?=2R:H(KTP"*<\ZH['GF:FCG6-8/,R20U MEGR8U$.8:/;$$4B.JS[9%T%2WVGO8UTH<-*Q:SW#'M?:F-]A'7I.LI^6GNR" MOC\7\-HHU1KLB4@IR5P/K_("5R/ ?=,HTW GS=<9;(=K "7RWC MU=?DLV;^82\7[OB-&,L8>8MS)W[)/B5Q [)O[5Q4ZK1W-NO81 SE1O.(D"8PQUK'*'$ M/1O!6KK>K$G,?+65&N#2'XUUPI:W-X"\,,G8WZ]P_/T*S5E]P\!B'!<3!PFN M^8-,SCV?"WWO(_?6JW_"2UO2LOZ)8*& MFZ9OSR [-9RVSF'C 9A8[@2-=;QZ.!-($1WO.T'5(2%XQ_GE;'!_>_99:8F] MKBPJTCJ!;M6^S^L1W!V/Z/Z-Z(_EQ*.+T(BO0'E^ZK.-1Q;KV5-X)T^!GUU? M^G"DR5M.1 ;CR+(8'MCQZXOGF7V6;N&W>GUT\Z]18W!_?7,_\E61\OL;O?^\ MT%Y0X]E&VA\-;8KYZP+/.M^U-^?G+,O0TZU/:*Y2HK6(O%.@_=L;41C<7YW" MDIC)4?8_%T!7<[67==("]AVP;_!VH9O^)T?]R[L;\''>R=ML MQ,/:/!5IQ6!UZOVIV2X"K\_DG864@(445ED(-_"K9N*5$&&9=13B6G?&2[]* M$5E,]TW->'-T;Q6^(2?"7OZ> OG,(W*6ANM]9+A OMO,.6LI/8; #;3%T3-Y MIRTUH"V55=K"#?P'V7#4L8-$MDT( ^$7C-7OA, ,BU3R=H3^L[5T!5)R%KG" MH^[\P3<(K@F:5J]J219&452=Z$DH>CO]T\0A@9K+B6S^39?=#9#@KCUMVA M%\WP/08_5:P*+D-38@B20#8B-/FN%G=-[\N=3=MW M!Q(O^>9X53(")PAH"6BIQL_D MFI;8WD92R<4,4\W;M?ZV(-4VD*E;=HB.*D$],D, !>KAZ)E<4P_3NT2D=5]U M$WGW*F$'*+1;#90#E%/?9W)-.:V 9 M7)--.R";-I-D@UMW\V.F/^O<'UQ0BFQ[\OC%XI/1:RA9.PZ\<^SYV< &'"JD M+D2."\>=!%52B=SHH)@3Q&@>LIR1-3[[//(+)TQ)AKV[.?Q#/GCJX\:TC^(> M.EHK!&=K!7WRRQDYYKE*V?&3=")7)Q\Z_[E.V@E.Y)9U$)>>D+3'F&\M^[MF M3QIWEO6'=T'"ZJB9OQK5L&2;SV'9LO5F:Z_<$:FB^X^E=_NO\2;XU92#^Y&0 M5YG9&R C&"!G?1;/*Y>EFUXQCCG2S*"J1XJRU%X9#VWN%^5Z1[X0E"4-?SBH M1?K^7!C-D(/"@C4;"<\:.3!HF<(\>F[G&1DZFOK;*-B(EO.%=PS'KTV-OZ)O M?']A[!?DQ3W77C7=\#C'M4)//1=N]P]!,$Q^"9/P4RUSC&Q_2):VL+ <1_?8 MS/8;1(J*+=VE36K^K \,6>L#0X*#7#+R[BPHMT.>/T/^'1[!6%$\KW2^J@.; MT'/-<*QU][=&)+@1X[M%:J-Y]9*QME=U9W\LT-B-U+8UL8^F+_ S=M_1"?-/ M=E\EI8=V7_-T_AIY ,(PG\<\&"O(T2>A*KJD-+2.'1?-%G CR655GB((U)88 M:046[4IKF*,%U@I2%__S) ,H:/9P 8^9[-OJU*@ FV[OR! MK6]);,+5L$XQ,8B[UGDN#+&E[%@%^8Q7^F9FD2LX_0HW#K;.-V&B3Z?X%:)< M6_?*CT]QK[&E6 Y:J="O/N9Z_+&?R,ZQ%6@34K.,]&^L>56O-F4$%TN76.&2 MM,K02?<$SWC>$A_)V6QQU"3Z2 J_XR'VZB4)3PM#=ZL]9_;]&VONZ9"IY928U*QYMEOY/ZBJ1F?_@= MSZS0#V2/=<<_-(;ID#3-JXQIDUM%B=U@_>JO_D&RH/X;,6GL*P;UZ&8:?L>[ MXD&;D+'QJ]%A#][PKGOP"MH%'?9;1[I=8O7#FJ[?5%B_G9@Q4R_=@@(8JV6: MGR8I1)9OF0IDE+"6HU9,,?V:!1'*"@9E'!Z49\WPIFAGAA!A.L]#>4(+UZ\& MJ$I^-4"/]:[1.'A57E&VN__)(3]HVUE?75[C8O3[=&J27OUK02[S490WY4L2(DS:6K$$Z8S7>X8<)FAK7 A/6V* MU3$PQY0+Z46D7PT)Q3S=7).2=$_#N\%U?X1_N>S?]>^O;H2GO]W<>%7JV*I+ MMWNU"2T'AL;6Q.J!V Q=Y/4)76#8?[>U0DXLQ@A<>6$3,@!G>QRLOTC>G\A= MH[W(5://ENM:\SA_J_ ;7+>V1Y*M:(M+"P=L^H80&H\]^EF^W@%H%/2[Y2B= M%F<2"S@[P;4L)P=VS/'S[!@N"2_OOJV#^R_AJZ8_UH>AN%)D MGTTU%G.U]]'9$QMF[#\]17S67<"MRJ26CKSI]##RRJD06[Z5PZ S8I-5ZFJ- MM0R#SIYIE3+=!=)6(1P_;8-L(*.MJ/?I!ZO&.(%!9\HX&4C@5KTF7VG.C(6A MBI$1FU2JS>O8>*; I.]ZV1$6-WCK%H+H *!&@R*F!(C5DI:'*N8&B M*F*7' 5@#":Y*RJ61X /-EIH.DFZ69"=3(#U*>DPL%-L=OK';2LV(C7Z:D1 'LBP*KY 7OD7"#+Q&60N$ LTPYR M\4C93657"<5,^WK^5L8Z]Q788!9WB#IRDOL](W0 M>&;B=KV\D21D+]58&X^7\Z7A93MKA$Y&4_)W6J1;-3QT;&R/J]U8SI ME)OA[(&-G(5_\,MX8\&66":M(KRP]JX7=JMC%:,[K( )QI5FOI SV[YKAA%% MPQI446U*8D>!V#LCDDN 7:< V!V[&A#;2D_LDJ1MQF 'ZP&V#:!JW:VCY#JI MF(/U@%^/TH_U"BR,&>RS[$[9W=TIV].9/T73< OE%IZ%2B^0I"+I.[1XVI5['7;8JMS.-+$ N0@# !KQ'H, M-*B893ZAZ?]M7+Z[0?]R<#<8#6Z>A/_1YHN/PM-H>/6_?QO>X4GHZ6?AYA_? M!J/?&'4& ;G5'6A0,M&<-LHN#GU MPVQ-)==)Q4QOQ?K'-/OCL5\@?:&]D5J<+ P;1T>1N]'3,\& /OCC2?$834=J MBS*#AY.9DLPL<*('8M(#Y]B3C)(LJE*7.> P[<6MZ=)>(E9/M;,WG1=A*9&D MY4 )=QL/FB++JIAEI0Y[::,UE5P"WB+9RMGP=NRNI:R*$H-'8_GP93UR]NXF M0([+N$];*:.)Y L. B70]X/EGBK*G0YS%E-3R26 +9+UEP%LQ_K.:E-L-J/G MWDX]\!SXSH_(/]>YT&SW;<7-X$'3MY=>),_O>HE&5J"/!ZP.NBZTTA.;$GLF M4U/))> MDN27$6_'GDWNBFV%/;QQX$%?>5=KKN]0W^Q,^;=9+I^=L:W[E]>" M/46J]/EZ\BZ??2+7G#I/8=50X7!L5%+S\ &=6JF^TJ"+5-K+ ;ICB;RE MBNTN!*IS,/GUYB;C5:8!5-B@;C4M*1(\W"BBG'AUKRN)DG3XC%JM%%]IR$5" M;YDA%TO3_T6V-?'J:B>@K<$L5:6-@)_NH8)0C657"<5 M<^ K_E]R([6QG.!/+\V@ZAZ:$&IRA8GN>&DI@AU$;UT+O^%JXQG^^;MFVYIW MK[?IW50>PVH'ZO9UMDK+[I"SFL$>2/LH%;43VU)7[,5X3_Y- M\I:)H+X=NZZ0W-N&TPK5WS:@OL:8O@X@'2!L9%T'>/YG .>^.0E-T=V$UQI#Y7-MS_90 R ME09KES.PPBJAW%5"<%!DX<]W>##PY+A:)0B-]82\\&=(1NRFTA8;R3O8[[!< MD=;H4QU-:&:^R&)7AE /(Y*I U"1(AOYQP+PZ#MQF 0@!VNN0^R.A[/!-,/O MU MZ-O# YF+WX$)14!T"M M*X4"^LC)IM/C!L],+R^2[E^#4^FG<>PBR1;E;!8K8J_7%3LR>\ER-95< M0B M)Y;+.=?44Q11ZAZ^\)5IJH921+ 9"))!Q;RZ?G[LX7X[UK 39F@8R''6#N$J M/L'"T *&ZS#0H&+F:(KAM!22>/&,3#35QSI9QWI;H0YAK"G2O R43(DK?ACV M0-)*;V_22B0.DC)OY=A*0!U9;'6BAS,@:X6+%5D[2R) WYQ!0^ Y%I'1>2'54RIN+S59'5%(466)A[@:DLH/42%&Z M0T@]-H&PV4F50,@"3ED,NV_F!*^$V\PR)GC]\;-P\^?2JPW&Y+3 C$U5TW>I MJ>0ZJ9A%]W0GK/Y@HRFR;41D8F82DT+=K8B#M/ZV1VL/FCVTGUP22?E5,Y;H M =E>LEW$KSY_0G9>.;JAT(MVT_^ZH53MJ>H![\09GBF&MS?GGV6SB7\ M)UJ8@^QH"J^D71^%_7UL1X[Y;K?$%]I?NC/+)C&FX_W":#>\>Q5$58HO)B@X MWA<$;=T&$4-X]:KN..0:#LL6K*7KN)HYT7.0D MR#;,//M)CRU.,R1J*KD$>$5NN$L++TC *77Z]2<^H2^$ZU)FFI,/$$FF.3G@ M%N;FY -^1Y8Y.5O?@(>=W"0XX?T>[!$,3Q:'%*=DKB 3!"_(*TG0OMV.@ MB!UP#"I,R)$+ 7([!EEAR"DGUU1R"5",5,S,[1O4!(HY.T2/1E#[Q9G5)/E);8Z\JB(D7KMGG^ M04++DY85!UN>*==@;\M)R2(U>AYUQQ\B_VI$L0XB';T)Q.=C)5F8 =!GS1T4QAK"]W5#$;P6FE+ MB010-NIXP-H8F%>^+FAP+R<+_VCTQ/O%)W+"&SC\Z[K4T'\78*]17(#'I&KZ2::W&BV MB9=+3DBMU[Y6*7"]X.#V_G+6P#;8%.5V1VQW6^4=W'T/&&4:HY&03TZ,'C<] M;##:[(EM2185I<3#Y>^Y<=C](VU/P\M'X4F;(I$4Y3CWPY'K0PTH.-3 TO3 MC&T5ZD]% HSATR7^V1+_6#RVHZ $8M]U;?UYZ9*"3R/KWC*)*=F68>"/#+!1 MV;JNBI!QF_EJ!I-+PC$21*<+SR-4!AB9>'$@,7L; P>)@6TV"'NB) M$:#'.S7LNUVT'*Y(AL)7W;1LSQ:IT7]H":"*;54!][_."(PD)J1"8%$./D9@ M2^7'N:^8V\&LPU.U[M91F#!7;^0/#1XN(A("? E M27_%S# M_NV-GWVXO8:C+OUJ2'#R=',MX)^>AG>#Z_X(__(TPO]\Q0!Z$H:WPO#AYK$_ M&N /E-RZ=]_N^]^N![A%[^E*SL$,H6\;:.I28PJJI)DCW. I<9(.HJ&NLE U. ML@.:B,G8=*/3ZP3041(Z)$ 'H .X ]#!!'=0WRJL8H;!SB9PD@]=J0UA&/3: M#?IJE#MGIVH%BZFL8=(^^_R(7I&Y)+>',Z&S7+7C1QE6@WD=BK? M+>ZUGU?::4BR:\$=>S7$2N0442)6I!!6),!*S; 2R6,_Q"LR\$I=L1)),S_$ M*W(5>04RQT_M9]IJZGD$A 8 MN:LA#P(/;CRE1Z#B G!R9ODJ5'8%.21%GI,(= IB-COCOK%!>\R]4NBDZN02FC[LG*S0RYW8LZ*:BJ9/O!ZT2+AZ8$'N5.5DEP" MVJ(5OC/17%'NJJHV144!=Y41R24 +Y+HEXWF"O-295&5#E^9Q;23>IJ8ZU?- MU%Z\,GJ"HQF:O2H%38KN+0UO8W>*F$VLKY0M11(A-[JY165%7=NJ(O;:[-WQ M6%/))< N<@-Z:M@5&&I56XJHM-L .S8DEP"[R'93%K8KRF&5Q797$5LM]N); M-95< O BNTQ9^*XHAU4694D5NPRNE3@(K#XB!VGV>.8YJA/TB@QK0=3'"(8K M;3V1';*5,OKFY'JCBI*\5>^BDE:+.2.JJ>02\!?9'\N.OR(S!+#;*BL0UV=$ M<@GXBVPHY>*_XOQ7"2.PW3I\5W>M<%!A!*I23,V&' Q8E".K2CVQ*;''@!R$ M7ON.@UQ!GR\TW?8"L-J$7!G GB<+]^CZEA?99?,T.%@K\&J&VW[BVBDL7*4+ MF&4'LY$-N@R8+2L/ 3 +F UC-K(1EHUG2ZDE Y@%S(8Q&]E%R\:S1;GC2DM4 M%4ELI8B)L8!@IH/-JM=D_Z9L*W+,'- +F W#!R(YN"J5FWL,QCL==LBETY M^S7Q@-UZ8S>RH9B:=0OSV3NBW&F)BEQ!GQTJ59:^QU2U[M91,JBX\I)!Q967 M7"<5,QW)\RI5WEF.(TSQ9U;!/,N$(-[I7/)W"3YY),EJ[9,/S+$U1T25E.-X M@H,;^\M9H[" 7I;Z^^\!DZQA4HZD7:7%9''QN0TF"PG4 2+Y1F0D'2D#2Q84 M=]L@LJ '&"2;TQ&THTRL&1!\;0-)HL*K.4 )03)8.U5CX$&%5=^H$'%E1]H M4#$$R;SK7-P9L@7=\]6$=T&NVWNXTJ5.**VI9%!QY26#BBLON4XJYN",J[?I MYI6\)C&@I>[,O).NUE28H&=7Q(]@[*PK>Y M(,E-CIQ.^:+IID.4@YRA>;.E MG.'T&JOFI(=8:Z7^2@,O>JE0+N!!1>Q*22X*> T&^E)'R47I+VDG*7H53U[F M*'Y?J=T3Y6:&&KFT-Y!.4X:/*(3X=E--MX57S5BB4 43H8$'S]9?O;MJ&,NS MXMAB$@PF\1Q82C616N&@T@B,).4=SX%%G3-L2TQ6BN0@BCG :K&1 MX\+-?>4M )5(*N%*"R75EE:4CMCL9*@MS6GN:D7A$RDBE@8^!=;2:,IB6\EP M)16@AR7T1#9,4I)/8?4L>CU1[1X^<@3P81(^D6V/E.13V/4B4D=46AFJ,EH MQ0QP/CG]=@NEW\+/H"J*(JH=.($*> WPVBN4?PO/(Y#%)O;3VREB3*P<3RW% M=]^JN^R=1PG"K@RFB\+!;]_4U&AY#**Y>\L<8Y_$/_M=3MPV5)*@U155J7SC M EPRA,MHD8Q,N*11O"5E9!A@66%81NMD9*7+PKWGMB*+G=;AK$; 985Q&=DU MRTR7%+SDCJ**S1,P9MX(=S4C(LR80C4/\]54,JBX\I)!Q9677"<5,QT[VU0Z M?D;8[T+"PK9>=7^;VUH7=G&U'ZQM=[,'VD+\Z9@\HE491.(R7^'6Z^92-U^& MZYK4EY[B_,^-B**N\0\.;DII@3-%Q,\2FW(;TH_X1%U,^E&QJ*,1%NNH';$M M94'&E1<^8$&%3/G%9PD7O?)<6W+?/E\CUS! ML!SGTX?@!1:&CV6<%K$#WHR<),)J.'S_,^2, 8ZV<10Y^7,81Y %!BC:05$D MWS45&T%>%^!H&T>1#-94;%2W3*U2?#R_E!YQ[M[Y>['O/2]/T%S7UI^7KO9L M(,&U<*=,HA7;,@S=?%G7VF,$M!"4W;*O2+;NE35?V&B&3$=_#9(CL5(Q/%I>/DH/&E3) K8 MYSN'?><2(_2M/;G()#R_[7 _:#8R:0<$HQO11U**'E=:>B-*N M5\KUS>_)U5PTQ_8VF.-Q@;/'@&1V=C-:D>RFHZ%PSRQC@FQ6#Q[M M %W%79Q82]R-?"K\*9M=1<058U@M6=JZ7!'K*;KBO?)T]!12$8-AX%W;4JOG MQU0%F*KDSV_!P#'*N"D7I$<=\+0,4".%\C)2I$<5WQ0N2=* M;0GCKGS,01HCVYLI5>MN'26#BBLO&51<>HYRP#SVXOPUYT=*Y!&&""L$JD@*4!U:Q(:FLL,I^+AY@Q2RL(ADO.=DJ M&GC*""L9V*I"L(IDG^1DJVAP*1.LE'-%A2 2K$VJNS:IJ610<>4E@XHK+[E. M*F8_B/1/KTEH(FA8EO:"!',Y?T:V8$VW@DB.8"U=Q]5,4OZ$A9'-Y$R?&MQ% M.N )_G] M#GP),-^!>23QMD"8YT[?BH>Y)$K-MMA4CHR> -N\T M,=2/S(D%F-<0YI$"?,6R>;Y$M5B8RZHHJ9+8;1Z9HE;FVN.#^VQ-WLB_),.O M*"$A4?ZQB>"ASY8]0;;7-:RA"RD,A?\L'5>?OGF2/)G"KIQ@@"3IKUB9&(D+ M;4(4[8W]IZ ?L6LI?\F$5U%8L/G+F2R'1_-V>#]J/ W^?7,A>#T5O!=N^U\' M=[]=1-H@?.T_?AG<7Y %TD2#URTW+Q(S!> M!,WTBI._V)HA+#3;)8LH%W\<(W-"[B,D;32]HT@:67%-=5,SQSK^L+,Z'.2< M"Z4H,(7JZ.G)9YO9XGEFGQU<)Y\EL.:S@=?0H?-=PNCF7Z/&X/[ZYG[D:S!. M@:U4(C_ MC*PQ!I(W_!@B5X2XL.X_?=#P@\@'4ZB_(%BOK'(+&-1L9W7VRJ^OU;^]\>MK M"=OGJZB+OQH2B#S=7 OXIZ?AW>"Z/\*_/(WP/U\Q=IZ$X:UP];?^_9>;)V%P MC]\87OWOWX9W&'M//PLW__@V&/TFO+N^N1U<#4;OUXT7RFG]NV_W_6_7 ]SB MTD3[V!"R$;Z!IBXU%J'J%9;M>,TF28[77R3O3XCG#KI=*\5MYL0VS2EQ;5=^ MP/#)+W62=&3RP C3P2^C+:D8"-:GH $'1^%@K36EMB/"3DM -^RV9+]N]NRB M[:?*,ES?T.&ZGTOV>V_^7.KNFP"4#&;/?TOX,ON1Y6H&TX:7.AX", ,*8*,E M?%% ?VXM39=I#F"J)6!Y[+8$+ ^TRXQV)Q.=;,(R[E\QU1+@5G9;PIKUA?.% M#^Q,7:.I/M;=]V"(8(C\MX0U0\P=6&1L:"'2<.)]0*KDLL:CET+'-!"9:DG% MU/_N)^F<-%46'C0;'(+JPB"]>PB, % =J@7) [D"FGZI*&;A6^#IP?BE;;0 M6=^98ZHEW"$P/1;ZX_%ROC1(;OX)$1G$4 "1@,C/F>ZA/KTFV&D)=YA(QL&] M99+3;;9E&%[YA5*SQ@;D=^0 (]45?4':8#'1?>J%5:IW/&1U+C=>ZQSW#P:4 M=X$PH#"@; N$ 84!95L@#"@,*-L"*SV@[)=H7*W#+C5#,\>DUH@K_%TSEYK] M)LBB0&K;\'%!+7]W1;>RU#A:J6#O%7Q*I*27OR4Z<)SE;@6COC.<*I+<:\A* M0Y5_#[[P>^B&OJ^(%$8ZHIY16VRV%+'7BZO!N(93>G MZ+@S@%I5BJ VE&KF!X=H8C=ZN7GL'9& 6*#B75 W !9 9!LBDPLBLG6)D[U< M]E]D6Q/-F2726 -8#.": -?(G7(YX;HY($7R;09FD/-RW!PLDYJOLJCVXFJ^ M HIKAN*$>\?5R!UV.6'\B%Q--]%D=:G44?C=W!8E]\26+(MR.^XJLCQ SJ.[ M]WM% 4K+06GD2KR,*-7G!OH]_)U@MYRD\) ,GH$Y+@BPJMA2>V)'E@&O-<9K MY*Z]G*RZG5JTRO4I"*HM56S*$N"TQCB-W$F3#:=%L&5/%66%);;,>U=D>5L. M0257A^A*T+WP-%$$N1)J@4Q'(P-8[TVP>%7DN &AI4;NL_%,Q-\4N%[:F)8? MD*U;$S^(O[I(%4VN0LI(<_V!2FTC08JSKMH@HT)0C%S&L0>*OVK&$I6#Q-RA MM-K @3?\-6HT5+SI9C\W-..W >ER \5(>VT042$(QF_@T(4@E>BY(HE=*6YA M7!N05 B5\?LT=%&9)A@.U,B<0'H@C-]EH0-"VK%NH,0'A3C-TVH0+$:U,=^9'H M5X8O"XE1MF\" #D"X,&L\@J/':_*2F"-7LFL47[:>(7AP1T>]^*P)96,0RH1 M[79+["@PG54#D7+)B(1H-I<"Z0%0*0F U"/9'BW&G2RH#4@JA$JU9%J$*#;' M NG!L%D.#*M!>7SF6I/H-7)= PDV\@I2"PO-=M_P_]^T9X-L!-XXL/M%@3<@DLVS0'HSV($=%0I(I!++;O944>K G%8)4+8/;*]0 M "6$L[D42 ^"!_93"H0@]8"VSXVPT5<-8![89Z' C1#3YE@@/2 >V%HI#H@5 MX3T^$[,W86UM/"9:G[&KD)%,) R%OMBJH"$>]JX/+ "8+4N*03_@8'A#F!$/GF2"#UR'<[Y8X9 M+?Z ,#C/ NE-:RDW9&C!DDI,O*>(:C?NWHW:X*5" $VY3T,+H! ?YU(@-3QV M4F[1%(U'ZL%R(,T*@33E)@XMTH3 .<<"Z:$RY0Y.P:BL!B%6*S=\@IY=,*N" MS"K'?M0U'G\& N3M9E?LJ#U6;*P6 NGA,,?Y!(+#4^>#MP%^',$/HN+\*2N! M,U+NJA7$&1 $YUD@O9DKQVFF(U!()>;=5=IBK\7,4=9:"*0'R!S'9(X ),2X MN11(#WXYSL;D@!_UD+;'B6UF\B!K(9 :*+LYSL8$[WO.^\1 V(&Q-S912[@9A(F8PAS;9T;(4ZD&+E-NKA3'C!#*YE@@-1SV4NZG M'(W#BK >^PG8Q!=OZ*8P]KUQH2%,-=T67LD%H8(U#<+WO9NWM9:]Q:;C7:T[G'JD./3-YE?/:IBIW@$HY 6%0!D<*2N! M,I2R* ."O3P+I.>VJV4!D$J05^V)S18S5\;70B ]*#;+@B+$=KD42 ]Y+=K( MHQ[3!2*L$!S;91$AA'(Y%D@/?QW*^*L&R;&?CQR-X+Y@OT? RH[F(1/5X18Y M>$#!CB BPZI ^A&9[G[R^X*M9QC9OKI:&P[$<>LC$%B#(X'T6:-7(FM *)=G M@;3<]K8DE8A!.BF[2E-4>G (I1IP3-@-+QR.$-'E4B ]\"7LJQ8&/OJ)NL"' M%8)DPDYKX7P(@5V.!=*#8,(.:U$0K C7\9B>&Q_<#6X9="# "Z$:#@32#M6T MI83-_B@)KFY:A2 O ]C@%8S '!PI*X$Y$O(RJ# '!'IY%DC/C4_(SZ""0RK! M7D61Q5:KPXK#7PN!]""9:=>\ $A"P)=+@?0 F&D#]@@ 4@_Z B]6")9RICW9 M G@1 K\<"Z0'PTQ[L?EA6!'.XS&SU[ K"EL_4O=F-9FB2C:Z;+8N!&&]]! );<"20/ELD9&D4QA80U^59(#TO M/2$]HS#LT4GRXK_70B ]&"9LD!<&0XC?R0%H"^"K ;^QFT]\CU8 M70X?KV\>&Y?#T6CX]4*0<9L=R] G'T]M.WL;5F XYJ%_?3VX_Q(64F*_0>74 M5)[ I^O-_V#>O<#6B9T]:X[(KA?KT5Y ;$41"R15.Y4GD%2G6)(J/\(,H*T: M:/>#M5LL6#/$HPM:" -8*P;6=PEH[16+UC1QZ]3+:L'!O?CEK''VN=F21$DY MG D5!]WX88K7ZGN X4E@J$K%P)!V&!L062E$)@!2+I87TT>S,P0=FSV8R^L& MV20250K![/'4V.R)W10!\8*HD?VTY-4*]U(S-'.,OZ*YPE?-'L\$518%,O*A MA2,#YG-J*RDP=*"JNS;Q--,P]0X<9[E[:V+?&4ZSAS3W&8@O9X>R.V*WB_V& M;IQQU#8Y+8O-KS3^4W2\Z&.I%<%2R-.\^7.INV\T$17U #I=P!''M%7GQ&AN MC#ZR09;3Z"&MN<8@BFQ@Y 01G>3DKBBK/5%1XJX 6PQ@:VD95]DPR$GN"C% M;N6>V&O+HAQ[P\P>>.49_/?L@)4?[$3"_QFQ4U[ 51:["O[;4P!%K*&H&8G> MYV0@"E'2#8!:JJBT@8/80T\DU)X-/44P2Z)G+HVL)T\K_4 IP<51?7/2]S5R$RADE884G_O7#.7^M1NJ1"7I M259D4>K$Q>UK@Y,* ;-9$##[<_)^6<",N?@,\,@1'B%CBC]E)9!(Z[0D KE8 M/ ND-[>U3PM+2J4G55'I23#;<830PP3:.2U2J9:G! IE'J#[@=D]#3!+J%]) M:!06#=5 :>^T] FU+3D62 V5+>DDJ*P(([)?]S(YO&XC0W/Q*PO-=M]6,7:( MIQ=E6W(ZVWKTM?! E!#8%PLA]&9+5-IQASUK@XP*05'-#\53!\WCTN=K@PCN M( A!<_Z4E< ;*7?>"N0-B)/S+)#>#)9R^Z9 )%()C7?;8D<]7$.KPA#A#I.' M63+E'DZ!V(1@.-\"Z?%DREV: K!(/?Y-N+()NXC5P&7*39H".1(BWAP+I ?$ ME/LPQP.Q&K3'9PHYN>8) PBYPF)ICV>:@\!^BK&?]H$=HUO+[I.!?PC&G8%( MMJR(DB21OZP852T$TH/@@8,*NQ \>01; >#Q!#R(8?.GK 2V.+#W51!;0-R: M9X'TYJH#.R@%H8]*K%KIB++<(^7#8?KB"(N'&?' 7DI!F(08-=\"Z7'B@?V2 M(_%'/2Y->%&!]61U\'A@SZ0@/H1X-,<"Z8'OP,;(<>"K#L6QGVM-/.^&;@IC MW_<6&L(S,KVI!_^"U85;X!#=3Y'F+FT(2&F^40(H1I.19(#WTM MJNBK#,>QGRX<#=-.-=T67C5CB01K*OAYQ-\UV]9(Y>D7\@^:@!U!M)81@?0X MKKV?XVZQC?Q*3&0X]7RV?P;V\<4W#XC85EX@1&PY$D@_/-$ICRL@:LNS0'K3 M5;<\"%*)W+9[+;'9:L(LQA$:#Q-CPI9WT:B$V"W? JE18S=A/[4H$%*/WP(] M5@F1"5NL1=,B1' Y%D@/@0D;J@4AL"),QV.J[0MVA 2L[_B2QJ'T6S G".0R M(I >U25LW7_!AC(TXZK;;#:O()I;>8$0S>5((/6@13!]":N MA"P+*CBD$M=M26*GR4Q&1BT$TF?(A+UQ*LB$V"[? NEQ9,+.:Z%(I![@!9ZL M$"H3-F.I\",$>3D62 ^&";NO1<*P&I3'8[*N83D."?1B'6&[7^K.;(Y,ER3N M^C%>5\<:Q6/FXN>#54&LEQ&!U!BOE[#5?X=M96C>;%G*<'JUL9-[8B80[:V\ M0(CVBRCEY"+08DR(-[+LT!ZDU="3@8E)%*JE*N*S38S]U+70B!]FDS8 M1:<$3@CZ\BV0'E$F;- 6C,42RN<"658'F D[MI1($B*_' ND!\2$#=IB@5@1 MWN,QRS>N4H.U(*/H"*^8!*!. X1\F1%(C^HRG+T>^M;QJV<<$.FMO$"(]'(D MD'X((\,1^>.8 @*\/ ND-U5E. U_' #IQ'5;';'99<9EKX5 VJ38D3(#(/TH+E!CA?"8X6S\<90(P5N.!=+#7\)6:R'XJPC+ ML9^P>X]P$VM8KFI_# S@+9JH-T/UG:Q8,T0DH9)%< :!]9W"6CM M%(O6-,'JU MGP<&]^.6LX=TDWI$EL=<^7-XP#KWQ(Q6OV/> Q-,@L5L,$FG' MK &4=0)EKUAZ3!^XSH%'N=<#(%84B+)4"!"+X3Q9E-MJ65!C/\-XM8"]U S- M'..O:*[P]Z6)!%42!3+VH64A X[NJ>VDP," +.]:Q=-,PXPZ<)SE[K9.WQE. ML\Y,V?2]U] MHPFIF'W#V!LY:PLD[HBKSOG/W%A]9-\KI]5#[G*-0139H,@)(BKYQ\VNJ$BJ MV.E(@"U6L96T](ML*.0$%Z78;+,CMCN**+=:Z>&59_#?LP-6MK"3 )U(=#\C M=.A7[U5EL2NW@9A8!5<2,44B]CF)B6I4M$7.RV>8^8":RJ&F2&0]&WAR.T.= MKJBVV".TE[*5*LAU@8(%4)> MPITVQ2"/>@X4$&&%X)APDTVQ1 @U$#D62 ]_"1?8%(*_:I <^R40K_57?8+, MB2,L_/OE&T_(UO%7^PUYZY+RQ6I-Z =DP9 @X,*(0'HDMWUUS=I4'GQ+\0VE M+X>NYMH.G$ @MO("@1?8%4B/%[HE\P+$8SD42 ]^O9+A5WYIP K#@C<<)AS, M4J62@4CI9*GU!5&.:[ M%>:$<61 9 40F0#(?#?"%!!L3I]KF1-],)5SC-@$#FWFNSNF\+BTQXS2X;CT M*2Z..4F.;]S%,4]HX7K&[V.'T3MD=O"JXAY-K.6S@5BSI%#+"BQ>VLQU[TR6 M("?U>V=VC4RMXP1P$!T%U4HH@-$5E98DJMVX8Y& T4IA-&EY?L3]/F6$V#%,6QU9 M[*AQ5[YF@"GG%VM4&X-'7!14M:(;6M M HKB\(C[B*%2Z!H&@M:H)!*WQ*!"TQJ- MT!J/ D%K/ H$K?$H$+3&H\#*:8W/O+F_:^92L]\$V4N7DYE.EZM2WNGA3=A6 M)/TT1;*M MX@A-V(QOY<_CW(8HK12YGMB69%%1CG3BJI40PAT"$P"8/T?3!R#U2Z144<(T M*%=*";H7J15<2W"0ZQI(F*POIVH(H6NI0J5OA?6Z5(!KJ?:H+4_YD=;V M'1.A^*,?3A]93YZ*UM6)#Y8E7@7)8XI R U)7A6!P#^HM$+R3564VSTHDUT% M@+;EH@':GV,V=(L&*)1N9TX@W-G%KL!C^>*@X]A6&.&-\@/J%88-=SC=CT^5 M$7Q2B;++4B?5E1$51@YW4#U,J4U&()LFZ@ZDRJY >J3:.C%"J8?E@5BK!-/#NGA6=%.)+]_'?B^#=T4QC[KK_0$*::;@NOFK%$@C4-HO;6 M@HRB(VCF1'A\^B:\8HI ;%R$QHVQ04R)7=TD$.'V/?!;Z^1;;"F_$D,93CV* M&_I6TC8% "^P*I$<+O7)IH;1+Q"H,ANJ@KR.5BSY*<>*6 M*,EQA2!K Y *(5(N%Y%4P\"U@4.%\*>4@[\2@KS BM5!I5HN*T(LEV.!]%#8 M+ 6%%6$\]O.IHR%;&QF:J[^BV-CM=\VV-=-UA!?R#T1M(3S#C$!ZE-?:3WF/ M@;'L4M\_ SOYXIL)1&XK+Q"H@5V!]*BA73XU0/260X'T$-@I'X%4(KAMN2>J MW;A[&6L#D@JA,F&CFQ8J(8K+I4!Z&$S852T:@]0CN<".%4)F-V''E18[0C27 M8X'TD)BPTUHP$BO"?#PFX3XCTYN.\"]C+Z/:(2B8(LU=V@A,"<(TC BD1W,) M&_J7:^.X6MO&K6\:$+6MO$"@ W8%TJ.#A$R*(ND (K4<"J2'NH3,B2)11R4Z MV^Q*(O;$ 8F50&+"AG:12(2(+)<"Z>$N8;>T"-Q1C\(""U8)C0D[IT6R($1> M.19(#WT).Z0%H*\B#,=^_NP]<@7#X,Z MBFDX@3I[NZ7H]>+N^H,<%@)'$:NN\V%PX(8KZF6 MAC3VLWY7MRY<:H9FCO%7-%?XJMGCF:#*HD#&/G0C 0->[JGMI,#K+'K1.WB] MR^3\XM:QETK2O+1.:8F]=DM4I+@J*+6]E(+J!:9%@BGO/:4%02JZ3E?:&>[$ MK3Z0N".N1HV5Q8W51[:TP7_/#EC9PDX"="+1_XS0H9[Z MJXI-#SM 3!H#4>!8+6 M>!18.:VQG_[D9SL(_B4UNI=XXYW(G6ICW=#=-\% F@.U#K-%QO9'Q+8+R(12 M3?R.!=(#GTH3?-6@ M-_;K/D9OV8F[+MU:D%%T!,V<"(]/WX17;/]P:7HV2X([-MC530++)=QVL'NC MV-"WDKXY>726OWHF L':R@L$6F!7(#U:2+AZ@@8MP!4\' JDA[Z$"RAHH(]* M<%96NZ(D,^.JUT(@_>ALPF44-) )85J^!=*CR(1[*8H$(O5X+=!DE5#9*Y<> M(7++L4!J*%2D4E!8$<9C/VDX&L.U@SOO8X.YWX.+[X47\@^$<2%>PXQ >I0G M[Z>\Q\!8=JGOGX&=?/'-!$*YE1<(U,"N0'K4H)1/#1#.Y5 @/02JY2.03KYM M1Q55):ZT6&U PATJ#X9TE80=<%KHA+ NWP+I467"OFO18*2?B@MT62%D)NS) MTJ))".]R+) >$A/V8 M&8D68C\M,1_@7K"K? (2B8(LU=VE @ N(V MK BD1W,)._R7:^.X6MO&K6\:$,:MO$"@ W8%TJ.#A-2*(ND 0K<<"J2&.C4A ME:)(U-$)URI=L=5K 1(Y0N+!<*V:L--=)"(A1,NW0'J4F+"?6@0 Z8=E@1:Y M0^-A6DS88RV2%DL(R0(Y,@_'_3!,V$PM (85H3SV4V[OD2L8EN-XQ7G=&1(6 MR-8M-E)I+X>/US>/X:OB!<782/$SIXU1W?8$AF-ZP) *P90H*"J:SB!@MK%4E!IL63 :-4P M>GC!VRD6JQDBT$6O; &]%4-OP@W':K=8V%*Z@UT66TU%[,AQ=]H>!F^6&X/? M Q!/ \1>,4"D':X&3%8,DRFN@6]*Q9(DU=O@,UP$?RPN&;PC3]GPU(XKV5-;('%'7'6^+8X;JX_L@857EC=_+G7WK2#;A_04=@72QUED MHR,GSJCD+;=:HM1KBVJO!_!CE<.2%H>1G8F92" M+>PD0">R.Y 1.M23AQ6QUY)$M=L&:F(57DG4% GZYZ0FJA'5EBJVE2Z0$V/D MU(I$Y;.!)S_E=+$WU&EE0 3C>;R5(K]3+0NJT:?J"P2M\2@0M,:C0- :CP)! M:SP*!*WQ*!"TQJ- T!J/ BNG-?:SG^"Z!VF]AS;\:=LJ@-2"J$RH2-;EJHA"@NEP+I83!A M5[5H#%*/Y ([5@F9"3NNM-@1HKD<"Z2'Q(2=UH*16!'F8S\)%R[/.4F]3KBY MHNH:3J#1?)?GG#CZ"P"M&$"!@JJNX00*RG=YSNFCS(#1^F TWZ4Y1<2A :P MUHQ5]MOY[LHY*CZ=HUR9(F)18E-6X%Z2J@(QWUTYI0>I 9,I5%]08;U2+L+I MY+L(IX 8-%R$ \R8@AD[^2["*2@T'>6[N+*T5/B._;SBN(MPGM#"]8R=T=MP M=K"JXKY,K.6S@5BSHE#+"JRPVLEU@TZ6P"7U&W1VS4NMX_KL(#KH^""40-G, M7_:W"&C&% 3.N58Z(B;@ MK;:HXA5 LP43:>4Y-6GU?L1-165$UEM-46YWQ':W=1Q,JQ5:XA"#"1 \XL:C M#]J/ W^?7,A>%($[X7;_M?! MW6\7PJX2B+Z-7\8 P9]ZL35#6&BV2RJ%D)QSC((),ATT(3]Y&SZ:BW^9 MZJ9FCG7\8<2N-W1TCPI'CJ6$EZMFP,7 \1N%,7DJ=R3_D1,=_U MB3O#;TE_Q0#'AK?0\+K(?/'@^2G0=>QVS%G8:&>+YYE]=O @P5D"H3P;VOB/ MT"[:5O_C=-=.)6TS_C\OM!?4>+:1]D=#F^)G7 B:\5U[A^>=/ MFC"SB4'_962-,8:\D&*S2<9$Z-L&FKH4,6(96"J> M2&5EWPF?W6VZ_*,2WJN+M_G5=$ <6>&I?WLC"MB7/1=B=NP.(9G1GET-[Z]O M[I]NK@7\T]/P;G#='^%?GD;XGZ\W]Z,G87@K7/6?_B;/UAI0J'A]O#R3^V$Y 3S+7T+L M4U)[S1[^%-/[ZV&O?F/^I7+JK64+Q%N\UTTD?,5#,7.$&^P)3EA(]*@CB ZF MAV5&5!B79?LBX?PA0%3U$*64C:B#.6@U._!1<5U+K.KZE$3B+UO_>KJ-\1 D M(HX.7;LJO^LPZ&5W/66%FGA9='I M!QR078>!!A4S1UYEGUOW8T+7:($92]<\KU4S)X(VM[#0_WHOL#"&+(/U^")A M:O3 ;U@C^&<#D1_ZYJ0?4@SEE21>+/1$J9>B"G&=P%!I&$9.?.:&87&+U\^R MJHJMCLP<#)EV2GU>)[$% :MX@IY= 6L(>YI+W9D1-U4DWB@CR*ZT36W?8$LT M,L2F].S>;*GC'KGYZ+RHFPOJI/5*XZUS%-X*Y&VEW1/E9ER),HYX^S3^^-5, M,U\0B1!LWT<[0;;^ZE]4:^C:LV[H[ALCR*ZT345.S%ZO%?%%T\V5D:U> S*O MA>0R]HTB9V#S(8_&7E);$MNQU2Q.M(]T&A<[O!(B%*T'QXN%!M$#;H!#WI@B MS5WBEQE!+O\VL]]DNMN7@X;U,YRN#G]?K55SZVN&>BQ%442U$W>:]^0JJ:/D M$F H%P;#(F,I8E/JB.U.7&4-\,IS4CTCF*ZT-2DIK.D2F5XA&LW8M2OJ[-YI MB5+K<.7W6J&BTGA4B\=C@33?Q9[YX;K<3%/\:;QYK[B+8"W(>#D"^K$@]3P8 M076E[2F^XO'04\2#H9DWOBIH$[G:ZXE*J\>! M5=TC=S@=:3^HT[K:%!4%,ED8D5P"("-E=@L 9(%TWY1%56)OO8U(^BNM%UUM]>]1!F#M2XV2?"P_5E]R26@K7<$VHK,9&F) MJB*)K1:$S=.UTL]?<4@"BT:4YGA)Y:N4%3CD4K,3$#657"<5<^ Y/M@(3QV3 M55@ &[,!'9 2]_-M-$A^KAPW'TPFY,V5IVV29 MY2FG-%KNB'(SP]8UL#)+Z(KLXAZ#+AHYRUVQW864Y?$8-P(ORA?:&[D'@A& M_G_VOKRY;23)]ZL@>KK?VA&0A@!O>]81M(X>[=JB5E)WOWG_;(!$4<(T!7 M4K+FT[_,K .%@^!-0A0F8MJV1 )565EYYR_?_M4HN!F9-'/V9LACN>&GLNN< M6*O6,#OU\EDM[_3->^#!3))V/1[<9CERHV9V:V^\4NU QX/P7+[%L>Z]FS->,HVPV?LAZ^Z%\;)V%_8*0]T[9KM>-?65Y,V[%].-6F8<[-ILN).6 M;+/5+2>R[QZE]"T;T]Q5',WZ*D5T9)2$2=_^]2BX'4MD^\YG[#X01W0#)[1[ M _E+>Y60WWO@A+?/@T4B>HG/9^# MT-41OWM#-#$^^]+S'7]8\O'9%=,>/:&K(RZ=7#I,CAT,4I"';F2,X(- BBE3 M>1OCQ BU#+Q7E:;N(_.>*1^4)X2>@);I?,51,#O/RYBU>LVLU:JT>TG>O <& MS-3GK>//AQ<&H$N>'+V*QEJ@SO,9C$DG*,]Y-N;=X MY:KB_8T&)M\PLOR5B6S2VJ" S%/*KF]]ZN5J3W4K2#]4NW!!*\U M*Q.\/&_> _-EL#U68K[MHMNV6F\<*_%0&&6Z4.<#Y*8>BG27#4 )ST)6SOK8 MX[Q1&3P3_4:=Q:>SCZ"*;39K55"E1&_> _]E2E=6Y;_*/C^8?8YG8GA1-'/\ M(8.SB2J$L[U$3C(U-/J=N1+GT1_M162W5S3!JS!)B81O!NQC14:J9&])S.A@ M-&(A%D\$(V,2,OA'R' UV'I6\NCVNZJ,++B+A>G-^"[>R-.E;IZ>[_(?,/@E M_>2@8RG*T,M3\71Y>+HP8[HA3V]U9'1[2;^S# Q>:L>@7LMM+IF(ZFYC\&J, M5*5?U6#R-NZQG4G5SBG:5T6<>^LO^=(P[24SM66XNQ53EX>I,SGB#9EZNPII MR01#&9AZ76_I.*]7:6[1<58.O],WOZPV-'BF%(74-PN]P$W7>^V^&*7;M,UZ=P5PXO? !$?-?IEBE!79;YOC.[MM ML],YGFG+1\:,I;T&Q[;=]_CF]W3$;\E[47]$ MVMVR3^K6VMJ];IN=QF+M7H9@4,7!Y>'@3&W=VAQL=3?CX%;',MO-MP%C6MFL ME4'S/@A='7'IY$EI;-8+WWV+UFH=]N0&L\&8K8?#]O-JBCOSNBUI[DR%[_JV MY\8]&5:G:=I+C !*Z^YZ97T>$4=F2H4W\88VFT/?[IJMQN) >QGXL;(E*T/C M?1"Z.N+2R9.#VI)WPT?FSL8,C*K]_WF]_3 M$5>F4,5L[X/0U1&73IXEL1D)Q0--QDGHP7]?F1,:SG 8SIAKN![V*OINN4$]CD1U6\6J M&\\)-/<-GM(_X)!Z_(S.Y1'MO >EADT E7WYOIG4W@&35C9G97-6!DGUYNJ( MC]+F]*>AYT?>T'C&FIV3 ?/9R!MZSEC ,T>H8D;,06SF,I#TV%5X/:G"Y?%0 M1=57=3AGZFPN^='LVK[LUKJF;37>A!:OF'-7S-G8(G-N%3*G >Y/LU;5!;Z] MBU)9(,=+Z.J(2R=/#F)DTGQ$[YD9(\<+N:&),4X>W'QQPM#!T7P/^ =SRT#2 M8]?CS80>E\=S":=#JKP_HE#1'^)D?N4'LP<8G7K7;#=;;T*+5\RY*^9L;8TY MJ]!E9556)D?UYNJ(C]&J/"L:'V>X7C2$)59EEGO0V)G^T"M0Q2&+IA<_)LR/ MV-UL$(2NY^,@$AK4V//=Z\C=A0Q:.[XM',B)7->;0R+ROS MLK(]JC=71WR,YN5E(E;)G@;,Q2$V55;\$-H[V66_R3&55 M'A%?-FK;X4Q,:6^7 M*;Q,7M#RG9'*O_M^*YJ%&<\ MQ569FH?2ZLFF'GE60I?W?%Q"$SP1@!A1(9 MR;[R,I#]V-5\>ZZ:/X<#S*KX'A[>A3B[_NA,G%RBL;>R2BMVW1&[=O;%KENT M6EM-LVUWW@3C5D9K9=&\#T)71UPZ>5)FH[4,Q#QVW=Y=4;=79F;%BKMAQ69M M&ZRX11.R8[?,;JL*?+Z]^U$9&,=+Z.J(2R=/#F)#XJ#LL+(CRZ*\D]U!<#B5 M*5GBZWWLW&AOB1NW";K>:IE-^VV M5;69&5JO ]"5T=<.GE2HI[SRJ(\H ZO M+VCMK8S*DMWR8V?(QO88[;@&NM[,K*Z'@?A*Z.N'3RY"!VY=VC M$\('O2C"QG(<3(YEEV!F#IGW##\!JS.>5%[57NY!BR<[?OCY7-'Q7 8AEJK= MBK.Y\M7@YZJXLN+'7?%C:VO\N,T>\IK9>2-@K95-61D<[X/0U1&73IX<9@8Y M: ?''_(FGN#I"?0)M?"81FI")&(:#;6I/WXP962#PFFRJ3&9A<-')ZH V?>@ MY9,=/_($^Z,S.C_JC$BT1_1\5YO7A -6P!KHX;'=B%.K3-**67?$K)W],.LV M[=6N:=NVV6TVWP3K5C9K9="\#T)71UPZ>7(0F_4F9",6ALP5-JKK/7LNBS$W MRT#%8U?KW?1(OW-Q")$ZG5BW5^9EQ8>[X<-6;6,^W&I9IF5V.E6H\^U=CLJF M.%Y"5T=<.GER$+/Q;]$T#/R'+W>SR63,GIB/4$;G7C0/Q*D$/?-Z01=,RT.[8XQ%V M.AYQ)8A_ Z=QS::['HW=:ILMZVU U55,N"LFK*_#A%N,@[5;5>KT[=V%RFHX M7D)71UPZ>5(*PW 8/#%CZOQ@5;O('O1R(ZN7\0#ND?X;V8=5JK3BOH7M*\..\!Y6Y<+R$KHZXS/($Y/ 8%N?_YT^6K4BTP#R\[%_?G]Q= M_;^+3P:MV: ?7/:^7WW[QR^_VUZOK3T;*1OQL:%IER#!P &^Y?V18 M71<\P9I>/?^!VC\BPPEQV#4%&!]"9TQ(-]A),H6/@R9Q<6HMM8U$P=AS"0QG MY/F./_3@P]$4?H!IV.@T1;"_3@>!^XI_XIBRK6PQL:U_SJ*I-WK]+,^+_]>@ M5= KY?L&0>BRD-@$-OVI1GQ ')%YF>"L6NT74*+ V!/'=>$[I/O^)O:3RP@_ MZ9?B<3)X#']:R#P_%5@K@S$PEF'!:1+1/QOW%__W_N3J^OSB^IZ3(N^ VTN] M,CZ*_Y@X#^QD$#+GSQ,:!_3)<,8OSFOT'U^6X7[Q-/;TY6^.\1BBR?"7^V ( MC$;D!Q8Z0T.$1@@Y\"#\X*'Y0^>2;;]1G8,J4NA_O37N>I<7I@%FVFFR-F'G M;[_NWU_<&?=]X_[O%\9OU[W?SJ_N+\Z-LSYRT1W_VUW_V]5Y#W]\>77=NSZ[ MZGTS[N[A!]^!T>Z,/:_XCDU F Q8:-1KIH%^TFX7D&81>@DW<*]G3RSTAKKI MW4J;WOWPP?&]?SMH")\I\0C_Z/GN3<@B+$[!?_9'EU)>WBEQ&=>LW,."OHY7 MJK!ET="9P$JFX4QTTGC^C+D]L.7Q'_\[:#9&@]IV],H75V>]ZWNC=W;6 M_^WZ'OP%XP88\>SJXNX ![Z[E_#[[XP8O__&A__SEXYMUSZKG]._K<\?37+% M6#A^->Y#QX^^>J"9A_Q;IO'B1!3E"2=!2.H7_GWUY("]PHSOS/41KSX H\"L?5OE?,]A? R]VK7%J7(Q&#'S(9UBB MNO96%W]K6::^%'JZ,_S7S,-N@4&"1,8)+ /?Z1A3_*EPF$D1>R./T\HQ0@9F M5\3X4R*/[SOB"T5\A<=@#"9"A.O-/#QD4P^I]!OLQ?'3\!SB,>VYE%=M6L(@)%RCT#-SELUA%9KTC8,\$ MJ?%DX.!=D]I_I^GWZ0]3C$D?S7]T]K3D"TX7?1]W_LA"!CLD>J@6$,11#,9C MS@^PX>LNG/@XF.#^8"63,:P$WP)F M_I]L2C^+P+X#U@!9?^+YSTZ$G.B,AP'P OS.C_!(H]<(]FJ GS%\Q"LXGKEH M,(.Q_.!S+J*T/ KO[!+ NC8>F,_$G86?(AN"G(XX(3TX5U@AOX;1Z6YLDCU+ MO+YO?'="()9=)P4.:GRJD67DC9$4((N RSVZ_%;CS)B$P;/G"H_$&S+XCL,Y M_6L ?$72"R[_T6^QD;NHS/!E>, E>@/'$SS3& MLMJ?H\1MYM<8OH6O ,YQ)KA*1M\; :\&+_"I?1[:8I]&G M @BF\6'P$3,R<,FC_&\ZL^DCZ+U_4\1.LT?)XIB75[*ZM4Q64X=V( BRGGIR MTD_M1?U1[)O^+R)$_"\754)2]4>ZG/I.MN-R14G\Q>DA7+6:6>/_SV2CN'4= MF1C#-)Z=\8P9/Q=L.I-,TS9]XX3]D)PG]W=\T T+:3FYFZ^=U.HG=GWIS>LI MMIOL+J^N+W_Z4CN%'=:R,+[(%P5[RI2-K7J0J^YE[8.TMG>0F=#,N@>Y*A=O M5.+C_IR=B;FPBN:XG@ M58[ZBW2CN4B)\!W+F-()0>3@/DD2&@,V?6',-ZP3X*&3NDWT$/]H&A]>O.DC M/9O] (J)[TSQ:T!A,'&>R"L?O-)G8O.)!R#0Z@G&^/,(I"7Q"SX/EF6,9B': M24*@@T4E'J%' N1AB9/X\O$T;1KM.WR]8T>#?'4Z(W'(HY$P0W@9?&OIV"&T:)'!Y8ZP*OEN'C$*BP7 M+1-KFJ*G,B+O9*KH(9Y[YSLSUICR+O&P^6>/B2[48%KN&F@!)YFXPG:/# MK]LL1/@S9?N'LS&+A%/_,!OS:)Z\+G=L. N]J2<^<2'"OBA/G[PH0K6DD@(7 M9W)9%$N,V)ITBT#+C5U4D^ FT)[@._^<^4.E!>=X#NI5"U[ ]\K'XO 2 JQ# MQ6#R8NAY72)'N8-2;M +_^0=^ M*GA9P((2>9.AX&(\:1_M>U17P,DA?DS[]D?8'$:6G/ 5KX/,48P<#U-9%"I5 M:YD$<>(%8U>97"^]+8=M.+M%L_&4OAB'S#F<*19#C\;!2\R%T\>0<=7H8XH, M;$]@&_B6%[B1X,XY;RJ_4/3G( MO7FGY5Z=JMQK<2V/L( =%3+2"V3R[&.G-ARV=EPZLYPP_BTBJE[ ]Y[0$EW* MP)6 M$H_D*=SYV=-$Q$@P[>QP!SDDLQ5?\*3D/<&J\Z^-/6?@C6-7P%7U7QRUG5:$ M;YWW'>Z-NR*ED+2M4L8Y=]2SRU'U!_@A]F."A(T,=T9F7?PE(@V92\*U-^XF M;$AFX1@#&=$,K.Z8*!0+>7) W26#1PVS],QP#[84KOEG$1K,Q;/"96QKC MP'\X&=, )+Y_;NJB9J.R$/0+0 L^^L$X>'CEO\2PL.(8H@VL^=FAT(U&.1,4 MG\]@\4@H#GY/?M>(.=,9E>)P.@BP_).!P[GM"7\L2J0$3>,W.E@ 0$ZH=(2 M65Q5SN+\$-LX-7HRVL,-V"'Y9JX'/!/RI,ST,8@T'GO7YJ>JDS2N_ @$#[&T M7.$2PB^3_+@$3X2B_EH-IO9H;I"64";>:$$&OO\X0(1Q"=]U0G!FS@)7>6LJ MD-"[4X$$XQX\QZ'1 3=*4!&4,M+$(*(8WYF#$BB6''%5:D0*G'M?\$1X1E-_ M1MY!J6]P$_/5\)1<=;DP_0%VZ[^Y63SCRBT88*T#&1">/YF)98!UF_GDS,]^ M]N41[-DGV@02!OU.GBTZ%6OF<5E8.UXP^*87/:+XTSYI/'H@FL+AXZO!;W[ M@Q-C+"##]WK GA/T&OVI"/:>,'S- Y*F(C(B:YRP8J\Y7/)G+MP0ML5]\"+(DK*_APA,5KR#5Q M#$M[[E/,$EDBTF0ZD*K_9I&^5Q#3@?"ZZ9U",3XYKQB%FD^)3\<0L<'K\ UW M+=\&_[9V_$YZGV%A"FN,Q@'6IW&S 52N;C6@"N;5BU0:1.4__YH%-- :9">+ M>$B5.)K71O+O(&]3@47^#LY>[^#$;0LH>PDWS$\=);=&T:", M!:6TP?B '^TEK]R,)9OX.Z[(8 M=>'9[^&>U->[)WF6@E!TL07_Q,#P=LF=B"].CFK4]*'RNV)M*9/#1RLD[W/R M-'G&"X\F>F!UP%4!YO?&5'F-T7DS#H%.G%<\%%,.>="<+_D3B7,7?Y;O4_I9 MV)WZ*G\)W^,)*/5A?;J9R\#S0Q\OXF8L%YSZ"1FZG9TR=LR\G>\A_P2HH.4' MN9&B! 93-C(A(Y^'U1K"I.8?\KD?+-(LHF !!-AT1F%I40418IQ M"H<"V.K M.GZ#1Y!%_BJ:%X-105@HTRK,G[/YCGXT41]1.FW"AWA0OV&4]B<.OX-WQ0OT0 M)[$M5-;"!I_SK.G]>FAPH*5S^OM GA&4B+VRJ(2_L^ MRVL@V1$*G55A(!XE2V;R?9NPY/U+4+%DQ9(;LF2FIW CEL2VO4BG[3J4<8Q2URJY4$?4JNU+Q0I5=*;'M?D1QPPPPR/)Q MP]J)99_4K2J[4K'D5EDRTTJZ"4M6V96*)3=GR0Q,Y48L.2^6<41,6:54WE, ML-/-(&%N%@ \M&E11:J/E5$S@*;;9M0JI5(QZC92*@6.V988=<]F2*GR*'H( M/Q]-*OF)_?2-O%- J6X%*+4NH)2 CV!/'/&<2LDM4PBR@5!2O)^7^I#CS@,)8M)DQP'Y0:,SX,B^#Y:3.KS M*S8+GNK2ZIV"!=T@9IB'H+J\AW@ISE;EF:A_/XE'R">4GY][ LS+\ZFUER,B MN\^$1"5@Q$*!+SYA(1D3]"L$*T (K@>F@%"QCU7U&A,.,B>GUONJ=[9&LE=; MHO?RY]"H(B_U"B\2([V81!"KV/7+UQB%["Q&(;OD*&3+,6\KP;SQ ^/GR<<1 M)V.[:HEY^9+0SSP^Z0;_3,Z*0_0@+XIF+-'3S]O]%;P0;LJA\8^%(&\(N;0( M!4@H,.4@!-1" H]32@L+)H$'(&+HQT27@B8WK@]FFCNN2>(#NE,O*DS MYDM*/@S>!5\-IR3L\!@D#(64>BC;.+B6-V()DLTB2>!X=(3Z.H<9.4I0/_&2 M)<6?EEU.0,8EQ-X[,@&8>/89%$Y$#\YGPL#H*#%' @ M>%$(;"D!UA'J@)41UY]'G8)?.Y6X/PL)K !D%9"+Y!I.*BX@Y %JTBZ8<$31*>>F-'P(A]E#[%K\ ME [_ZCR *T+K(W+G0(\0L1%07$!H"2AP(WID')L*%2,Z(WPH!;)>_(B4],4Y MN8*2_H-)_R0?1I 1>$E*2N2KU#$+6U&>?]XZKOBFDA,(%%.(*R:: M:\BU_ VF'&],5K#80F(6M(2*U>A(#^/'1L@X$C\WN12@5&H-*.+Q]:2VA0*, M#R4R-6RJS.T75YV&X3X[H4C&5>ZVBH%@&-ZFG8. M*KH4WK MDLQ*R)/Z#5%(N32N* ]I5UA7\!'V-!D'KTQ #\GI7ES:Z4"]BRYFDFBSB. _ MOZ,M;)PYX3@P[KPG,;6%8\?AR_D-*!*&4^U2$K:4KU^T&&:,T)..8[;S??9Z M)@5C@NKQ6!%@,A*XF4N@#ZJ)!8T.N,0U%*/I7R9>9ZF!I=[!<1Y*TF70JXWS MO,4E8;7#!'\+#9,44!C>$4!:L""2?.*?"N9+[I%^/P6Z3KET!%=Z.DZ Q^72 M2\!"$R4$7JY ?85+*H--HYRED>Q,.]?9F/I^8^CO.81NU:H8^KHQ=!$IS['S M1P.KU6V7(H9^CF[C582H@4/4*U'&B9->#SZ!> M(6($%*4DP#]IV, N9L-8L0VF,AZ4$+I'Z9Q>YKYN$\Y.0D-ZT:G)M$^S[T(S9"9%STB>W[3\6HQ MZ,G'F4HP4 HERF"!9.>4H46@^$DDVHDZ"3*'3XWX:/CP9#1(_TE3/!%ZWP=3 M(0C1&W49'U]B?/!&F(OZF#:"-"/L-6GU"K<^AK^<)G#M_U"/H&6,:<#ZYA,%8R@X^]A6M M-8U&V@,5DGXPY*;>4(P@&+*00C3" 45;#\<,CU_ERQ"C5;S,1$).X9%PC8#P MW(H%-Y+/X!,HWLB/L/$$_?$9F;U[(HPL)M8*,%[YU/',,8+)7_Q<2EQU4F(*_ET^8SDH^5/28S]H\QBK*=-EDN/HL-0PI.DXA-E MFM%=%]H1*8BSZ4*09A.E7[):>L&T!/I=V*#+7Y:[V2JHWY!H;5TFCV1Q5(8ZURE*F8F9L3P( [NIG;2:*@+S %)% X'4210]O4C$]F..>_@H5V5&A+) MFWD?3@PZB8]VH@XBSF_D/L D^8=A;2YRX[R2''-$JW]:>-UI MH:PS+1*VE*3*P)+03/.O^##]67U2:CW?O?+Q?,%&O@'"EW?XD7[G.$1WE#2^ M9 !'^Q7) M%$\BBDF9%9RSBS'A!Y&)X+D'_JHXN*EPZ2E4S=!_$0H?WL[SQAA.)RV?L,4^ MJ)0K/8(/I!-)C&32EF)C,LL WW(ID";FC;F)E#=\FM*VFE_U%<,@)W=#L#MP M46+P'4[ZP$^(B"E* 1Y:U8;CC41.8(AO>0XPQCHF4:E^Z'HT1,F-M)\A0.W"1V82,',;Q/XK(H$7,2V!4N"Y^KT:"E/Z-!S_I:]=.2+J_ M"2+)AX@CX23)?$(>F,C&\S$%?*9)?,;BGD0>L"4W03F+QQX*,BVR^ R3G\F7 M./S"B(W+50$;R+]B91V]"3\]&<^B9))&/B1Q0DGK!%'XGSP^O!'$%Q]>$T_= MPKQ9@@HQUR"SQ .R!*O_=GH'GPO)B7DU7CTV=C' 2Z$#$4>0X64J3U&W0@[3 M$>DLF3_2R?&NE=DMF$0TDIT;4\]L'$Q06BVCS+(-T/)IH+BT9XE:O3>AO!(& MHTA-DQI*O@35$)_:)^9-Q_,^^5-'5%H0#YT> MPEJ#)PK'8](11Z6$%S6[P3)QZL2?$$&21,"FX5.EQ M%WP KD6D1O \_O2#ES%S'ZAX;,#GT@^"V30YW>D)[8)X.BP7ZOZ0AR7D+%*7 MX7=D.<==_^LMFA,8"5RX31I]^K-EUNR6V6IWZ5,_%SA%F8[J0A[/Y>Z:QMTU MR=WK 7'5:UVS4:MG7"0]K^ZC<4,9*%4XBK,0W7DN%*[*U.;(C-]W;*+G4G4? M:5HDSW<:"X;_6C9ST,CB;FL/I:>4/X::)L.3(D,L+H9@]CYPWU6KV-%EA\AS M+GH8OY0%MS#3>JA.!:ZA]O2B:YA+S_6N8;MFMKIV]A8N$B:9)HTUMK%%:0+; ML+K9>,MVA8FI8M B2DSA=S'EF__.Q2@Z^$D\QZZF7,>!X,5U8HFB]:J 764^ M)^"B>GGAB?Q\[AZJ,_4U\7)J\E'(U'<,Y +TRTYP ^@#P">4,R7Z'&(W*SV3 MG+?ZO()^YFX%EF.1IPE\K[U5.@7\X\B",9O/YV^L3=GT(35:SUP187=K.0@N M\4MW+=?J9K>=(P\*Q1JL.0?3?\&:MRC$FF:MDS6(DC+(.)U7:O-.!,$5+_F\ M=WXL9;]DF)!_'[Y>?L-EOC?':3!U?K *R*LZXBO"B]/OT;ZKF+-&[)9JS1E0!3K4+F&&-*KF5]9F8NWCA%;*/S#>EF1!,P(C@ M=2# *0Z/X9KHA8(*>0*?&1;R)Z- %5P9#"-2##1"GE!M-:%L$^#E*MEUO7CP M>_PR%?[Q1$=?7R89S+DRWR0UY8-2[.]/.Y,362=X7\F@@>1DSK&PI&(QQ53>=48/TFZZE^EP?:D^<99Q67 M%RO+9Q9SX*M_R>.J?.>W*LG<:TFF595DKEN2*0HO0T\IOWGRU<&62A_V3_I\@E7VCT[($JX0 MVA"8!U->N/RX,YV&WF#&Q0*8+GKZ2909X9>IZ3.5WS+ I$9!CDE*E:Y,I*^" MV13<:YZ@R?3IR%#.N3>F)?)_IO;P0(Y8K-BHJ1,4IHM?0M]^$N MXLVC_,UB M*46OEO/$X_X$L5Z>0#*-1%XUV9ZKLJ_I]>>< /LAJMAPR6JE8][3S 6Q*.R2 M<[C%+K$3%3Y[(K(\>2)IYK\4_EK]SC9([@= MJ*$'Q&6ISR1S85HI[;N.]X)D1[T3JO:8,["5P&J\]:*E:F6S0;W$$_$QYSS9 M Q9*F273F2B4S&^6U.^#JL!,YK2&^KZY>.&DQ.3NJ7$YO\MUU8>GGLW;YJ,I MUCC &R;T'/P(]O.XX)U$'L*[(!2.\8BI8ZSZ5'Z5_(ELJ$2:>!-9]SV MY$U\5)\KI#<^SIA-<.=% >4,=B3N$;][Q1_'P4>*!L6L&W:QF_DC84Z-/QZ] M,4OB0@3PG" 4D#NBAHP\':R;S3D)!?$@RO#@4ZNM%W(% =#RGJR\Q3!UZZ V[&& D M68MN%=J[Z /"0X"4R-87PP;_VP\!B\,=%/R64.04B*N@,_! MD_!!U;;0^<($0L3B.NXX@ZIVR#,O$=4T+^ORI?=>' S,3%.\!U$D[E#4F_;# MWB!X9HI'<:O?\)+L@DDMLUMOF-U6-S^FB0,.4H'"#) '741Y.<5M?L_J\E:T M!-\X(5HI2VG(I.,OGB >4'Z+7>YXPA?, SD(+0$:2[:\>C[9ZS-@/+JV>&7" M8/8@ZP9Y+$K5[5+M,6\G>&(.FK 3*B$6=5DBJDAE(B%9C:$16Y+\9QH*3!SN M(JZ>"""AE*WYKKGV&AYZ$P9^@/T@9'C$ ZH6\V]&R\+C>JJ2-?EH< M'[[>[C0L=Z?\?N7'*L"N65TN_B][=U]EKW_O[C?C.CBEWYY8MFE@Y.2.ER*^ M2M\M)A Y'G$& H4&?%Y93O@T\21I0,GZ7E7>&*6KA],!?=-@*)Q]"I:JEA^) M:Q#)7A\1V^Z<27]41B?L;>1B_Y.E,T/4/GD^]9APO2AV1U93I MR>\!=A4 %[HQ*J(P ,BYQCIB'E<755E8A\5;Y3R9TX#E2VW(#2\Z"D2ZD"2( MG_^$QECZ 2&;:H^ 73P%+B]03?Z&'IZJ+5-@ ^:JO,A"3A#)X]FU@BKV$^/ 08";G1O]H"G%9MS^?<9 MD[$M?CNP<9CB$_9GZB&F;A8-!@_IU"<5UA=W[,/=;# -)B [&^W:B5W[*,S) M&#$)__UWY@(G/XA'GXF:8C)5+_!>Q$&1_HLO^BZU1W,PE(^?TO+E3 O[7*4: M(!,O<0K>8_++SX6/X[HAJF0B$OSAXK6-(55B6!E>I *2BOV@ L4H"C#W+1 A M>"LJ+E/4O(PI+\DX"HS>#T&^*Y;L4_EGH385;7Y7 M>F$U7$4E4.L6RFK3N*5>)@QS1R?7@1^R$=C/%/6^E%U/7-Q3 :N0E-JM2+1[ MD:FEC,0V+>E#ZI4@PW&5-R%[PFF#/0[V(.)[OG$S"T' 40,8W$E:".FA.Q4A MYS:;D9#6#,V2\13EJ#&DU -/GZ.<&LKG$$Z$B+1O+!S7D$_KWC4A =#<&JKZ M.6JCDH(@WDP6 M$MN'F=^.AX28EHDJ/0EBI2V.Z=/'R*W:@R[99=9=KG,\@R M^7:559_[">&SYWCS-=8=CH:[]N:_.Z_"*BI0&]9)K6&*_0+196(]3M ;'^Y) M>-NM&OCG*(I/OFL*AM_QBQ\2184K!7Z \/\/=_17W4%HPG/B%^I=OB?48IUH M_-6>Q)?1MCH?S2('XV1)UT);(JQN$L0^QAS]0K0+U:-200EIMS\E:$-]M;+" M"Y@<.QU5PIL;Z2<:G,A+B-+]>B/&4(HT["),9.ZT?A(PTP:C I+'$4R,] M$#G\F1$*DF\PW* 1Q\>F"J9)8Q!9,H%,+FKZYP[VH&9N>J@&FTKU%KS.0F6N M\6<\7>CCFH!)G3&'A\(WBQ9'% J3&"H8RS8IV>>%_(>4"N42(!\UMMXBP))& M\R@\H&_;HUPM4XV)<23/Y'>2T-Y6E F=?60*"5!0N&KHM/(M#/VY0IY M3@*Y?0G*"W2EM2A/7=?_^=,)/X)FU^QVYF3)\Z@<(9EIURA0XTW'-6A4>)(1 MC1&5#V"9@RB'\Y/UC0C)E"UN6TH*'X.4ZZ4#RU04*M6RN92JRNM'6]2[69-Z M$!4)*JW5V7) -I^0_?+GNWU\8]JGQ:__J^E?CK']] M=G%[#>8=_^TQW)UT'XR&5(%_D1U4+"OB\:X\$H(F1ZPACX!/F9. $P+\%MD\ MF(74*W7)P??CWU!25:9G,/+()HS#S#\1+)9#Y57":P7?W!X"0EM 5]5 MODIZ#Z8H?0:'F?0<+_/2X2]2H7I>0X:ECMK0';D73TIE$+<24>F.[UO![ KA M0.]ZE3(+OHA#^C)PP'QFA?H*]_&>'8_"L:8<6H HGO[(>0;?A/>HA4\139EP M7" N=CYA2)KG7S#J&0SX0 8"XZ0-#9+);=Y 1M4S,_3*QWK#^#'P?&_.!,*< ML1/D),QH;@*-8. X?V@?8?7D#VJH!CG^<[-AVC4J[3PUSO-P .8W2"??"G9& MD"R29 ^\P3_VN!-L3 6@$KLF9V6V69<+NYKB+RF>P>L]5>&O7OR(09=G/MI MSM6*YP4X#P\A+HB95+PU)-0I@3 =##@#IL?"2!Z;^;+_@G*B!&8U@*.) 3#@ M6\C25%_BSIB"FO6%$<-C+ZJC+UFCJ6E;7MJ/L3H:9H+S&(C*O.(_BG46S5&> M"D ="JQ'P*>@R4==SQ3+Q*:(,[<"R$L$MK )P^2_.K4-0:B M3U&;8^AXF(G:/L%E&5J^H6)UK0R4C QKWE.&AECN;.QX3]$YF!NA-UD%)X"/ MM+ZA^"GK8W:_^B\'[+7P]=(#?F7^_4MP_QC,(M U]R^PW]>^+Z=@ M?^G[AOBP%DG4+P\?1,5'WX@W&O*5Q@<-TT[^4%73(XPS5<(W:L9O/MZV#_-K MXKN6G:@VE4\38SB+JHRW1XUUG6&4;KE5]1]Y7( MU62LBWZPAY":9NG*\"FW=/\(PC&6'SACD+3]\,'Q93F;;'7XX^]]9=7"+:2N M$32P'L;@?(R-1_Y5\/W"!VH<&(@&K0=)D@G$/0S3LHU!_ ME?#1_-W1!!X$HHEO8?PJ991'/<.>"%/3 L%O]Z5$CXGV][X^2(5,@/0RN>,$ M9H'+GKRAF82&#IV)AQ)PB.C0' _ZQX2:K=6:!,3Z#.0J[Y=4]FKF3=)7(R*P MYV#\K$]UC6>0TIQ2K& ^A1VI]BNLS) 1<='T*@,HXH@C;SI3)8[)6<3*\33C MX*.9B/%%,^JTX$%$%Q@R%.B*+T'X)Q@,: +_ZCTSB17DC5]I#S,]\YQ#77'X M8HE\-'?$20#6^8#6R<\YY=+QZD,9#)&X?&EDH_RWBOWG%F:8^60AU"(9EDU5 MMH@>F+_+%EO1YBN9)CY8@H3"B",Y]A@7$VVS+)&22KLRVCK%V-7\Y<8E)QP M2B[7\[.K/0:#1>/^ 0/FI"JL(8^?B&0M"06Z!\Z?R)N!B-RF[1LU%<)E M$+ M+QB7.3*[E40$F!=62;9:1]SH$9BU]*T'7"^-C))KY=T)<*1H>,?)3!7-Y'1;$H64&6 M*)FM&&8C:W51K%$%-+<>5A.HGS3GACV+J-.<6/E!J[[FYB_;UW=W%4F4DT&&<^,YIY M< J\<8R'1<&X\R/AC^MVVWW\A""A.-\G@A=**^W# 8!-0" MQ^$-I?Q"Q(RG//T$PCEZ]<'*ILXYO@J"UQ -O?(QO(>8RG:)/O.#=W9VL!,& M/:\H+,7S:#IR/ M3F>54!Y?5AH^8WY 6@O\\OF)>J"7@FH/WC-57"D@,#+6&5==_(,16+-3\0F6 M.XT619RTH+5;84Y/6@:3)UQ<=2ZGL$*UCIQ,3 7W3BOZ"$L MCEOO@*WS(&$:G:9IY12[Z1(7Y20N7@,D0'8D/ *6R$T44":3NL/X;]Q!W>=> M^QA_*B*'%:4A$E!3Z!H"8$ X45,A'AT:/SDE)!KAD&K8@2^,3H&D!1+8\;4N$9P$ M1V&,,4><@5_^C-N(5_U1#M/"DOF0Z>$#CC(IAG:QB?,J5;:\,E28(+)ZA @\ M\D(.S<:'ENLZ82CEM>'T91]K>;R+K) >2OMZ*>;;A(9UY*\&1)^P>TUW4P1WXJM%'UB*?\X91-5U0:O MHREP8S)]+_GS:7OQF-2OK_%';K@ZZ.%P MY>J4&Q$'K /6@;@1?S.T,H_"N? M^T7;;9S)=6>PT6157^;#!$4 J>:/4I'RFA)-CQ:PK)TQ7^2L@#GD_ -$W)5" MD[L0[R([9UDG<2N&"T70A;[XX'V4V6/*,KAR]*HSYPKPT*8OS1#ZDN!'S!-( M D[CGN:8I',]YG?\ZQ#\)? [@B"$,4?HT&V&=*_.G2STDP*W"7F'G M?+%D7+S@2MB8LAE%JQ?##H5:3DR2$ RF88YJ7TZ4+8DZ),P+/8M)1NEB49QZ M*"N>CL&DN4]J"&UX14XTBE0NS4EV%S@.=K*,A<=9I&S]#7P6O!>.<"1VH5WM MKFG;MMG-;6V3\WFIBD^%YT3HGK,]#UCKD<-Y978%1&@L003I3$E!L2DI-H@E M)62O4(X4A, [4W38&5^;JY_O-)CGRL>!QBA=_V<&'HK+I^[A )+=''S;M.:H M&C,3DU%Q&!(A(*[&'B'6I,,RB_2,O2FW;PRUVZBUS5HSI_),YI>3,\YU\2E. M>L$6VXDM7L+3Z C[(UGRR=EX%[MK=9MFHYGMNY6%5E>^PLR1TCV[6T^UV:H M2!]HKN6I M>::3(RB,9 D\]1GQ>EB1S-%$ZZ;6"AI.D$QG+KY2^?1Q7C)(YCT_[<]8G8OD MG P@W-%V7OLC$>+1K-"(V&%S6/+B6ZWM8\Q&TX);#NM\\/P3_-0G9S8-Y ]" M8FSZ"1<$G>:J M*>/=Y()[Q#<\7ID0@+]\!IMZRHBZ[!,X>2^ADUPC4ODW"5 M-H;*=052-D"L_0^PI/S[M&"%6[IHR1$7:4"='847K';3M.M9+S-]2#>]\_.K MZU]U&NS]?%:Z=R70/_<8=7@+5XZ;W75@:RR='+//.]%*R[UT2Y>IE;A,=!([ MO4?SPG2+[E&][/=(TU][L8,.9X$=6LLH_C^J[>Y8:*^YRFL]'_ A&6?3(\>I MP:!8T19A$@A=LH_E(?)[DNS)$.YU7(Q52?;\ -.^0Y&[+JQ%F#7PYEE<37Z? M#2(EX^))_/I,6'TN=(K=237?*WB4_D@E#R[4!/BE0SQ?1%!:A=]5.Z)(W\6A M40DT="_1[40E\'?.B"5#ZU,V?/1!Z#Z(SD;19Y7,-F@/ MCQ\\FWIC8%2L.&DW?U&?D?E(7ME#O[;AUS1;-63368BEAS2FP23 1RJ#$+MT M*55]0EUMN LL:L2NG&@:,N>)N@&&4S5LRD6P;OP. C_Q;@6Y%T70#-2&\55O M^'1H4IXL.XSY(_2P>+$>;+,XWM;(IM1@U]>P1KC*+YB)U;A'S MM0 C5105$5JCI"A6^VDSM M!,XE]-+)@=AUK>E4'L.BJ32:>_R,2>I8GJGD: MA1ZE_SCY']/+($BV<]%PA/:@: M"Q>:&8;.V?.!=\_*6BLG4EDY'GJ7%S.Q=.J2P\*X!X9-A:ZCVFGPY=I"!0!\ M.3O.,@TL5*]UQCMBN/M5YBF=B7ZRQJEQ^I;-1B=4"!V>! M/;N'E_9W0ZD<$ET#R1.)[XIUEF&=^CJLL]D$G"^699F=UA&63Y2@;.FVO,5ZI4D5;^/>9.9ZB= 0 MTG\7C1!VS6RUVF_BRE1,MRNFRS0)+V*Z7$%]1#K^K9FZ5Z!>0VSC*0G/5L6D MB?N5&4XF[IZHW"G\ MO>T.!L,]PM\W3XVKZ_O>]:]77[]=<"3\XZI7S#0QSRU8Q#N;9=K#ES$V:UD< M8E7&>(FS3=DW+&Q/\VG)ZADW XO9J2F_[W!)<1'(7VKTOUT4@ZRY$RDQ"+#! M.,,AJ7A?YLB)#5_")U0:&U6];;@$>7+E7,$;9Z)>/ M^9PP$&Q3C[\IZB(=? MP1MG(^S$C37>CCB)6K?*>H"'7\$;9Z$"0;&M5W"75GNX^/.#YW.$W8^'.-NW MT6L?=Z!>Z1VH]ZIKLUQAV=(7NC4S;D2!\S ?FRL1;-!/)CZ8S8(.=;/3;)BM M=OD O$KUYM*R608/N8#--&-0E\:'8;RF53>[S<6%""4X_(KM,FR7&096P'9@ M/!Y*MM4;-;-MURLF*\>;M\R862B09B;O,9\O?XO8:#;^YHU63 MS:DG$1M^ M=CDZXC*)222%S^)[/1"I9#+KFV"?9 MI )!\-!8#00?^=GN=LQ:MT,_+4@>MVI)5!AM+3W?/6>3$%0-_;,HC5S3I$AM MP\$+=L=L=#HY^<&011,^\@]GC1- ?Q1#_(#S^\!\%B+*)8Z><'%V ;C!#LT( M5,@28A8?YFLP;D#8)M$4_J"93C0S:2+04:+3PV05C27P\_>5(CD\GGYSQ9[P M"D]?X>GO(>][$:-F\9D:SCQAQB=?Z_A8V;D8'DZ\%LG3J Q)TF1)19PA5=N^ MI%WK4E.(R:-*E"X=A+VS\S+YC1&@% M )H5L@F=IMG(A40H16R]/&_>?M(*V7,;6:L,GL%JS"88[1_,">]?@OWR6.E. MN>*O+']E0%K6YZ_'D.VD^[_BL#?-81G$B+4Y[#*8A16#50R68K ,SL/Z# 9? MJ1CL>!BLOAT&R[2;K\5@/?3B=LEEEMFPZF8])]]ZZ-->JFQC_T,GC.*>STR= MXBVC0L0;)YR^ZO.8=]KP6:\/W(&SOX;/UJEQ>_&M=W]Q;MST;N__8=S?]J[O M>F?W5_WKX^K\[.,,\/$K[^"WFDG4 #AXGT\;BJ'6Z7,-DZ:UR6%M6M,[C1?_ MYO@3C-G 7UZ,7\-@-C'A&2'G'/B2F+8D&)#ZQ!^#L<([OZ#\\R,GZU: M!YO+,4WM)%[Y?_[2L:WVYP@GM_A#;^*,C8$SQ@Y[G!_C12 5!H1I0!-C6(0_ MX+-R^*"9 $2>Y\.W,M^78XSH;45 !7:MEHF"G,-;KWS@CQE2XQ)$"N_4RQ-U M5O.DUH:K(#K2!KV1;=I7\! Y M="FF1<:)2M-"3/0J&RFL6@M(D:VCYQ4Y:;9]<#Q_$24RJO)7^!)-HF)1'Q0B MXN;.O.@1R=(?(9GR)"72I'5B-U%2"OK8AZ%/)Q_? :NR<(I7Z/+I81+R R^5 MX[DG0"B0ZM[4&8LK2>*$#U<;1X$!V^7B1=VV]-W&25=8T01/GZ.A@-H9URK) M=]^=Z2STIJ_G\)S]DQE73\5NKO.*]:3,_RD>6V%SF9L=IW8O"?+"!URA_<9I MG$#1T(:(33'NP(%6(E%0QY%9XDEB1Z*M^+8Z1+JVF:-J#"\,V7,P!$YZ-=A8 M#;=C/U@X]"(6#QW%FXP%*,2\?+9= 39+.SE"O">&X>6ACPBA!JQ4/ZEU-H!6 MZ;806\0JPE;1]+6Z-PDN\;!LB4\V$T//0%V#OG[ BZ6(HB:U_6Q9MMEI6U(5 M(PO.(C$PC>86,G?&:8.?;F,3DHU_C14&56C6.Z;5[9+B'@[#&<<>@H.*IDJB MBB%VF]H6_+[HJEZ0)?&8>'G%TMO*2.^5=+HX)N8]L M2.[S)3>.%S/AVC2RS%8KRSRG!CH+CD\P8W6N5LRBB[:DX9C)[JQ@.(I"[?HA M#*,Y9,HJ[0)AD^E[P;V?T9+_D@ UTTS0;)]2[7<:]MH-LQ:-QNI+T+TRUB9H"REGA,M*@XI+/CZ M"Z?F]_ TMN;X^4Q? IS'_02$#H"#4*]$IXD/*ALWF$AX26FZT]AAOD(R6OD3 M:81U^$2K'H)00/_]6P"\U$O:E3?Q:Z]):P,7C) O3=Q/< M]+ M[ P6V0.A-C;074'[DC["@V[B)]R*X/11X\'Q9B@:FI(K0P;4Y7N=R*N1F++, M*6!RHV4"Q/Q!A?WPMB*!FH):E R%#^Z/2LR_.=B<<] HE_%FDJ$>XKY\_X&+ MTN7):R?(>RO?V??U:'HV$%1::IX6"<&,/;4(Q:_\2;'S[6W73MK-IH]T;R3[F"8(9?(:..V1/8--B(B!K.>_&K"R(676[18;D M#N7YBB>:EQ&MF78GYSRW:C@6Q<%J!S(2-R:=15F*;%R#)U#3T=0%5,@@%*T4 M9CXD&1HUL]7.AI9/C:]4=2#*"D:.%W+\^^35$A9"4KYCP/G!]_[-YB>BEW9" M:IE2GK72TH>1P#DX9':^GR=X#F6>N*W>%)OPB[/3;*\V6RTW['N(^*5V#.O' M+^/H[=%DF7<=P_R=A3[R%;QS%F$ ,U$$M07;*R-&=VE[_8XU#GPO.W>Z.@VS MV\IQ,[=O=O$-B<-PTM;5(8RK^O:,JQT=68Y=U;'-9DXY[E)V55KIK9'1![(U MMF=8[8UL&&ZJY55^K&Q3 0$R$;D-;*K]4:"&C),-N)7#G@*J9B)76[:G]D;I M=NVMFE)P"@O*_S8RI=8X@7N[9M1EFM M=2QW+)W:/(1M-?LV7&=Z12, M5+B%8Q.$EE(QZ>8-%+AP6UT/%,PT"'D]XI"[Y]L.$W8R.8%=V+<2@1^H@$3@ M--A]%6.W:W9;>TG0\AVET[,E2,=V[,TMW)V?7DXFK=DR6XV2HU@@:'H &5J=EUG-XA]\^)2(3[3R.,<:9K;#_ M)//0[60)XWLULS[3I[ EL_X0=&TTYI2"+A_RJVW'/.\LZ!A:RSS?B*3+U;]U MK4:>/CJ^N!_OT;5WE3R]"9T_G>C1^-5Q'[SR&%/M7 2$S8VING;UZR>VB$T+ M(G :[-R8:G9RG,KM&U)\-R5*N78V+LK:PXGEH2!UFVO&!K>20)5RU$P/WFJ7FV\4 MFIQ,B&L/E-1U,&13SRPR',X>/38R+CW?\:FYM#\:P4F"N;"X&]2R,S58*[:V M-$YJ(F:,R^6KW5B3USMFH[YA;Z?0W C/0__F-Q9+T$?L '$.(/7&N:E-:9TW M]ZUM=AI;TL*.3(Y+35Q88&K9M4WU[V[HT>B45;T"S3(!C[75:T-3K]LG9*.[ M1^7)Y6EC*W7/EKU]W(8B\FY%,1Z57FPOTHMGL&@%]O\S,5RX]5NWM5E=NJ%>%LK:\>O@1.Z^,US0:5#*LT+[MU M=$KGD@U"7IAC\Y'.A:'@(M2_<^?9<\WT/)"$=/GABQX=Q +H\ITI> M+Y\1C2R)[5,T2#J9._TC"/^$@S[CK#P/NMP^L01Z**U8O'M#G+$YY=EXY5[X MJN0-0P4Q"4",2$@IN'#B;S,_8L,9DIOH/'3"T-.S@7#7"FB1C^, "!D@FQ/\0& S2AG!S%92E!1KI[S+'=N5.V7#S2(8]YV+$ *]GD":X$[_<(!@H?$;R0H:6A GFF)@*&2KFR":GIR- Z+86?#,?'AT&CR* MR*S=.;F$-+ZJ5YAL:#5RB7PAGC$?XF4^<9=+3.;E"F)E)+;UAT2Z C-G" Z# M@EF-$=08OX!%6TR"Z Z'SZ/'9<<$K,D[68':Z9B-5@X&J(:G''D_3@A-&>G@ M!:[ 5/ZO&?A"\A*BKP.,,T5M!5=H-HVF)-(>C'_.W ?.'1\BQCB>F-7X"$H- M#;UIXO+&-BY0(?)% VLL2B[>-6 S1;PICHY.!IO/%Z8 MP&QENATV0&[:W@'FPS&U6V:WGM-6.!\11OD//W,&0'Y5HE.7E@%:(9P-Z'B) ME@+SJQ?IKL*C0T+7&##F2VDS>$VRB:EE.W/?YR$2]7 \H1W%[LU$EP5)'OB=4<3R1<:CX2P0#%/Z3U!\&%LQJ?*O>+;U_D(QPH&$EZ4 M(H\A*8&1O9'("'BGWH'/BT2/TI)JS]H(C'&.EB/L2B\BO:89P,"4\"=7[SPN M8Z!KYHN_*WM/<)H.6UA$F*3^OQ*/DV8?QR*^A76SYZ6-@26IDM<9.I\D3B9& M)8-3W&$5&$GRAW$DBP;Z&$\DE]*HSLDPC;2C=;YSV0"$Q(SP;$.6^!5%WX)E_!P6W'Z$*AYF)^J_(JTTX.N$XRD#SID@]99"IC?H69&I3 MDZG-#>YT@9;)BE01>]FZF"R@U98S1XI:FPJ$;8ASV%ZF#V.-*[)^K]YNQ;EM MV9NAP@GIO9/@]F)AO_^1?.^Z6:Y=-/WKPDZ,:P'B6IQZ5L44QH6BJA/ H M&(^#%Y0!^]O[7'XK\D&0]>@*;*7\G""_HOHLQ\76SUNB8[4ZV"J>$)USQ5H:W6KODK=J)96?B*?]F M8> ZT6,A6YV4CIU6DL4C^M\>9/%O<'A8>H+UE-0!C%XJ!0_+=1$6A#0.L+#\ MN[74.E>Y>A\*[MX"Q$WM;.6IWH3LR9L]7;-=R'(C@H7_YT\G6*C:JG7,;DXH M6-161 X M=:_@W/'2B5W$#1KUKME9(FJ0OE/U=RI*CY\E:[(XLK/N .5NLF+%KGV6=_KDSI2GFMO7Y8Z)<; A_CMF46DQ'''$$ MNQ%"QX\$VTEV"]@Z&6#K>^X- M"S$)X3S,+7K.)G*7[NFRLH7\OQA]N'T>MI%2:5 <(LK7R/JNU4_EWLTYF'(B M"ICXLOA9@FRW[,&#&\T;JVY1*$0ZP<4W;V\5L4]%:]%4'S^/_X #F=.\-;=^ M"DXC&4J_$0TX2/I+R2CWR"?4>+O\^:S;#]R<5S^I^JLDA4-1'A>WR(OZ4OQ0 M?'BB<#*OE+"(+,EJ?12\ER#+=J?]YV<-:)M_Y%7_S2;XSX)-M'.;OG@YW'T@ M"2D@$D2!XC8/.+^]QK2MKMFT[$VJ M64^$SMB-7HI(^.O:3;%;K]7$OV\'WE^'Q$-<<=OCUF$7T4FM4^; M-1/N\@2^PS@4$I;@22H-A>Q77>N9WB0!2@ RAB2SZ[P:WM,3Q[V(&5I5#AA8\D10F8U''/8?:#O"?@"F(8G6JQ)03P84 +1SW9%W(7_6&287Q/S.P M!D;83-T7BU2Z8P$G91F)7ZDD,=-'K$B1! &)-T$?B!>>71\OW(XO"IP.U63' M8'D<@<$VP61&4RB8"OCHN-9]YN.J.3X)WC0$:G@6 ,E .0>.0NM43.A ]6*^ M#JF$XP'PCB@(5S=R^A@&LX?'K(W56H;$N+1D'^X"O9(I;",92>@A*.\8&&3X ME1ZNFS=Z?GV-/W+CO.*/>B].Z/9YUUX_;@[E'917_C!D\.%SQO_\@P(>S.WQ MZUO0\KN4O550S&Z?YBENK9Y='&S>>=(5C4C^":!G1=YB[0P)8Q01(\B2^&'MV05P,P1LCRFA[#9X]NJ>#&1#'!^DFKARG MG&[FC1QO3(;!(TCH)*I)J!N7P"93;E7R'S,EK9.X*72UQJ_REW*]^J49P .H M2!Z[F0WJ9HYB"TU7(GKG.ABQ\.I_S3Q\B[Z#::"61)VT\'N'6I]= P?0(YGB M3?E(*."<: 9[]0&\2'T>] +4C1(6E#%9RS1%@D2W?PRJ98'%B/E-Q%C M% *31:?&W6,P&[N9H\'=/3'&STPC 2XTPCLQQ<\@]I!#X!DSHAVM7MT2X"=R MX3SJRT7C _M?S/E&4#.)6H@8A9XS_N;!F_$U[KGS!+(@6LL2TC>(2.9CWM,< MI,V>B%",$-IRK-X+FZ07&T #9RR_!-R.L$NX4UOIHHS%CJJ"NJC00S'L1FR8 M/("_](#44]\Y-:Y&^9<$URJ^E[,L<;X14AY-%[B=6/@?GX^HGDXZ6B23\,$Z MY(G5^44<+N=$@=WEA$QAB8QFXW':5DD.$V"((D4K3#(E,KBK<%(,5%PNC1L M9H7/ 'L2IJAF6(V8T,3X$94?R,[)<4I(O#@<1V1_)#L%=D-AJF78C9TB!Q$X ?<+RD#$29=8B=O" MV3=* &FH?CIX0@&QDG$ S=B2WO3FE%K12^:<14!Q>/4):^[)"?\$#9. G)-0 M6(KP)#P(/VT1DR7#2I>PR.^TQM]QB?T1!R< M./4Z"+[EB2/BG(J?%@HU)<3D+Q>0I)5)>TBA=,$?,!>U<(M4L1IFK9Z#XZ/+ MJN6N3%*?@WF"D8C"D&PK*:!EK)K"=OOBBN:\8"0(EWG!\\*>=-A6IL]:>+,1 M!Z*4B"AG0;1[D3 79X)WQ MMF JJ6CR+V./?RUS]>ZPDVHV)MP6T'GW8"11KW_5YE^U8A^P%9MO4?^O<1V+8K[KP#^9 M+\5+>E]*TVBXC3M6SQ8)B,.Y5D/0E\4UW;D\M\R.50GSDKQY#\S9V!9SKBWZ MWSQSEM-R?Z.0,N4'Z-@)C Q"-CJ)EVVS*;[>S(RG<(-'/<'%S MP*T=@@,ETG] M3F?43W8H9?'%;M1,.Z<\HXS7KN+;W?!M!H!L4[XMC]M1!K8MIRLBSL^X$=-5 MW]HU.R+S[8-DYLHLK\YU]7,MKS7Z+? ?3K#XYFU(F6,#?K)K]4U'=NW<_+0[ M9L->W?RLH,J.E6,SM7Q[B7=72&9OJE#UGAJ%,UTQO.,_6\-:V"AAUYJ+^L1T M3MIYOU33M)ISL)N*]I"Y-ZONH:;MH;;9'MI=L]G-QIW7:)Y1;:*I!I%CJ+;^ M&];WR:?3)UQL=J3^QT\<.@/H%%=E\YC>@N*ON,H+GWX45>EZU^.C@W@?7CC% M6?;SQ_\2#$@L!SP6F09SAH^<1JXLD!LE"N1RYZ)N-E2TUD[V8*TQ5#2VP*X# M?S=&6/'H6()UX( P J AQM,8.&/'7P!59-=:F0 3A9'Z(\&L_9#0"K66^/V8 MHW/:Y><5SV$+3,9A-A+E@JC&] M.@+(?-IV-#,>1\["?GU6!C'(8M(8[P38K.$DL%,93X,\>OB&J6_:2 M&>,0*4KH",@XPBGS0%(CN(;>:HMOYBVV\"7^")<#O@Q8\N5!2&L=*$H13EHQ MA%B,/A0Y3Q*"R(GF0%;F+E5QL424,L""?U20A'Q6N +*RX.$T9\A=Y8Z;(G\ M9,H;(D['U*"@Q/(()@?!2]21_CUX8? P4_\BD0H1?<2+Z TZ/H?$RT%NB:E$ MG.&-)+H=X2])+"AM9X0*I' ^$Q07(*'2J(F_9!HOCZ">',+ @5,+$']..SL- M2U=#^WOQ8ZDAMP:/YFWA0[ 4B&L(\(D^)S]#6(4*[BL(]=4C1B%2@Q;@J:PO M+) IA BBFDOI,6^^,#\(?X8WMDX[?XR[TKJ-$X@:HJ^DJ_I\U2MSBYA0A), MH/:,>3/:\:3X!'.:5R\NCKR,IL!Q2^ W2E9(79J%@L5;XC/8K\FH41MA(P?6YH 0WX88=?]A^9'ZIH#A4!=^!J.983'.N;PCP@&Y!O7O;OSWO\403;- MMW;6AW!*OB^-Y<1A$U_P/PN0H,C>0J .'<>I\#LK0#J! 9$$>OZJ'KP"N--\ M3VV7\:U&HV-VNSGP'ZN!027.>[N 4,3DUN<%I[4]V"@XS4R>/(D3$G]'KF!)UV#&OE%1-T]?JUU0+#.Z%GPZZ; MK4:[+$A80,9]BMR=D-2RVV:]F4T4K8/Y5\'*[!M6IEO!RBS&MA +HZZNSJ( M2PZ\B\4Z=G<7W>$["U$?45"Z[QO_-?.9T11J3 ?QU::'Z$9\[Z9'Y$!OR4GE MJ2@N[>1&5H6RG2_=-8C,!3G3XIJ]6NNDUMR7.#<;G:9I=;*>D2F!\'@8E).Q M8/.-C&I+#MJ>KK7I[>VT/2>8K(7.IR"BBOS[;#:## GYLW1$I-B9MIH9@J4R MA?.R@TTM.[A'5FF;K1PV24;XIFG#TNKJ1BJ/]7&&BHS(PQ%6R\77[6P%#?&4 M\I E8"$W2^-0.[>I=D;*Y8/P6=;[A8)5C@]'8/*@*$8070:2SS4%5/YK.G*; MBJ1E4F"UTV9-"X)]X,'X!^\9SXQ2ASRU C[3IX MYAQ@-24'Z%$B?H0B^Z%EZ&0"066*M.2$GZ-RETJ$V_6,H295QE(&FF6=6/L[ M60P*-:T.RDZ55L<>W1H7DZL[AB(NT-V0)JW.#3 M"Z=\")B8F'::@P!Y#+:N,F*U0?,N.E?J7&OWO+6&F'A*Z=R$>[WO'WGV#_)10VF4#X7W?O?(5 MX.[^T._J.=",69LZC81ZMS+V[L[:*;"6)G\F5 FYH.*_#/_EH"]NB?\254@K M\E\%QKL7@5[2RW)H5(RM7K"B<@6$C$#$B-7 "78FRYLML]7)]L>5X)S>XYOW MP)N9>M-U>',3.?_F>;/$)GP%OUZ6:];.VEAS$:X/KP4:MMFLS/FRO'D/[-G9 M$GON1Q&4E#W+:?JO'K^I%,+.;YQ5ZRX]\Z9$D9XJRE.B-^^>2:W:=IET3VY" M*9FTG%["&YW/D>[**LWM6VJ=6YK5T'![[7O&2,2[U9B9XE#Z1UZBG+]"RO9![@MVK-\QZ MO7P!W%*]N;3,E:DL7K[1=A]6OU5KF%:5'5@V.Y /2YY@F#A0"2)2D#,6NUTQKC=! -2;C6)DV"ZF][IB, MW3'M^(/.>M!K.4-37R(<:"JN0_5W(=J[D,U]Z%,*C=?N8^[ 8,O%4S82O;'0&AJ;TD00\Z\\%":Z156P>36VQHMS,1&K5-H,GV MQ4)SQB+D%WF?QBJ\W+,1:JUDB>\.9B-LL6:R89GMVO( _MLC8\M6L@UW..D < ME6K6P7JS#DHTT> ]S##(#M9=B$.?$_%+!.)6'0W;+L("6(S>O^:T]XU[K-?! ML4Q9KPD4RPC^ZS^@\36"TYMOP5JUW*+@G0%:%A/U?Z-P^K_?/=][FCVM#'"9 M-0M^,4Z*=I[AE(/OW/FQUL[SYN(2W] =DC">*9:X9(-PAK$XNV;5\2:"[3Q\ M1.ZR@;M> FGB\SO,&8V"L+F GUEVU/P_ LI/O;[ 2:_E8JQJT+3QA8Y/BP#T MK2V$S@MYL !#WSK-F@SS* XZFF&(,/;.*(!*OB]&]-:9P3GWC>E7P94**,K*M<$Q& _:P 4N M%N.>,AUVY-W@C,X0W8$]$/+$8>3_R MGJCW@2@L6Y836YA7)=M'ASD:O?3**EW\H77:7D M[+R*C'E#7?9XICFA@5;+;.?-?N$26T=A]]R& J',V%2 M:QS@Y*4?X.$_S+SH$:TC$2'%Q.1D$@9@Q\#W0$<6$3-C\?^*PY^^!5'$HKY_ MD7A^\;RM TGEO+:<>OYTX\HD4"9!'F?-G;1!FAT90)_:XQB/WL-C:E!$\A%Y M!8_JH073& L9MJ@H=XE1A/7]32B>4YN;+_/8UUJ9G-W*PP0WVVQ!@" GT82A >D59",$F@4P!E6,^CY[;W96V_^Y%IEMG*LY^.2+7'FEL4CJ$]5SAXOKN+^/Y>5:*N ,TYS M8UJ-](# =9/NVH: M\C!I5Z!ZWVD7&UFYME'@[,7W6S96LF-_ MB(QKXW@3KGW?^.Z\&I:=EU,%OF'>,Q6?!4-0P]&BFY1LMKSAW[H53\&3Q=/# M=F-G_-7Q_YQW\DTM^MZ$PU^_>\ALM7*JE\@V=TA_\L6 ^[KW?!W7WL8Q@B# M\=B 74P9W^DWO"+P[X?0>3J=:_S:J0(P_!8\#!G^G$7#T)O@PY;>.T4?Z'*& MC%JXD[%)BWLA5D=A$$SXN^BPM,9H7Q.(<;^\U-J$0])11SK\E!=(XD=ET(-C&\!''SRL#(L>>8,YZ".43$ O6+3G MX&>>F#*R@6_5TMNB[4UG7=2LH!V]D:<5A>9$7-;0%QMFJD&681WPFH'K1DZR M#?MLEF4;$(UTT>;\^C1KV\8KKY2.S[Q%Q M*/!93A7.$AA">7:1B-1&JP=J[6SAPKHIRP,': N1@?@1K]+ Y$6B] %(C\%P M8.5D@551ZWVM6ZK&I27IOHWX(LIK&6!$$G7_:ED8D6OH-(4_YS;J++P"W/V4 MCU*W!_L0$!Y'0L0HD!D-)XG6R'Y,"%LF$-9D"\_WM/U?-25'/=Q%O@I F[N$%7\?@@2XK5'XRP/!W)JBSP=+<<7?R- S\ MAR_7_?L+HWMJ $==_=Z[O_K]POAVU?MZ]>WJ_A]@ O /'8,1<.5KF4(%]*(C M94W&;$I&[PC4@S^D F.0>Y$WE2%KY>C.5>IUR^KD.;<1'OJE?.Z]>NSRG+&F M(X"9TWSM3-XMDD#&1T+A_,4!8H$_!OJW8+_)]I>^Y]Z %H"+[,R)H>?N;GG] MEPWF_6)(E6Y0F6,\2DUOK0?E#HO2T(;RP,#F&VM=JYG8)]H*E\Z0]9X6X9ZL M'[FL-3IFNY.-"DME'6^(L!&C57#T""C/>'; 94;J9)MR]?@Q97&*8,MXOH&P M]R@\HOHL1S,.Q448@+H=[L!QO?X[ 3R67%^<3!"[C.OO4_V@X)?C&7"0.+A7 MKH"*$H&:WMUO:&6T3RS+^-"[.S,Z5O/$:IJ&)K6)7G]G+J9D/W+?.-$LJC6= MYJU5Q"(0BA#5.H\FD$N@+7/ 8C \!::72(!D2NO THIF@W\*;,G\XR*#&!TF- EOX@<+OTL=%$\\$8@D5*H= F\ ML"QO<.$LHQ8:U<= ,&_L35^/HQ?V7F=%;9MQ8D@)A4CX3ZX$1TQ?7NFD1H^, M39/,(25,EHSX7 +\HF2K@/XB(-ZGF&,D6I!$5)SY8#:.J3]9:A9?9T5X9@)- MCK0Q>.EQ3C$?&BZ%#"<2C?"(* V)+:/7Y*I?^5425(!8V2.B_2.O1B^Y*3X MBI^;$@\:S681O+#=I>O*H+L9[?U7)N"\HUN@F%;W=DCD;)NQM5[HS><4^*^C40 M+W+\8]/X8'\T0B_Z\P0=V^6#"4#%3)OE5JEX"VM"I&<]#G%P&M9.:SE57EPK M?JAKK$CX!44%3-U.ICJ.:#-83+[!*DR(,VVLW= MKUA.L^=.(C;\Y,["5^: M&]_(U#Z!C)SG1UI6)K_^-HF3K)2;2YQ6ACB\:?,4DS2::]8Q=?<,3 [*/XF; M2D56Z#TYHKB$Q&8LY,5'\L1Q85D)W/2<0D7YW6]"^WFL (-]]1NYGE_0[L1HJC5NHP$?0NI7D4K[1J?$;"O-_(\D1@&%LU.$1D]DT2IIHKN=2 MQ(]K;729,T"@/',4\LXM'5 PV:L[#S=^N3-55D.N,B=3(K9<%C% YCJ^.0;( MP_Z,@ZO^OB?,S V@-3)5GY;-2_!F Y7Y5A-+WDH4S:J=&G?W_;/_-NY^^WIW M=GMUW(RK"MS3R+3NG7NL2S+K-F-]=EG 8S4LNRS MS5WFLD\+M%8G!^AZ'O?DI(;?M^#,ZQ-;P/XYH$F;"<^%">^UKT&]939R1I0O M?0U:.Y"B6]IM[G7HS ' 6%Z8SBN@**'!E\%7HI,1\V4N_C7S.''C&/.F1I\A M*@F8VYL*R.=!K=MTVWLT!\&3.>M__]Z_%E;AL=I_^4-L-"]])?\/_DM9G$C% M?E54]-.1$4[F5^=*M5HM&S]+3Q+A8T2XB+EF+_2K%2=;Z,&FRR"\8^'S<#L: M/Z>CI: W:42CI>*UT \B6 U'"4:&"9E[% 6:*W&!E9T;C6E&-_R-9L.LY<#4+&*!5-*OT,2I67/0-_L)S9VM[-L]37)GP[;M MG&8DV&'*KA,B=5[LV.JTI'CH@Z" EFP) V^4)L?A^RNG5K->@UM5/QK MO5YKQ*#/F:CO9!;BD#9*:?-)@CGI[Q3\371:=#WRK8MY0I)^V9+R)"?74/%EQ*;3,>9.QP&6:Z*EK ]ABM%7WJ'LS,6,CR_*F1R"&9Y 7A5"WP'VO6@E+J'.+Q>JC] MD2TK9=M L_;\^65&S\AK;%RZEP6HDJG_[+DN5?,YXQO' V*<.1-OBLMY/NYOB7'JN@WG=]OL%O1N21 M!0GC4 OB1&PQ6(N*S,+I <7:Q>%,7$UU._'#T M66Y**/I\L<@N7%18I"N2CPW3Y=I])8PEVVQVC=%5W6SN[:R MN3$/BONJJ>23]:DO(Z7NF_C2YGF9/;T]*$KZSG$? 3R*2,O.$;S)@+-LK)NQ MK9E,6VR=T>\6^SLSM>8E#IY.4^^U2<+EHVW2-7)^K*&[OJ7U!BWL;ARRT19T M+XQL%$I,T;C0.C^&9&$.%/][C]]UQZL"=.UGW^^ MP2)TG"U@\WF9(?:6Y8T:L/&KRR8VM1_Q7EP^,4ZI6=5+U>$%KH+F^ME#&WF& MX!I H;B^=UDJM8Q-F.^S,0'CK=. >WJ_7QS*D&'\L?ULCX'6"AT*<9T!M=!- MN]:HV2^=0+N^,E)=E^(SB#D/U$DH5=N@:S'#,XQ38W@K2,3UPYMOD(@_,RO8 M8I*BT7V+6%P E/6=-1N1W>;@*'#2#?1NR;1?! (HZ&,':^63[N%Q\JNE.;@1 MQ7*@1IE(?[9;[L3II3T5\3ENQJZ/,AO;M^^V7V^_? M;S^?8H'4O0M"[5G*3&ITF^YS%BO#GSP+^ *@Z&<;*";T_ !;]TT]GTC#XM%B M_)YST#$+8"5"<$Y70L"*Q' Q4-[R5["[C6:^0#J-:=\L_]Y_0#H:4W^91<.C ML96;<66F59HB?>9!U6=6B00U&R!FBHJ)$K6693Z@D/T%P-Y=H_:K#-FEZ L^ M2Z\_H]2TAQ&W>Z2\3,\&"Z(L M"+4+_G0XQ9724]L^BT4N&\#KE"57>01O'HRQ(>,)0P@0%]^A[#'^Q9VW[D.@P89;(-_CP-7B1]A!:BWJ'BQJAM)C8*0N<=GT+"FVK)]V^" M.=3B+[1 CKYU-N?7 M0FA9<$K:QPR6L'SLIEJ0:B8W"/O@W1CE9O ],^MW^>%RTGBV/=&Y4?8A0_V= MN[X5R!(3XC*)AM.N &-XF9L*R,6(KW(@02DQ,\$M7$LFH7V)V,,<[B@AUXI>H'[(?(0_*ODF4OY??F6-.JB_:JP?!7$ M?,.+&9CM;?U#;!*^'4W(D""O0FX@G0)G*)!VY$D VJG/+\)\NU_VOQ[GL"]!P@ MB>U%1 +DQ?RGG!^.\W%.Q%[J:7\N)M1DWAM8/#A&86N?>J0 H80V%Y..(Q12O_6)S.HSFF;SOOV VW2MP:\>F1KM(90 N$26+8ZH>_>:/R*/?P,I7\-P5 M[S)X&4<*0%<,-:.#802ZM+'U&FCV#*[9YC4VG G&64((](;V#^^%P3]0N5(^ M7T\V8GRWD)>!!@4$,!I%OE1*5H%=UK5R(%@*WK@F1*GS9$A^FQ"3>KJ]5%!X M55'XC'Y@.@(.:<)MX7^'2"/\?:0$<'BK2SOVS%9:-@LE)1X^L\ZMHCJ!W$+F ME-D3H14KR35\]%S#3 MGDTF0M_-;$+-Z:MSY_>8.]^J<^>7NS6+D^;WX&2\5P8^#OAXJ96];B.XHS#M M->BGMJ0;]QHYF?+;2!TN$9;XDL+BS4^D5=VHJ265B MTP!\KWR-$M@0EB>WJ*06'^L*JV,!2GD:PHEI"L&',/H,C5WA>^.K)@@910L%NX+JS%Z M.0,>$(O4(9'R00G*>!^RWB&8.W:(W@. E,N4 MU"KRE:!Y& ^[TF)@*,E7647J$FY]? F+C!EOJB]OG70Q,O-?&+?T0\DF=+ : MX8>M)E>;7WP[!.E,0X;)\@]IWRC9A**'"BXY6N-<"SG 4>*TSAW0:+M*(U@Z M.=9(O4!EVN@T8QVTA'3@R.R2K")<2IQ7J-6Q34VC(":7)'%L:+O M:D@H9O.C%<^<8F/ZR/@H%/\3"0?&>@F?HIY13#12,/EX:9SUI S"\ "'+[ M-PE /GR[%O"[Y+C-L%[U-:5$G__%$\NFO\ MEC0LG@#!HSWQ%I1:'FM$X\LU0PIZA;UZ8%&OAF5">F=3M,O[_W?RHUZVIWIM M):NK. 6G7!U2<2)&&1(E\L)SQ1Y\NB$^EWX *36'OJ?1C_F>SZ+MZ8J^&!>8 MS7CJJ;60G]W!5T%(9!@3I$"_)VS21H,D<8#%GR,G"FAL!3DQXNQ&Q'_XQUR" M/)HK\O#P:N1N=32 M3Z? $?#QGY'SJIE%",G^9*,(N?(U8B:AW%>OH9G2/5N.D(+ASGT/M>L@B>!1 M2FPR 9,D>JR"8^=Q\L;%G\B("NHHN@;:EXL.,E309*!!ST1VA9=?^,A\]@1V M-_E$Y10_BVL"?(.*.TT(@G%2T-I0<[:._)X?5]?<0#ET ZTH X![ZY>-,0.[ MPDQQ#-XN=B(CT\=O62P;:58T-#:V*/6X HL:X044G=/*:WG$JHHC13469 ME^[[:P=4I^AIRO,\Y._)$Y-D9 C>GV\*KH(<,TSS6>NKU-&UC%:^.E&^8;E# M)1.3VVL&?]&43H'7@@*$U#%HDYIN5C)YIR<<'W;Q55ZG-,* M&\"(,2;#*3J&[2ZXAK2?._9JIWXBOK3FMHBEJJ:1#:^2N:.'N&X5*E./+P?P4F MX,I5Z)=CK% CUO2!%#,0.>S=3UQ,R?L'4,!C/YT41%)=M&0?$C0AV6SN>*], M!M0\,8F.$N73@R>X(GO]<*/UC#Y/F86_.\T.E4CX#)0O82^/O "#Y[XRKC<] M]3XWZI?*^L>B7B_Q2TL3-S\:F":(@422U:"!*+P5$AB#A)@E1LE88"_9P')> MM1FS@LCG)191//:82CB0_UX]C, $9F0_H^B I\?,:6B_\HP^RDU]P:QSX5,; M(P#3=NH(E?M PH&)82,43L/]X4OQVM()!Z> 7V!G74=/\$^MOSS4Y:Z10:&X M-JUT />+[<-RHC>N]F\^SSI(1[R^W/Q;B75M&L)J:/ >JAN)YO!K+$C!G\XC M?^X!.CPS0#G8>AQF^Q8OBAB<#L:]J:$!OTHR*V7LH+S4O-4MYE\&R=W)YX1F.YVZDYR!5:*L"G&-O"TLK# ??-V1O%H<-?,4E" M8FV:.XB>"611?OLW_-'B9!@UWY5O87K>;Y:-1B7'L=+44F2_W\#\O;H1J]R 1>A:J<0,-1^N&"%Y M8\#5,X2 LM+^+"E#Y0Z+QUT"X705(H*_.]OLH]@RUPY%:!=S!!ZE]5YNHG(D M W52<$BI&&79427G7ZU?2:?@G%OA Z= AJ(^XQ<+L%$'QN;;O+43RB7>U['0 M'. *#U5'3T!7P%>HA:LT)S9. B"!)4&L])CKZ^L14LYF?HLN]$93U=0[:]+/ M)B23,U2WIJ4G8%AI_,/:%!2^>"L(TE.@(!!DB;)O]G65;(2D^4P)>M)%M)"< M9($]_OV9#;E"740\O2+B,733&.@=P]Q,0]J2>G0*MXK'I\!WRN@39OAM:P@=BDGKG31Y40(_ICUPE05)+>E,C:P+SKJ@/S7>E]![A3&\^V6;G(_FHF0! MHT9BF0C?LB6OU"7+6W'32-4LTKP_CG#34Y%:30[2#=I]2W6&[Q;EB>E ,)ADW!!WM3,\I]L M]PI_]0'3+.4'5.;$/^&I5?W.1IE5RLWB)JX"^[^,=D)[NII8,]MY_5"\JP]- M?(G:*P7?EV1>O4SMD-&IV0?@CR^^-?_X;B<+RO2P,0+@74GF5Y+SQ2$V^.$C M&;@CRQ%W,?3"T)L5)8#!53N8JO*W=^863B"39M*\OB0+YHUK(/:FWYRYI6_7 MGS_???V["J:/^[NY:J+*7YKTOPJBC%!U4IBS,\1IQK&9:N)/>?[DQR&(OB

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

  •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end